,cluster 4ER+ log adjusted q-value,cluster 9 log adjusted q-value,cluster 7 log adjusted q-value,cluster 3 log adjusted q-value,cluster 8 log adjusted q-value,cluster 10 log adjusted q-value,cluster 1 log adjusted q-value,cluster 2 log adjusted q-value,cluster 5 log adjusted q-value,cluster 4ER- log adjusted q-value,cluster 6 log adjusted q-value;
RMTs methylate histone arginines,1.0131954096926223,0.3351332739777284,0.3384666561332321,0.42061976167530685,0.41296485373344116,0.5214101064826875,11.007225929798535,0.4558627681021531,0.32815084485870327,0.4637408625584409,0.3058816822504121;
HDMs demethylate histones,0.6875281949141528,0.5324309296314834,0.3617239240045207,0.3468013020091587,0.4146172972667351,0.3748291066993173,10.077248761017568,0.4628527562793292,0.3406966434873319,0.31100904921848943,0.3058816822504121;
Senescence-Associated Secretory Phenotype (SASP),1.122874798132619,0.4081569957992947,0.40290303984431897,0.3503872330012344,0.3722027189435112,0.5192809610235131,10.077248761017568,0.32753430183444365,0.3779014763245248,0.30218917574215476,0.3058816822504121;
Cellular Senescence,1.5345670566679266,0.36231980452174045,0.4817082643823941,0.3628766921649118,0.37913461146889044,0.31776991236841967,10.077248761017568,0.36434155364310694,0.30320189929542807,0.32478513403513554,0.3058816822504121;
Nucleosome assembly,1.8042258469991819,0.5103124098378026,0.6765362912914509,1.1320327613955314,0.5175224287576984,0.4306777496994055,9.987477695750279,0.5745029716188665,0.539731828546328,0.5414036179247865,0.3058816822504121;
Deposition of new CENPA-containing nucleosomes at the centromere,1.8042258469991819,0.5088725168895247,0.6760373314996082,1.0238204670937987,0.5366385219176562,0.4306777496994055,9.987477695750279,0.5745029716188665,0.539731828546328,0.5414036179247865,0.3058816822504121;
Chromosome Maintenance,4.380873455322685,0.9398134822000689,0.3112446042751675,2.102950751985333,0.33096675554030125,0.8697868830266144,9.91064646021675,0.5795150420091576,0.32397177416554596,0.5908248562853247,0.3058816822504121;
Estrogen-dependent gene expression,0.8121277182997256,0.6689711571362104,0.379389836966941,0.3213115419718923,0.3535867649444133,0.49243425586061645,9.853027648095987,0.35971925328583354,0.33154605935666304,0.4404591951700404,0.3058816822504121;
Meiosis,0.781284151231661,0.4583996963357266,1.3087269907221424,0.49786442742870163,0.4148892332525716,0.3861455410117313,9.773526368166493,0.30481780719897456,0.31197598096833934,0.3206530510344374,0.3058816822504121;
Oxidative Stress Induced Senescence,1.0613856725718245,0.36189234081749233,0.36706903502488153,0.3503872330012344,0.35830085846035925,0.5487753153582212,9.773526368166493,0.31056998837000566,0.3227320418931485,0.3146249156431087,0.3058816822504121;
Reproduction,0.781935049956095,0.5190362919886475,0.9964277710234618,0.6432246813744723,0.37913461146889044,0.39579425561555787,9.733080854399784,0.31234950701946074,0.30380343648068064,0.3048872385952527,0.3058816822504121;
HCMV Late Events,0.7576573359533003,0.5524457627902223,1.070454754960547,0.380333723709027,0.4146172972667351,0.37643217605883994,9.733080854399784,0.3637629906536139,1.0949631728026215,0.4502976898301002,0.3058816822504121;
Telomere Maintenance,1.11620765558179,0.3544283016474602,0.7655756230481994,0.5375314615485541,0.3394918967507969,0.3542943274052089,9.733080854399784,0.35971925328583354,0.37714526130064224,0.49557946442898926,0.3058816822504121;
Meiotic recombination,0.7921344959206581,0.5611493586797773,0.44856352610286954,1.132441599487645,0.32268003167388554,0.3276651348471423,9.733080854399784,0.34311923132904953,0.3170116103066843,0.38240110994955606,0.3058816822504121;
RHO GTPases activate PKNs,0.9962224759148058,0.3508263610994628,0.6066943934222234,0.708674131521239,0.40888718273980784,0.33395231861614705,9.733080854399784,0.36371079402101386,0.31837078236812505,0.3013223548358037,0.3058816822504121;
Transcriptional regulation by small RNAs,0.9739411088375305,0.4408812240548287,0.9420434623734547,0.3163170636750133,0.3226140943665297,0.36521777569155567,9.733080854399784,0.3317123913477366,0.33154605935666304,0.39091888813155207,0.3058816822504121;
HCMV Early Events,0.8014644050563535,0.6441853723194954,0.5167649349726674,0.3036485086668611,0.4393593943366305,0.5161708497611757,9.6772983143029,0.3613559184988038,0.5140766613827893,0.5231412627684151,0.3058816822504121;
Activation of HOX genes during differentiation,1.0618356127985409,0.421441415526736,0.48721442257665054,0.34114908780953945,0.35285346570080445,0.3655112529379501,9.6772983143029,0.3317123913477366,0.33154605935666304,0.30738279210111424,0.3058816822504121;
Activation of anterior HOX genes in hindbrain development during early embryogenesis,1.0630414842988893,0.421441415526736,0.4936950005019528,0.34114908780953945,0.34981833229815285,0.36504209043534924,9.6772983143029,0.3317123913477366,0.33154605935666304,0.3084605076514881,0.3058816822504121;
Condensation of Prophase Chromosomes,0.9895583915825663,0.45199084089717,0.7663667792126356,0.3503872330012344,0.31755520336620824,0.38644297502167896,9.610686920379056,0.37731415007330193,0.3484005984762255,0.4121812366547547,0.3058816822504121;
Transcriptional regulation of granulopoiesis,0.8072884376667768,0.519430721527618,0.38028241523990847,1.0927459224895548,0.3439134979171695,0.3636895842323911,9.601519797321165,0.4147150908432823,0.30320189929542807,0.4121812366547547,0.3058816822504121;
Metalloprotease DUBs,1.2309582212743344,0.6580511292336844,0.8657888542379367,0.7788886971023855,0.3073643548426107,0.32582525152199426,9.550217576868627,0.5918767786718077,0.4051903053373253,0.43873817992078307,0.3024439670208732;
Base Excision Repair,0.862000890960607,0.522282795009411,0.35583470878974294,0.330334113068339,0.7232182629085795,0.321223791693833,9.531563624666463,0.3239555711055185,0.33154605935666304,0.4121812366547547,0.3058816822504121;
Gene Silencing by RNA,0.9022054815080813,0.5141793256264056,0.386334459306641,0.41152679958989247,0.3726312003584851,0.357285094513129,9.418640321993667,0.3276485336328003,0.30506998063627244,0.3062654297221931,0.3058816822504121;
DNA methylation,0.761799590907872,0.47698398560067923,0.4018400955900535,0.4697453280545078,0.5486587637805331,0.35399026492638497,9.381180067353954,0.46644770628979537,0.3156659602261388,0.4678954462589095,0.3024439670208732;
Formation of the beta-catenin:TCF transactivating complex,0.980413177315755,0.3699715056935029,0.5135324116895287,0.9866419833135416,0.36291076110700615,0.4013208343401238,9.381180067353954,0.3317123913477366,0.32562191479076025,0.33258796371861915,0.3058816822504121;
PRC2 methylates histones and DNA,0.7822114120327258,0.40635828091759346,0.3470627101458231,0.3881184602725714,0.4787052772642629,0.3540970261426587,9.381180067353954,0.4589589677230645,0.304022170806971,0.44065582267788694,0.3030467691849685;
HDACs deacetylate histones,0.5207997001917796,0.30844391279468925,0.3196134621449584,0.4587439285777226,0.3439134979171695,0.30146276932778043,9.371041894335699,0.5441976880079119,0.32815084485870327,0.4523752385250782,0.3058816822504121;
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,0.7175472994770875,0.4884606935737067,0.366949816375034,0.3861917421038416,0.41200215293113845,0.39430841547958956,9.364424194509207,0.4628527562793292,0.33154605935666304,0.45624654297268663,0.3030467691849685;
RNA Polymerase I Promoter Opening,0.7151269155074763,0.4081569957992947,0.7405497402194402,0.3881184602725714,0.6365226938672327,0.3602412378659337,9.364424194509207,0.4849021760868862,0.31837078236812505,0.47469881290334454,0.3030467691849685;
ESR-mediated signaling,0.8095567597018617,0.6548547433458314,0.6572321378897701,0.3861917421038416,0.3439134979171695,0.3131733022391502,9.364424194509207,0.3425206096678787,0.5499710518837738,0.5395292439805308,0.3058816822504121;
SIRT1 negatively regulates rRNA expression,0.737234817812786,0.3918158246299093,0.30940075881351375,0.3861917421038416,0.3949868831937319,0.36504209043534924,9.364424194509207,0.4681429621674421,0.32862921558872876,0.4724375413774212,0.3058816822504121;
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,0.618211570078509,0.3661244522353381,0.46664001802859756,0.3386982920238717,0.3560720414244286,0.44569311077594786,9.35521608786933,0.45581352672996794,0.33154605935666304,0.4835502797846719,0.304386645547509;
Amyloid fiber formation,0.9149588627223844,0.6667335201465007,0.39270315707408476,0.3503872330012344,0.30375222730238194,0.31386541612384017,9.342950285367806,0.43689376352239484,0.33154605935666304,0.3160906252949544,0.3058816822504121;
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,0.7239736512740405,0.4730357518880468,0.6066943934222234,0.42473955215330406,0.35573771241937,0.3540970261426587,9.342950285367806,0.36874386332471404,0.32815084485870327,0.44297218450032194,0.3058816822504121;
DNA Double Strand Break Response,0.8667064535396588,0.32191146796407205,0.7489325828238745,0.9291364593011864,0.3042255279326703,0.4900916220639341,9.24916931856126,0.33990809468773525,0.36494779765230456,0.37624361554160873,0.3058816822504121;
Pre-NOTCH Expression and Processing,1.012327603540305,0.5357174180674569,0.8766094637153571,0.30369550171821563,0.32241542142330576,0.42626866561660953,9.145757483721125,0.3843543347571224,0.30320189929542807,0.3999098848210651,0.3058816822504121;
Pre-NOTCH Transcription and Translation,0.9811650749744681,0.6400399366779007,0.38859813124312903,0.3198395805486888,0.32162569628297455,0.3829935829538375,9.145757483721125,0.3300822406904645,0.35498464823095066,0.3460910784833522,0.3058816822504121;
RNA Polymerase I Promoter Escape,0.7310097309575617,0.4081569957992947,0.7654194085499344,0.3419116764261123,0.3363756870848458,0.4902850695312733,9.078557008445102,0.3365679382419524,0.3973359698996325,0.3172734172535683,0.3058816822504121;
Interleukin-7 signaling,1.3611983823695928,0.3294692550550253,0.3880260456385692,1.1972211483346187,0.35830085846035925,0.48028547546007494,9.070907556781187,0.3798463884820114,0.3667930924250126,0.3126363644087619,0.3058816822504121;
DNA Damage/Telomere Stress Induced Senescence,0.6693465453492974,0.4973390331284095,0.48229794972224077,0.4122898044496199,0.30205993956164995,0.5581083835580521,9.05011049491788,0.35971925328583354,0.6378208783171073,0.32876304540081414,0.3058816822504121;
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,0.5564095875223556,0.37241732449433484,0.9025292611706707,0.6331163983894467,0.3726312003584851,0.4449779716204163,9.05011049491788,0.4160132539854251,0.418328270869041,0.33136141337096764,0.3058816822504121;
Cleavage of the damaged pyrimidine ,0.5559180708397177,0.37234464403614825,0.8924130679511554,0.6224873233331033,0.3726312003584851,0.4449779716204163,9.05011049491788,0.4160132539854251,0.418328270869041,0.33194577730543684,0.3058816822504121;
Depyrimidination,0.5570690974099597,0.37249060790310484,0.8911643813619001,0.6224873233331033,0.3726312003584851,0.4449779716204163,9.05011049491788,0.4147150908432823,0.418328270869041,0.33194577730543684,0.3058816822504121;
Base-Excision Repair, AP Site Formation,0.5371694080478244,0.3667015217797265,0.8684664226929528,0.5352341583752406,0.3764809604369917,0.4300466631842503,9.03843575931445,0.4147150908432823,0.4188260016559483,0.33239293645350926,0.3058816822504121;
Meiotic synapsis,0.5580015467292053,0.45420597324553597,0.3222246234534123,0.38834181595987294,0.3612714049482728,0.43542751860299406,9.017798047628979,0.37363972655453026,0.36494779765230456,0.37636770226551464,0.3058816822504121;
B-WICH complex positively regulates rRNA expression,0.7384307257286054,0.46476382621388357,0.6638647364013122,0.5900152111207688,0.30418705243734856,0.36661029332342004,9.006795889151855,0.3367084026894726,0.33154605935666304,0.4121812366547547,0.3058816822504121;
HCMV Infection,0.6228686233239953,0.36231980452174045,1.118210307214934,0.4697453280545078,0.30418705243734856,0.5462729377806315,8.94842314589692,0.3363632797967757,0.32562191479076025,0.47575535715786293,0.3032374359194824;
Depurination,0.4744429550612993,0.31575954172831694,0.48334727750452494,0.38834181595987294,0.3446537762589258,0.45383436213121164,8.94842314589692,0.42864408325691356,0.36912070063627533,0.3125959432148359,0.3058816822504121;
Recognition and association of DNA glycosylase with site containing an affected purine,0.47476612700521587,0.3161945191525057,0.4854620550605871,0.3885437114480813,0.3439134979171695,0.45383436213121164,8.94842314589692,0.43082664047868263,0.3692084556559849,0.31251058493821443,0.3058816822504121;
Cleavage of the damaged purine,0.4733641387973989,0.31575954172831694,0.4763371513150519,0.38834181595987294,0.34567611556003847,0.45383436213121164,8.94842314589692,0.42864408325691356,0.3686373679969023,0.3125959432148359,0.3058816822504121;
Mitotic Prophase,1.8042258469991819,0.8294461261044188,0.3222246234534123,0.3628766921649118,0.31425684010309535,0.4300466631842503,8.94842314589692,0.5621778024384817,0.37721347556427365,0.31976599226670577,0.3058816822504121;
Packaging Of Telomere Ends,0.48313498722766435,0.32033896412378116,0.4729950177607321,0.39026723080694775,0.35287049791273545,0.45754070803288877,8.947778001709427,0.44770267919471923,0.37721347556427365,0.3109481832046546,0.3058816822504121;
Positive epigenetic regulation of rRNA expression,0.44892267618575543,0.301642737608084,1.0823857520889626,0.3163292158034775,0.5003695008016937,0.33959079579710477,8.578918825694043,0.31539388260432966,0.46398019506563953,0.500617207250586,0.3058816822504121;
HATs acetylate histones,0.5713099103892809,0.30402224815377643,0.40817777475727235,0.34552125769421904,0.30985369422832876,0.35080794711616836,8.531842286225439,0.31950585589685954,0.327558860071622,0.3016079287765944,0.3058816822504121;
NoRC negatively regulates rRNA expression,0.563031714284851,0.3090278240817252,0.6572321378897701,0.3503872330012344,0.35573771241937,0.6240899428585395,8.502755573223194,0.41726320199610084,0.3863260201897388,0.30241267449194814,0.3058816822504121;
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,0.6201674709820884,0.42627266988006274,0.3858912259508796,0.3861917421038416,0.3764809604369917,0.474224940380697,8.486203814667666,0.4174204318185248,0.33154605935666304,0.4232200116160087,0.3058816822504121;
Negative epigenetic regulation of rRNA expression,0.5580015467292053,0.3041785410778355,0.969339437530591,0.3847207861136189,0.3764809604369917,0.6261490231295497,8.435510627044566,0.4815653043880472,0.536884289765251,0.30241267449194814,0.3058816822504121;
RNA Polymerase I Transcription,0.3250327858327181,0.45199084089717,0.36003177662526326,0.5874431926211804,0.33627276072485157,0.3650672982623884,8.421315303316735,0.6292013533408742,0.7782429355668223,0.3109481832046546,0.3058816822504121;
Nonhomologous End-Joining (NHEJ),0.6959881424282498,0.3667015217797265,0.7213539227030125,0.34745656842859673,0.6700667843712858,0.3542943274052089,8.35360961630288,0.352267490683119,0.35355391238807776,0.3109481832046546,0.3058816822504121;
RNA Polymerase I Promoter Clearance,0.33895461643817115,0.501568677588103,0.4285139600766767,0.5325001957863879,0.3918027183993316,0.39430841547958956,8.304035752743616,0.9897043482796474,1.0681008405557673,0.3566887822435721,0.3058816822504121;
Activation of BMF and translocation to mitochondria,0.618211570078509,0.36189234081749233,0.4625334376321326,0.4179753949677151,0.32297793958928395,0.5683890433722195,7.719915686491605,0.41975460648763435,0.3217238872603119,0.30377756914377746,0.3058816822504121;
RUNX1 regulates transcription of genes involved in differentiation of HSCs,0.4416826026365212,0.3508263610994628,0.4322549751498343,0.3854968630694043,0.33140832466933967,0.3508313973814462,7.612803626789818,0.5856301026206966,0.3083030765023187,0.4540611718827999,0.3058816822504121;
Entry of Influenza Virion into Host Cell via Endocytosis,0.378064225064369,0.3363770646607851,0.35645281201837986,0.6396844441883475,0.5053758918905441,0.3508313973814462,6.845779651001943,0.30762701980706253,0.9045344860174249,0.39091888813155207,0.3058816822504121;
Processing of DNA double-strand break ends,4.2203106668852834,0.5698796886264856,0.5396819360893818,2.7120106683136838,0.3472192758278547,2.0301826871262523,6.463906962392844,0.6957826084663753,0.32426094406474487,0.3829311111901347,0.3058816822504121;
G2/M DNA damage checkpoint,4.285827577321098,0.6617160530759545,1.129947338811452,2.478579817509079,0.41229240926373606,2.0456176209887227,5.912973823134498,0.5238886509233606,0.3728343545959842,0.44811482431034744,0.3058816822504121;
Phosphorylation of the APC/C,4.97102262819926,2.057050905066398,0.36657082889685344,4.2409474137233625,0.4829239057523196,1.7753467427019642,5.57354027290931,0.31904744688740305,1.613465439751566,0.3196274963593275,0.3058816822504121;
TCF dependent signaling in response to WNT,0.31140499623217854,0.5131391727266793,0.3322983180309776,0.34552125769421904,0.4146172972667351,0.31776991236841967,5.57354027290931,0.4628527562793292,0.3693665271664583,0.39091888813155207,0.3030467691849685;
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),4.986474147929792,0.9722026967614994,0.35516354224109725,3.970064910361211,0.3119959467823231,2.7347307709443758,5.404577093100158,0.3207891067373377,0.34910353042129927,0.30738279210111424,0.3058816822504121;
APC/C:Cdc20 mediated degradation of Cyclin B,5.391206456480938,2.4014491587271913,0.5017359945597698,4.375603718835916,0.39113834579371415,1.7740468834196925,5.3221892397923325,0.3595677799732618,1.617689245415894,0.3148961138192713,0.3058816822504121;
Homology Directed Repair,5.300245129400749,1.1251268407618977,0.8841879790629011,4.468395893293236,0.3363756870848458,2.9052938277257545,5.179184033010584,0.35082679893314456,0.3061107917419532,0.3109481832046546,0.3058816822504121;
APC-Cdc20 mediated degradation of Nek2A,4.463200542850821,1.8815589255708167,0.7802377786070451,3.5401876181159166,0.32162569628297455,1.7522753557731587,5.033063690810944,0.7214872606359403,0.788004927573652,0.47469881290334454,0.3058816822504121;
DNA Double-Strand Break Repair,4.463200542850821,0.8536663919726355,1.070454754960547,3.5042844838551903,0.3439134979171695,2.9808766599588936,5.033063690810944,0.6307067120683201,0.302360173742951,0.37636770226551464,0.3058816822504121;
MET receptor recycling,0.3023351326496606,1.0325428322193408,0.8517982647455866,1.3882829029635468,0.3274981301462102,0.36661029332342004,4.961980514872893,0.4628527562793292,0.4834775083772459,0.9957966159779494,0.3058816822504121;
Epigenetic regulation of gene expression,0.3183418551275479,0.31445410540840596,0.302486742965228,0.35287359016834924,0.4146172972667351,0.511477330150265,4.7506452245178075,0.35440324608796253,0.4564353693270964,0.4353740121305991,0.3058816822504121;
Activated NTRK2 signals through PI3K,1.9786450395875674,1.6469296834212683,0.4077557145318142,0.39834720327783957,0.3791920767944086,0.44569311077594786,4.745129716552196,0.3094759427026921,0.4183824020347335,0.328039331434427,0.3058816822504121;
PKMTs methylate histone lysines,0.467227049797955,0.3090254582300101,1.0764082393445782,0.339711750805525,0.35573771241937,0.5028146812875487,4.709113443680212,0.3057187886796813,0.39328194195957444,0.44065582267788694,0.3058816822504121;
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,2.8547955688028646,1.7141258107208215,0.3186523149786101,4.273548385985072,0.31351737387980566,1.1440271903015207,4.215672171513385,0.4681429621674421,0.3061329461218883,0.33194577730543684,0.3058816822504121;
Neurodegenerative Diseases,2.8547955688028646,1.7141258107208215,0.3166308670980508,4.273548385985072,0.312768577621854,1.1440271903015207,4.215672171513385,0.4676910181003361,0.3061329461218883,0.3306556298996619,0.3058816822504121;
Synthesis of PG,0.8716519885708844,1.3371730286787165,1.3666897932217905,0.3163170636750133,0.33140832466933967,0.3096785300256161,3.89860503424442,0.6303443794140307,1.846515403629212,1.7359615954624459,0.3058816822504121;
Depolymerisation of the Nuclear Lamina,5.5103769116062775,1.7818542576584766,0.35275308129702004,3.1352336241966814,0.46163953884057446,0.70206723630419,3.89860503424442,0.35971925328583354,1.548245642681925,0.3460910784833522,0.3058816822504121;
Cell junction organization,3.197638878114059,2.0383904428181117,0.33288866926600447,0.3503872330012344,0.5185164443893374,0.6363603198934134,3.8541558072883375,1.0118680386453138,0.36494779765230456,2.7980008285229334,0.3058816822504121;
Protein repair,4.483104557844059,4.638673871238915,0.3186523149786101,1.9519024788992985,0.31139775125619096,0.43075902825616436,3.836861329480875,0.3251934547032587,1.1218450576214711,1.1709531977191223,0.8979013090577435;
Interconversion of nucleotide di- and triphosphates,0.35031899134905103,0.5160538865147885,0.5439930076286128,0.3070450077802019,0.32297793958928395,0.4300466631842503,3.8329287534555547,0.3999878562041873,0.3329607429278685,0.5714564697988486,0.3030467691849685;
Transcriptional regulation by RUNX1,0.6036351212336205,0.4583996963357266,0.3327614819001198,0.3881184602725714,0.37921048227433873,0.45440791578523587,3.8053809353438734,0.42864408325691356,0.3522221105554151,0.33239293645350926,0.3058816822504121;
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,4.444140927527829,1.6376116017644116,0.6503741717742904,4.486182936165595,0.4677023943293453,3.2348137969970816,3.78212015555226,0.30980925894012945,0.6606921149715522,0.33623172585815414,0.3058816822504121;
Mitochondrial protein import,2.1474814612448485,1.2883328945183445,1.1088565736270573,1.084615210247727,0.30985369422832876,0.634492123355756,3.769774042085921,0.3677622666458591,0.34010467491250734,0.5165725457528514,0.3058816822504121;
Mitotic Anaphase,3.788075609137058,1.3135433472284037,1.032525609571466,4.660965815393155,0.7532679976993287,3.966583389673829,3.751167752529202,0.46950761507088173,1.3686749076877267,0.3117369630687721,0.3058816822504121;
Mitotic Metaphase and Anaphase,3.794625258328683,1.3323443163951993,1.0193284028017302,4.710521454381419,0.7576852196375048,3.989941610683478,3.735450209642059,0.5226955554832011,1.3778969952040085,0.30979469541785326,0.3058816822504121;
POLB-Dependent Long Patch Base Excision Repair,4.832904426365584,1.5413360588125733,0.802493326583057,3.616482209827902,0.34456538471876236,0.9884930676166624,3.7149471754984003,0.6303443794140307,0.47281314511628797,0.4540611718827999,0.3030467691849685;
Separation of Sister Chromatids,3.821051059497753,1.3123306771721275,1.0970230461575994,4.724779756982359,0.7460829399514947,4.088714448076953,3.7063293202035528,0.4247022560867204,1.3617613108832036,0.3084605076514881,0.3030467691849685;
G2/M Checkpoints,3.395871417133958,0.8014923610919136,0.6823205052245426,3.608664145972128,0.6231688405270283,3.4803221714587678,3.577426915423097,0.3545295527271077,0.9668183243741935,0.5124302984800859,0.3058816822504121;
Mitotic Spindle Checkpoint,5.133367885982449,1.6469296834212683,0.35583470878974294,5.615690242831487,0.4725673524789271,4.165285200589449,3.5641016950478748,0.7214872606359403,1.2404921252029872,0.4523752385250782,0.3058816822504121;
Sema3A PAK dependent Axon repulsion,5.485495285762694,3.7570290465468044,0.5730967190536839,1.4565173004041339,0.4146172972667351,0.3154827146412667,3.5584212852673027,0.7214872606359403,0.5380488165948838,2.32983204473155,0.3058816822504121;
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA,3.9455119654941835,9.83267623203174,1.1088565736270573,4.096391469409593,0.37572915566633974,1.2266820738215025,3.5584212852673027,0.3125493997793474,0.46024504142413253,1.0530759327306038,0.3058816822504121;
M Phase,4.421865726096109,1.2859613470789373,1.1645996582777804,5.016030376317258,0.6797765241920838,4.290527847858179,3.4161690391216846,0.36593959197886095,1.643522912461931,0.30738279210111424,0.3058816822504121;
Telomere C-strand synthesis initiation,4.048949669066338,0.94045423193971,0.4396862978485929,2.629076272493864,0.3401010458333853,1.1035302521089236,3.4157662951876744,0.41975460648763435,0.3115924460534767,0.5714564697988486,0.3058816822504121;
DNA replication initiation,4.048949669066338,0.9418709601982405,0.4159131212520216,2.629076272493864,0.34213827433994565,1.1035302521089236,3.4157662951876744,0.42600919707224844,0.3115924460534767,0.572602207453692,0.3058816822504121;
Signaling by NOTCH,0.40511607004227757,0.3142762591661267,0.5550431915575533,0.35287359016834924,0.30246496029501807,0.33955767216648003,3.41254932107611,0.3348159503392942,0.4881499224650157,0.4121812366547547,0.3058816822504121;
Signaling by Rho GTPases,2.9650636060332687,0.8231798698180065,2.143544166152827,3.8968313881740335,0.7545067537691059,4.165112663699326,3.331575578519357,0.36710932947589353,1.3617613108832036,0.30241267449194814,0.3058816822504121;
RHO GTPase Effectors,3.657550535445228,1.0283274780935037,1.8437272037867236,4.830359990124229,0.7279019710294058,4.460539542243616,3.3016432943686453,0.352267490683119,1.5290916492432036,0.34366498333663376,0.3058816822504121;
Cell Cycle Checkpoints,4.870995076244162,1.3635492747710871,0.3557042064788556,5.238226444283933,0.5705700121496526,4.316479479523637,3.2623472938732307,0.48606186013240477,1.2952038174159926,0.703515987512065,0.3058816822504121;
Resolution of Sister Chromatid Cohesion,4.97102262819926,1.6644464141991977,0.4502915740068935,5.614436511023885,0.5390637741992622,4.170257495204747,3.2143911015734825,0.9221426572870339,1.3778969952040085,0.41912518944327204,0.3058816822504121;
G1/S-Specific Transcription,4.428836373354384,1.178357966478976,0.6214317248794013,5.426176768502208,0.6477998746815469,4.398554149835581,3.2126405205059845,0.6869070635429356,1.042470285322291,0.33443521061762477,0.3058816822504121;
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,4.988717593215858,1.5314921912779529,0.8393120086878098,5.559740059812881,0.4677023943293453,4.246028912100134,3.2125715709259226,0.4518495329376567,1.2193717037228295,0.37218965236252843,0.3058816822504121;
Amplification of signal from the kinetochores,4.988717593215858,1.5314921912779529,0.8017891949040372,5.559740059812881,0.4677023943293453,4.246028912100134,3.2125715709259226,0.4518495329376567,1.2193717037228295,0.36615546095938395,0.3058816822504121;
MET activates PTPN11,0.3081642843377598,1.2007978621688389,0.3180102748962083,0.40918454326908915,0.30418705243734856,0.3542943274052089,3.1651505444825307,0.30762701980706253,0.3061107917419532,0.4121812366547547,0.3058816822504121;
Cyclin A/B1/B2 associated events during G2/M transition,5.053043201500383,2.3034994562759215,0.3369901152529043,6.154995722638868,0.6278261191361808,3.455836115267905,3.145444924229997,0.5167969904376682,1.5131387942786263,0.3160906252949544,0.3058816822504121;
NRAGE signals death through JNK,1.1117793188086327,0.5324309296314834,0.7060971157697995,0.7188771784227584,0.33671639369305106,0.3591971527530989,3.131790598948675,0.3637629906536139,1.2193717037228295,0.36956882019668214,0.3058816822504121;
YAP1- and WWTR1 (TAZ)-stimulated gene expression,0.5086090191266497,0.9142165648525804,1.1088565736270573,0.49786442742870163,0.4148892332525716,0.3420003235500663,3.1114357414259097,0.5238886509233606,0.4049598252116228,0.47469881290334454,0.3024439670208732;
G0 and Early G1,4.421865726096109,2.0049114338084766,1.1639187855194855,4.544914066206372,0.4549475819776362,3.9580873428343493,3.079001818277911,0.6834181834101111,0.572985278493807,0.8040034233399342,0.3058816822504121;
tRNA processing in the nucleus,3.4487160662741694,1.553934274347136,0.5899768161580835,3.1316088049983044,0.33664443463132226,2.5481696035778856,3.0752466812672874,0.5174152264767676,0.31808512104917774,0.4540611718827999,0.3058816822504121;
RUNX3 regulates YAP1-mediated transcription,0.4029927195800096,0.8826240100075539,0.3254830673281677,0.6830590249119001,0.5352610187418227,1.4913294770057988,3.0648216794725682,0.5174152264767676,0.3329607429278685,0.4523752385250782,0.3058816822504121;
EML4 and NUDC in mitotic spindle formation,4.791558050070914,1.480239217920042,0.33530251087995344,5.614436511023885,0.5705700121496526,4.316479479523637,3.0191155302948687,0.4313030976096779,1.426065400577132,0.3302665829120577,0.3058816822504121;
G2/M DNA replication checkpoint,5.729335600523741,2.0049114338084766,0.47160753149999735,4.875796818678323,0.37572915566633974,1.9053740434844029,2.952526420015095,0.33030236244002353,2.376208045576133,0.41376887048902816,0.3058816822504121;
Signaling by cytosolic FGFR1 fusion mutants,1.6003726115247088,0.4843431191386555,0.3387918290444652,0.5770272568140488,0.39026309562416256,0.33893742591410053,2.9406377539786113,0.5167969904376682,2.3977188328456367,0.7325121903592762,0.3030467691849685;
Cell Cycle,4.966220845174469,1.553934274347136,0.6760373314996082,5.615690242831487,0.5718721379043165,4.434155846068263,2.9224797914028473,0.44203855648039064,1.3617613108832036,0.3811579239158923,0.3058816822504121;
Cell Cycle, Mitotic,4.837668366507382,1.5493947540511843,0.3384666561332321,5.615690242831487,0.6268557198068822,4.434155846068263,2.9041942261817217,0.32587291250103156,1.517975922803317,0.31895786627672174,0.3058816822504121;
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,4.583588601761948,2.4133597200006895,0.5177252238437636,4.660965815393155,0.41200215293113845,2.4637218446109217,2.871633616348162,0.5238886509233606,0.9045344860174249,0.34854112028784845,0.3058816822504121;
Resolution of Abasic Sites (AP sites),5.133367885982449,1.2057201578783334,0.5958918847559157,4.2409474137233625,0.7201364544849929,3.1010915341796355,2.8644096189007313,0.6795783218532508,0.39210057593400716,0.4232200116160087,0.3058816822504121;
Extension of Telomeres,5.648148227007931,1.7729520378034704,1.4644735799552022,4.273548385985072,0.33627276072485157,2.9049322955425505,2.8582174796380584,0.3094759427026921,0.3170116103066843,0.5100898491572277,0.3058816822504121;
Cell-extracellular matrix interactions,0.9904163235718711,0.660536619186009,0.9492441905690125,0.3881184602725714,0.4146172972667351,0.3314791681136684,2.8399070124940198,0.7316766047041314,0.3327832096024327,1.658587024963112,0.3058816822504121;
CRMPs in Sema3A signaling,5.034811302310374,2.3817873843884776,0.3631909114164981,1.4117478790949058,0.3535867649444133,0.35080794711616836,2.8064130353760164,0.39014468230695576,0.5619633128815374,1.903460289886698,0.3058816822504121;
Cell-Cell communication,2.765972153807887,1.2007978621688389,0.5017359945597698,0.7521841837642104,1.0159588578062426,0.7155883661323684,2.7810637389229496,0.9906850191388271,0.3266862348880042,3.4449015650011026,0.3058816822504121;
tRNA processing,4.380752440231118,1.8815589255708167,0.7320923959849781,4.121866374473799,0.3249489042896067,4.106413225120388,2.772545390979696,0.3108923324961582,0.3693665271664583,0.3172734172535683,0.3058816822504121;
Synthesis of DNA,2.8547955688028646,0.8616783838721066,0.8490978546174842,3.904934981808079,0.7460829399514947,3.691433629679302,2.7160499381500895,0.3999878562041873,1.119743111813597,0.4232200116160087,0.3058816822504121;
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,4.266085643803281,0.6661757515657146,0.5080281462892785,2.629076272493864,0.39026309562416256,2.640018273127109,2.6899890085483054,0.4786707687617883,0.46973565379933857,0.37228578428448916,0.3030467691849685;
Apoptosis induced DNA fragmentation,1.3611983823695928,0.4386912358120347,0.8322617489258197,0.4713179984058352,0.30246496029501807,0.4453298839223913,2.6842587484695293,0.31539388260432966,0.4881499224650157,0.780698910099279,0.3058816822504121;
S Phase,3.031862368482593,0.9900473145611959,1.3910627630217562,4.085644736690576,0.7460829399514947,4.192333372904334,2.6526691556921658,0.35971925328583354,1.0113999391816824,0.3600587774940227,0.3058816822504121;
Factors involved in megakaryocyte development and platelet production,4.793465774230655,1.7291076827125254,0.4552760920564336,6.154995722638868,0.6100144101391141,3.9580873428343493,2.6526691556921658,0.3947737880623761,1.9127709318886323,0.30241267449194814,0.3058816822504121;
RHO GTPases Activate Formins,4.452863835527824,1.3451313714885675,0.5556716950704882,5.615690242831487,0.6326764164089309,4.534053923431101,2.643355972346963,0.46950761507088173,1.375938918985344,0.5746891901519758,0.3030467691849685;
Mitochondrial translation elongation,1.6191496972679087,0.39701699993581774,0.3186523149786101,0.3347311511299859,0.30418705243734856,0.5088596082323055,2.643355972346963,0.48606186013240477,0.3266862348880042,0.8067966244509088,0.3058816822504121;
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,4.2496876321759425,1.7136788087072563,1.2681836512335347,4.06966763875463,0.30246496029501807,4.341251401139958,2.636341460596962,0.34594152313947746,0.3170116103066843,0.39807543893028463,0.3058816822504121;
G1/S Transition,2.412609453638615,0.6441853723194954,1.1088565736270573,3.114144262745647,0.7576852196375048,3.685190823363033,2.6359624343243895,0.3251934547032587,0.7310550317671739,0.3458960799904469,0.3058816822504121;
HSF1 activation,2.2548717975063814,1.7291076827125254,0.42380638310507274,0.3232519888569888,0.3082126526753394,0.31689428964627836,2.6356855243590256,0.3610048682403598,0.3693665271664583,2.483157765439062,0.3058816822504121;
DNA Replication,3.442763605173436,0.9900473145611959,0.5300117253243696,4.5853995384373825,0.7545067537691059,4.180780135734192,2.6356855243590256,0.37363972655453026,1.3653360894472852,0.5100898491572277,0.3058816822504121;
HSF1-dependent transactivation,2.239350107137072,1.7291076827125254,0.3329387001691024,0.32083578734886836,0.41766883099928126,0.35399026492638497,2.598268739456539,0.45209511687783316,0.31952804471255203,2.5866465158846497,0.3058816822504121;
Regulation of FOXO transcriptional activity by acetylation,0.6780733998458848,0.301642737608084,0.905257448815168,0.3881184602725714,0.3560720414244286,0.35039829473538353,2.598268739456539,0.39361440195896213,0.6546690571542668,0.47469881290334454,0.3058816822504121;
UCH proteinases,0.4285257794946782,0.4081569957992947,0.8481794204564727,0.4392846139050585,0.5442360620589024,0.7052649115632583,2.598268739456539,0.3947737880623761,0.3293878277257215,0.5014049853346438,0.3058816822504121;
Mitochondrial translation initiation,1.5970665700975755,0.36250846227187006,0.6552450750306614,0.34049658036688124,0.3377810260292985,0.6091496236054034,2.598268739456539,0.48606186013240477,0.33154605935666304,0.7345664248454543,0.3058816822504121;
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,5.307297935141997,1.0346589951790564,0.6958388428680018,3.76310690045082,0.3764809604369917,2.951867680636181,2.578556386290151,0.31482486972733703,0.30320189929542807,0.7257968543160326,0.3058816822504121;
Polo-like kinase mediated events,5.799276095139586,1.957760521811249,0.7338387423275315,5.615690242831487,0.33140832466933967,2.8829588951038683,2.5753773615480315,0.352267490683119,1.1033715792095793,0.3811579239158923,0.3058816822504121;
Cell death signalling via NRAGE, NRIF and NADE,0.7239736512740405,0.33402483609309025,2.018582131708924,0.3232519888569888,0.3764809604369917,0.6396323705007485,2.571414244156556,0.6795783218532508,0.3359886954858688,0.3811579239158923,0.3024439670208732;
G2/M Transition,3.7282557560433434,0.9394394484219818,0.8589930368594442,4.434595686397295,0.7567825887366332,4.170257495204747,2.571414244156556,0.38454701793058893,1.933772209926543,0.4189205258768189,0.3058816822504121;
Telomere C-strand (Lagging Strand) Synthesis,5.114844707666711,1.0252121355181019,0.9579023496523752,3.9685093926196995,0.32297793958928395,2.782404799622282,2.5451553626108514,0.3237300342738156,0.33154605935666304,0.6934476135044898,0.3058816822504121;
Transcription of E2F targets under negative control by DREAM complex,2.2740267119532396,1.4212203466760567,0.4760528568967101,2.4483609755578173,0.30246496029501807,2.920811872517149,2.5388084305250658,0.3251934547032587,0.33154605935666304,0.3380807223148382,0.3058816822504121;
Early Phase of HIV Life Cycle,2.549009451102888,1.3570134356717731,0.7654194085499344,0.9931336021114981,0.3439134979171695,0.6858714623388955,2.5081648956973734,0.3272468962834211,1.231500012211471,0.5103027601099676,0.3058816822504121;
PCNA-Dependent Long Patch Base Excision Repair,4.883096230060422,0.8627662521295353,0.3320544482519389,3.2936837641831365,0.31074822873640523,3.086486779614614,2.4950099986856555,0.35082679893314456,0.400638262471397,0.566896437184706,0.3058816822504121;
Mitochondrial translation,1.542607112490525,0.3650614398467666,0.5017359945597698,0.3163292158034775,0.3439134979171695,0.43484701553531135,2.494603409529822,0.6834181834101111,0.31558403987910877,0.8338588690146164,0.3058816822504121;
Mitotic G1 phase and G1/S transition,2.8547955688028646,0.9363641915722525,1.037247511104453,4.088475608088637,0.8663173673384363,4.316479479523637,2.4908920034138426,0.44448953253707935,0.9944631593630215,0.5632994792488358,0.3058816822504121;
Activation of SMO,0.44351687530887374,0.30713105125946294,0.5839126285149882,0.7314997931615257,0.42858510349574563,1.470766490846704,2.4739135121897893,2.1126085293724817,0.3406966434873319,1.7387034335731002,0.3058816822504121;
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,4.047279755137316,1.553934274347136,0.3605928617833285,5.004149488044551,0.5442360620589024,3.9580873428343493,2.4036875083824154,0.45482312314956885,0.6794802308977953,0.30603264219956966,0.3058816822504121;
Mitochondrial translation termination,1.4112383392284498,0.31437418350960494,0.3794834863277264,0.3753302144164982,0.3324283932379276,0.4107256546615841,2.392252335525637,0.7796931658740366,0.3238546517872322,0.7810722989770186,0.3058816822504121;
Attenuation phase,2.1766464010048794,1.6232159985424242,0.3408790815282517,0.3246799062727365,0.33664443463132226,0.6812402240206983,2.3738337378035466,0.36046186142273234,0.47227709359950737,2.4231988773254285,0.3058816822504121;
Mitotic Prometaphase,4.793465774230655,1.4879452815809386,0.4859396922429659,5.615690242831487,0.5905879164149995,4.273883413908051,2.3676758869286756,0.46237839526257996,1.6047064599004204,0.39091888813155207,0.3058816822504121;
Mitotic G2-G2/M phases,4.0105637213020975,1.0162487431096416,0.5439930076286128,4.7882873307740095,0.7545067537691059,4.316479479523637,2.3627486619176286,0.6834181834101111,2.157269182424066,0.7257968543160326,0.3058816822504121;
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,0.9759808104049144,0.5698796886264856,0.5116843411446564,1.5200946157223625,0.5681648570673938,1.0295568279064669,2.359725574251628,0.33696163270265517,0.4188260016559483,0.3286979716130023,0.3058816822504121;
E2F mediated regulation of DNA replication,5.617584045129475,1.4212203466760567,0.35516354224109725,4.6915483067272605,0.3082126526753394,2.9049322955425505,2.340743693094978,0.4843159419563512,0.8093683332048278,0.30245448354214916,0.3058816822504121;
PI3K events in ERBB2 signaling,1.5846473559546523,0.8627901050786347,0.3240344544485519,0.3145544860480906,0.3439134979171695,0.7827320658652741,2.3223707105774647,0.37363972655453026,0.3340537124683427,0.990368680150761,0.3058816822504121;
MET activates PI3K/AKT signaling,0.33440806025273945,1.2647518802880215,0.3654193179949343,0.6340372832772738,0.3560720414244286,0.36504209043534924,2.3218865607615027,0.45374902011684204,0.32855021388126704,0.30596442116887695,0.3058816822504121;
Processive synthesis on the lagging strand,4.544282527543613,1.1599948410697627,0.5584567455831462,4.2592382714073205,0.4146172972667351,1.82771025815591,2.307510595077214,0.5766853584012566,0.3729062334678565,0.5278203201689747,0.3058816822504121;
APC/C-mediated degradation of cell cycle proteins,1.0925235400679418,0.3105836898586958,0.460777811568592,1.8286180489296855,0.8350420563859239,2.2956480828364043,2.2985398740996184,0.6693387366649604,0.6558842702431266,0.30218917574215476,0.3058816822504121;
Regulation of mitotic cell cycle,1.0925235400679418,0.3103336721805107,0.4723509770354981,1.8286180489296855,0.8350420563859239,2.2956480828364043,2.2985398740996184,0.68254284126733,0.6551157402536134,0.30241267449194814,0.3058816822504121;
Termination of translesion DNA synthesis,4.463200542850821,0.7306530008539828,0.558058855721835,2.629076272493864,0.33627276072485157,2.691705849089768,2.2974102957741698,0.34728051223511597,0.32562191479076025,0.33740247317007105,0.3058816822504121;
Nectin/Necl  trans heterodimerization,0.5828705094117614,0.3647503989234912,0.5411442378076691,0.34114908780953945,0.3535867649444133,0.6494417602692866,2.2973192276644543,0.32753430183444365,0.37818098826263175,2.1498864835578857,0.3058816822504121;
DNA Damage Bypass,3.4484672425440075,0.32979575975804937,0.5798296840686574,1.439219908439872,0.4146172972667351,1.789706960824425,2.291300987428713,0.3782219967604676,0.33154605935666304,0.3117369630687721,0.3030467691849685;
Regulation of commissural axon pathfinding by SLIT and ROBO,6.781528579055216,1.553934274347136,0.5135262003282529,1.7472174756851602,0.32162569628297455,0.3762215469973146,2.2791634127093645,0.3445913271108731,0.418328270869041,1.2494578528832947,0.3058816822504121;
Signaling by WNT,0.4198206145214917,0.30397605771269914,0.30134832367833375,0.5903828720471492,0.3439134979171695,0.3111782497541377,2.2713921819649534,0.5226955554832011,0.572985278493807,0.37636770226551464,0.3058816822504121;
Formation of xylulose-5-phosphate,1.9001704435113675,1.0488753634966745,0.4018400955900535,0.3816686884212616,0.56267084582879,0.3665801123277985,2.2674357628912993,0.3317123913477366,0.4502323698043533,1.1404565985013442,0.3058816822504121;
Kinesins,4.568847298721612,1.8421080202185456,0.36516085144117183,6.020671754843908,0.5457806137591187,3.525242669736441,2.2639323377665574,0.48606186013240477,1.548245642681925,0.3109481832046546,0.3058816822504121;
HDR through Homologous Recombination (HRR),6.034212750143057,1.0675658215078154,0.3592904035310348,4.660965815393155,0.33627276072485157,3.164306400741602,2.2618945681474423,0.4628527562793292,0.45174765924593724,0.43757953279887496,0.3058816822504121;
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,0.36284462529049,0.40129433999547554,0.3112446042751675,0.3271459557820616,0.5705700121496526,0.3260350496628621,2.2469591662890296,0.5918767786718077,0.3693665271664583,0.41104584371777314,0.3058816822504121;
HDR through MMEJ (alt-NHEJ),5.476287470162528,2.6568974100916467,1.7214238292055908,3.8655045653973876,0.3726312003584851,0.7284869631520305,2.239169846531973,0.43929821085455234,0.6042626547165951,0.3095581397528177,0.3058816822504121;
Downregulation of ERBB2 signaling,1.5194667063642882,0.3131565448775929,1.9409122592803525,0.518409827601242,0.6881908609437631,1.6460229943568587,2.235505356915434,0.9408642598773541,0.3693665271664583,1.5411777064602739,0.3058816822504121;
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,3.1160438919742046,1.0675658215078154,0.3864908560259685,1.7745193701505773,0.45873877254042,1.4400240880267874,2.2308621593271036,0.5238886509233606,0.3156659602261388,0.4256081140909801,0.3030467691849685;
SUMO is proteolytically processed,0.8072884376667768,0.6423514982627504,0.4018400955900535,0.3628766921649118,0.42272067676020203,0.44569311077594786,2.183813991403837,0.4465891410792702,0.3167022141326965,0.40065294812408603,0.3030467691849685;
Ca2+ activated K+ channels,1.0613856725718245,0.410263052557199,0.9471078057820748,0.4096323736562922,0.3119959467823231,0.7072001173174037,2.183813991403837,2.6345324360108244,0.3329607429278685,1.424312272504176,0.3058816822504121;
Activation of NIMA Kinases NEK9, NEK6, NEK7,4.97102262819926,1.5097361812481982,0.3715033535019827,5.025020574292233,0.46222000596710305,2.8366622884131485,2.1775340333539925,0.551193378697791,2.5056557102950343,0.37292988085554196,0.3058816822504121;
Resolution of D-Loop Structures,6.708122059743883,1.5314921912779529,0.9539396480393402,5.291010556073852,0.33627276072485157,1.6941774204840818,2.1741590173720726,0.5578106790042832,0.9045344860174249,0.3866317659379911,0.3058816822504121;
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,4.6033321964263925,1.3570134356717731,0.7331173198609205,3.1018216374890106,0.32741484957780614,2.9063541495868566,2.17272312002051,0.3243668380962858,1.6422120536897118,0.3302665829120577,0.3058816822504121;
Galactose catabolism,0.5587013765220952,0.7392907361800659,0.32642853715013426,0.4303767648874029,0.31583541384964053,0.3037454888756527,2.168416281187605,0.4747676591404618,0.3389374015397122,0.42581119985693494,0.3058816822504121;
Synthesis of dolichyl-phosphate-glucose,0.34171450624887706,0.32389535055404894,1.333307968049021,0.3612995601475251,0.3479596344454571,0.37158725940729187,2.167673432785889,0.4589589677230645,0.35776326036887945,0.5280321394999583,0.3058816822504121;
KSRP (KHSRP) binds and destabilizes mRNA,6.034212750143057,12.115637095765019,0.9755889006351273,6.154995722638868,0.3764809604369917,0.8191093977027304,2.1613967630490207,0.3367084026894726,0.32855021388126704,0.9807617714784836,0.3058816822504121;
Phosphorylation of Emi1,4.488727666304262,1.553934274347136,0.41725135670861263,5.238226444283933,0.6231688405270283,3.1507550872675116,2.160521170014733,0.9221426572870339,1.9040404129500301,0.31182882727391925,0.3058816822504121;
Resolution of D-loop Structures through Holliday Junction Intermediates,6.708122059743883,1.531431485572001,0.949593691853667,5.271405198836137,0.330372459861341,1.7030698994869287,2.1525293407756543,0.6121973354446032,0.9045344860174249,0.3928910506494723,0.3058816822504121;
Nitric oxide stimulates guanylate cyclase,6.432699449669013,1.3635492747710871,1.1436573242825248,0.5576760922391598,0.3764809604369917,0.3226008759993232,2.1408057157370037,0.8986880030650579,0.3693665271664583,2.401748522196262,0.3058816822504121;
FGFR2 mutant receptor activation,2.1945191902010186,1.427057439003852,1.200161912746773,3.561647052237907,0.6278261191361808,2.947393516622821,2.1369303970438014,0.35971925328583354,0.9644846059805651,0.37636770226551464,0.30540190655612415;
Scavenging by Class H Receptors,5.250260241429556,1.553934274347136,1.4511080008514845,0.9849589810571827,0.35573771241937,0.3420003235500663,2.1282876890966094,0.4628527562793292,0.3170116103066843,2.0635130261661336,0.3058816822504121;
Cell-cell junction organization,6.894665228796102,2.0099539321842257,0.36529076748613304,1.352363913995439,0.3824048831138682,0.3829935829538375,2.1229825796860835,0.39014468230695576,0.405929460478443,2.5682270669616347,0.3058816822504121;
Release of apoptotic factors from the mitochondria,0.980413177315755,0.3998527053714512,0.5439930076286128,0.48666653987532343,0.30418705243734856,0.5646191142917181,2.1187075609984274,0.6292013533408742,0.3359886954858688,0.3757469855773337,0.3058816822504121;
Muscle contraction,2.4892130527374565,1.2057201578783334,1.2957633497091234,0.4296023820159213,0.6326764164089309,0.34699522989044684,2.1183414782518266,0.9674975239409703,0.30181279042607134,1.5989857264412672,0.3058816822504121;
RHO GTPases activate CIT,5.133367885982449,1.9196460896247916,0.35516354224109725,3.8835958440661265,0.4393593943366305,1.32684311812447,2.115109564911046,0.5174152264767676,0.45174765924593724,0.3413952918045016,0.3058816822504121;
Removal of the Flap Intermediate,4.538054433490094,1.0346589951790564,0.5141407861261728,4.085644736690576,0.4146172972667351,2.3197741425458918,2.1068495116063204,0.5111346635224848,0.5019652381600472,0.4404591951700404,0.3058816822504121;
Intestinal absorption,0.3198989629278931,0.4631345202388002,0.6641674729061878,0.7387438327391023,0.3285435148042968,0.6625151035877471,2.1068495116063204,0.3094759427026921,0.33154605935666304,0.9591658912352792,0.3058816822504121;
Processive synthesis on the C-strand of the telomere,4.463200542850821,1.0911242852140608,0.5045580962716097,4.097438259630141,0.30418705243734856,2.04569561278149,2.081362803334725,0.6022668237915776,0.3667930924250126,0.44297218450032194,0.3058816822504121;
SMAC, XIAP-regulated apoptotic response,0.4975336219701357,0.5199119484690351,0.5080281462892785,0.5037140572510149,0.45810052203947244,0.31776991236841967,2.079554262325291,0.7796931658740366,0.7039798500328718,0.36461080291170556,0.3024439670208732;
Lagging Strand Synthesis,4.97102262819926,0.9874628953643209,1.073527017168443,4.2392396541409365,0.6231688405270283,3.0365590484755733,2.0731161005470544,0.32735598382599135,0.37714526130064224,0.49474662873127906,0.30276807564634967;
Signaling by FGFR2 IIIa TM,2.3742754674832476,1.5314921912779529,0.8471307234098818,3.6445994681790848,0.6231688405270283,3.110868989734823,2.0731161005470544,0.30481780719897456,0.8217340409495298,0.4355689693819607,0.3058816822504121;
DNA Repair,0.335368352224608,0.3299417989905663,0.5477402159444688,0.5016914801173993,0.330372459861341,0.36504209043534924,2.072602296619733,0.5795150420091576,0.3667930924250126,0.4825096878688224,0.3058816822504121;
Ub-specific processing proteases,0.44995322335121024,0.3170649431462248,0.7806341170784341,0.3271459557820616,0.33627276072485157,0.44569311077594786,2.0609240395842687,0.6303443794140307,0.32562191479076025,0.4540611718827999,0.3058816822504121;
MASTL Facilitates Mitotic Progression,4.67326088692401,0.4828154453378415,0.570996877482731,0.5909038326857987,0.4536790728889417,0.7092446564770029,2.059740222773043,0.9652238352966773,0.33154605935666304,0.5278203201689747,0.3058816822504121;
Activation of the pre-replicative complex,4.769014742842074,1.3173861593652125,0.8410170842254203,5.238226444283933,0.30418705243734856,3.5979738970095556,2.059740222773043,0.3811801504530512,1.0480457650448696,0.33443076555210144,0.3058816822504121;
DNA Replication Pre-Initiation,1.437006392775407,0.30402224815377643,0.5653080456879184,2.3401752907478897,0.8279148580470003,2.836219035044139,2.057208640969575,0.7214872606359403,0.7638802662367795,0.5100898491572277,0.3058816822504121;
E3 ubiquitin ligases ubiquitinate target proteins,0.43486369648632767,0.3667015217797265,0.4545456547511497,1.0907646901544714,0.3226140943665297,0.4902850695312733,2.056786990859295,0.4133310857960066,0.6346345296616243,0.5323145474341873,0.3058816822504121;
Activated NOTCH1 Transmits Signal to the Nucleus,0.9016601303226309,0.3090278240817252,0.7967758165849417,0.44798064657680453,0.33627276072485157,0.4769486051022631,2.056786990859295,0.4628527562793292,0.34010467491250734,1.9043886828020296,0.3030467691849685;
Spry regulation of FGF signaling,2.4542833698137287,2.0049114338084766,2.143544166152827,1.1578910544844385,0.33096675554030125,0.538849893387461,2.0532802237094367,0.352267490683119,0.32855021388126704,1.2510473607388921,0.3058816822504121;
Processing and activation of SUMO,0.9155007632782378,0.5900981993023308,0.9545136044261276,0.5187531396662611,0.33910487705697223,0.5639084856040545,2.049041533184633,0.37731415007330193,0.3414062616665845,0.37882480811887304,0.3058816822504121;
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,4.583588601761948,2.410257389274893,0.3222246234534123,3.970064910361211,0.3791920767944086,1.3931951322484968,2.049041533184633,0.35082679893314456,0.7863744803902321,0.5280321394999583,0.3058816822504121;
SMAC (DIABLO) binds to IAPs ,0.32374734715606046,0.3846306930187274,0.4468858906158422,0.8273762681817375,0.32162569628297455,0.3111782497541377,2.049041533184633,0.33047102262751354,0.554461158330871,0.637960727516886,0.30370155596674026;
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,0.32466910742018407,0.38285324972283774,0.4398876401776831,0.8136552826731047,0.32162569628297455,0.3111782497541377,2.049041533184633,0.3317123913477366,0.5527307274968848,0.6419266585486041,0.304314835196113;
Golgi Cisternae Pericentriolar Stack Reorganization,4.169914729869479,1.7291076827125254,0.5584567455831462,4.375603718835916,0.6776561166140836,2.8301625337014915,2.031655459707353,0.41975460648763435,3.222157262549377,0.3184671951240273,0.3058816822504121;
Sema4D in semaphorin signaling,2.644215411394122,1.7291076827125254,0.3186523149786101,0.7961500054884454,0.3439134979171695,0.30146276932778043,2.029865359891562,0.3645145576644601,0.3596562854316725,0.35882421529420916,0.3058816822504121;
IRF3 mediated activation of type 1 IFN,0.6667144050394884,0.8203361120909318,1.5091682442257912,0.32552608200489686,0.3249489042896067,0.4317114540437308,2.0237775574408445,0.3108923324961582,0.33154605935666304,0.35815713029086216,0.3058816822504121;
DNA Damage Recognition in GG-NER,0.3888911851573813,0.594073051554009,0.5017359945597698,0.6214267086654077,0.3014957305548291,0.3591971527530989,2.0237775574408445,0.37770911594983014,0.3406966434873319,0.39091888813155207,0.3058816822504121;
Mitotic Telophase/Cytokinesis,4.881051486592438,3.0462133961333127,0.6429143441319403,6.015114254375357,0.33664443463132226,3.740924770593674,2.0217765970382113,0.829854390072768,0.9045344860174249,0.3085529757305799,0.3030467691849685;
Sema4D induced cell migration and growth-cone collapse,3.182776335996717,1.4879452815809386,0.4134699577910062,1.3502190666773035,0.4054565637555915,0.30146276932778043,2.011917496621437,0.4023947834050888,0.3156207600629333,0.661173288081862,0.3058816822504121;
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,0.38523662041238443,0.3579101535729101,0.3192251131758922,0.7720926985654486,0.7433781605289134,1.4251318833135074,1.9777610821873015,0.3909454933235953,0.33154605935666304,0.32837788404645557,0.3058816822504121;
PAOs oxidise polyamines to amines,0.6284918354782628,0.49882509403717307,0.7317982382126464,0.46609434777676034,0.3764809604369917,1.1143603888025917,1.9765490768183032,1.0161680515499365,0.46973565379933857,0.5220859610129244,0.3058816822504121;
COPI-dependent Golgi-to-ER retrograde traffic,4.793465774230655,1.7291076827125254,0.46543457405871613,6.020671754843908,0.4549475819776362,3.7920251266695986,1.9535301020184843,0.33696163270265517,2.021352086492167,0.39091888813155207,0.3058816822504121;
Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR),3.791187161600752,1.2567397901919064,0.7500066157472146,1.0757855889695138,0.4053350549556549,0.4900714565162325,1.9517811523242585,0.481603248531199,0.3086647282719282,0.5183803556000907,0.3058816822504121;
Acyl chain remodelling of PI,0.5557714001529779,0.4421464839057635,1.0183374655546191,0.3628766921649118,0.42318328395149263,0.35767155389389355,1.9517811523242585,0.38203354463751305,0.5150564954008329,0.4872466407939922,0.3058816822504121;
HSP90 chaperone cycle for steroid hormone receptors (SHR),1.522490014463982,0.6684810088964953,0.47620779881555453,0.5186944834847285,0.3458722606147499,0.5245047266062759,1.9291104359469398,0.45640854842187634,0.4499404543933704,2.3158211287109594,0.3058816822504121;
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,1.705873701652396,9.589286984997319,2.996204187321848,5.004149488044551,0.3073643548426107,0.5407089222379899,1.9256258590548707,0.3569622340932903,0.33154605935666304,0.5100898491572277,0.3058816822504121;
DNA strand elongation,4.7900786362931935,1.5671211051990475,0.3222246234534123,5.459146691967248,0.32297793958928395,3.4293581478348734,1.9194624717625193,0.4628527562793292,0.5424034113042814,0.47469881290334454,0.3058816822504121;
Negative regulation of FGFR1 signaling,2.5433359049391178,2.167602637702731,0.6874299491778388,1.7784858565397055,0.3701740018252065,0.4449779716204163,1.9170603525949794,0.4815653043880472,0.4884401207480335,0.8468551764211115,0.3058816822504121;
E2F-enabled inhibition of pre-replication complex formation,5.1625953949087435,0.8522925565223789,0.3081915935170801,3.90676401577355,0.3439134979171695,2.9985250519965447,1.9170603525949794,0.9897043482796474,1.7379183444904103,0.4232200116160087,0.3058816822504121;
APC/C:Cdc20 mediated degradation of mitotic proteins,0.32281253267039184,0.301642737608084,0.5081062850296953,0.5595898307253171,0.7102816092546838,1.2886150914238699,1.9087404159401924,0.3613559184988038,0.30380343648068064,0.3286979716130023,0.3058816822504121;
Chromatin organization,0.435056961084513,0.3978958665537758,0.350539890489017,0.380333723709027,0.36066296047909274,0.45504877774201197,1.9020241338954913,0.3317123913477366,0.33361647008615525,0.5201607101204013,0.3058816822504121;
Chromatin modifying enzymes,0.4352206705400219,0.3978958665537758,0.3482341025567932,0.380333723709027,0.35952474696705994,0.45670913707475397,1.9020241338954913,0.3317123913477366,0.3340537124683427,0.524324692113882,0.3058816822504121;
Gap-filling DNA repair synthesis and ligation in GG-NER,4.883096230060422,0.8760628227046386,0.6638386087641549,3.28949112223162,0.3439134979171695,2.7527510053106834,1.9020218576058832,0.3363632797967757,0.3728343545959842,0.4170778848741611,0.3058816822504121;
Inositol phosphate metabolism,0.7572523997667203,0.3667015217797265,1.405432806416354,0.3503872330012344,0.7711384752069886,1.84574950367176,1.900366774168635,0.6652097340320369,0.33154605935666304,3.249024081041365,0.3058816822504121;
Invadopodia formation,1.1359866762783553,0.5698796886264856,1.180391215551179,0.5040887524477986,0.30418705243734856,0.3338497085090671,1.8936353758703546,0.6292013533408742,0.35379178849489046,1.576137499417919,0.3058816822504121;
Fanconi Anemia Pathway,3.8693555332363587,2.0049114338084766,0.43068441469191265,2.8755036981306215,0.3430871225976707,0.6858714623388955,1.8808748095194738,1.053092947380614,0.33154605935666304,0.30241267449194814,0.3024439670208732;
Negative regulation of FGFR3 signaling,2.0554617216749116,2.095028411349065,2.124707996289505,1.0907646901544714,0.36461620055334687,0.35399026492638497,1.8807958961901705,0.4849021760868862,0.31165489437756005,0.59909883417329,0.3058816822504121;
Retinoid metabolism and transport,0.727768550865018,2.3817873843884776,0.6430466072693578,2.7740306419780314,0.735495224638357,0.3508313973814462,1.8774113121378773,0.5795150420091576,2.603042384386574,0.32674146906659945,0.3030467691849685;
Switching of origins to a post-replicative state,0.9012977446627628,0.421441415526736,0.5441269426029018,1.7325377719745674,0.8817016239439482,2.463746298899367,1.8640734569990351,0.3027579187486238,0.6052596979838009,0.6822681791391376,0.3058816822504121;
Tight junction interactions,6.781528579055216,0.8996407754356102,0.32416998964978666,0.3265325825462171,0.6109240307787517,0.38381811256955944,1.8640734569990351,0.33030236244002353,0.3733674433073597,2.6919240583465,0.3058816822504121;
Homologous DNA Pairing and Strand Exchange,5.729335600523741,0.8247510397063494,0.7830399204887082,4.473118811357106,0.32162569628297455,3.5792370727766314,1.8567243316116187,0.6834181834101111,0.5619633128815374,0.5278203201689747,0.3058816822504121;
Metabolism of fat-soluble vitamins,0.7248517608239233,2.3817873843884776,0.5081062850296953,2.81359356832426,0.7460829399514947,0.37279380859743294,1.848050371535571,0.5753977044168755,2.734616557860927,0.32029029252084185,0.3030467691849685;
Recognition of DNA damage by PCNA-containing replication complex,4.463200542850821,0.3650614398467666,0.39679477643070366,1.900992698620638,0.330372459861341,2.6995368917150806,1.845031517685394,0.31386088966176257,0.3733674433073597,0.3438912602278897,0.3058816822504121;
Smooth Muscle Contraction,2.49213647564696,1.1514840829839768,0.8409525117526983,0.3213115419718923,0.35952474696705994,0.5892932499870671,1.845031517685394,0.5766853584012566,0.555793014702259,0.8931746108399806,0.3058816822504121;
RUNX3 regulates CDKN1A transcription,0.3407996132956933,0.30397605771269914,0.4129105594128844,0.3468013020091587,0.41200215293113845,2.0731005569343277,1.845031517685394,1.4098981773384807,0.37721347556427365,0.4209700519911368,0.395069469041425;
cGMP effects,8.161244263348058,1.1599948410697627,0.3081915935170801,1.1229056895464988,0.3439134979171695,0.35069233134632966,1.8327393411486457,0.4582847620118485,0.36494779765230456,0.9717408988765865,0.3058816822504121;
Activated NTRK2 signals through PLCG1,2.851250694860466,0.4828244220940114,1.1841713365801751,0.6865430266974362,0.3274981301462102,0.5040377049096719,1.821642553876791,0.3317123913477366,2.376208045576133,0.3494466004440475,0.3058816822504121;
Regulation of APC/C activators between G1/S and early anaphase,0.3119979840557615,0.3378343987873051,0.3476841421741344,0.6537324347207828,0.7649116976674908,1.4678096918162264,1.821642553876791,0.3301441399438418,0.3115924460534767,0.7164596722064461,0.3058816822504121;
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),5.968475944953354,0.9900473145611959,0.39316139250370125,4.5853995384373825,0.35573771241937,2.3262967927331495,1.8164765141848638,0.6665031139237775,0.9045344860174249,0.4540611718827999,0.3058816822504121;
Presynaptic phase of homologous DNA pairing and strand exchange,5.610214999826762,0.7083061017751114,0.46299827936706456,4.321206726706416,0.30246496029501807,3.5122847656208163,1.811168328884559,0.371248279207672,0.7638802662367795,0.5819951510366843,0.3058816822504121;
Activated NTRK3 signals through PLCG1,1.632853759229625,0.47698398560067923,1.468199384759467,0.7727786937880755,0.4146172972667351,0.46829287577570267,1.811168328884559,0.3425206096678787,2.0527654408810543,0.3497435959916622,0.3058816822504121;
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,0.5654079179337074,0.3757662919161499,0.5046869968440628,0.5595898307253171,0.30985369422832876,0.42264146081960646,1.8046328378400398,0.5174152264767676,0.31808512104917774,0.47469881290334454,0.3058816822504121;
Signaling by FGFR in disease,0.9759808104049144,0.7759719336519098,1.8815679743403972,1.9926150074197988,0.6913841997159544,2.5425637613819556,1.7997093842905956,0.6370660872345657,1.1976178087574374,0.3806709461682284,0.3030467691849685;
SUMOylation,2.2625724944476393,0.3351332739777284,1.3910627630217562,3.017323905454381,0.6109240307787517,4.434155846068263,1.7921727126115534,0.3027579187486238,0.4597267485164966,0.3675462541234331,0.3058816822504121;
Cristae formation,0.6715168394742667,0.576173559427021,0.6756090716445822,0.30621980073319044,0.3866814419733902,0.37649015236135064,1.789106712112378,0.35971925328583354,0.3329607429278685,0.44297218450032194,0.30574005727865033;
SUMOylation of DNA replication proteins,4.576599180187884,1.0929874257862304,1.1668198504358058,4.387615663162987,0.33627276072485157,4.935015110779719,1.789106712112378,0.4265158405784998,0.5527307274968848,0.5278203201689747,0.3058816822504121;
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,0.7923273098286002,0.5128621037960388,1.4746456317007623,0.36360503738442823,0.30447768946963627,0.862073219993503,1.776233063832952,0.37345730523527865,1.1031089904778386,0.580011512980169,0.3058816822504121;
Non-integrin membrane-ECM interactions,0.8711980530919565,0.90414944737465,0.30734867613921363,1.0907646901544714,0.30418705243734856,0.4306777496994055,1.74733664396489,0.39688813005863777,0.48124263349989904,0.7128626496065233,0.3058816822504121;
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),0.8072884376667768,0.30509925427685003,0.3149477046576787,1.8277482863326857,0.30246496029501807,0.44569311077594786,1.74733664396489,0.7372930190504967,0.3728343545959842,0.3458960799904469,0.3058816822504121;
Diseases associated with O-glycosylation of proteins,2.171295521471604,0.8410357410402534,0.35275308129702004,0.350714016868682,0.37572915566633974,0.30259970477602033,1.74733664396489,0.6370660872345657,0.32562191479076025,1.9869655244911948,0.3024439670208732;
Ligand-receptor interactions,1.7874104207120947,0.31575954172831694,0.35535755172665123,0.344765288813386,0.685996197704649,0.3167789875738771,1.7467098667817365,0.33696163270265517,0.3065164849314509,1.4315058157363154,0.3058816822504121;
RHO GTPases activate PAKs,3.101410090874919,0.9285413398621923,0.36876285793093794,0.518409827601242,0.32297793958928395,0.5736247228917777,1.7467098667817365,0.3476737760490837,0.6065838599288306,0.4232200116160087,0.3058816822504121;
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,3.513925845785902,1.0465409745822256,0.33143140025985224,3.934006359469161,0.5724292987597449,3.9801245118437696,1.7449667452480937,0.5825020384574686,1.2679826263964467,0.35352371536264976,0.3058816822504121;
Netrin mediated repulsion signals,0.57445182538829,0.6469085717535941,0.5111303216523466,0.3861917421038416,0.32297793958928395,0.47055855225156185,1.7432346050389542,0.34728051223511597,0.6606921149715522,0.32429151923420935,0.3058816822504121;
Biosynthesis of specialized proresolving mediators (SPMs),1.5846473559546523,1.0346589951790564,1.2228080473521203,0.6572083800736843,0.3764809604369917,0.3111782497541377,1.7372674190678319,0.31950585589685954,0.31837078236812505,0.7131212844176323,0.3058816822504121;
SLBP independent Processing of Histone Pre-mRNAs,4.568847298721612,0.9639794752193329,0.30747772415026436,1.843270475035219,0.395589721156635,1.802216401705541,1.7320912924931708,0.4550485827068064,0.9045344860174249,0.33740247317007105,0.3058816822504121;
O-glycosylation of TSR domain-containing proteins,2.0433505138837758,0.9394394484219818,1.769331991127427,0.34049658036688124,0.3119959467823231,0.33395231861614705,1.7274008365154796,0.37731445527559043,0.30150053284191936,1.7398086808229944,0.3058816822504121;
Telomere Extension By Telomerase,3.4485008740080163,3.654915515787562,0.37490798352710286,1.912435157830287,0.6258463409846801,0.8264678200355074,1.7210051105744164,0.4249621288821221,0.33154605935666304,1.6839835745055527,0.3058816822504121;
MECP2 regulates transcription factors,4.144020285235012,0.36250846227187006,1.070454754960547,0.3760011131095386,0.39794629746034765,0.47055855225156185,1.7142215773962666,0.37363972655453026,0.3086647282719282,1.782862096605737,0.3058816822504121;
SUMO E3 ligases SUMOylate target proteins,2.320636649973854,0.3667015217797265,1.5284777681968063,3.2470119190423508,0.631676288554392,4.576028912807682,1.7032011584283775,0.31482486972733703,0.34010467491250734,0.4678954462589095,0.3058816822504121;
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,0.47615683619677523,0.6735631991464341,0.6826888831877675,0.3861917421038416,0.6899473180595564,1.1133126369809128,1.681648513100384,0.33030236244002353,0.3728343545959842,0.44297218450032194,0.3030467691849685;
Elastic fibre formation,2.2242387712377516,0.8294461261044188,0.5853831675475044,0.8191557923832719,0.4549475819776362,0.40857645150366523,1.6764282142783753,0.30318050255984674,0.37714526130064224,1.2778763660326218,0.3058816822504121;
Defective B3GALTL causes Peters-plus syndrome (PpS),2.111991804703528,0.9363641915722525,0.7806341170784341,0.3454633916917074,0.3119959467823231,0.3247733431537802,1.676176827688929,0.36593959197886095,0.31952804471255203,1.7387034335731002,0.3058816822504121;
Post-translational protein phosphorylation,1.9408956008642335,0.9864467409131318,0.4119606365962435,1.407523383713084,0.5352610187418227,0.32582525152199426,1.6721858296759586,0.48606186013240477,0.3156659602261388,0.5709612416275753,0.3058816822504121;
Activation of ATR in response to replication stress,4.738044297678027,1.2704541370857034,0.31061548093833846,5.2935118880358,0.4027637435721038,4.273883413908051,1.6711999860999434,0.32900248352243355,1.1228697515839787,0.30352660857733577,0.3058816822504121;
TP53 Regulates Metabolic Genes,0.32058587970876234,0.6277754778003083,1.8138294843570146,0.46400369563241667,0.3076326161437668,0.4791666961557156,1.6679380721735457,0.48707618061008195,0.32855021388126704,1.122924133277537,0.3058816822504121;
Molecules associated with elastic fibres,2.72974796987782,0.8902912872545319,0.3654193179949343,1.2674788897941585,0.3726312003584851,0.5163579268941797,1.6679380721735457,0.34728051223511597,0.38395097131164374,1.111235682674113,0.3058816822504121;
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,0.4320545812171227,0.5722327885723628,3.4288675997688203,0.6924045926167081,0.6503559917182676,0.46829287577570267,1.6643397459718552,0.3677622666458591,1.9030870272226388,0.41171584476224793,0.3058816822504121;
RUNX2 regulates chondrocyte maturation,1.1224086228961996,1.3016660431821256,0.6898696912462724,1.4546697777633681,0.33966982472258983,0.49798337678608023,1.660118893024475,0.3425206096678787,0.8532127963693008,0.692461588309156,0.3058816822504121;
Regulation of HSF1-mediated heat shock response,2.4251888899572567,0.8410357410402534,0.4018400955900535,0.5874431926211804,0.4137125282224772,0.7545306860698988,1.6520335144887663,0.4681429621674421,0.3728343545959842,1.2326340977078138,0.3058816822504121;
p75 NTR receptor-mediated signalling,0.5683909737176474,0.3056840411843316,0.36059612953966136,0.3881184602725714,0.7718999313456109,0.887962512340968,1.6486120852012367,0.4045210707684523,1.2609602041702876,0.7364624317206159,0.3058816822504121;
RHO GTPases Activate ROCKs,3.102340911232108,1.0929874257862304,0.47620779881555453,1.26254191554577,0.4519979558883274,0.3111782497541377,1.6465713401241038,0.34869478305219637,0.41922428215661073,0.39233585251921227,0.3058816822504121;
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,0.6194513358056227,0.340846924720855,0.783086348819216,0.5594375996414769,0.7668371077295931,1.3166856995971514,1.6452518749763083,0.33696163270265517,0.32819706770507,0.37636770226551464,0.3024439670208732;
HDR through Single Strand Annealing (SSA),5.95981388527215,0.964165667994885,0.3925098753478222,4.434595686397295,0.3430871225976707,2.9655972209669788,1.6447205045965803,0.45374902011684204,0.7098944793005644,0.8588565143591822,0.3058816822504121;
Removal of the Flap Intermediate from the C-strand,4.452863835527824,0.852232363567517,1.0619460329506734,3.6967927679806074,0.3226140943665297,2.9274759460721342,1.6335559301914229,0.5976383571432007,0.31837078236812505,0.4121812366547547,0.3058816822504121;
Defective B3GAT3 causes JDSSDHD,0.3219535167637239,0.3667015217797265,0.3208535148713935,1.4562188067639485,0.31167319664073184,0.3111782497541377,1.6322452950390658,0.5693729600094288,0.36401522101493045,0.3062654297221931,0.3030467691849685;
Expression and Processing of Neurotrophins,0.9962224759148058,0.49235411393427414,0.3044513732107998,0.997789980105063,0.30418705243734856,0.38449502973852007,1.6313637066367588,0.35971925328583354,0.3061329461218883,0.951176730912015,0.3058816822504121;
NGF processing,0.9962224759148058,0.49203839829599755,0.3044513732107998,0.9968641398880723,0.30418705243734856,0.3845667208434919,1.6313637066367588,0.35971925328583354,0.3061329461218883,0.9397250270818209,0.3058816822504121;
Diseases associated with glycosaminoglycan metabolism,1.4230067018621506,1.2647518802880215,0.34921955778274816,1.8196271376003803,0.33910487705697223,0.416812166468743,1.6313637066367588,0.48606186013240477,0.37721347556427365,0.44003228136851946,0.3058816822504121;
Post-chaperonin tubulin folding pathway,4.568847298721612,0.30188327596459563,1.9867092325683653,0.39485276920195894,0.5294621773748719,0.8754497890577562,1.630980403094236,0.34311923132904953,0.3340537124683427,1.397736080653779,0.3058816822504121;
The NLRP3 inflammasome,2.799193160247602,2.0049114338084766,0.3081915935170801,0.5259000391854405,0.45810052203947244,0.416812166468743,1.6272257481533692,0.34398443282195684,0.34010467491250734,1.9363460356494893,0.3058816822504121;
Extracellular matrix organization,1.9470140752866025,0.9233243633931332,0.3654193179949343,0.7196693241280046,0.3764809604369917,0.4740958533880879,1.6255184737012287,0.3317123913477366,0.30168577129534885,1.397736080653779,0.3058816822504121;
Axonal growth stimulation,0.6635617905334938,0.34088690059804977,1.2511337055754643,0.44798489210058173,0.531793620499492,0.5191204755954681,1.6234548000050808,0.4961726669538443,0.33154605935666304,0.40829289210720515,0.3058816822504121;
A tetrasaccharide linker sequence is required for GAG synthesis,0.618211570078509,0.33875335399120593,0.39270315707408476,1.3585263502892364,0.3764809604369917,0.39430841547958956,1.60946852301488,0.6292462693883455,0.3728343545959842,0.30245448354214916,0.3058816822504121;
Signaling by NOTCH1 HD Domain Mutants in Cancer,1.2457772246121592,0.3918158246299093,0.7815200265528655,1.105966811920846,0.3764809604369917,0.32896239937812116,1.60946852301488,0.48606186013240477,0.318798370249978,1.6236159785959667,0.3032374359194824;
Constitutive Signaling by NOTCH1 HD Domain Mutants,1.2493275443344851,0.3918158246299093,0.779594076484441,1.1578910544844385,0.3764809604369917,0.3287334607648631,1.60946852301488,0.4849021760868862,0.31952804471255203,1.6236159785959667,0.3032374359194824;
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,1.0925235400679418,0.40598791126682915,0.6231240255902294,0.3459514817071011,0.3540024647605433,0.36504209043534924,1.6030801585574594,0.5941411603251999,0.37714526130064224,1.397736080653779,0.3058816822504121
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,1.0925235400679418,0.40577227024084006,0.632881360818366,0.34571014914919185,0.3535867649444133,0.36504209043534924,1.6030801585574594,0.5972444500514024,0.37714526130064224,1.397736080653779,0.3058816822504121
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,0.31395498614929856,0.4052791032235589,0.6068610223149116,0.33946015577309996,0.7035401242362743,1.0353214596801192,1.6030801585574594,0.36046186142273234,0.4748157664261176,0.7341780968319545,0.3058816822504121;
Anchoring fibril formation,0.36470840116198694,0.8731452798884973,0.3149477046576787,0.4296023820159213,0.3062883347986083,0.3111782497541377,1.6025024275024415,0.32735598382599135,0.31197598096833934,0.4678954462589095,0.3058816822504121;
Repression of WNT target genes,0.34171450624887706,0.3287763939899654,2.2730142328589253,0.4041685192123315,0.6948548813022634,4.170257495204747,1.6025024275024415,2.1126085293724817,0.3221822393925188,0.5973478083216586,0.9105851671176385;
Metabolism of nucleotides,1.6253403645869988,0.652403918986381,4.165829338515609,3.608664145972128,1.140011728673705,4.877972316111282,1.5959614780610978,0.35971925328583354,1.548245642681925,0.4671320580295842,0.3058816822504121;
Unwinding of DNA,4.0778187634191525,1.8918086097467384,0.3327614819001198,5.677792461818851,0.3918027183993316,3.3201652883190977,1.571876709320024,0.4160397494096559,0.9855919644519695,0.45080380185398955,0.3058816822504121;
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),3.173788606190508,1.0929874257862304,0.824931137133459,1.5818756201140158,0.3701740018252065,0.416812166468743,1.5689610320365055,0.6851051365582749,0.304022170806971,0.9717408988765865,0.3058816822504121;
Glutamate and glutamine metabolism,2.1393282481914127,13.831299297989082,0.7309875701584904,1.2093445819168447,0.3712537213651401,0.41662170072861154,1.5672505165025787,0.3765097523720731,0.3444643675395693,1.511390710286128,0.3058816822504121;
Biosynthesis of EPA-derived SPMs,1.4646749096374088,0.5825284386456702,1.1950274300413128,0.3503872330012344,0.4686364711018711,0.3111782497541377,1.565991616379178,0.39014468230695576,0.3693665271664583,1.005482149478308,0.3058816822504121;
NCAM signaling for neurite out-growth,1.60587601523418,0.9426378308077454,0.30134832367833375,0.9968641398880723,0.3540024647605433,0.44569311077594786,1.5521424655567555,0.32753430183444365,1.0867742081767566,0.9826765143167525,0.3058816822504121;
Chondroitin sulfate/dermatan sulfate metabolism,1.7710604420483493,0.964165667994885,0.5946564056402482,0.6739582054110552,0.33627276072485157,0.32044843640589793,1.5466140852593848,0.30705368811069295,0.8259314828665482,0.981959263237452,0.3058816822504121;
PIWI-interacting RNA (piRNA) biogenesis,0.33440806025273945,0.4843431191386555,1.131757588112227,2.102950751985333,0.7398335368874693,1.8230513130835295,1.5338771080028337,0.638700226611994,0.41359881610222476,0.6061512233343724,0.3058816822504121;
Biosynthesis of aspirin-triggered D-series resolvins,1.2364378352286354,0.47698398560067923,0.996131501942276,0.3443618466988464,0.37572915566633974,0.31756868525892934,1.5326839517425284,0.6370660872345657,0.46436677939709486,0.845018555877083,0.3058816822504121;
TP53 Regulates Transcription of Cell Cycle Genes,1.9261651267983866,1.0283274780935037,1.180677839324132,1.6097929264053723,0.3119959467823231,0.4838797903392124,1.5228981546469225,0.43791357279423887,0.3074603287870551,0.5100898491572277,0.3058816822504121;
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,3.0534563828489176,2.068010548112878,0.9578594167399495,4.387615663162987,0.32401567573131707,0.609620681310484,1.522874484027763,0.33696163270265517,0.3089310108463698,0.47855894419573153,0.3058816822504121;
tRNA processing in the mitochondrion,0.7951459799759365,0.4064277384336719,0.44896251260719916,0.4147520762862274,0.30447768946963627,0.37649015236135064,1.5180551783468028,0.6178914059636784,0.45174765924593724,0.7528132738568389,0.3058816822504121;
CDK-mediated phosphorylation and removal of Cdc6,0.32213490899676,0.44979020246864093,1.0978943125065814,0.33467796722904414,0.697971698746192,1.0060496764132285,1.5180551783468028,0.45482312314956885,0.6435207819871164,0.4835502797846719,0.3058816822504121;
Phospholipase C-mediated cascade; FGFR3,0.3119979840557615,0.36250846227187006,1.0675872021284738,0.4147520762862274,0.3073643548426107,0.38644297502167896,1.518016332193685,0.35440324608796253,0.3406966434873319,0.3458960799904469,0.3058816822504121
Signaling by Insulin receptor,0.8072884376667768,0.6265184382363416,4.1185868944174455,0.41152679958989247,0.36717436297633466,0.9867923454306361,1.5065981767660523,3.5793220696144203,1.564493937350366,0.7495217694509368,0.3058816822504121;
Interleukin-18 signaling,1.4397746972757666,0.31070106152335225,0.43440649245058266,0.37342135828898027,1.2874327802868115,0.4495174142269448,1.506121755662293,0.3239716014333915,0.5618996433484565,2.184054235873919,0.3058816822504121;
Integration of energy metabolism,2.2455083828528766,1.2572936848446095,1.2878758335600908,1.5788367381604902,0.3935706368707596,0.44619406038606135,1.5025523457460142,0.761143084226597,0.30181279042607134,0.5100898491572277,0.3058816822504121;
Dectin-2 family,1.4829427746179273,0.4081569957992947,0.451301273526655,0.6224873233331033,1.477195955714148,0.5587546077562368,1.4973927361102781,0.4890921202267072,0.33154605935666304,1.9810374856610522,0.3058816822504121;
Laminin interactions,1.6897480225924955,1.4879452815809386,0.5958918847559157,0.39485276920195894,0.3682477132294071,0.3338497085090671,1.4973927361102781,0.4681429621674421,0.33154605935666304,1.2263648351639698,0.3058816822504121;
Signaling by NTRK2 (TRKB),0.4901045059710578,0.5232489845437017,1.3581963328275921,0.8811803124746056,0.403416377453631,0.624482589357438,1.4965505839035242,0.48606186013240477,0.3115924460534767,0.3545884713873209,0.3058816822504121;
Hyaluronan uptake and degradation,6.710489978662851,0.9846254897589394,0.5349670287033231,0.5043782219039552,0.3764809604369917,0.3321209692064086,1.4959037018085328,0.6348586776665224,0.32855021388126704,2.1235677133489212,0.3058816822504121;
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,0.5919316624496747,0.6937041650548988,1.3317043145500196,0.3388488933313274,0.3439134979171695,0.8048345693718679,1.4929557509995115,0.4628527562793292,0.3167022141326965,0.3113648294328876,0.3058816822504121;
Respiratory electron transport,0.44351687530887374,0.3861355519940489,1.200161912746773,0.3198395805486888,0.311114601116272,0.46829287577570267,1.4929557509995115,0.33696163270265517,0.5509385147508098,0.8618477111312528,0.3058816822504121;
MAP2K and MAPK activation,0.8323775981906836,0.4258502143176426,0.3654193179949343,0.4147520762862274,0.3479596344454571,0.31776991236841967,1.4869146491341396,0.37363972655453026,0.3156659602261388,0.4327164396326923,0.3058816822504121;
Toxicity of botulinum toxin type G (BoNT/G),0.35009297739730705,0.6748754522273666,0.5017359945597698,0.5993005284414504,0.6121291063627028,0.41883107863637975,1.482525599532588,0.4889749192665897,1.9819638635181802,0.3413952918045016,0.3058816822504121;
Transcriptional activation of p53 responsive genes  ,0.3914332839728542,0.3667015217797265,0.6371763478650965,0.55939732041043,0.5358107092946165,1.0507967390247956,1.4793043133182604,0.35971925328583354,0.33154605935666304,0.4121812366547547,0.3058816822504121;
Biosynthesis of D-series resolvins,1.3565219580137446,0.5319885558386853,1.0313275062642102,0.35523088969171535,0.39841886726404796,0.3864143810579853,1.4743180117709778,0.6370660872345657,0.4505231252205524,1.0028924848030474,0.3058816822504121;
Constitutive Signaling by AKT1 E17K in Cancer,0.9811650749744681,0.47780177796510204,0.35355852462954734,0.5259000391854405,0.5470726880024228,0.5587546077562368,1.4672627450374789,0.3027579187486238,0.36494779765230456,0.4724375413774212,0.3032374359194824;
Interconversion of polyamines,0.48313498722766435,0.3029713996082115,0.8833146903713517,0.7619189767331388,0.7409373343908842,1.2886150914238699,1.4658910110529497,0.44203855648039064,1.7410512355515222,1.3535894708088327,0.3058816822504121;
NOTCH2 Activation and Transmission of Signal to the Nucleus,1.5998049824849891,0.30397605771269914,1.333307968049021,0.4602774105125744,0.41200215293113845,0.44267892191844305,1.4621714882302796,0.4139362081018729,0.33154605935666304,1.3560558566552476,0.3030467691849685;
Synthesis of PE,1.603124623320052,1.1251268407618977,0.5017359945597698,1.6765841645246748,0.33664443463132226,0.4107256546615841,1.4611947008609767,0.3323267677217555,0.42382662266091486,0.35923491767026133,0.3058816822504121;
The role of GTSE1 in G2/M progression after G2 checkpoint,0.6428982680515768,0.5270321910194009,0.6066943934222234,0.5139469552228029,0.7052081630476319,1.29306110417138,1.458446637386149,0.5972444500514024,0.3065164849314509,0.45956823263269403,0.3058816822504121;
Downregulation of ERBB2:ERBB3 signaling,0.5494083030290889,0.42498593976503624,0.4984568805588768,0.5950246338700154,0.32592363025525606,0.9676958418812457,1.458446637386149,0.6552415765802345,0.33739819261535414,0.40014141471750087,0.3030467691849685;
NOSIP mediated eNOS trafficking,0.5444973561544064,0.9846254897589394,0.4601839886153217,0.6461654038759334,0.3354368375654175,0.3650672982623884,1.4576967662843883,1.610204622191721,0.3327832096024327,0.8169149444586311,0.3058816822504121;
Alternative complement activation,0.39955822389257056,0.5103124098378026,0.3240344544485519,2.330657766589097,1.4527835083452083,0.7305728899620716,1.4567195517327394,0.4594542354595542,0.5140766613827893,1.203171060141853,0.3058816822504121;
PKA activation in glucagon signalling,1.7078957480558237,0.626417905743313,3.5447973533556087,0.3163170636750133,0.45283873819800846,0.36504209043534924,1.4411476760901136,0.3239716014333915,0.37721347556427365,1.1526365629019313,0.3058816822504121;
Biosynthesis of E-series 18(R)-resolvins,1.1580213671162425,0.42036494793775453,0.8103200644570416,0.3388488933313274,0.3726312003584851,0.33395231861614705,1.4400654748518846,0.6758900339821093,0.554461158330871,0.766173444477121,0.3058816822504121;
RUNX3 regulates WNT signaling,0.5087320036543982,0.3051715086707191,1.2858180776004795,0.34114908780953945,1.0256912932043623,3.455836115267905,1.4377513870278193,3.2049222455102298,0.441266538994127,1.121605189596718,0.6091415281040035;
FGFR1 mutant receptor activation,0.5828705094117614,0.3021233944379066,0.648943628171041,0.49786442742870163,0.3013326104404369,0.50226676089624,1.4289215027310374,0.3841922058752813,0.34010467491250734,0.7164596722064461,12.9767469590817;
Synthesis of IP3 and IP4 in the cytosol,1.390158676262722,0.31407750847502913,0.9223691915843929,0.6078708492958841,0.6881908609437631,0.7086199605226483,1.427674026451407,0.3751809727502707,0.34010467491250734,3.3534585797797267,0.3058816822504121;
Antiviral mechanism by IFN-stimulated genes,1.8042258469991819,0.3650614398467666,1.800774298705817,1.8772690127110976,0.8217143319876616,3.92718081101197,1.4269264264390171,0.32753430183444365,0.6346345296616243,0.3146249156431087,0.3058816822504121;
Regulation of TP53 Activity through Phosphorylation,4.2203106668852834,1.4879452815809386,0.35128019774592034,5.238226444283933,0.330372459861341,4.460539542243616,1.4246470269028744,0.42495982760195505,0.4066299711850315,0.3262060548532868,0.3055571020292233;
ECM proteoglycans,0.9962224759148058,0.852232363567517,0.3232761497961631,1.9546483118621103,0.39026309562416256,0.3980703831398632,1.4228211654696634,0.4174204318185248,0.31808512104917774,0.4678954462589095,0.3058816822504121;
Intrinsic Pathway of Fibrin Clot Formation,6.553106532948259,1.2007978621688389,0.3240344544485519,0.9613470798906708,1.0702835859303041,0.4462005514578704,1.4228211654696634,0.5578106790042832,0.3728343545959842,1.8792239064126597,0.3058816822504121;
Biosynthesis of E-series 18(S)-resolvins,1.2701910827760183,0.4843431191386555,0.8437040000824775,0.3503872330012344,0.397151474618249,0.39579425561555787,1.4228211654696634,0.6303443794140307,0.536884289765251,0.9359892439418809,0.3058816822504121;
Chondroitin sulfate biosynthesis,1.6577062689292843,1.0980016918828854,0.6591677457613747,1.6219073365732768,0.35573771241937,0.395942775053262,1.421886013428326,0.3108923324961582,0.539731828546328,0.7840023142261238,0.3030467691849685;
Defective B4GALT7 causes EDS, progeroid type,1.190418935806063,0.36250846227187006,0.5016034104344255,0.8273762681817375,0.33627276072485157,0.3420003235500663,1.4199530076673927,0.43025942071938894,0.3065164849314509,0.3359029760347333,0.3032374359194824;
Type I hemidesmosome assembly,0.8546910920022099,2.068010548112878,1.2236276047772852,0.38194996297766176,0.40860079057844856,0.4127644252979026,1.4198894963669024,0.48606186013240477,0.3418975449068169,0.4404591951700404,0.3058816822504121;
AMPK inhibits chREBP transcriptional activation activity,0.7982483117508167,0.7690386449904469,0.41725135670861263,0.3503872330012344,0.39113834579371415,0.39885350230807887,1.418326831472235,0.31539388260432966,0.4141350390547139,1.0029080880852357,0.3058816822504121;
FRS-mediated FGFR2 signaling,0.4762854385211099,0.353449013856183,1.0074404268934358,0.3589172357363164,0.397151474618249,0.3111782497541377,1.4145962574325526,0.32587291250103156,0.3089310108463698,0.41587100762065193,0.3058816822504121;
Visual phototransduction,0.670812212167234,2.095028411349065,1.3803583777110435,3.970064910361211,1.24961484388584,1.0636399438489696,1.4130166104932096,0.7808545639669524,4.097646175707529,0.8500482847680241,0.3058816822504121;
Prefoldin mediated transfer of substrate  to CCT/TriC,4.903830897189275,2.410257389274893,1.804489342542497,3.558232156772713,0.5352610187418227,0.7469171680434654,1.4117565886828156,0.3251934547032587,0.4748157664261176,0.5848007762955076,0.3058816822504121;
TRP channels,0.47785491858863993,0.32069448362191266,0.9579023496523752,0.9358640275879555,0.30246496029501807,0.4374379877874899,1.4090754909196275,0.524218023045207,0.4007681651647539,1.534402703378459,0.3058816822504121;
AKT phosphorylates targets in the nucleus,0.3697786288314644,0.34355423434661836,0.4119606365962435,0.32978641818617105,0.3226140943665297,0.3111782497541377,1.4090754909196275,0.7086724457561365,0.3693665271664583,0.6749860520434376,0.3058816822504121;
GP1b-IX-V activation signalling,0.5954492320468132,1.2359522214369099,2.0596888903720814,2.7172194266215093,0.377484511377512,0.3362870662398766,1.4090754909196275,0.44203855648039064,0.3170116103066843,0.5572543696805208,0.3058816822504121;
EPHB-mediated forward signaling,0.3119979840557615,0.30397605771269914,1.1958388200667958,0.46898504590813767,0.5587610474053752,0.3748291066993173,1.4073371082735582,0.31539388260432966,0.3878635720534119,0.3321330512604211,0.3058816822504121;
Common Pathway of Fibrin Clot Formation,4.793465774230655,1.5506854247546016,1.2149703771791165,1.0105202562664246,0.37205774949981,0.4126833593188166,1.4073371082735582,0.48606186013240477,0.32855021388126704,1.0087083329123843,0.3058816822504121;
Cellular response to heat stress,1.8281285984430655,0.5825284386456702,0.39161510178558023,0.350714016868682,0.3582517495823203,0.6051375835311831,1.4038986532606814,0.35082679893314456,0.3522221105554151,1.0782287355523688,0.3058816822504121;
Transcriptional  activation of  cell cycle inhibitor p21 ,0.3914332839728542,0.3667015217797265,0.6371763478650965,0.5602202638675143,0.5358107092946165,1.0507967390247956,1.3901210411898957,0.35971925328583354,0.33154605935666304,0.4121812366547547,0.3058816822504121;
Defective B3GALT6 causes EDSP2 and SEMDJL1,0.49952890526364874,0.3225308422051359,1.1088565736270573,0.9505926281081596,0.37908593583689865,0.3636895842323911,1.3844668696546127,0.4467806963553069,0.32445914808929255,0.35352371536264976,0.3058816822504121;
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.,0.5580015467292053,0.3090278240817252,0.3186523149786101,0.3163292158034775,0.3073643548426107,0.42442973454356425,1.3805499676552768,0.4467806963553069,0.36494779765230456,0.6492080770480536,0.3030467691849685;
CD28 dependent PI3K/Akt signaling,1.388819899095895,0.3998527053714512,1.9308829881164158,0.46898504590813767,0.8052575170093531,0.3762215469973146,1.3785949921276002,0.3094759427026921,0.7959865845481315,0.923825570314111,0.3058816822504121;
Activation of C3 and C5,0.4146405080672999,0.32979575975804937,0.4134699577910062,3.970064910361211,1.4151794689700676,1.1981792125246076,1.3775852912138769,0.4147150908432823,0.6459758662785066,1.3252235613115686,0.3058816822504121;
GLI proteins bind promoters of Hh responsive genes to promote transcription,1.618060390072973,0.43811797663171387,1.322897513905359,0.3454633916917074,0.41200215293113845,0.4541009858801141,1.3703339289640541,0.3843543347571224,0.46398019506563953,0.800110475091163,0.3058816822504121;
Apoptotic cleavage of cell adhesion  proteins,0.4319217421672363,0.7052414227406532,0.46128263629471095,0.3156748741478961,0.41200215293113845,0.8300173452917683,1.3699615162575398,0.5238886509233606,0.554461158330871,0.4121812366547547,0.3030467691849685;
Metabolism of non-coding RNA,3.5239547057790594,0.5698796886264856,0.4738126440768114,1.8196271376003803,0.3439134979171695,3.3731187884892058,1.3699615162575398,0.4467806963553069,0.3973359698996325,0.3133010171588978,0.3058816822504121;
snRNP Assembly,3.5239547057790594,0.5712132946545383,0.4738126440768114,1.8196271376003803,0.3439134979171695,3.3731187884892058,1.369772337078217,0.4467806963553069,0.3973359698996325,0.3146249156431087,0.3058816822504121;
Dual incision in TC-NER,0.4373746700048119,0.41369910628145334,0.9961962041516388,0.5016914801173993,0.46152238547560237,0.47111129867808327,1.36630418311145,0.48606186013240477,0.46688681742838806,0.674623706347905,0.3058816822504121;
Viral RNP Complexes in the Host Cell Nucleus,0.7011912520187482,0.3579101535729101,0.8490978546174842,0.3861917421038416,0.3363756870848458,0.4453298839223913,1.3655706518695245,0.5238886509233606,0.3990354706674196,1.0481684024711797,0.3058816822504121;
Assembly of the pre-replicative complex,0.33137564217830273,0.3051715086707191,0.3925098753478222,1.1578910544844385,0.8393533749514014,1.8648540081184395,1.3629605963216245,1.053092947380614,0.36494779765230456,0.5340244204278254,0.3058816822504121;
Phase 2 - plateau phase,1.9802663135012615,1.7291076827125254,0.34733542328568157,0.6739977932252961,0.75191901519524,0.8205962637560629,1.3629605963216245,0.36371079402101386,2.7323640632263615,0.41171584476224793,0.3058816822504121;
RNA Pol II CTD phosphorylation and interaction with CE,0.583134493938734,0.6937041650548988,1.3255828262854117,0.3388488933313274,0.3439134979171695,0.8048345693718679,1.3596976082585837,0.4628527562793292,0.3156659602261388,0.3113648294328876,0.3058816822504121;
APC/C:Cdc20 mediated degradation of Securin,0.5259896618479669,0.30713105125946294,0.6807884037372909,0.3655278051779804,0.6881908609437631,0.8475278621954552,1.3596976082585837,0.4849021760868862,0.3329607429278685,0.30795647085368,0.3058816822504121;
RHO GTPases Activate Rhotekin and Rhophilins,0.6614043453156894,0.576173559427021,1.0198426587787275,0.3213115419718923,0.3500419343212808,4.877927094460445,1.3581609599956568,0.6834181834101111,0.3406966434873319,0.9286390457962913,0.3058816822504121;
EGFR downregulation,1.5611808986035012,2.0049114338084766,0.4201686359858995,0.5076203200586503,0.30418705243734856,0.3111782497541377,1.3581609599956568,1.053092947380614,0.30150053284191936,0.35352371536264976,0.3058816822504121;
Downstream signal transduction,0.674860751334052,1.3746331134388452,1.180677839324132,0.3454633916917074,0.33664443463132226,1.351760201889807,1.3578899092984074,0.7214872606359403,0.31122200488443763,0.30585742098687774,0.3058816822504121;
NCAM1 interactions,1.2147961176089028,0.6161081789146999,0.366949816375034,1.0107456055527555,0.34981833229815285,0.3540970261426587,1.3578899092984074,0.44203855648039064,0.36494779765230456,0.5975724142236022,0.3058816822504121;
Nuclear Envelope Breakdown,3.044897753401928,0.4064277384336719,1.7218543805079656,2.6417222582683317,0.3439134979171695,4.316479479523637,1.3578899092984074,0.48606186013240477,0.43163069758557865,0.47575535715786293,0.3058816822504121;
Biosynthesis of electrophilic -3 PUFA oxo-derivatives,1.012327603540305,0.3691439136623758,0.5439930076286128,0.3198395805486888,0.311422158602307,0.4461518232477087,1.3555693950200884,0.30982906409707045,0.3227320418931485,0.7258445780105085,0.3058816822504121;
Biotin transport and metabolism,0.636646383863816,0.7380453821386058,0.5824548699977211,0.38650006444627144,0.4393593943366305,0.3111782497541377,1.3545969229441515,0.6652097340320369,0.40185191351970145,0.4601156100258348,0.3058816822504121;
Formation of ATP by chemiosmotic coupling,0.39952318228467737,0.3225308422051359,0.8003745452845533,0.4609306983002966,0.4053350549556549,0.6283251473032605,1.3545969229441515,0.35357383253505825,0.3115924460534767,0.3698281574991312,0.3030467691849685;
Mitotic Metaphase/Anaphase Transition,2.324449573773478,0.8705631581546994,0.4603095424324561,5.178422163737668,0.7553018753694412,3.4990063583191167,1.3545969229441515,0.3811801504530512,1.042470285322291,0.4540611718827999,0.3058816822504121;
Formation of Fibrin Clot (Clotting Cascade),6.475275925847549,1.707790182337754,1.969790304079922,0.8109639229343182,0.9553950326482782,0.4008567504272784,1.3545969229441515,0.35971925328583354,0.3728343545959842,1.8218862440784502,0.3058816822504121;
Trafficking and processing of endosomal TLR,1.173248810608057,0.36231980452174045,1.0675872021284738,0.3703490861278739,1.3219685002111123,0.552499617515074,1.3521367238898498,0.3610048682403598,0.3728343545959842,2.6536993984911748,0.3058816822504121;
Orc1 removal from chromatin,0.382661322523146,0.3294175279576714,0.4978925854600094,1.1876979507336975,0.8350420563859239,2.089802430780147,1.3382644744314531,0.6834181834101111,0.3444643675395693,0.4569839190337219,0.3030467691849685;
Signaling by FGFR2 in disease,0.9053507140392372,0.3635359057979434,2.2236859201531085,2.05197241851647,0.7727766962590503,3.3569336385898523,1.3305565549153133,0.6552415765802345,0.5493482026354087,0.5280321394999583,0.3058816822504121;
PKA activation,1.5039403706297234,0.42498593976503624,2.2258969211531747,0.40156829804312644,0.33910487705697223,0.47677687539221214,1.3304379795540895,0.32753430183444365,0.3522221105554151,1.1825458727854834,0.3058816822504121;
RET signaling,1.2539408448910911,0.3029713996082115,2.019520967943918,0.6953694944185232,0.9498004825038061,3.0866357806647517,1.3304379795540895,0.4594542354595542,0.5843054969729731,3.422367428088535,0.3058816822504121;
Synthesis of Lipoxins (LX),1.1414855379932005,0.8471359067348253,1.5977118412502447,0.6114469800652148,0.33627276072485157,0.31129525456137674,1.3304379795540895,0.3610048682403598,0.37771151139769193,0.5100898491572277,0.3058816822504121;
Signaling by Hippo,0.6875281949141528,1.0465409745822256,0.3648511899524546,2.103550734576822,0.41200215293113845,0.48673523054203316,1.3304379795540895,0.35971925328583354,0.31752877036645083,0.6761130629120682,0.3058816822504121;
Collagen biosynthesis and modifying enzymes,0.6700409074769473,0.4081569957992947,0.8725696590204259,0.39994270381988545,0.330372459861341,0.46297556448329885,1.3304379795540895,0.5174152264767676,0.3900183977157809,0.6577463599492671,0.3058816822504121;
Synthesis of 5-eicosatetraenoic acids,1.0023696317814863,0.6035242997208347,1.742583669847864,0.3628766921649118,0.433323819297691,0.4461518232477087,1.3304379795540895,0.32897364575734395,0.33154605935666304,0.4678954462589095,0.3058816822504121;
Crosslinking of collagen fibrils,0.311283752599729,0.3667015217797265,0.7141385296207127,0.4089998179955564,0.3374622944877682,0.34039227692083646,1.3253212134778356,0.3356960773573929,0.3900183977157809,0.32876304540081414,0.3058816822504121;
Plasma lipoprotein remodeling,4.905282963979559,0.9285413398621923,1.2288352490974646,0.4303767648874029,0.6193726337099273,0.3809356452270987,1.3253212134778356,0.35231647076248385,0.37714526130064224,1.2158216177904453,0.3058816822504121;
Folding of actin by CCT/TriC,1.8281187148127382,1.0468879055270799,0.3866502381950895,0.9052240726206379,0.35573771241937,0.7155883661323684,1.3185622405482527,0.31539388260432966,0.35302810544728686,0.44811482431034744,0.30540190655612415;
Signaling by MET,0.9016601303226309,0.8294461261044188,0.3196134621449584,1.0907646901544714,0.3439134979171695,0.3762215469973146,1.3138846825983324,0.5918767786718077,0.32855021388126704,0.5572543696805208,0.3058816822504121;
Polymerase switching on the C-strand of the telomere,4.452863835527824,0.8539647186613414,0.3206195074938858,3.90676401577355,0.3119959467823231,3.4293581478348734,1.3066699549674592,0.3595677799732618,0.3406966434873319,0.3117369630687721,0.3058816822504121;
Polymerase switching,4.452863835527824,0.8603489564765663,0.30546889817514716,3.90676401577355,0.3119959467823231,3.4293581478348734,1.3043007010624086,0.35971925328583354,0.3406966434873319,0.3118244763702296,0.3058816822504121;
Leading Strand Synthesis,4.452863835527824,0.8583037473769114,0.32016539430862967,3.90676401577355,0.31579531127581695,3.4293581478348734,1.3009056560405983,0.35971925328583354,0.3406966434873319,0.3126363644087619,0.3058816822504121;
Collagen formation,0.6194283810406251,0.3667015217797265,0.8709807152239016,0.32100808197395886,0.3764809604369917,0.3570912656132062,1.2888378267229204,0.32753430183444365,0.3418975449068169,0.9276051636564756,0.3058816822504121;
Cyclin E associated events during G1/S transition ,0.3119979840557615,0.33875335399120593,0.3081915935170801,0.32942621734780814,0.6707343576859068,1.3831501552662897,1.2879234589521615,0.5976383571432007,0.33154605935666304,0.47728954306028143,0.3058816822504121;
Methionine salvage pathway,0.4839303881219001,0.4408812240548287,1.7620369297399114,0.3163292158034775,0.3439134979171695,0.3620735944925361,1.2851982720914055,0.31539388260432966,0.3170116103066843,0.3196274963593275,0.3058816822504121;
Cyclin A:Cdk2-associated events at S phase entry,0.3162862152926333,0.3659796444425064,0.4037156908175814,0.3503872330012344,0.6776561166140836,1.437473387234977,1.2851982720914055,0.5693729600094288,0.32397177416554596,0.8670481697574285,0.3058816822504121;
Signaling by PDGF,1.4261949681745547,0.9900473145611959,0.978012979940111,1.8149276105574745,0.3116400599828412,0.3016396502031023,1.2847280687799272,0.9375579230609761,0.36494779765230456,0.30241267449194814,0.3032374359194824;
Defective DPM2 causes DPM2-CDG (CDG-1u),1.0723302102384076,0.4916469925647314,0.3366102940742713,0.48547093371219235,0.3824048831138682,0.42626866561660953,1.2745879305025287,0.34398443282195684,0.3767180855717169,0.951176730912015,0.3058816822504121;
Synthesis of dolichyl-phosphate mannose,1.0751753536267907,0.4916469925647314,0.33530251087995344,0.4863905316506313,0.37913461146889044,0.4229789398482754,1.274551784582329,0.34398443282195684,0.37489773248453867,0.951176730912015,0.3058816822504121;
Defective DPM1 causes DPM1-CDG (CDG-1e),1.0751753536267907,0.4916469925647314,0.3384666561332321,0.48737980949925297,0.3764809604369917,0.42442973454356425,1.2726023434592206,0.34398443282195684,0.37462851021829596,0.9562192771334456,0.3058816822504121;
Defective DPM3 causes DPM3-CDG (CDG-1o),1.0814758562789666,0.49023002456961257,0.33097803809829474,0.48853611966738064,0.3764809604369917,0.4229789398482754,1.2726023434592206,0.34398443282195684,0.3731178213186263,0.9562192771334456,0.3058816822504121;
Biosynthesis of DPAn-3 SPMs,0.9778686103620936,0.35463206527573876,0.35275308129702004,0.3163292158034775,0.3073643548426107,0.4541009858801141,1.2726023434592206,0.3272468962834211,0.3106584475526706,0.6716459391729103,0.3058816822504121;
Biosynthesis of DPA-derived SPMs,0.9759808104049144,0.3518599213100919,0.34733542328568157,0.3163170636750133,0.3073643548426107,0.45669304565302665,1.2594896299455547,0.3272468962834211,0.3099928391378753,0.6716459391729103,0.3058816822504121;
PLCG1 events in ERBB2 signaling,0.51684419531862,0.7816596912323202,2.775606181270381,0.5043782219039552,0.3764809604369917,0.40222260368643264,1.2572375750586822,0.7214872606359403,0.3985982400107937,0.42736543431067714,0.3024439670208732;
Binding of TCF/LEF:CTNNB1 to target gene promoters,0.375817106410999,0.495607286091514,0.5303554176778794,0.3816686884212616,1.007071052446887,3.2341808430148733,1.2572375750586822,0.8392145373470217,0.33154605935666304,0.6631740676600648,0.3058816822504121;
Integrin cell surface interactions,0.9972316535966268,0.6667335201465007,1.0676748864658985,1.1876979507336975,0.44616793114086584,0.31776991236841967,1.2548224023909005,0.8811614588125113,0.441266538994127,0.45080380185398955,0.3035709016788323;
Interaction between PHLDA1 and AURKA,0.43052755340822224,1.2567397901919064,0.7332120241169651,4.5817959078878605,1.0674530881986561,2.296320264963004,1.2548224023909005,0.761143084226597,0.37722828848982887,0.30998757970726104,0.3058816822504121;
Adrenoceptors,1.9926929520975971,0.7993822973929178,0.6774436904910512,1.4839082806637571,0.4054565637555915,0.6289210074036768,1.2469192684784196,0.5918767786718077,0.6030427894263353,0.6638900922726186,0.3058816822504121;
Synthesis of Leukotrienes (LT) and Eoxins (EX),2.1766464010048794,0.9874628953643209,2.2570106663027447,0.39485276920195894,0.6109240307787517,0.3636895842323911,1.239433362730151,0.37731415007330193,0.33154605935666304,1.2791370700133242,0.3058816822504121;
Biosynthesis of DPAn-3-derived maresins,0.8938579921881726,0.32979575975804937,0.32129615227399566,0.3220708023044529,0.37205774949981,0.642400699933169,1.239433362730151,0.33990809468773525,0.4803178108338217,0.6740409396839165,0.3058816822504121;
Biosynthesis of DPAn-3-derived 13-series resolvins,0.9006595699269484,0.32979575975804937,0.3167249184563738,0.3198395805486888,0.3726312003584851,0.609620681310484,1.2317288638046062,0.3425206096678787,0.4881499224650157,0.6749467764774163,0.3058816822504121;
RUNX1 regulates expression of components of tight junctions,0.3481518561848366,1.4716788766927762,1.0197385901956895,1.6436782248202857,0.4027637435721038,0.31776991236841967,1.228739344853089,0.44203855648039064,0.3167022141326965,0.800110475091163,0.3058816822504121;
Synthesis of pyrophosphates in the cytosol,0.382661322523146,0.7083061017751114,1.7007113797573465,0.7213282986733195,0.35573771241937,1.2266820738215025,1.227296298948033,0.7214872606359403,0.37721347556427365,0.9189824627807782,0.3058816822504121;
MET promotes cell motility,0.4637962833951004,0.6539777764191337,0.3187470695503694,1.4020500854296265,0.32241542142330576,0.3188192698585969,1.226334108470892,0.35082679893314456,0.4917345000954562,0.4121812366547547,0.3030467691849685;
Inflammasomes,2.500540184850819,1.3570134356717731,0.3282913982361713,0.380333723709027,0.41200215293113845,0.43795195395984354,1.226334108470892,0.4589589677230645,0.371978773408492,2.4231988773254285,0.3058816822504121;
Hyaluronan metabolism,4.988717593215858,1.3636497081157748,0.6214317248794013,0.9266982369643003,0.4549475819776362,0.36504209043534924,1.226334108470892,0.3317123913477366,0.3329607429278685,2.183014455168301,0.3058816822504121;
Adenylate cyclase inhibitory pathway,2.298777125199066,1.0315778174135966,0.6196374237856637,0.5079620479270834,0.3666939927690388,0.47111129867808327,1.225758569548726,0.8253612893047934,0.6386368173287679,0.5100898491572277,0.3030467691849685;
Regulation of PTEN stability and activity,0.5106793381285393,0.9864467409131318,0.3186523149786101,0.3781533650620131,0.6707343576859068,0.9137094895429514,1.2165131932469888,0.31539388260432966,0.33154605935666304,0.6638900922726186,0.3058816822504121;
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,1.542607112490525,0.315650141649467,0.4134699577910062,0.39485276920195894,0.46163953884057446,0.42626866561660953,1.2155170590710251,0.48606186013240477,1.6603756444240487,0.5487808641124696,0.3058816822504121;
Defective CFTR causes cystic fibrosis,0.3516315902402807,0.4973390331284095,0.47160753149999735,0.3881184602725714,0.6094320344124834,0.6831411768175794,1.2153546863559037,0.6370660872345657,0.31966777048058687,0.41376887048902816,0.3058816822504121;
TRAIL  signaling,0.48313498722766435,0.3998527053714512,0.49881455715241907,0.34049658036688124,0.30418705243734856,0.45383436213121164,1.2107381211340034,2.7127242840664545,0.3248635531929545,1.7651903192172087,2.8600795292673964;
EPH-ephrin mediated repulsion of cells,1.7846574508567377,0.32069448362191266,0.4615098988112631,0.3198395805486888,1.1431615389490235,0.38953730540479536,1.2085096024617488,0.48606186013240477,0.46398019506563953,1.0087737611780307,0.3058816822504121;
IkBA variant leads to EDA-ID,0.4416826026365212,0.5160538865147885,0.43384618055957813,0.5051382176619013,0.39794629746034765,0.3126743134218902,1.2085096024617488,0.6552415765802345,0.7751171480581569,0.3633654668872511,0.3058816822504121;
PI5P Regulates TP53 Acetylation,1.1580213671162425,0.34397653289691277,1.462672958438261,0.4318721489856693,0.4298306147902347,0.5988041926881311,1.2039907400184409,0.6799766290735694,13.59933018389872,0.44445179257789924,0.3058816822504121;
Syndecan interactions,0.3568834151495811,0.30814244538089003,0.3355219527266201,0.6114469800652148,0.3119959467823231,0.4541009858801141,1.2032902363447098,0.37363972655453026,0.4834775083772459,0.41171584476224793,0.3058816822504121;
Autodegradation of Cdh1 by Cdh1:APC/C,0.3851513712885939,0.671007123935896,0.3683253397837756,0.38459539265859194,0.6466469555923923,0.704980305313448,1.2030233558055392,0.6834181834101111,0.37721347556427365,0.32204584831205535,0.3058816822504121;
GDP-fucose biosynthesis,2.4463965715486773,4.565979674034963,0.530089235023403,0.348933994183457,0.33406583255714095,0.3362870662398766,1.1900869105176977,0.3472764440688459,3.080651144049089,0.41104584371777314,0.3058816822504121;
Protein ubiquitination,0.5205111652447068,0.9221840381709459,0.4426141841101584,0.5037883573514967,0.3439134979171695,0.35384340849436446,1.1900120109610066,0.5226955554832011,0.3484005984762255,0.39091888813155207,0.3058816822504121;
Signaling by NOTCH4,0.5437888218575485,0.3378343987873051,0.3493291651614246,0.34493403884766827,0.4829239057523196,0.5892932499870671,1.1900120109610066,0.34311923132904953,0.33154605935666304,0.4209700519911368,0.3058816822504121;
Complex I biogenesis,0.4826960453306865,0.421441415526736,0.33423491029840957,0.4238720058153167,0.4393593943366305,0.5646191142917181,1.1900120109610066,0.30762701980706253,0.5843054969729731,1.0724163704412397,0.3058816822504121;
ABC transporter disorders,0.38523662041238443,0.6161081789146999,0.8781730033946207,0.5084365731528091,0.6761194459288201,0.7948749809263548,1.185801588961583,0.360087866740119,0.5380488165948838,0.5124302984800859,0.3058816822504121;
Plasma lipoprotein assembly,0.3439432282083857,0.3725694337922093,0.6371763478650965,0.34114908780953945,0.7649116976674908,0.5722558485099711,1.1824290472283883,0.5578106790042832,0.6839180635564396,0.9562192771334456,0.3058816822504121;
activated TAK1 mediates p38 MAPK activation,0.39952318228467737,0.5030906923983931,0.9454426836008242,0.7212622829819871,0.5630931066485048,1.7046043062227327,1.1824290472283883,0.4628527562793292,0.46398019506563953,0.4540611718827999,0.3058816822504121;
TGFBR1 KD Mutants in Cancer,0.43458744757661255,0.9846254897589394,0.5573559501887005,0.7323545191286396,0.47931777411784515,0.3016037797893944,1.1824290472283883,1.4351867368392095,0.3973359698996325,0.7302267570893407,0.3058816822504121;
SMAD2/3 Phosphorylation Motif Mutants in Cancer,0.43437865752464877,0.9846254897589394,0.5569247897499532,0.7558688152758588,0.48046633727165955,0.30146276932778043,1.1814137782855154,1.4351867368392095,0.3973359698996325,0.7302267570893407,0.3058816822504121;
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,0.4738283916537067,0.311151884547695,0.5130503622174319,0.3411192642224706,0.3791920767944086,0.416812166468743,1.1814137782855154,0.7214872606359403,0.30150053284191936,0.4523752385250782,0.3058816822504121;
Biosynthesis of DPAn-3-derived protectins and resolvins,0.8154588260514137,0.31070106152335225,0.5326692938651336,0.3156748741478961,0.3726312003584851,0.5449961805871676,1.1786039119990845,0.3356960773573929,0.42382662266091486,0.5560681788194175,0.3058816822504121;
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,0.3119979840557615,0.3393935927201346,1.705151093821797,0.7171066529313128,0.33313699616693,0.3111782497541377,1.1758044370203784,0.3677622666458591,0.3046287227980124,0.30241267449194814,0.3058816822504121;
N-glycan antennae elongation in the medial/trans-Golgi,1.5472801707795352,0.9170022925106858,0.42888022381690727,3.9898187500773092,0.35830085846035925,1.7413511542440867,1.1758044370203784,0.3317123913477366,4.040430321248823,0.3286979716130023,0.3058816822504121;
SUMOylation of ubiquitinylation proteins,1.6735258646091584,0.5550410065029113,0.928144241752816,1.3964847376477811,0.5724292987597449,2.5021196303280515,1.1739433428462296,0.34728051223511597,0.33482577791173423,0.3559809740974252,0.3058816822504121;
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.5654079179337074,0.4730106764532055,0.824931137133459,0.5496045095142982,0.3082126526753394,0.3410850662423667,1.1739433428462296,0.48606186013240477,0.7574177165397277,0.8618477111312528,0.3058816822504121;
Negative regulation of NOTCH4 signaling,0.49987486155554384,0.3351332739777284,0.8493158983861442,0.45814106070834476,0.5277268907652843,0.7354251946547213,1.1739433428462296,0.35200545937489847,0.3506743079000685,0.6518466751524737,0.3058816822504121;
EPHA-mediated growth cone collapse,5.485495285762694,0.6667335201465007,1.101305719684011,0.3657188180620897,0.433323819297691,0.35726191615601155,1.1739433428462296,0.682677286879512,0.31837078236812505,1.1356409598867205,0.3058816822504121;
5-Phosphoribose 1-diphosphate biosynthesis,0.3081642843377598,0.4052791032235589,1.192546288252778,0.7272749296705056,0.3073643548426107,0.44843851121524814,1.1723133224620044,0.40342728894670354,0.33154605935666304,0.4400161725783085,0.301074066609359;
Interleukin-12 family signaling,0.3119510433974464,0.4219935598497626,0.6041665715926541,0.3163292158034775,1.4497014587581227,1.7489317519499181,1.1598576479084846,0.5389628321778192,0.37714526130064224,1.7889291130233775,0.3058816822504121;
Intracellular oxygen transport,4.195852749615313,1.553934274347136,1.3670311978785765,0.3232519888569888,0.35830085846035925,0.43795195395984354,1.1598576479084846,0.31539388260432966,0.30458685905162125,1.4414183071780486,0.3058816822504121;
Assembly of collagen fibrils and other multimeric structures,0.6201674709820884,0.3486664547515465,0.5446089274005077,0.8457709501390084,0.33627276072485157,0.3829935829538375,1.1520343963086814,0.5065936427260506,0.39838117936895323,0.406803115424453,0.3058816822504121;
MET interacts with TNS proteins,0.3672789551152327,0.9846254897589394,0.7360132459775123,0.3657188180620897,0.4393593943366305,0.3260350496628621,1.1501276360100252,0.3280402703349836,0.3522221105554151,0.800110475091163,0.3058816822504121;
Degradation of GABA,0.37370124783103914,0.4081569957992947,0.3654193179949343,0.34712825185525215,0.4146172972667351,0.39236392368147566,1.1501276360100252,0.35971925328583354,1.3584128054537563,0.3460910784833522,0.3030467691849685;
BDNF activates NTRK2 (TRKB) signaling,0.9222666017504344,0.6441853723194954,2.12515089083502,0.3454633916917074,0.32162569628297455,0.5175419987834062,1.1460045214926282,0.30980925894012945,0.31751321075844985,0.3794607950605625,0.3058816822504121;
Relaxin receptors,0.6747043208872688,0.5698796886264856,1.3947624066701454,0.3684705508289915,0.3726312003584851,0.6173359364348264,1.1458963492125787,0.37731415007330193,0.42933067375325595,0.532096178369972,0.3030467691849685;
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),3.513925845785902,0.8731452798884973,1.2935374733013651,3.90676401577355,0.3401010458333853,2.920490837272141,1.1434294291585632,0.35971925328583354,0.3903925719755383,0.46947200515560084,0.3058816822504121;
ARMS-mediated activation,0.781935049956095,0.34355423434661836,2.224672789121102,0.5837403236847422,0.33627276072485157,0.575932328187862,1.1409102063268721,0.33030236244002353,0.42382662266091486,0.3779099013633024,0.3058816822504121;
Collagen chain trimerization,0.6800605264950956,0.4753617019431409,0.3081915935170801,1.4565173004041339,0.33627276072485157,0.36661029332342004,1.1403872186278845,0.39688813005863777,0.31751321075844985,0.6057521514329932,0.3032374359194824;
Interaction With Cumulus Cells And The Zona Pellucida,0.35630097879567885,0.3998527053714512,0.5336487132370172,0.3861917421038416,0.3833312594850901,0.4300466631842503,1.1207091050286946,0.32735598382599135,3.4794704452045395,2.7980008285229334,0.3058816822504121;
Defective CHST6 causes MCDC1,1.542607112490525,1.2859613470789373,2.274460951015449,2.484633989732495,0.37205774949981,0.4449779716204163,1.1207091050286946,0.3821027672910627,0.4748157664261176,0.494813019504267,0.3058816822504121;
mTORC1-mediated signalling,0.38151213155035224,0.5524457627902223,2.7601178302984697,1.5926007218340952,0.3764809604369917,0.34084875043490775,1.1207091050286946,0.5347685416390742,1.2193717037228295,0.44065582267788694,0.3058816822504121;
Negative regulation of FGFR2 signaling,1.665362574307122,2.0049114338084766,0.4978925854600094,1.4632580675369928,0.3439134979171695,0.3131733022391502,1.1187211576900122,0.9408642598773541,0.3266862348880042,0.5395292439805308,0.3030467691849685;
Major pathway of rRNA processing in the nucleolus and cytosol,0.48313498722766435,0.4081569957992947,0.44631250225872743,0.3861917421038416,0.5565529203210395,0.30849637038472894,1.1148732050045913,0.30980925894012945,0.34130316986521125,0.32441519453153156,0.3058816822504121;
MAPK6/MAPK4 signaling,0.3914332839728542,0.3294175279576714,0.3222246234534123,0.3163292158034775,0.5724292987597449,0.7086199605226483,1.1115047844961343,0.5389628321778192,0.45588453227098574,0.38240110994955606,0.3058816822504121;
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,0.3672789551152327,0.7656302527157366,0.7345312812033951,1.7553854990874889,1.4497014587581227,1.9862542162815602,1.1115047844961343,0.7441213175540436,0.9562533704796862,0.30738279210111424,0.3058816822504121;
Synthesis of PIPs at the late endosome membrane,0.3222424055806548,0.4189941393851465,1.9192270715319373,0.3216716125879247,0.33154182128857623,0.5722558485099711,1.1100495327493987,0.30318050255984674,0.3406966434873319,0.37636770226551464,0.3030467691849685;
SCF(Skp2)-mediated degradation of p27/p21,0.3288559388871276,0.301642737608084,0.8724582219656833,0.34242551078476546,0.697971698746192,1.3580772444178408,1.1057902636521542,0.3356960773573929,0.4183824020347335,0.38255419212893865,0.3058816822504121;
FasL/ CD95L signaling,0.9159507800071126,0.30188327596459563,0.735284600181154,0.330334113068339,0.3977920397900884,0.5352545584205672,1.100009878052027,0.9170098499594981,0.3187254357066004,2.098433648179519,0.3058816822504121;
Antagonism of Activin by Follistatin,0.3851513712885939,0.7380453821386058,0.734791934999741,1.8928898049558602,0.395589721156635,0.7749547701770431,1.0960775000216239,0.4628527562793292,0.329509855487524,0.44065582267788694,0.3058816822504121;
Negative regulators of DDX58/IFIH1 signaling,0.6098863292854918,1.4124990695405277,0.3569903115106941,0.3881184602725714,0.33627276072485157,0.5892932499870671,1.0936991651007115,0.32735598382599135,0.4644723627826459,0.7302267570893407,0.3058816822504121;
AURKA Activation by TPX2,3.9056836913532607,0.9233243633931332,0.824251251211372,4.2767157658415185,0.3560720414244286,2.273153270135932,1.0936991651007115,0.7193610937200206,1.9577678968020311,0.3196546939901526,0.3058816822504121;
Synthesis of Dolichyl-phosphate,0.6569886717314473,0.3165159964142589,1.196277770842612,0.3881184602725714,0.34375968214870317,0.6240899428585395,1.0936991651007115,0.33696163270265517,2.1835763489648667,0.47855894419573153,0.3030467691849685;
SUMO is conjugated to E1 (UBA2:SAE1),0.6245376956542105,0.3029713996082115,0.30645246957728123,0.38834181595987294,0.3791920767944086,0.3620735944925361,1.0936991651007115,0.3784754571208943,0.34130316986521125,0.47469881290334454,0.3058816822504121;
Golgi-to-ER retrograde transport,3.3554467601809845,1.6266739613271828,0.7596468158725196,5.548375529263906,0.384241151119403,2.062719946518636,1.0936991651007115,0.5111346635224848,1.438359750541821,0.4540611718827999,0.3032374359194824;
Digestion of dietary lipid,0.30554816552217945,0.30188327596459563,0.6515843562752316,0.39485276920195894,0.3119959467823231,0.35399026492638497,1.0921445769143707,0.5613944991412845,2.376208045576133,2.0013458358771636,0.3058816822504121;
Processing of SMDT1,0.6693465453492974,0.5103124098378026,0.39903972764696444,0.5051382176619013,0.4054565637555915,0.5646191142917181,1.0921445769143707,0.32753430183444365,1.1033715792095793,0.3370467040211229,0.3058816822504121;
Asymmetric localization of PCP proteins,0.6188386975716889,0.4243600375054851,0.36678512690310255,0.3861917421038416,0.6260612349337609,0.6480227603632602,1.088196399166523,0.6799766290735694,0.47514208089199056,0.4232200116160087,0.3058816822504121;
Metabolism of amine-derived hormones,0.3344139120290288,0.48371352640443255,0.7695585986948226,0.5879866812394244,0.3764809604369917,0.42924963491620954,1.088196399166523,0.4849021760868862,16.470576066019824,1.6512098538110724,0.3058816822504121;
ISG15 antiviral mechanism,1.4149993365040678,0.3041785410778355,1.9493330703177867,1.0777842431921825,0.5457806137591187,3.051590376705389,1.088196399166523,0.4147150908432823,0.3828268894890131,0.7164596722064461,0.3058816822504121;
Regulation of MECP2 expression and activity,0.3081642843377598,0.3393935927201346,2.993865667155949,0.3881184602725714,0.6398038670075493,0.9470898334811291,1.082595488657947,0.4628527562793292,2.376208045576133,0.7349362739842445,0.3058816822504121;
Disorders of transmembrane transporters,0.3697786288314644,0.3010748960204856,1.3650833694697109,0.3881184602725714,0.8350420563859239,1.6821633459490786,1.082595488657947,0.3234063097880479,0.7203797623308206,0.4540611718827999,0.3058816822504121;
HDL assembly,2.2135504621107365,0.45199084089717,0.7296558000778703,0.4410075290989604,0.8350420563859239,0.5646191142917181,1.079948855913666,0.6319864399547618,0.3384177868520018,2.4072876984101277,0.3058816822504121;
CDT1 association with the CDC6:ORC:origin complex,0.3672789551152327,0.7834004270680736,1.070454754960547,0.3881184602725714,0.6899473180595564,0.9190238686272136,1.079948855913666,0.3646829165254219,0.33154605935666304,0.5404034066670892,0.3058816822504121;
Dopamine receptors,0.3081642843377598,0.3667015217797265,0.3366102940742713,0.3861917421038416,0.3824048831138682,0.6910567342002203,1.0759858078443576,0.5753977044168755,0.3593300772343251,0.6585396001676244,0.3058816822504121;
Disassembly of the destruction complex and recruitment of AXIN to the membrane,0.7797053118867384,0.4795596063169615,1.3087269907221424,0.7868124106539722,0.40011734818170236,0.3899407675434497,1.074254904176918,0.6834181834101111,0.34015616903958523,0.5363788369295108,0.3058816822504121;
Toll Like Receptor 9 (TLR9) Cascade,0.43458744757661255,0.3057534806262932,1.1950274300413128,0.3198497854101864,0.6761194459288201,0.6858531250811165,1.074254904176918,0.35971925328583354,0.3418975449068169,0.5404034066670892,0.3030467691849685;
Translesion Synthesis by POLH,2.644941873946949,0.3351332739777284,1.0394768555096892,0.48726154948720196,0.49397349821228864,1.3682532712781112,1.074254904176918,0.5226955554832011,0.4141350390547139,0.6378704800725659,0.3058816822504121;
Assembly Of The HIV Virion,0.9759808104049144,11.828631724767966,0.7391101653549697,0.3142325622507859,0.46163953884057446,0.30259970477602033,1.074254904176918,0.5849889455049392,0.3326837406564544,0.4724375413774212,0.3024439670208732;
Defective HLCS causes multiple carboxylase deficiency,0.5371694080478244,0.49882509403717307,0.35516354224109725,0.36311486150506656,0.4146172972667351,0.321223791693833,1.074254904176918,0.31386088966176257,0.49668439604146514,0.47469881290334454,0.3058816822504121;
ABC-family proteins mediated transport,0.3390466778271897,0.601299658616172,0.6975061126349537,0.4397133281520862,0.6109240307787517,0.8243783587208424,1.073418523584151,0.4628527562793292,0.4156689500982106,0.31100904921848943,0.3058816822504121;
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,0.3120931253111028,0.5043313628503414,2.5759157192245343,0.39718831089691875,0.403416377453631,0.32860130936304466,1.073418523584151,0.34311923132904953,0.7405552827601248,0.3109481832046546,0.3058816822504121;
Deadenylation-dependent mRNA decay,0.8072884376667768,0.3667015217797265,0.7950820635273264,0.708600123500403,0.3791920767944086,0.48487375011027734,1.0732517391049174,0.4313030976096779,0.33154605935666304,0.4107549475395722,0.3058816822504121;
Nephrin family interactions,0.33895461643817115,0.6428029190167239,0.34193401791422934,0.3163292158034775,0.397151474618249,0.5040377049096719,1.07040341385839,0.315823518935115,0.33154605935666304,0.37636770226551464,0.3058816822504121;
Formation of tubulin folding intermediates by CCT/TriC,0.939881054665771,0.5878606479246475,1.3978305096688755,1.5014661879762816,0.35977304434813895,1.3931951322484968,1.0677885300694605,0.6303443794140307,0.7410614035594498,0.669644009748287,0.3058816822504121;
G1/S DNA Damage Checkpoints,0.3494888882207228,0.31193520510287587,0.8438685221695885,0.3861917421038416,0.7576852196375048,1.4373879458895074,1.0559191998399031,0.37816616888872967,0.378780953316455,0.3811579239158923,0.3058816822504121;
TET1,2,3 and TDG demethylate DNA,0.3181810258801609,0.6661757515657146,0.3186523149786101,0.5484133433813776,0.3119959467823231,1.0959136617025333,1.0558700959689362,0.42864408325691356,0.32815084485870327,0.41190486574419305,0.3058816822504121;
SUMO is transferred from E1 to E2 (UBE2I, UBC9),0.3272676534265424,0.5698796886264856,0.36876285793093794,0.9916833167931186,0.4511622529328227,0.33922161650894833,1.0515687407228982,0.7086724457561365,0.3061329461218883,0.7257968543160326,0.3030467691849685;
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,2.324449573773478,0.5232489845437017,0.3081915935170801,0.4296023820159213,1.0192124260773991,0.3111782497541377,1.0515123917149778,0.559800260443346,0.5264377585191584,2.1733796621331583,0.3058816822504121;
Synthesis of Ketone Bodies,0.49414180652094974,0.4347606387904254,0.38598716032143504,0.37782083903056873,0.45629440597618165,0.30146276932778043,1.046421508007242,0.6834181834101111,0.35776326036887945,0.462385235379379,0.3058816822504121;
CLEC7A/inflammasome pathway,0.41955155407635125,1.4255806559206314,2.274460951015449,0.3163292158034775,0.31734913788042046,0.3976005671239824,1.0454562587932785,0.48606186013240477,0.3156659602261388,0.5174219674490554,0.3058816822504121;
Activated NTRK2 signals through CDK5,0.3219535167637239,0.7834004270680736,0.6456887498484641,0.36903555914521596,0.330372459861341,0.5487753153582212,1.0429770898126285,0.37770911594983014,0.33154605935666304,0.39891851694034464,0.6091415281040035;
TNFR1-induced proapoptotic signaling,0.378064225064369,0.40129433999547554,0.48612061125083217,0.34552125769421904,0.37921048227433873,0.8076758870528746,1.0429770898126285,0.35971925328583354,0.3728343545959842,0.4724375413774212,0.3058816822504121;
Xenobiotics,0.7320559335945117,0.4155240941545764,2.235973608771295,0.5950246338700154,0.3472192758278547,0.3762215469973146,1.0395813934397595,0.42495982760195505,0.3693665271664583,0.500735103188049,0.3058816822504121;
Deadenylation of mRNA,0.727768550865018,0.30402224815377643,2.128780127984899,0.3163292158034775,0.5724292987597449,0.35767155389389355,1.0360752129914403,0.3236959244504871,0.48960016442446236,0.33740247317007105,0.3058816822504121;
Deubiquitination,0.3344139120290288,0.3467462991435672,0.39161510178558023,0.39081707964633383,0.4146172972667351,0.3181920679733564,1.0360752129914403,0.32735598382599135,0.31075100083854396,0.30585742098687774,0.3058816822504121;
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),0.39952318228467737,0.30844391279468925,0.4328969862201485,0.3142325622507859,0.4885269804840307,0.3328673103460413,1.0351290455631896,0.9897043482796474,0.37714526130064224,0.40442442825996894,0.3058816822504121;
Regulation of IFNA signaling,0.3729976114331958,0.3203499212257818,1.3530680439001457,0.3503872330012344,0.47980892873346814,0.3420003235500663,1.0347494949285738,0.5174152264767676,0.33154605935666304,1.087737376477904,0.3058816822504121;
Antigen Presentation: Folding, assembly and peptide loading of class I MHC,0.41053342463006914,0.4081569957992947,0.4077557145318142,0.3163292158034775,1.239479955932051,1.1003448142231438,1.0347494949285738,0.5238886509233606,0.3329607429278685,0.728520522915135,0.3058816822504121;
Rho GTPase cycle,2.6741124166574117,0.5270321910194009,0.3028277843853224,0.361961215039608,0.9810357787120494,0.38644297502167896,1.0347494949285738,0.37363972655453026,0.3089310108463698,4.413434828291935,0.3058816822504121;
N-Glycan antennae elongation,1.6442296502744895,0.4155240941545764,0.43068441469191265,2.2882197868998713,0.397151474618249,0.70206723630419,1.0347494949285738,0.30676358637777745,1.6897372176690348,0.3109481832046546,0.3058816822504121;
Initiation of Nuclear Envelope Reformation,0.469082934340401,0.4583996963357266,1.094034008285139,0.39485276920195894,0.6829114505337207,0.6077603829921325,1.0308440430229366,0.6652097340320369,0.37818098826263175,0.4540611718827999,0.3058816822504121;
Nuclear Envelope Reassembly,0.4669940870135927,0.4589854816754815,1.0964869439918954,0.39485276920195894,0.6844983104267376,0.6091496236054034,1.0276707940852259,0.6652097340320369,0.37818098826263175,0.4540611718827999,0.3058816822504121;
TRAF6 mediated NF-kB activation,0.3592920448352783,0.4052791032235589,2.1351019041384744,0.34493403884766827,0.40109453410937307,0.32040422109571975,1.0276707940852259,0.3677622666458591,0.3156659602261388,0.6592194040715842,0.3058816822504121;
Toll Like Receptor TLR6:TLR2 Cascade,0.3016763054275278,0.4284698207307233,1.585507937318083,0.3691573656851328,0.8663173673384363,1.162786089998547,1.0276707940852259,0.5226955554832011,0.32397177416554596,1.0736363732000191,0.3058816822504121;
Role of phospholipids in phagocytosis,0.7410430601092073,0.6617160530759545,0.6037000977769527,0.3074220055826222,1.4353727597575503,0.4541009858801141,1.0276707940852259,0.5578106790042832,0.5995387994397396,1.2477350955513915,0.3058816822504121;
Highly calcium permeable nicotinic acetylcholine receptors,0.40092328276644357,0.31917807339907006,0.3512635275580232,0.30944117762601814,0.30447768946963627,0.3314791681136684,1.0276707940852259,0.3234063097880479,0.33154605935666304,0.30738279210111424,0.3032374359194824;
NOTCH4 Activation and Transmission of Signal to the Nucleus,2.417947363876308,0.9846254897589394,0.6404379918504467,0.3454633916917074,0.39113834579371415,0.40857645150366523,1.0240837094249964,0.524218023045207,0.32819706770507,0.7313596113245048,0.3058816822504121;
TRAF3 deficiency - HSE,0.3481518561848366,0.3051715086707191,1.0883057006766685,0.8658408100012669,0.35830085846035925,0.35384340849436446,1.0240837094249964,0.34396528640542523,0.6625909336695316,0.3240658633672765,0.3058816822504121;
Suppression of apoptosis,0.382661322523146,0.6025095823481236,0.34327971991130646,0.5259000391854405,0.33627276072485157,0.4008567504272784,1.0233471136532317,0.6121973354446032,0.7080666312006226,0.4716648533813419,0.304314835196113;
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1),0.33991984304289263,0.3667015217797265,0.701781429761201,0.3952396679299647,0.3226140943665297,0.4214928495246554,1.0199804039084535,0.3610048682403598,0.37714526130064224,0.5124302984800859,0.3058816822504121;
Erythropoietin activates STAT5,2.0042707039232845,0.3522313504995742,0.5544664037021174,0.6114469800652148,0.44109918192222525,0.3540970261426587,1.0198404671014538,0.6370660872345657,1.5898444742017548,1.383310968338142,0.3058816822504121;
Toxicity of botulinum toxin type E (BoNT/E),1.2309582212743344,0.3659796444425064,1.6969458827082358,0.8452387558632973,0.3864974753487039,0.5581083835580521,1.0185688496080432,0.7214872606359403,0.31122200488443763,0.4404591951700404,0.3058816822504121;
Negative regulation of FGFR4 signaling,1.7710604420483493,1.7439729110569755,0.5492405352637058,1.415519098636928,0.3446597697341202,0.35399026492638497,1.0185688496080432,0.5065936427260506,0.3231340566037976,0.32442300608423663,0.3058816822504121;
Platelet activation, signaling and aggregation,2.813261909898603,0.414631796717393,1.0453146405782519,0.3922480685341312,1.1431615389490235,0.3028133569923738,1.0185688496080432,0.37363972655453026,0.3089310108463698,2.089521959943691,0.3058816822504121;
p53-Dependent G1 DNA Damage Response,0.8100096260219354,0.46476382621388357,0.7635003516328472,0.30939713028032856,0.7418097657992928,1.2266820738215025,1.0168498646862316,0.5718121961194007,0.3156659602261388,0.44811482431034744,0.3058816822504121;
Metabolism of ingested SeMet, Sec, MeSec into H2Se,2.10262706050627,0.6176324424494146,0.31188141411333176,1.9015902661456126,0.361019414163406,0.3410850662423667,1.015909428296459,0.3148620432933206,0.3728343545959842,0.3160906252949544,0.3030467691849685;
p53-Dependent G1/S DNA damage checkpoint,0.8095567597018617,0.46476382621388357,0.7635003516328472,0.3083281217691119,0.7428775978778895,1.2266820738215025,1.0151287824890165,0.5693729600094288,0.3156659602261388,0.44811482431034744,0.3058816822504121;
Inactivation of APC/C via direct inhibition of the APC/C complex,0.5918730312013908,0.4081569957992947,0.6541994802932344,0.5950246338700154,0.3414159115902961,0.34699522989044684,1.0089730009752949,0.7730739488448432,0.30320189929542807,0.4040184592514595,0.3058816822504121;
Transport of Ribonucleoproteins into the Host Nucleus,2.853549600773622,0.4973390331284095,1.7007113797573465,1.5840995333594994,0.4146172972667351,4.273883413908051,1.0083160478140094,0.4612616436760333,0.3234983503075021,0.32532264275231887,0.3058816822504121;
Eukaryotic Translation Termination,0.41932664382931056,0.42458004458367476,1.5277568268259665,0.3074220055826222,0.35573771241937,0.48104437864202465,1.0047970386621703,0.3480320923463457,0.3728343545959842,0.37990598960137445,0.3058816822504121;
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,0.5919316624496747,0.4081569957992947,0.6501875029960035,0.5950246338700154,0.3439134979171695,0.34931748325276374,0.9933622250824483,0.7794465563553059,0.30168702611388065,0.4040184592514595,0.3058816822504121;
G alpha (i) signalling events,1.1098280637652032,0.3667015217797265,1.4355280646143322,0.3115144235208682,1.4497014587581227,0.8807950592959372,0.9933622250824483,0.8821346624304645,0.3234983503075021,2.4072876984101277,0.3058816822504121;
Noncanonical activation of NOTCH3,2.384175986726662,0.5892408336468945,1.879272483096239,0.38977595796733894,5.921994909126089,0.4719885775701651,0.9933622250824483,0.33696163270265517,0.3089310108463698,1.7465134874129782,0.3058816822504121;
Gap-filling DNA repair synthesis and ligation in TC-NER,0.4310481057004165,0.3029713996082115,0.7105050100372742,0.3213115419718923,0.3726312003584851,0.33531881000409625,0.9933622250824483,0.41811200490375733,0.47514208089199056,0.4232200116160087,0.3058816822504121;
NGF-independant TRKA activation,2.8764316224384867,0.34355423434661836,1.742583669847864,0.34712825185525215,0.35830085846035925,0.44836832077940414,0.9933622250824483,0.5174152264767676,0.9045344860174249,0.5105655863752099,0.3058816822504121;
SHC-mediated cascade:FGFR4,0.7152508242843777,0.45420597324553597,0.3654193179949343,0.34114908780953945,0.33910487705697223,0.47055855225156185,0.9933622250824483,0.6298029648437563,0.4562331140630506,0.6899463049956933,0.3058816822504121;
Dermatan sulfate biosynthesis,1.427543977892061,0.5892408336468945,1.2149703771791165,1.1839348110274626,0.30246496029501807,0.4791666961557156,0.9933622250824483,0.5613944991412845,0.33154605935666304,0.39107319360898024,0.3030467691849685;
TCF7L2 mutants don't bind CTBP,0.6284918354782628,0.4854094446363663,0.350539890489017,0.3220708023044529,0.33910487705697223,0.5312410536886313,0.9933622250824483,0.7441213175540436,0.33154605935666304,0.3804737589978425,0.3058816822504121;
Signaling by ERBB2 in Cancer,0.31696645752904035,0.3090278240817252,1.0313275062642102,0.5016914801173993,0.31473900574551567,0.8398834316151859,0.9933622250824483,0.5436742173320427,0.33154605935666304,0.6343918608690577,0.3058816822504121;
Lysosphingolipid and LPA receptors,4.877155702641654,0.8948324690638854,0.3471380490000285,0.32289368140643626,0.7460829399514947,0.3542943274052089,0.9908294457040965,0.36038059057015526,0.3070173328785859,2.4072876984101277,0.3058816822504121;
MyD88:MAL(TIRAP) cascade initiated on plasma membrane,0.3033630444136484,0.42908297552151636,1.585507937318083,0.36926780817120297,0.8663173673384363,1.162786089998547,0.9894803778049562,0.5226955554832011,0.32397177416554596,1.0736363732000191,0.3058816822504121;
Nuclear Pore Complex (NPC) Disassembly,3.5827687032871878,0.3360441324278193,1.7392747843810215,2.25369692698962,0.34604507203067597,4.316479479523637,0.9894803778049562,0.5389628321778192,0.30458685905162125,0.3086577387734625,0.3058816822504121;
Pink/Parkin Mediated Mitophagy,1.05959797977676,0.7661452010021158,0.44241434154399695,0.3068385808775283,0.444957695365014,0.3420003235500663,0.9894803778049562,0.42864408325691356,0.4769644995478627,0.8084765055104299,0.3058816822504121;
Role of second messengers in netrin-1 signaling,0.382962692574789,0.9221840381709459,1.6896484315078442,0.3881184602725714,0.33910487705697223,0.3465576003186093,0.9894803778049562,0.5389628321778192,0.37721347556427365,0.3084605076514881,0.3058816822504121;
TRIF-mediated programmed cell death,2.3603400962295167,0.4896647082490096,0.4817082643823941,0.4823062979997039,1.0702835859303041,0.5588744344857842,0.9834882831361773,0.33990809468773525,0.3406966434873319,1.6657394623477824,0.3058816822504121;
Glycerophospholipid biosynthesis,0.41932664382931056,0.33384552093415076,2.238327940594223,0.47632588316774416,0.9475010004123795,3.110868989734823,0.9833753982577316,0.3301441399438418,0.3515439172895968,1.5702940380886865,0.3058816822504121;
MET activates PTK2 signaling,0.4416826026365212,0.59842826146496,1.0807599529121545,1.4485993837815194,0.30418705243734856,0.3111782497541377,0.9827556641994234,0.3120922108743096,0.539731828546328,0.6343528131464561,0.3032374359194824;
Platelet Aggregation (Plug Formation),1.2407590249616494,0.49037620732391435,0.7672466098286923,0.3388488933313274,1.4046070710486018,0.36661029332342004,0.9809138803812646,0.4628527562793292,0.7130561524594311,3.3534585797797267,0.3058816822504121;
Formation of the cornified envelope,0.4395662013281129,0.3165159964142589,0.4855633791610883,0.3531561851347241,0.433323819297691,3.709290241584238,0.9805781913008766,0.37770911594983014,0.3692084556559849,0.4404591951700404,0.3058816822504121;
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling,0.9050907398884578,0.5645142031600183,2.5759157192245343,0.3304831969753468,1.4497014587581227,1.5945953640146877,0.9805781913008766,0.31234950701946074,0.5296096740034458,3.4449015650011026,0.3058816822504121;
Adenylate cyclase activating pathway,2.3270469126193087,0.8294461261044188,0.5920950995985617,0.4296023820159213,0.3560720414244286,0.3057869412058158,0.9801215461022705,0.3790971098032292,0.441266538994127,0.47469881290334454,0.3058816822504121;
Regulation of mRNA stability by proteins that bind AU-rich elements,0.5331145403440923,0.314824977833682,0.47160753149999735,0.6924045926167081,0.6231688405270283,0.6503434402589143,0.9750049710933831,0.3610048682403598,0.8457374043787689,0.4404591951700404,0.3058816822504121;
Phosphate bond hydrolysis by NTPDase proteins,0.6358339648159018,0.3393935927201346,0.35254875998474566,0.5043782219039552,1.3778827873106971,0.41662170072861154,0.9750049710933831,0.5238886509233606,0.3170116103066843,0.33194577730543684,0.3058816822504121;
Cellular responses to external stimuli,0.3165446042742289,0.7816596912323202,0.3557042064788556,0.33467796722904414,0.32162569628297455,0.308172013518533,0.9750049710933831,0.8386828002913995,0.37714526130064224,0.4996089833347668,0.3024439670208732;
Transport of the SLBP Dependant Mature mRNA,2.8576883881325674,0.30397605771269914,1.5977118412502447,2.164833185798109,0.3396325673262649,4.1923699354674175,0.9716491924713215,0.41811200490375733,0.3729062334678565,0.4395763307211742,0.3058816822504121;
Cross-presentation of particulate exogenous antigens (phagosomes),1.5970665700975755,0.32069448362191266,0.6052488258288762,0.771680982345107,1.1582851637021123,0.3111782497541377,0.9716491924713215,0.30318050255984674,0.3693665271664583,2.1427736621192977,0.3058816822504121;
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes,0.41739522758667835,0.3051715086707191,2.0643625106227965,0.5595898307253171,0.37913461146889044,0.8168485299433758,0.9716491924713215,0.35971925328583354,0.3061107917419532,0.38630092353663426,0.3058816822504121;
MET activates RAP1 and RAC1,0.3672789551152327,0.30844391279468925,1.200161912746773,0.3163292158034775,0.35573771241937,0.47677687539221214,0.9716491924713215,0.3947737880623761,0.45174765924593724,0.30603264219956966,0.3058816822504121;
Potassium Channels,0.5060144357640547,0.7142094393317582,1.326914048724724,0.40156829804312644,0.5905879164149995,0.339370993914336,0.9651461540359005,0.3182027195995063,0.3359886954858688,0.40627271643284196,0.3058816822504121;
PECAM1 interactions,2.178863124630871,0.6161081789146999,0.4988882553702614,0.5899368858697199,1.1881095655489549,0.3976005671239824,0.9651461540359005,0.4018372923384269,0.3170116103066843,3.3534585797797267,0.3058816822504121;
Pre-NOTCH Processing in Golgi,1.6417577870419224,0.5099776809737453,0.6925289797262356,0.5043782219039552,0.3073643548426107,0.3693748414877889,0.9644561538862443,0.34396528640542523,0.3578586759482637,0.9064061091606519,0.3058816822504121;
CDC6 association with the ORC:origin complex,3.491835872016039,0.7759719336519098,0.48721442257665054,5.173729393093316,0.697971698746192,3.525242669736441,0.9644561538862443,0.48606186013240477,2.5056557102950343,0.6343528131464561,0.3058816822504121;
trans-Golgi Network Vesicle Budding,0.35985985502915246,0.37241732449433484,1.1088565736270573,0.39718831089691875,0.3439134979171695,0.4306777496994055,0.9641174184816131,0.30318050255984674,0.418328270869041,0.3633654668872511,0.3058816822504121;
Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3,0.4883570466656608,0.7123613805345899,1.4422302729943435,1.0042168880016937,0.8581642160581328,0.3011893605750236,0.9641174184816131,0.30676358637777745,0.5509514948484421,1.4906273858738652,0.3058816822504121;
NTF4 activates NTRK2 (TRKB) signaling,2.274753870968122,0.7689740979101132,1.4228933798479544,0.3213115419718923,0.42272067676020203,0.47055855225156185,0.9641174184816131,0.7808545639669524,1.0113999391816824,0.6338289461983533,0.3058816822504121;
IRAK2 mediated activation of TAK1 complex,0.33797301854850675,0.3029713996082115,2.993865667155949,0.3283439964211864,0.36125084206021507,0.47677687539221214,0.9637103224115378,0.7808545639669524,0.33154605935666304,0.4451611421708856,0.3024439670208732;
The citric acid (TCA) cycle and respiratory electron transport,0.5106793381285393,0.900266676388589,0.8824343576034807,0.3468013020091587,0.3726312003584851,0.468029122621951,0.9637103224115378,1.0118680386453138,0.3170116103066843,0.45032973087605116,0.3058816822504121;
Formation of the ternary complex, and subsequently, the 43S complex,0.41932664382931056,0.30844391279468925,1.178032104779015,0.3536741872163679,0.3439134979171695,0.47055855225156185,0.9637103224115378,0.7214872606359403,0.33154605935666304,0.39863298409526765,0.3058816822504121;
Regulation of gap junction activity,0.4331749168084484,1.6469296834212683,2.167284369193624,1.6928841781312194,0.37572915566633974,0.3341378659957258,0.9590816013231799,0.30980925894012945,0.33154605935666304,0.4044798143565832,0.3058816822504121;
Defective Mismatch Repair Associated With MSH2,0.5916150883788236,0.3996046003891602,0.7406927588948709,0.3070634265024376,0.33664443463132226,0.5646191142917181,0.9575937099373618,0.3582339302818586,0.37721347556427365,0.46947200515560084,0.3058816822504121;
Vitamin B1 (thiamin) metabolism,3.3128458264788727,1.0465409745822256,0.9578594167399495,0.3271459557820616,0.3146304837686816,0.44569311077594786,0.9575937099373618,0.39014468230695576,0.4502323698043533,0.9125629518729945,0.3058816822504121;
Organic anion transporters,0.342995323706734,0.3225308422051359,1.9878792449742015,0.6159828369950922,0.3560720414244286,0.5442336194283345,0.9575937099373618,0.34311923132904953,0.3406966434873319,0.3779178337852975,0.3058816822504121;
Transport of connexons to the plasma membrane,0.4286986574548852,0.32010506335144423,1.037247511104453,2.358763548349984,1.1431615389490235,1.7084791467867435,0.9575937099373618,0.3274720765353536,2.191963999524005,0.7164596722064461,0.3058816822504121;
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,1.192914425070923,0.47300501140253504,0.6642928075581533,0.3541571802879987,0.33627276072485157,0.3111782497541377,0.954627996694221,0.48606186013240477,0.3083030765023187,1.3722198697504886,0.3058816822504121;
Vitamin B2 (riboflavin) metabolism,3.957703933879005,18.943916631901278,0.7391101653549697,5.614436511023885,0.33664443463132226,0.6289210074036768,0.9491213092913,0.6834181834101111,2.536348155576816,0.35815713029086216,0.3058816822504121;
Recruitment of NuMA to mitotic centrosomes,2.5115102967903344,0.6617160530759545,1.4422302729943435,3.4905885273729007,0.39794629746034765,1.1711497683991736,0.9454009572783013,0.34311923132904953,1.5494482277348092,0.30241267449194814,0.3024439670208732;
Classical antibody-mediated complement activation,0.7848146562853118,0.6441853723194954,0.679627017174595,0.5013149199817412,1.3778827873106971,0.4398451825355376,0.9451600576956029,0.37731445527559043,0.4881499224650157,1.0580362116500721,0.3058816822504121;
FGFR2 alternative splicing,0.49414180652094974,0.44477246566769213,0.48346237348866605,0.45600329065599,0.41200215293113845,0.7372963255753604,0.9418308248162085,0.3207891067373377,0.31197598096833934,0.3025747027936126,0.3058816822504121;
RA biosynthesis pathway,0.6667144050394884,0.47698398560067923,0.5494530568571484,0.4296023820159213,0.37908593583689865,0.4520855181919509,0.9394249058841686,0.43082664047868263,0.35498464823095066,0.3302665829120577,0.3058816822504121;
Transferrin endocytosis and recycling,0.4373746700048119,0.5001845172573633,3.4420765909763595,0.5576760922391598,0.330372459861341,0.7567192353591567,0.9394249058841686,3.5793220696144203,0.9045344860174249,0.30218917574215476,0.3058816822504121;
Surfactant metabolism,1.4050502554181492,0.3691439136623758,0.7231429863510273,0.330334113068339,1.1431615389490235,0.3028133569923738,0.9386929508130927,0.4354642089669324,0.30150053284191936,2.355060719198553,0.3058816822504121;
Regulation of IFNG signaling,0.7011912520187482,0.46763856361506245,0.47531146190153706,0.6224873233331033,0.6398038670075493,0.9125813387362648,0.9379526785024216,0.7796931658740366,0.32815084485870327,1.8408357983929062,0.3058816822504121;
Synthesis of 15-eicosatetraenoic acid derivatives,0.5065318103776832,0.3650614398467666,0.34327971991130646,0.3861917421038416,0.3728262573756636,1.1516495716257158,0.9341011944349413,0.5795150420091576,0.7441222546207356,0.33740247317007105,0.3058816822504121;
TP53 Regulates Transcription of Death Receptors and Ligands,0.7432242533096001,0.30844391279468925,3.7350445961706944,0.460398612828236,0.6268557198068822,1.5869323539619207,0.9333626920588026,0.6652097340320369,0.3089310108463698,1.1857208932300791,0.3058816822504121;
RNA Polymerase III Transcription Initiation,0.3479743390395984,0.43132950797384156,0.3528845675322629,0.32552608200489686,0.32999522005241466,0.4902850695312733,0.9318447605498614,0.34396528640542523,0.539731828546328,0.30900336778122756,0.3058816822504121;
Suppression of phagosomal maturation,0.4826960453306865,0.34088690059804977,1.698699067760762,0.36360503738442823,0.5402348016460524,0.34084875043490775,0.9318447605498614,0.6834181834101111,0.3329607429278685,0.6335858605331677,0.3058816822504121;
Negative regulation of MAPK pathway,0.32648569807719524,0.4301895395995331,0.34733542328568157,0.369743844672561,0.4536790728889417,0.4794000133923282,0.9309171189429709,0.3251934547032587,0.3329607429278685,0.6638900922726186,0.3058816822504121;
Signaling by FGFR,0.43458744757661255,0.38557147814578563,1.4078528827358816,0.40304736475579483,0.3146304837686816,0.8166208659207264,0.9285453884448525,0.30676358637777745,0.33154605935666304,0.3109481832046546,0.3058816822504121;
Abacavir transmembrane transport,4.2666735704504575,0.8165709239080776,1.8799508667356668,0.8632876716026172,0.35290876980663655,0.3632803726492419,0.9284604836566792,0.35082679893314456,0.33154605935666304,0.3439018182909123,0.3034996034775484;
TWIK related potassium channel (TREK),0.5494083030290889,0.4052791032235589,1.6541049894515727,0.541039048298216,0.33627276072485157,0.416812166468743,0.9266406281096038,0.31856818801142184,0.35069838849845003,0.38946540392582374,0.3030467691849685;
G protein gated Potassium channels,0.43458744757661255,0.6153450361207902,0.8017891949040372,0.32100808197395886,0.330372459861341,0.6702561517274862,0.9266406281096038,0.3148620432933206,0.33154605935666304,0.4448245137365865,0.3058816822504121;
RUNX1 regulates transcription of genes involved in BCR signaling,0.7557862538575085,2.0049114338084766,1.9981676955464427,1.597029122625791,0.33877395455060044,0.33487600055918676,0.9201860512848012,0.37972459487062293,0.7250613691886592,0.47469881290334454,0.3058816822504121;
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S,0.3775870832267736,0.3010748960204856,1.2699638742658215,0.3657188180620897,0.33910487705697223,0.5114821196645826,0.9201860512848012,0.6162943241566933,0.32562191479076025,0.38820904859778893,0.3058816822504121;
Activation of G protein gated Potassium channels,0.43474740894302966,0.6100164037991691,0.8058702959459212,0.3198497854101864,0.330372459861341,0.651553621145545,0.9194128433865053,0.3148620432933206,0.33154605935666304,0.4448245137365865,0.3058816822504121;
Arachidonic acid metabolism,2.974572269528992,0.3864631808225056,0.3384666561332321,0.3399804683290169,1.27292890664036,0.32085969385975094,0.9163850634605853,0.35082679893314456,0.33154605935666304,2.594019802813395,0.3058816822504121;
The AIM2 inflammasome,0.44376278251035534,0.7816704313010397,1.2807549148683874,0.3881184602725714,0.3226140943665297,0.4462463516006881,0.916363021852021,0.33696163270265517,0.3522221105554151,0.310717530566632,0.3058816822504121;
Activated NTRK3 signals through RAS,0.6558037141499062,0.30590329751427836,0.8182895624179669,0.5993005284414504,0.3726312003584851,0.6606059318480162,0.9105359190190688,0.5795150420091576,0.3406966434873319,0.40014141471750087,0.3058816822504121;
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,0.43474740894302966,0.6161081789146999,0.8219084041657259,0.3208009770365678,0.33021183431640455,0.6576217584037184,0.9105359190190688,0.3148620432933206,0.33154605935666304,0.4448245137365865,0.3058816822504121;
Pyrimidine salvage,2.795108621443126,0.9363641915722525,0.39161510178558023,3.6086386026326336,0.395589721156635,2.0772325989509564,0.9105359190190688,0.7808545639669524,1.753062665712739,0.4030133825628864,0.3058816822504121;
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),1.5472801707795352,1.2567397901919064,1.8437272037867236,2.6417222582683317,0.33627276072485157,0.3260350496628621,0.9074186898474698,0.3143469738899474,0.3900183977157809,0.3337452048421423,0.3058816822504121;
Type II Na+/Pi cotransporters,0.3914332839728542,0.9576238979351611,1.3962086813568306,0.3881184602725714,0.3285435148042968,0.4541009858801141,0.9033825960045916,0.4550430406386394,0.6984965161303884,0.37999331431798156,0.3058816822504121;
Degradation of the extracellular matrix,1.129094399557059,0.5261728792807606,0.3196134621449584,0.9028839649271022,0.3439134979171695,0.461038760471906,0.9010606053487371,0.49240764263677456,0.569721328093352,0.7156448359643428,0.3058816822504121;
Miscellaneous substrates,0.4319217421672363,0.35899301983987586,0.9314040112860305,0.3283439964211864,0.330372459861341,0.423493503427682,0.8977167340773354,0.36682087221042325,0.378780953316455,0.34295065847682293,0.3058816822504121;
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,0.3975156023891009,0.42498593976503624,0.5364862889262716,0.4975432167099843,0.6692056431172262,0.8205962637560629,0.8957697542656623,0.3094759427026921,0.33154605935666304,0.5278203201689747,0.3058816822504121;
Metabolism of polyamines,0.44766682252123474,0.7083061017751114,0.3985215853282274,0.7046161052985309,0.7060763901582591,0.8807950592959372,0.8957697542656623,0.352267490683119,0.3061107917419532,0.4540611718827999,0.3058816822504121;
ERKs are inactivated,0.39184073081929416,1.2704541370857034,0.3044513732107998,0.34114908780953945,0.41200215293113845,0.36412558352903635,0.8957697542656623,0.6799766290735694,0.33154605935666304,0.34032309265129573,0.3058816822504121;
Formation of the HIV-1 Early Elongation Complex,1.60587601523418,0.900266676388589,2.2800584638170864,2.05197241851647,0.40888718273980784,1.0296289104967442,0.8957697542656623,0.30222076309715623,0.33154605935666304,0.4569839190337219,0.3058816822504121;
Regulated Necrosis,0.30296962315825304,0.6667186920202449,1.0394768555096892,0.3388488933313274,0.31583541384964053,0.3154827146412667,0.8957697542656623,0.38454701793058893,0.4881499224650157,0.49695366037282207,0.3058816822504121;
Formation of the Early Elongation Complex,1.60587601523418,0.900266676388589,2.2800584638170864,2.05197241851647,0.4099884398602422,1.0296289104967442,0.8871239027218909,0.30222076309715623,0.33154605935666304,0.456986264226675,0.3058816822504121;
Intestinal infectious diseases,0.39952318228467737,0.42458004458367476,0.8125271143163799,0.3628766921649118,0.330372459861341,0.5020638336149624,0.8871239027218909,0.3167418100550727,0.3061051753392431,0.43049227661877426,0.3058816822504121;
Formation of TC-NER Pre-Incision Complex,1.0208440660577247,0.30590329751427836,0.9301172040297273,0.3657188180620897,0.37572915566633974,0.4541009858801141,0.8871239027218909,0.46950761507088173,0.37721347556427365,0.4678954462589095,0.3058816822504121;
Regulation of FZD by ubiquitination,0.3288559388871276,0.5035229067081838,0.5164446137948445,0.3612995601475251,0.35573771241937,0.39885350230807887,0.8816433556129614,0.3317123913477366,1.1613036119086872,0.36352781355431213,0.30370155596674026;
RUNX2 regulates bone development,0.6114846292543552,1.2883328945183445,0.3252885977488449,0.3454633916917074,0.3764809604369917,0.7072001173174037,0.8808898879049436,0.7086724457561365,0.5353937284422016,0.5939891923739383,0.30574005727865033;
Transport and synthesis of PAPS,0.4217790971947763,0.6753629744360657,0.44589400980910454,0.38459539265859194,0.41200215293113845,2.2894016663815893,0.878716904289983,0.4184113112236314,0.47514208089199056,1.257772409996723,0.3058816822504121;
PI Metabolism,0.36765290593325656,0.4697962182768528,1.281375305554749,0.34049658036688124,0.31167319664073184,0.34001871314248505,0.8734858997075947,0.3915294309870907,0.33154605935666304,1.483370356290762,0.3058816822504121;
Synthesis of PIPs in the nucleus,1.2972114744366496,0.36305624463054287,0.8219084041657259,0.3628766921649118,0.5705700121496526,0.36839134508532334,0.8640061379481738,0.309018298085769,15.03403179105811,0.7302267570893407,0.3058816822504121;
PCP/CE pathway,0.34301749695865813,0.46763856361506245,0.38239861593688573,0.31253798057480614,0.6894411731757567,0.7062972612850885,0.860619959168696,0.32735598382599135,0.6459758662785066,0.37096668120567977,0.3058816822504121;
G-protein activation,1.5117290814450903,0.7361588323232348,1.073527017168443,1.4117478790949058,0.3764809604369917,0.47055855225156185,0.8582229418185561,0.46950761507088173,0.3089310108463698,0.4540611718827999,0.3058816822504121;
mTOR signalling,0.3052983521599139,0.4677308630861021,0.34204109227197577,1.4944915325074148,0.330372459861341,0.3111782497541377,0.8556847546725553,0.3622738748717201,0.6459758662785066,0.39091888813155207,0.3058816822504121;
Signaling downstream of RAS mutants,0.3672789551152327,0.30402224815377643,1.871769564505781,0.31777509249296315,0.3712537213651401,0.4214928495246554,0.8552350110729919,0.3445913271108731,0.3231615712099826,0.38946540392582374,0.3058816822504121;
Hedgehog 'off' state,0.38523662041238443,0.6161081789146999,1.2878758335600908,0.30570651231582135,0.9586039753689268,1.277116723750645,0.8552350110729919,0.4422333400064222,0.32892132877066294,0.4540611718827999,0.3030467691849685;
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.4416826026365212,0.4301895395995331,2.5449959312857753,0.7840965975542565,1.4497014587581227,3.8871879316447204,0.855232685308995,2.15123962171681,1.140149492643115,1.8192564412246177,0.3058816822504121;
Signaling by RAS mutants,0.3672789551152327,0.30402224815377643,1.8718226839668777,0.3168344456512984,0.37205774949981,0.4214928495246554,0.8543721909293132,0.3452626441013441,0.32296005032747643,0.38820904859778893,0.3058816822504121;
Hydrolysis of LPE,0.39536377072906836,1.064819077762008,1.514297361956318,0.49090123691849546,0.3439134979171695,0.47677687539221214,0.8543079334971515,0.5558882199982746,0.7283839345834368,0.42581119985693494,0.3058816822504121;
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,0.45214922035971017,0.6025095823481236,2.2880270990023317,0.4677232180702192,0.30985369422832876,0.30262206950922643,0.8540589830840248,0.32753430183444365,0.43407027552478483,0.4167336646038495,0.3058816822504121;
Hypusine synthesis from eIF5A-lysine,0.3119979840557615,0.8286864734814368,0.6429143441319403,1.5178094094910133,0.4929397770449673,0.4155628056745965,0.8526423358073315,0.4969780311601389,0.33154605935666304,0.31182882727391925,0.3058816822504121;
Signaling by moderate kinase activity BRAF mutants,0.3625464245747208,0.30402224815377643,1.871769564505781,0.3198395805486888,0.36233576861030226,0.4183925565435587,0.8498484966066677,0.3445913271108731,0.32397177416554596,0.38820904859778893,0.3058816822504121;
Assembly of active LPL and LIPC lipase complexes,3.76536158208758,0.9038096594893055,2.4335850565322814,1.5741692131585654,0.3285435148042968,0.34931748325276374,0.8498484966066677,0.3030615030174226,0.3406966434873319,0.34875011987774196,0.3058816822504121;
Uptake and function of anthrax toxins,0.469082934340401,0.31692439918609516,1.6340723868910525,0.3861917421038416,0.3726312003584851,0.3620735944925361,0.8496740301116309,0.35971925328583354,0.31837078236812505,0.5462577028713769,0.3058816822504121;
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.3672789551152327,0.30402224815377643,1.8718226839668777,0.31645988626650506,0.37205774949981,0.4214928495246554,0.8489247055704229,0.3445913271108731,0.32426094406474487,0.3866317659379911,0.3058816822504121;
Defective SLC3A1 causes cystinuria (CSNU),0.45967369374994027,0.49023002456961257,0.3869111277921452,1.132441599487645,0.397151474618249,0.4141701923235453,0.8487713337955525,0.35440324608796253,0.3904434595475933,0.3448062407408486,0.3058816822504121;
RIPK1-mediated regulated necrosis,0.3044039864101217,0.6667335201465007,1.0373342112474155,0.3388488933313274,0.31685370967227006,0.3154827146412667,0.8486025904037912,0.38454701793058893,0.4881499224650157,0.49695366037282207,0.3058816822504121;
HuR (ELAVL1) binds and stabilizes mRNA,0.4489840067171152,0.3791687430799317,0.35275308129702004,0.39026723080694775,0.32162569628297455,0.47055855225156185,0.8486025904037912,0.35971925328583354,0.5509514948484421,0.4540611718827999,0.3058816822504121;
Defective SLC7A9 causes cystinuria (CSNU),0.4565686304537262,0.4884606935737067,0.37607450446298996,1.1391272219911779,0.3964344348823373,0.41548903650203944,0.8480947640355947,0.35357383253505825,0.3917839996697921,0.3439018182909123,0.3058816822504121;
p53-Independent G1/S DNA damage checkpoint,0.3711723153579064,0.5016280373708235,0.5080281462892785,0.6432246813744723,0.6526875770884857,0.8459312116920314,0.8429055120029566,0.3030615030174226,0.33154605935666304,0.5819951510366843,0.3030467691849685;
p53-Independent DNA Damage Response,0.37274229533255165,0.5016280373708235,0.5111303216523466,0.6432246813744723,0.6526875770884857,0.8459312116920314,0.8429055120029566,0.30318050255984674,0.33154605935666304,0.5904752280237027,0.3030467691849685;
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,0.37298018217520823,0.49882509403717307,0.5045580962716097,0.6408716818388634,0.6606648610106033,0.8459312116920314,0.8411240074042257,0.3027579187486238,0.33154605935666304,0.6001022687195487,0.3030467691849685;
Ceramide signalling,1.8167858547118845,0.3579101535729101,0.5358814324116861,0.39485276920195894,0.3726312003584851,0.31776991236841967,0.8391186983302411,0.35971925328583354,0.33154605935666304,0.8084765055104299,0.3032374359194824;
mRNA 3'-end processing,0.45031287653699437,0.3142762591661267,0.7802377786070451,0.6114469800652148,0.39026309562416256,0.3619469067314098,0.8391186983302411,0.3323267677217555,0.3667930924250126,0.32429151923420935,0.3058816822504121;
Deactivation of the beta-catenin transactivating complex,5.43040520996255,1.5023412461456176,0.4129105594128844,0.3503872330012344,0.7576852196375048,0.3061210216620263,0.8389200684966519,0.5795150420091576,0.4881499224650157,0.9783819662800657,0.3058816822504121;
HCN channels,1.1201070353001332,0.32979575975804937,1.9365202542765205,0.5259000391854405,0.4652531729958008,0.49024514376462613,0.8370188835091148,0.7808545639669524,0.41003154150330823,0.83732525579712,0.3058816822504121;
Triglyceride biosynthesis,1.11620765558179,0.5073445985405695,0.9248738113059218,0.3628766921649118,0.5358107092946165,0.715283727475772,0.8368598813394694,0.8265111326269738,0.48872304360099805,0.3109481832046546,0.3058816822504121;
Suppression of autophagy,0.3481518561848366,0.3142762591661267,0.3648511899524546,0.4697453280545078,1.1439209393511929,0.474224940380697,0.8323549074311578,0.4147150908432823,0.3329607429278685,0.4835502797846719,0.3058816822504121;
TICAM1, RIP1-mediated IKK complex recruitment,0.9158906917920631,0.4660251239708507,0.8322617489258197,0.5879866812394244,0.3918027183993316,0.4677097622537639,0.8321377169488834,0.6166031083213451,0.3522221105554151,0.4353740121305991,0.3058816822504121;
ERBB2 Activates PTK6 Signaling,1.8995179115583956,0.9203031332514169,1.037247511104453,0.3733837620133376,0.48365622352261173,0.9791760437254866,0.8321377169488834,0.34600861213325285,0.33154605935666304,0.8811554113958093,0.3058816822504121;
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,0.35199476354612796,0.576173559427021,0.39316139250370125,0.4392846139050585,0.6689626772894115,0.8205962637560629,0.8321377169488834,0.3646829165254219,0.32397177416554596,0.46947200515560084,0.3058816822504121;
Keratinization,0.3117629957183809,0.3393935927201346,0.8052404472273882,0.3881184602725714,0.4479997200725016,3.6463143324478393,0.8321377169488834,0.3646829165254219,0.441266538994127,0.4451611421708856,0.3058816822504121;
Transport of Mature mRNA derived from an Intron-Containing Transcript,0.3672789551152327,0.3021233944379066,0.40487844146094454,0.3881184602725714,0.39078536832471683,0.4018096526242101,0.8321377169488834,0.34398443282195684,0.605967398728144,0.4523752385250782,0.3058816822504121;
MET Receptor Activation,1.9470140752866025,0.42498593976503624,0.3780087693032461,0.38834181595987294,0.3900512129307848,0.3111782497541377,0.8312519959352009,0.38454701793058893,0.7209288851344792,1.1825458727854834,0.3058816822504121;
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.44351687530887374,0.3707383434838009,0.6765362912914509,0.3952396679299647,0.3446537762589258,0.5683890433722195,0.8286091949567093,0.4628527562793292,0.4051903053373253,0.4451611421708856,0.3058816822504121;
Serotonin receptors,0.3081642843377598,0.3691439136623758,0.6196405466110851,1.0776922874067056,0.40109453410937307,0.3620735944925361,0.8277251206886224,0.8265111326269738,0.4156689500982106,0.4209700519911368,0.3058816822504121;
Alanine metabolism,0.3479743390395984,1.0267839428606045,0.5257917995352324,0.708600123500403,0.33664443463132226,1.0060496764132285,0.8253000385152822,0.36046186142273234,0.4326147371542654,0.38300722113202923,0.3058816822504121;
Synaptic adhesion-like molecules,0.6228686233239953,0.8705631581546994,0.4018400955900535,0.3628766921649118,0.34998183722912907,0.888151598314085,0.8240020971020523,0.35331581607193274,0.3973359698996325,1.030872221906576,0.3032374359194824;
SUMOylation of transcription cofactors,0.3932382844445701,0.3051715086707191,0.8781730033946207,0.3816686884212616,0.3726312003584851,0.3131733022391502,0.823206465793397,0.35369056721333986,0.3444643675395693,0.32532264275231887,0.3058816822504121;
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.44351687530887374,0.369781887516653,0.6774436904910512,0.39710621317627126,0.3458323878495951,0.5646191142917181,0.8222518023588535,0.4628527562793292,0.39838117936895323,0.4523752385250782,0.3058816822504121;
PIP3 activates AKT signaling,0.3288559388871276,0.7925878159421703,0.6541994802932344,0.4296023820159213,0.5458802062090196,0.4306777496994055,0.8222518023588535,0.4595775962539899,0.327558860071622,0.3596609925416212,0.3030467691849685;
Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3),0.3407996132956933,0.5160538865147885,0.783086348819216,1.683303352904159,1.1558361138746849,0.8398834316151859,0.8222518023588535,0.8821346624304645,0.41922428215661073,0.6592194040715842,0.3058816822504121;
Signaling by Interleukins,0.6201674709820884,0.4753617019431409,1.346597298888214,0.3163292158034775,1.4497014587581227,1.437240749725188,0.8217074628439128,0.6834181834101111,0.31808512104917774,2.1813418051271998,0.3058816822504121;
Activation of the TFAP2 (AP-2) family of transcription factors,0.39952318228467737,0.31575954172831694,0.3067161466326659,0.34242551078476546,0.6718297994418723,0.36661029332342004,0.8182235389487389,0.3317123913477366,0.6459758662785066,0.44022807337003683,0.3058816822504121;
Growth hormone receptor signaling,0.37784732019519435,0.5067139839757604,3.0583390208778325,0.3861917421038416,1.4527835083452083,2.5488277324593978,0.8182235389487389,0.36710932947589353,0.33154605935666304,2.4447012532792813,0.3058816822504121;
PERK regulates gene expression,1.603124623320052,1.9505556825001291,0.6371763478650965,2.625486939365583,0.45810052203947244,0.4467220717805114,0.8182235389487389,0.6834181834101111,0.3293878277257215,0.6409956176175208,0.3058816822504121;
Signaling by EGFR in Cancer,0.3697786288314644,0.6151614309327488,1.169503780015496,0.38147026278566154,0.4677023943293453,1.277116723750645,0.8180287994582087,0.33814610392581557,0.32815084485870327,0.45032973087605116,0.3058816822504121;
Host Interactions with Influenza Factors,2.8953410763550713,0.6748754522273666,2.1671547506808206,1.6332026463389901,0.3868892941028258,4.316479479523637,0.8175136652064391,0.9213781162046868,0.32855021388126704,0.7325121903592762,0.3058816822504121;
Acyl chain remodeling of DAG and TAG,0.6919161119295903,0.4155240941545764,0.4018400955900535,0.5084365731528091,0.33910487705697223,0.38104536656071447,0.8175136652064391,0.30676358637777745,0.418328270869041,0.4238184686536508,0.3058816822504121;
TGFBR2 MSI Frameshift Mutants in Cancer,2.210072766170513,0.8154380545274866,0.3538601237188543,0.3534925376343175,0.3439134979171695,0.5168045402496553,0.8175136652064391,0.45640854842187634,0.37085161505583414,0.41104584371777314,0.3058816822504121;
NS1 Mediated Effects on Host Pathways,2.8953410763550713,0.6748639225787441,2.165624764806423,1.6332026463389901,0.3868892941028258,4.316479479523637,0.8175136652064391,0.9401324887614957,0.32892132877066294,0.7325121903592762,0.3058816822504121;
SLIT2:ROBO1 increases RHOA activity,1.7910442909887387,0.45199084089717,1.8634477644547396,0.35287359016834924,0.3784031339598603,0.43075902825616436,0.8173019453802473,0.3108923324961582,0.34010467491250734,1.2561339572121097,0.3058816822504121;
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,0.3969149687117272,0.3051715086707191,0.3538601237188543,0.3259138448761465,0.33140832466933967,0.5646191142917181,0.8163914203969319,0.5487000001707596,0.4409695697459638,1.31566242757387,0.3058816822504121;
Cytosolic sulfonation of small molecules,0.3126277267514732,0.3378343987873051,4.069315731527992,0.33629937585789416,0.4393593943366305,0.39361766140753845,0.8147895894703467,0.5053548155512009,0.45174765924593724,0.35516643484308213,0.3058816822504121;
Serotonin Neurotransmitter Release Cycle,0.4715749455752863,0.315650141649467,0.30940075881351375,0.5879866812394244,0.3439134979171695,0.3829935829538375,0.8145467925398002,0.3425206096678787,0.37721347556427365,0.4716648533813419,0.3058816822504121;
Viral Messenger RNA Synthesis,2.198956635377355,0.32228541996852034,1.8763118837089128,1.9546483118621103,0.3439134979171695,4.181834275178987,0.8144497687328974,0.35971925328583354,0.3329607429278685,0.46947200515560084,0.3058816822504121;
Phospholipase C-mediated cascade; FGFR2,0.48313498722766435,0.5698796886264856,0.5111303216523466,0.6114469800652148,0.5094891698509291,0.3693748414877889,0.8141663803742692,0.3272468962834211,0.36419136224313775,0.3999098848210651,0.3030467691849685
Transport of the SLBP independent Mature mRNA,3.041426167161493,0.3351332739777284,1.858161098708219,2.176705698633408,0.3726312003584851,4.434155846068263,0.8140751122041814,0.32753430183444365,0.37818098826263175,0.4540611718827999,0.3058816822504121;
Creation of C4 and C2 activators,0.8164242322505203,0.9001342152941485,0.31188141411333176,0.39485276920195894,1.4172697856175807,0.46851592783482815,0.8140751122041814,0.37363972655453026,0.4881499224650157,1.121605189596718,0.3058816822504121;
Cysteine formation from homocysteine,0.6922448735016377,0.3165159964142589,0.35516354224109725,0.5168399129149951,0.5835026754832157,1.3695662623898615,0.8131412981960602,0.3376553213397365,0.33154605935666304,0.3806709461682284,0.3032374359194824;
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,1.1372853568996961,0.49882509403717307,1.4090442824121523,1.7896761711040297,0.3722027189435112,0.5145174956340497,0.8090010066211496,0.6794930686051921,0.6042626547165951,0.4404591951700404,0.3058816822504121;
DNA Damage Reversal,1.7874104207120947,1.0346589951790564,0.5439930076286128,1.2139380577533165,0.3726312003584851,0.31756868525892934,0.805567422144937,0.4147150908432823,0.3667930924250126,0.37944120195443587,0.3058816822504121;
Role of LAT2/NTAL/LAB on calcium mobilization,0.8574980245024258,0.3815328977541353,1.1088565736270573,0.5375314615485541,1.3961847524716604,0.474224940380697,0.8045661271526884,0.35971925328583354,0.3900183977157809,1.1356409598867205,0.3058816822504121;
HS-GAG biosynthesis,0.35395902962098935,0.7678534252093862,0.3638088415947402,0.35457616746105136,0.9280318932209153,0.6494417602692866,0.8045661271526884,0.38454701793058893,1.6856890370120492,2.9665313475613817,0.3058816822504121;
CD22 mediated BCR regulation,0.7310097309575617,1.3687513583296684,0.480879486544494,0.518409827601242,1.3375113665528906,0.42924963491620954,0.8031327256436698,0.5238886509233606,0.4881499224650157,1.1931978617360253,0.3058816822504121;
Signaling by Retinoic Acid,0.6188386975716889,0.5698796886264856,0.36678512690310255,0.3881184602725714,0.33627276072485157,0.3508313973814462,0.8015359801187396,0.5613944991412845,0.6052596979838009,0.3240658633672765,0.3058816822504121;
Nef mediated downregulation of MHC class I complex cell surface expression,1.0837802485733614,0.42498593976503624,0.3977798126437877,0.33564575743536246,0.8647811005884589,0.37237779320036696,0.800740854889925,0.515231060699031,0.5779762566294223,0.4232200116160087,0.3058816822504121;
FGFR1b ligand binding and activation,0.8072884376667768,0.46978811903228695,1.45366218336228,0.3573763260808044,0.3119959467823231,0.312405934491624,0.800740854889925,0.3307172929743609,0.858026547560071,0.4540611718827999,2.6756222339641442;
FGFR3b ligand binding and activation,0.3775870832267736,0.36305624463054287,0.9199579265695127,0.43287052576841767,0.3726312003584851,0.3243961835685163,0.799433134523663,0.8090438287512713,0.3121738255632173,0.4451611421708856,0.3032374359194824;
Biosynthesis of DHA-derived sulfido conjugates,0.6633439444158509,0.6447356876307219,0.48346237348866605,0.6043340415024114,0.43466048072129243,0.30701965150343463,0.799433134523663,0.37910748651356085,0.329509855487524,0.4232200116160087,0.3058816822504121;
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),0.6635617905334938,0.6506211158397309,0.49321656382231527,0.6038541887701641,0.4393593943366305,0.30741925342711224,0.7977564435309636,0.378954871891739,0.33026951036094776,0.4237641280246898,0.3058816822504121;
Toll Like Receptor 2 (TLR2) Cascade,0.30625377870353887,0.4445315318218932,1.5643463147942942,0.3503872330012344,0.8715268134458334,1.1440271903015207,0.7970097646166914,0.5578106790042832,0.3061107917419532,1.0847504988898473,0.3058816822504121;
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,0.9432838371716857,0.32644608695254396,0.8881774991924806,0.3259138448761465,0.6223309115427085,0.70206723630419,0.79582397067592,0.352267490683119,0.5423130576971075,0.7302267570893407,0.3058816822504121;
CYP2E1 reactions,0.33735313748191564,0.6126757225476752,3.1256015750428547,0.3861917421038416,0.397151474618249,0.32139120730383397,0.7928221234658543,0.3622738748717201,0.3240295640978132,0.41171584476224793,0.3058816822504121;
Vif-mediated degradation of APOBEC3G,0.41033301975759273,0.4973390331284095,0.7391101653549697,0.3232519888569888,0.6776561166140836,0.6944258360475921,0.7928221234658543,0.343749190305229,0.8560717364167322,0.548103519364266,0.3058816822504121;
Degradation of DVL,0.4442528007617474,0.30955187441848364,0.4065906431250117,0.3115144235208682,0.6513359473202913,0.6702561517274862,0.7926055825874246,0.31952514275847455,0.4881499224650157,0.5858048402406467,0.30140128990347;
GLI3 is processed to GLI3R by the proteasome,0.5751813989481973,0.3393935927201346,0.35275308129702004,0.32289368140643626,0.6692056431172262,0.7730147984895923,0.7888953399271353,0.3317123913477366,0.48700045296036676,0.4435340852011034,0.3058816822504121;
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,0.8951729777990884,0.3659796444425064,3.474789829106181,0.5109471607838141,0.397151474618249,0.7305728899620716,0.7851320389724611,0.31539388260432966,0.31120063727890246,0.4209700519911368,0.3058816822504121;
PI-3K cascade:FGFR3,0.5010655922836115,0.6441853723194954,0.5340409034698799,0.49786442742870163,0.4146172972667351,0.30146276932778043,0.7829300431284795,0.6834181834101111,0.3404697512215013,0.31895786627672174,0.3032374359194824;
Degradation of GLI2 by the proteasome,0.8072884376667768,0.3010748960204856,1.1081772974668507,0.3232519888569888,0.6278261191361808,0.727804073060917,0.7807525110281487,0.32986775016343167,0.8059290852393105,0.661829187469421,0.3058816822504121;
EGFR Transactivation by Gastrin,0.4373746700048119,0.35817300272844155,1.4422302729943435,0.40508555541811875,0.6365226938672327,1.2605005628128787,0.7784309181348757,0.4478369225572017,0.4884401207480335,0.8529629531955053,0.3058816822504121;
SHC1 events in ERBB2 signaling,0.4217790971947763,0.9285413398621923,1.8734113197925235,0.49786442742870163,0.6776561166140836,1.7596946033347172,0.7757418304479694,0.31203325779164937,0.3065164849314509,0.7131212844176323,0.3058816822504121;
Sulfide oxidation to sulfate,0.9972316535966268,0.5261728792807606,0.8720417368224088,0.5879866812394244,0.7545067537691059,0.43249212968595374,0.7757418304479694,0.35971925328583354,0.5004823565456522,0.9007292583478218,0.3058816822504121;
SLC-mediated transmembrane transport,0.47061787251554776,0.36231980452174045,2.411391835264811,3.2685196876777582,1.5260476677623513,5.264229354273752,0.7757418304479694,0.4815076222783336,0.6720910999788908,2.7541605265695863,0.3024439670208732;
Carnitine synthesis,0.4770618959027905,0.3781360705648972,2.612080435887825,0.34187428482479,0.753199844868681,0.44372094909371484,0.7757418304479694,0.6658934010577968,0.4644723627826459,0.4121812366547547,0.3058816822504121;
Gap junction assembly,0.32648569807719524,0.6748639225787441,1.2346712003995064,2.2453324898857696,1.1160230815244887,2.1013692742223733,0.7757418304479694,0.5718121961194007,1.7145004784687619,0.4170778848741611,0.3058816822504121;
SCF-beta-TrCP mediated degradation of Emi1,0.378064225064369,0.4616324653259054,0.7500066157472146,0.6039833361262053,0.6761194459288201,0.8813681710037167,0.7745592354695257,0.31482486972733703,0.32855021388126704,0.44065582267788694,0.3058816822504121;
Melanin biosynthesis,0.3672789551152327,1.2397120796373553,0.47620779881555453,0.5287159761412032,0.3439134979171695,0.321223791693833,0.774184278288681,0.7796931658740366,0.3522221105554151,0.4523752385250782,0.3058816822504121;
Phenylalanine metabolism,0.48448207652563874,0.43246941553297696,0.366949816375034,0.8204438826608905,1.0423639475701816,1.4806066665647906,0.7727186172075964,0.3404366042983231,0.8059290852393105,0.9286390457962913,0.3058816822504121;
Defects in cobalamin (B12) metabolism,0.5375980675526403,0.42498593976503624,1.2020317108771463,0.4303767648874029,0.36233576861030226,0.4300466631842503,0.7727186172075964,0.9652238352966773,1.1740238920195396,0.3109481832046546,0.3058816822504121;
Apoptotic factor-mediated response,0.751754083961834,0.3294692550550253,0.4201686359858995,0.3881184602725714,0.33140832466933967,0.4398451825355376,0.7727186172075964,0.33696163270265517,0.36419136224313775,0.4232200116160087,0.3058816822504121;
Regulation of ornithine decarboxylase (ODC),0.5018773643065748,0.3688191716225742,0.3329387001691024,0.34523110574342525,0.6477998746815469,0.7362014428337754,0.7595021276578693,0.31482486972733703,0.5653234991684049,0.5070909379859709,0.3058816822504121;
TNFR2 non-canonical NF-kB pathway,0.38232763216433213,0.4179128650456059,0.44896251260719916,0.3468013020091587,1.1099716963084914,0.8852698768301113,0.7595021276578693,0.34311895659229713,0.36912070063627533,1.3306282568439491,0.3058816822504121;
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,0.3812752525395024,0.3057534806262932,1.4884460794727319,0.4785623264034495,0.45873877254042,3.325319267883124,0.7595021276578693,0.754498870576167,0.3178323774360328,2.4424617640482627,0.3058816822504121;
FBXW7 Mutants and NOTCH1 in Cancer,0.3794194863285861,0.3057534806262932,1.4937353575819188,0.4787629375979512,0.45873877254042,3.325319267883124,0.7595021276578693,0.761143084226597,0.31751321075844985,2.4424617640482627,0.3058816822504121;
Regulation of Apoptosis,0.4875425241158012,0.33402483609309025,0.7405497402194402,0.3259138448761465,0.6326764164089309,0.7026410464999637,0.7595021276578693,0.31539388260432966,0.7740546118678892,0.5244669103630071,0.3032374359194824;
Nucleotide Excision Repair,0.5207997001917796,0.4920142274166592,0.3825478653928037,0.6290221373827818,0.33140832466933967,0.3410850662423667,0.7595021276578693,0.32008659068880624,0.30320189929542807,0.3281579980837237,0.3058816822504121;
Signaling by NTRK3 (TRKC),0.3194411920163444,0.9900473145611959,1.0149029969129846,0.8615737011253088,0.3728262573756636,0.4127644252979026,0.7595021276578693,0.34398443282195684,0.3327832096024327,0.3109481832046546,0.3058816822504121;
SHC-mediated cascade:FGFR2,0.31186750211813125,0.3010748960204856,0.9443850209880829,0.3945960662795339,0.37572915566633974,0.48151769849856507,0.7595021276578693,0.4487304213364941,0.32397177416554596,0.3600587774940227,0.3030467691849685;
IKBKB deficiency causes SCID,0.4822664362971935,0.6748754522273666,1.0707885287000203,0.6675991867173691,0.3119959467823231,0.3620735944925361,0.7595021276578693,0.8386828002913995,0.42933067375325595,0.589177003658062,0.3058816822504121;
Interleukin-2 signaling,0.9895905770638133,0.30402224815377643,0.4763371513150519,0.380333723709027,1.0079842539256374,0.3880965446374992,0.7595021276578693,0.31539388260432966,0.31808512104917774,2.7980008285229334,0.30249811228335877;
Zinc influx into cells by the SLC39 gene family,0.40324195892511366,0.8471359067348253,3.5047245306337906,0.3271459557820616,0.330372459861341,0.4794000133923282,0.7595021276578693,0.43791357279423887,0.6577271283436212,0.4170778848741611,0.3058816822504121;
CTLA4 inhibitory signaling,0.47453674885557934,0.6813926051109291,0.30134832367833375,0.3347645018815191,1.4089716811145514,1.429074647254128,0.7595021276578693,0.4274366816141549,0.45174765924593724,1.6182057087046102,0.3058816822504121;
Neutrophil degranulation,0.8740151034321074,0.9394394484219818,1.3087269907221424,0.3271459557820616,1.239479955932051,0.8355252322315516,0.7595021276578693,0.4628527562793292,0.4026596990050985,2.2960819303063684,0.3058816822504121;
Toll Like Receptor TLR1:TLR2 Cascade,0.311283752599729,0.4445315318218932,1.5621779857084854,0.3503872330012344,0.8715268134458334,1.1440271903015207,0.7591351859401954,0.5582073633842422,0.3061107917419532,1.0847504988898473,0.3058816822504121;
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),0.4817292801788386,0.6748754522273666,1.1081772974668507,0.6739582054110552,0.3119959467823231,0.3620735944925361,0.7586155693203555,0.8317163119950952,0.42884493895991277,0.5851179785892223,0.3058816822504121;
Serotonin and melatonin biosynthesis,0.737234817812786,0.39651361378525823,0.36180188645199246,0.8325728134683127,0.35830085846035925,0.3712967479661517,0.7585405554141191,0.31539388260432966,0.32815084485870327,0.34335514650734517,0.3058816822504121;
Translation initiation complex formation,0.3887383370256969,0.301642737608084,1.2664242412085094,0.3612995601475251,0.3439134979171695,0.49788523180365735,0.7563841572112756,0.6285814395938571,0.32819706770507,0.3878945009222701,0.3058816822504121;
Binding and entry of HIV virion,0.3971734923445716,0.5717648254254253,0.6503741717742904,0.3906615914818883,0.35830085846035925,0.30836634995479767,0.7558613221779444,0.30980925894012945,0.44233412632640934,1.21219404816517,0.3058816822504121;
Phase I - Functionalization of compounds,1.473354178762333,0.6667335201465007,1.6694235073695038,0.3388488933313274,1.5828289611196062,1.0829141512581968,0.7558011760672825,0.3445913271108731,0.3061107917419532,2.2593550654011274,0.3058816822504121;
Defective ST3GAL3 causes MCT12 and EIEE15,1.4880462630977418,1.2032771054264193,1.951348190804263,2.629076272493864,0.32297793958928395,0.3338497085090671,0.7558011760672825,0.34311923132904953,0.33154605935666304,0.3286979716130023,0.3058816822504121;
Ion channel transport,0.382661322523146,0.3393935927201346,6.141570040292085,0.33741769099486835,1.0702835859303041,3.5661809475438275,0.7554515803694287,2.1126085293724817,0.9644846059805651,2.1972219634687944,0.3058816822504121;
Axonal growth inhibition (RHOA activation),0.7011912520187482,0.30402224815377643,0.451301273526655,1.1792918363963194,0.47902190640086667,0.3455123857306245,0.7545039243026552,0.39361440195896213,0.36419136224313775,0.3117369630687721,0.3058816822504121;
mRNA decay by 5' to 3' exoribonuclease,1.1365783624670363,0.4916469925647314,0.7243536117804112,1.1633498441602939,0.35646676400014793,2.8242544401475214,0.7545039243026552,0.5993574392337823,0.33154605935666304,0.3126363644087619,0.3032374359194824;
Metallothioneins bind metals,2.478999639403361,0.30844391279468925,0.3025960133980849,0.35726975603122774,1.5061060989817545,0.6307025544677579,0.7496763890106327,0.9221426572870339,0.3900183977157809,0.30603264219956966,0.3058816822504121;
Intra-Golgi traffic,0.6080489904843976,0.6151614309327488,1.8437272037867236,0.36760429667486116,0.6101308047348644,0.468029122621951,0.7481470021475535,0.37731415007330193,0.33154605935666304,0.6183593246693948,0.3058816822504121;
Extra-nuclear estrogen signaling,2.1858677614026787,0.6255863960340599,2.066464377214288,0.5934319195341671,0.9810357787120494,0.7305728899620716,0.7481470021475535,0.6370660872345657,0.3227320418931485,1.748177700993418,0.3058816822504121;
Hedgehog ligand biogenesis,0.5877105209035316,0.4155240941545764,0.5555381760798851,0.5084365731528091,0.7460829399514947,0.8813681710037167,0.7450594696913315,0.3317123913477366,0.3089310108463698,0.3286979716130023,0.3030467691849685;
Defective ABCC6 causes pseudoxanthoma elasticum (PXE),0.31959300312778277,0.8801008526206888,1.0874656267528842,0.32289368140643626,0.33664443463132226,0.38104536656071447,0.7409234487188037,0.31482486972733703,0.32426094406474487,0.33947331721842144,0.3058816822504121;
Heme biosynthesis,0.41368428722655964,0.6151614309327488,0.42507367602014473,0.39485276920195894,0.8184237073582252,0.31763670856740067,0.7293832915769082,0.8253612893047934,0.3167022141326965,0.32837788404645557,0.3058816822504121;
SHC-related events triggered by IGF1R,0.34778150135032254,0.59842826146496,1.5309896907524476,0.8655799992205404,0.3726312003584851,0.8601756721033803,0.7293832915769082,0.36710932947589353,0.31075100083854396,0.31015939694194117,0.3038105965870218;
Autodegradation of the E3 ubiquitin ligase COP1,0.5494083030290889,0.3203499212257818,0.5950270739792122,0.3213115419718923,0.6231688405270283,0.7026410464999637,0.7293722425344301,0.3251934547032587,0.4834775083772459,0.67103617616946,0.3032374359194824;
Transcriptional regulation of white adipocyte differentiation,0.47959881088156225,0.3393935927201346,0.9749224672435733,0.3861917421038416,0.3542809798398846,0.6609860355446091,0.7290186859666419,0.6652097340320369,0.36938299849264533,0.3380674904376626,0.3058816822504121;
Defective ABCC8 can cause hypoglycemias and hyperglycemias,0.4476355475197084,0.5113201656506292,1.726946968850598,0.3781533650620131,0.6269560508788569,1.4280897653334224,0.7290077262391089,1.044299525814588,0.441266538994127,1.1562074796831707,0.3058816822504121;
Cholesterol biosynthesis via desmosterol,3.159900279365289,0.8306568667285524,0.7923662097912963,2.7590857997482385,0.32162569628297455,0.6519587578748341,0.7222638342698987,0.6665031139237775,2.989752403292134,0.31846271886699135,0.3030467691849685;
Regulation of activated PAK-2p34 by proteasome mediated degradation,0.500133810884987,0.33402483609309025,0.5017359945597698,0.3219369464324067,0.6273431526178614,0.70206723630419,0.7212877135807099,0.3251934547032587,0.539731828546328,0.6638900922726186,0.3030467691849685;
NR1D1 (REV-ERBA) represses gene expression,0.31449879932068264,0.4081569957992947,1.7236398388371843,0.481054275110977,0.3712409546165301,0.35765380914162076,0.7212877135807099,0.9408642598773541,0.5811663370377547,0.4523752385250782,0.3058816822504121;
Hh mutants abrogate ligand secretion,0.4397502331886933,0.388169017711386,0.824931137133459,0.42329081273942404,0.697971698746192,0.7762920576970408,0.7211578669322246,0.3251934547032587,0.45174765924593724,0.4121812366547547,0.3058816822504121;
AUF1 (hnRNP D0) binds and destabilizes mRNA,0.4934957412491837,0.30844391279468925,0.4702734346865812,0.3156748741478961,0.6326764164089309,0.7062972612850885,0.7208074248377759,0.3317123913477366,0.7735404879884075,0.5816479321842641,0.3058816822504121;
Neurofascin interactions,0.3400679662812288,0.5415108956193776,1.073527017168443,0.46569355143615376,0.33664443463132226,0.5042473154489974,0.720757556068464,0.5753977044168755,0.33154605935666304,0.353801888386797,0.3058816822504121;
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,0.4770618959027905,0.31070106152335225,2.5759157192245343,0.3198395805486888,0.697971698746192,0.36412558352903635,0.7193123939676941,0.48010325862568076,0.4834775083772459,0.42134576627183296,0.3058816822504121;
Ribosomal scanning and start codon recognition,0.3637587916540856,0.3165159964142589,1.2699638742658215,0.3693453361803258,0.33627276072485157,0.5544912631413436,0.718626802719297,0.5174152264767676,0.3227320418931485,0.38946540392582374,0.3058816822504121;
Iron uptake and transport,0.382962692574789,0.42498593976503624,3.7550281484348407,0.6628320076168105,0.32822834131119466,1.5147445311366687,0.718626802719297,3.5793220696144203,1.6045179610646543,0.9286390457962913,0.3058816822504121;
Signaling by FGFR3 point mutants in cancer,0.45031287653699437,0.3090278240817252,1.459986029735789,0.3657188180620897,0.37205774949981,0.45383436213121164,0.718626802719297,0.31539388260432966,0.3878635720534119,0.33136141337096764,0.3058816822504121;
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,0.37821001808340465,0.7759719336519098,2.124707996289505,0.3684705508289915,0.3726312003584851,0.3693748414877889,0.718626802719297,0.41975460648763435,0.3294107031527259,0.539970287064255,0.3058816822504121;
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,0.44351687530887374,0.5533034614471986,0.3484189810996315,0.3163292158034775,0.56267084582879,1.452137294720206,0.718626802719297,0.3323267677217555,0.5380488165948838,0.6023219753609191,0.3058816822504121;
Ovarian tumor domain proteases,0.31696645752904035,0.7083061017751114,0.3315394577628418,2.103550734576822,0.4829239057523196,1.2703747830332628,0.718626802719297,0.8217497190823737,0.7283839345834368,0.86305871730435,0.3058816822504121;
Loss of Function of SMAD2/3 in Cancer,1.1277853311486246,1.8775290803228701,0.7117191178668506,1.2097778019785008,0.3764809604369917,0.36504209043534924,0.7182363918172375,0.34771675041091515,0.33154605935666304,0.41104584371777314,0.3058816822504121;
Ubiquitin-dependent degradation of Cyclin D,0.518386853782506,0.3393935927201346,0.30579569889678593,0.3347311511299859,0.6340855228863872,0.7464617740472214,0.7178978211760938,0.43929821085455234,0.4881499224650157,0.46947200515560084,0.3058816822504121;
ARL13B-mediated ciliary trafficking of INPP5E,0.40092328276644357,0.6689711571362104,0.3186523149786101,0.38459539265859194,0.32294597418133,0.50226676089624,0.7178978211760938,0.4172926860385218,0.3823295944692655,0.4226804593618851,0.3058816822504121;
mRNA Editing,0.4902811882553369,0.32979575975804937,1.0436818236799421,0.4074955743352819,0.4549475819776362,0.887962512340968,0.7178978211760938,0.4500870576843292,0.36494779765230456,0.9125629518729945,0.3030467691849685;
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,0.6188386975716889,0.3042610942237951,0.6453672315140071,0.4296023820159213,0.5705700121496526,1.5794624010909826,0.7174115763916942,0.5766853584012566,0.6052596979838009,1.1526365629019313,0.3058816822504121;
APOBEC3G mediated resistance to HIV-1 infection,0.5259896618479669,1.2883328945183445,0.44896251260719916,1.4839082806637571,1.1006916058888643,1.4790660885924087,0.7162299573435986,0.38454701793058893,0.9944631593630215,0.30603264219956966,0.3058816822504121;
Synthesis of PIPs at the early endosome membrane,0.538172561730402,0.3791687430799317,1.5929326002698512,0.3963459216698887,0.38403520953254044,0.35442848255346754,0.7162299573435986,0.34311923132904953,0.3395190423521366,0.3240658633672765,0.3058816822504121;
Export of Viral Ribonucleoproteins from Nucleus,2.191855770938605,0.4132837240099325,1.9696136285748287,1.4977211223066247,0.33140832466933967,4.2859625258343215,0.7122862287386482,0.31539388260432966,0.3156659602261388,0.4395763307211742,0.3058816822504121;
Signalling to p38 via RIT and RIN,1.7669202485720785,0.5405674868039902,0.5899768161580835,0.39426574827518807,0.3728262573756636,0.4225063520170492,0.7110177363873341,0.5238886509233606,0.3063901120454567,0.39807543893028463,0.3058816822504121;
Cellular response to hypoxia,0.39722190427788606,0.42498593976503624,0.5326692938651336,0.3861917421038416,0.6692056431172262,0.8376841702460962,0.7110177363873341,0.37363972655453026,0.31952804471255203,0.47469881290334454,0.3058816822504121;
Serotonin clearance from the synaptic cleft,0.3914332839728542,0.36642448936154975,0.9127868378715198,1.0907646901544714,0.3439134979171695,0.6056560839274541,0.7099480130000605,0.4147150908432823,0.7833072493658433,0.39863298409526765,0.3058816822504121;
CaMK IV-mediated phosphorylation of CREB,0.8240387731396571,0.3105836898586958,1.3954518564373424,0.3861917421038416,0.395589721156635,0.958673584270821,0.7097486369874028,0.4133310857960066,0.8180319778289137,0.4451611421708856,0.3058816822504121;
Degradation of GLI1 by the proteasome,1.1797252582573627,0.3051715086707191,0.350539890489017,0.3404051988889697,0.6326764164089309,0.7616720178786548,0.7081605806847059,0.30396128062304534,0.573654972903253,0.5647744386762132,0.3032374359194824;
Cholesterol biosynthesis via lathosterol,3.159900279365289,0.8321271111883655,0.7950820635273264,2.7590857997482385,0.32162569628297455,0.6553981422150078,0.7081605806847059,0.6698158922286765,2.989752403292134,0.31774785258472305,0.3030467691849685;
Aspartate and asparagine metabolism,3.577067120766731,0.4245237537802895,0.4625334376321326,2.5985208753702254,0.3377810260292985,1.3500165569350606,0.7053474762006324,0.42426681188822685,2.5586406654319847,0.32532264275231887,0.3058816822504121;
Phosphate bond hydrolysis by NUDT proteins,1.8865930163032059,0.6667335201465007,0.9582644958721781,1.5123371805538774,0.8748407446876449,3.5894551210514725,0.7053474762006324,0.31539388260432966,2.5056557102950343,0.4170778848741611,0.3058816822504121;
Activation of gene expression by SREBF (SREBP),2.298777125199066,1.0998559421736642,0.4638464394542238,2.0093749167695414,0.33021183431640455,0.36504209043534924,0.7053474762006324,0.3272468962834211,7.162132505349072,0.8490622050611334,0.3058816822504121;
Signaling by Nuclear Receptors,0.349808568082094,0.42498593976503624,1.6492379692157524,0.34114908780953945,0.6718297994418723,0.7372963255753604,0.7053474762006324,0.33696163270265517,0.33154605935666304,0.39863298409526765,0.3058816822504121;
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,0.9194528543244973,0.3029713996082115,0.46543457405871613,0.8325728134683127,1.4497014587581227,0.31776991236841967,0.7053474762006324,0.6834181834101111,0.3728343545959842,2.051687776345235,0.3058816822504121;
Diseases associated with glycosylation precursor biosynthesis,0.48313498722766435,0.301642737608084,0.3592904035310348,2.8559277830681817,1.4497014587581227,4.181834275178987,0.7053474762006324,0.4488400297962748,0.5424034113042814,1.3059797136759275,0.3058816822504121;
Adenosine P1 receptors,0.37051919734668776,0.6255863960340599,0.4116917806757118,0.5016914801173993,0.33627276072485157,0.46829287577570267,0.704926271719206,0.3323267677217555,0.31808512104917774,0.30241267449194814,0.3058816822504121;
BMAL1:CLOCK,NPAS2 activates circadian gene expression,0.4397502331886933,0.33875335399120593,0.556917742662055,0.4490722136303524,0.3285435148042968,0.3980703831398632,0.7026172200500586,0.3323267677217555,0.3693665271664583,0.47469881290334454,0.3058816822504121;
SHC1 events in EGFR signaling,0.35009297739730705,0.3250759886945429,1.5621779857084854,0.3265325825462171,0.7252307939108502,1.82771025815591,0.702004785726681,0.5111346635224848,0.32397177416554596,0.5201607101204013,0.3030467691849685;
Cobalamin (Cbl, vitamin B12) transport and metabolism,0.5064747394859815,0.30590329751427836,1.6402962334009734,0.33564575743536246,0.3559004303722288,0.6382081544241213,0.702004785726681,0.3293659749007217,0.418328270869041,0.5062109884217922,0.3058816822504121;
Inhibition of replication initiation of damaged DNA by RB1/E2F1,0.8109487688803604,0.8801008526206888,0.9579023496523752,0.5993005284414504,0.30418705243734856,0.3976005671239824,0.702004785726681,0.5174152264767676,0.4881499224650157,0.33623172585815414,0.3058816822504121;
Regulation of PLK1 Activity at G2/M Transition,3.5156354930488996,0.6689711571362104,0.700652533072232,4.06966763875463,0.30320248709849507,2.43727651100229,0.7014500473436441,0.30396128062304534,2.0125965975846594,0.4540611718827999,0.3024439670208732;
Glycosphingolipid metabolism,0.3439432282083857,0.3041785410778355,0.3538601237188543,3.2933857616075604,1.5516964445333434,4.473216327154641,0.7013816007156196,0.35971925328583354,0.33154605935666304,1.4580356932341085,0.3058816822504121;
Interleukin-33 signaling,0.45157137268716835,0.32033896412378116,0.3222246234534123,0.45025906807447985,0.4123868010473213,0.5214535874144981,0.7013816007156196,0.3931219998955243,0.3156659602261388,0.36956882019668214,0.3058816822504121;
ZBP1(DAI) mediated induction of type I IFNs,0.38523662041238443,0.4730357518880468,1.2020317108771463,0.8651694564980436,0.330372459861341,0.3632803726492419,0.699707019158724,0.3582339302818586,0.3900183977157809,0.32837788404645557,0.3058816822504121;
Nef mediated downregulation of CD28 cell surface expression,0.5435134029461398,0.3294175279576714,1.969790304079922,0.3881184602725714,0.43126189235088314,0.416812166468743,0.699707019158724,0.3452626441013441,0.3156659602261388,0.7759878936396359,0.3058816822504121;
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein,0.3919370534645718,0.4589854816754815,0.9016876705022483,2.690512727094115,1.6211298642155623,3.9580873428343493,0.699707019158724,0.31712948652399137,0.3506743079000685,2.594019802813395,0.3058816822504121;
Activation of AMPK downstream of NMDARs,0.7874425476922812,0.5698796886264856,3.5456896344915085,3.1017857006537954,1.5061060989817545,3.6682713617479097,0.6985171478849116,0.35971925328583354,4.180260242446005,2.0007560205265067,0.3058816822504121;
RNA Polymerase II Transcription Termination,0.7272333389986602,0.4795596063169615,1.2038324561269298,0.34049658036688124,0.309110606499298,0.37279380859743294,0.6981092242364338,0.9408642598773541,0.36494779765230456,0.5978124858893199,0.3058816822504121;
RAF activation,0.41368428722655964,0.3667015217797265,0.3538601237188543,0.3716656553937898,0.4146172972667351,0.3632803726492419,0.6981092242364338,0.3278380010085199,0.30380343648068064,0.4404591951700404,0.3058816822504121;
Innate Immune System,0.9419200076086187,0.34266439908148333,1.6570881202917616,0.3503872330012344,1.4497014587581227,0.9662702471036565,0.6922005982853139,0.33696163270265517,0.33154605935666304,2.4231988773254285,0.3058816822504121;
Degradation of AXIN,0.44991269397751044,0.31070106152335225,0.3186523149786101,0.3163170636750133,0.6330786994542528,0.7072001173174037,0.6922005982853139,0.32350686861876327,0.6052596979838009,0.5280321394999583,0.3058816822504121;
rRNA modification in the nucleus and cytosol,0.8090237191460051,0.5692089016558236,1.6476115585663034,1.1876979507336975,0.56267084582879,0.6289210074036768,0.6877910561779731,0.9068933016026804,0.5880701744094536,0.3109481832046546,0.3058816822504121;
G1 Phase,0.5535071145903584,0.413066088586355,2.2276406502899304,3.7032962458639638,1.3778827873106971,6.302943733477355,0.6877910561779731,0.6370660872345657,0.7682035069384494,0.9107625886734448,0.3058816822504121;
Biosynthesis of maresin-like SPMs,0.5094261828828982,0.47300501140253504,2.2483234071619544,0.5099505515132051,0.33627276072485157,0.38644297502167896,0.6877910561779731,0.9521400088762076,0.33154605935666304,0.30212584039343277,0.3058816822504121;
Metabolism of steroid hormones,0.31186750211813125,0.3691439136623758,0.4686749892684955,1.0946766827022336,1.3895649703949147,1.1035302521089236,0.6877910561779731,0.5795150420091576,0.3418975449068169,1.4614751638835521,0.3058816822504121;
Phase 0 - rapid depolarisation,3.2423324160819953,0.9494276736079174,0.4394989343370929,0.8452387558632973,0.3119959467823231,1.5722036364200949,0.6877910561779731,0.34990649827154013,2.2130171577930184,0.3286979716130023,0.3058816822504121;
Defective SLC7A7 causes lysinuric protein intolerance (LPI),0.4829104392658238,0.47698398560067923,0.7329841466517517,1.1631405880901788,0.8460285966547827,0.4541009858801141,0.6868871687567908,0.4849021760868862,0.33154605935666304,0.572602207453692,0.3058816822504121;
Erythrocytes take up oxygen and release carbon dioxide,3.1579280340379063,0.3815328977541353,1.5459410778839082,0.48853611966738064,0.33627276072485157,0.36504209043534924,0.6868871687567908,0.30705368811069295,0.3728343545959842,0.4404591951700404,0.3058816822504121;
Resolution of AP sites via the single-nucleotide replacement pathway,0.36765290593325656,0.9363641915722525,0.6225364988453915,0.6331163983894467,0.813000243923089,0.3829935829538375,0.684550718566136,0.3425206096678787,0.3506743079000685,0.7802431485169055,0.3058816822504121;
Tie2 Signaling,0.5437888218575485,0.30844391279468925,1.3642360856774947,0.35607005789003415,0.33627276072485157,0.8132148164039968,0.6843645837248971,0.4045210707684523,0.3170116103066843,0.7759878936396359,0.3058816822504121;
Caspase activation via Dependence Receptors in the absence of ligand,0.48313498722766435,0.4081569957992947,3.0834478156395653,0.585492006186901,1.1481739550259185,1.1647753235628877,0.6836977125265167,0.6457362346093443,2.9263999307496014,1.1931978617360253,0.3058816822504121;
Circadian Clock,0.6285471103463576,0.46978811903228695,1.18730192667951,0.5259000391854405,0.8503470961550441,1.3917802130409396,0.6799790668799602,0.35082679893314456,0.6065838599288306,0.3160906252949544,0.3030467691849685;
Defective CHST3 causes SEDCJD,0.6659459286562769,0.3202448349147819,0.3029863472831966,1.7592356223195151,0.3791920767944086,0.312405934491624,0.6799073794921534,0.8392145373470217,0.3506743079000685,0.46947200515560084,0.3058816822504121;
Defective Mismatch Repair Associated With MLH1,0.4793265617140399,0.3661244522353381,0.8657888542379367,0.5186944834847285,0.4549475819776362,0.45670913707475397,0.6798513547669957,0.3281831594165969,0.32562191479076025,0.33210750061061056,0.3058816822504121;
Selenoamino acid metabolism,0.3705538786804814,0.49023002456961257,1.3625813048377844,0.3232519888569888,0.3176342054010501,0.617122547965672,0.6780052329763756,0.3445913271108731,0.37714526130064224,0.40252020266210986,0.3058816822504121;
Response of Mtb to phagocytosis,0.784503390523303,0.5608949022435844,0.5303554176778794,0.42447319466534195,0.330372459861341,0.3067879155501381,0.6745911340988181,0.30705368811069295,0.7730125632518882,0.51104279764138,0.3058816822504121;
Defective Mismatch Repair Associated With PMS2,0.47959881088156225,0.3659796444425064,0.8671605759872623,0.5193681541207191,0.4549475819776362,0.45656252074684,0.6745911340988181,0.3300822406904645,0.32562191479076025,0.33210750061061056,0.3058816822504121;
Presynaptic depolarization and calcium channel opening,0.634875972349676,0.30402224815377643,0.7806341170784341,0.543500529637991,0.3791920767944086,1.512162253594101,0.6745911340988181,0.638700226611994,0.31165489437756005,1.6978019077937714,0.3058816822504121;
Class A/1 (Rhodopsin-like receptors),1.60587601523418,0.3368377974219193,0.8047831011363191,0.4038285808863057,1.3683876779047697,0.46829287577570267,0.6745911340988181,0.3251934547032587,0.37721347556427365,2.483157765439062,0.3030467691849685;
Defective CP causes aceruloplasminemia (ACERULOP),0.37338376901850856,0.3667015217797265,0.644935180956147,3.093200608811175,0.3817344749875123,1.529563565132045,0.6745911340988181,0.34398443282195684,0.33154605935666304,0.48090848935731906,0.3058816822504121;
Translocation of SLC2A4 (GLUT4) to the plasma membrane,0.32648569807719524,0.49882509403717307,0.33530251087995344,0.3304831969753468,0.6690453106869725,0.43974660283822303,0.6737196068674183,0.3234063097880479,0.7347552367163173,0.30585742098687774,0.3058816822504121;
MAP3K8 (TPL2)-dependent MAPK1/3 activation,0.3250327858327181,0.36250846227187006,0.6468125906699718,0.3232519888569888,0.4146172972667351,0.8997208297259155,0.6713618914075323,0.7214872606359403,0.46024504142413253,1.5558640259660477,0.3058816822504121;
Regulation of PTEN gene transcription,0.3914332839728542,0.3051715086707191,0.7527065770860261,0.3163292158034775,0.35573771241937,0.3549954513766429,0.6711483201136181,0.35524193396628306,0.3331357954895238,0.41656026628740567,0.3058816822504121;
Cyclin D associated events in G1,0.5557714001529779,0.4139487656799205,2.2290273392962243,3.7032962458639638,1.3778827873106971,6.302943733477355,0.6711483201136181,0.6370660872345657,0.7656970779251888,0.9125629518729945,0.3058816822504121;
Small interfering RNA (siRNA) biogenesis,0.5415759740759772,0.8826240100075539,1.0271210263264698,1.9196620360307155,0.6278261191361808,0.4541009858801141,0.6711483201136181,0.352267490683119,0.30597331000228806,0.34032309265129573,0.3058816822504121;
WNT ligand biogenesis and trafficking,0.44766682252123474,0.30397605771269914,2.2213923011518446,0.3198395805486888,0.735956800753507,0.34699522989044684,0.6711483201136181,0.48606186013240477,1.8480011499345042,0.7377129540255057,0.3024439670208732;
Prostanoid ligand receptors,4.421865726096109,0.5254335345474912,0.46003925549301955,0.34114908780953945,1.0019038319050186,0.4253316158697854,0.6710775274459876,0.3317123913477366,0.3340537124683427,1.964746184777371,0.3058816822504121;
Signalling to STAT3,0.8072884376667768,0.30402224815377643,3.0769969401617354,0.5494503778783885,0.37572915566633974,0.4902850695312733,0.6708465905007468,0.5389628321778192,0.3156659602261388,0.37228578428448916,0.3058816822504121;
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),0.3757811722764317,0.3667015217797265,0.6226847339346442,3.093200608811175,0.38403520953254044,1.529563565132045,0.6708465905007468,0.34398443282195684,0.33154605935666304,0.48083144768408004,0.3058816822504121;
Fibronectin matrix formation,0.3119979840557615,0.3041785410778355,0.9222796197517228,0.5879866812394244,0.40817078376215093,0.46829287577570267,0.6698695343062915,0.3582339302818586,0.9799404551560605,1.0880453727411499,0.3058816822504121;
Incretin synthesis, secretion, and inactivation,0.37397514495720063,0.32191146796407205,0.7806341170784341,0.5879866812394244,0.33140832466933967,0.4317114540437308,0.6677831347999036,0.34396528640542523,0.3327832096024327,0.5100898491572277,0.3058816822504121;
Interleukin-23 signaling,1.05959797977676,0.3853102637544382,0.7534152968415716,0.3163292158034775,1.0702835859303041,0.4467220717805114,0.6577263159104878,0.9221426572870339,0.3061107917419532,2.089521959943691,0.3058816822504121;
Fc epsilon receptor (FCERI) signaling,0.7835341861987285,0.3294175279576714,1.1619703486716784,0.49872499448686436,1.4353727597575503,0.8376841702460962,0.6568840829740856,0.42426681188822685,0.3179919430452987,0.888080305417378,0.3058816822504121;
mRNA decay by 3' to 5' exoribonuclease,0.46066971883957947,0.30955187441848364,0.9162582846119129,0.330334113068339,0.33261410504422656,0.42626866561660953,0.6568840829740856,0.6836046292614913,0.3406966434873319,0.3267680869989519,0.3058816822504121;
Events associated with phagocytolytic activity of PMN cells,0.431821667658144,0.6617160530759545,1.5779111655378955,0.3265325825462171,0.35577493496846524,0.4594757158104028,0.6557893862354078,0.33990809468773525,0.841070780956803,0.4678954462589095,0.3058816822504121;
Signaling by BRAF and RAF fusions,0.7577917899930378,0.421441415526736,2.5449959312857753,0.4296023820159213,0.3791920767944086,0.9159433215271222,0.6557893862354078,0.35971925328583354,0.37714526130064224,0.39863298409526765,0.3030467691849685;
Glutathione conjugation,0.41878227920580746,0.3393935927201346,0.5017359945597698,0.38977595796733894,0.32297793958928395,1.1817997448829574,0.6557893862354078,0.4184113112236314,0.9045344860174249,0.728520522915135,0.3058816822504121;
Transcriptional Regulation by TP53,0.9759808104049144,0.5892408336468945,1.8734113197925235,1.4747417306789243,0.43959201379489105,0.3540970261426587,0.6502155849203852,0.30222076309715623,0.37771151139769193,0.4678954462589095,0.3030467691849685;
Signaling by Leptin,2.8796703395276784,0.43811797663171387,2.4570670351367867,1.2340498540709834,0.35830085846035925,0.3410850662423667,0.6502155849203852,0.5327910439846112,4.994386362121999,0.5366842440460126,0.3058816822504121;
STAT5 Activation,1.5384059333897593,0.3667015217797265,1.0801688475148632,0.38741141821149655,0.35830085846035925,0.6051375835311831,0.6502155849203852,0.638700226611994,2.3620894734638185,0.5059822623459164,0.3058816822504121;
Zinc transporters,0.4679470918438496,0.40902976592044643,2.6602202288966255,0.3213115419718923,0.40544019855192026,0.48975163667491933,0.6497578771449225,0.5174152264767676,0.7763401413039768,0.49134624260713206,0.3030467691849685;
Cytosolic tRNA aminoacylation,1.535964430878942,0.421441415526736,0.4760528568967101,3.0445068026999493,0.38790175177324593,2.2442289478706834,0.6496633113293887,0.5238886509233606,2.3977188328456367,0.6136687820851401,0.3058816822504121;
RSK activation,0.36507011621124635,0.6161081789146999,1.4511080008514845,0.5390862025986808,0.4566501995022956,0.651553621145545,0.6496633113293887,0.38454701793058893,0.3728343545959842,0.47469881290334454,0.3058816822504121;
ATP sensitive Potassium channels,0.550325245823433,0.4697451878114334,1.9403404753819906,0.5120370352239828,0.8446972605608251,0.8300173452917683,0.6495393783698978,0.7796931658740366,0.33154605935666304,1.5955851576917726,0.3058816822504121;
Phase 3 - rapid repolarisation,0.7114908455678625,0.4756177540516632,0.30874407996004716,0.3628766921649118,0.3223947354494506,0.4794000133923282,0.6494465417459975,0.37363972655453026,0.42933067375325595,0.7302267570893407,0.3058816822504121;
Signalling to ERK5,0.44631117192110686,0.5193565621241749,0.4603095424324561,0.5900152111207688,0.34278026633975034,0.474224940380697,0.6487039106565731,0.31539388260432966,0.6495813182532031,0.37218965236252843,0.3058816822504121;
PI-3K cascade:FGFR1,0.5578026495840487,0.4631345202388002,0.5111303216523466,0.4147520762862274,0.3726312003584851,0.4284244389806044,0.6481650494857949,0.30318050255984674,0.441266538994127,0.5363788369295108,0.3058816822504121;
Formyl peptide receptors bind formyl peptides and many other ligands,0.9909815148296388,0.438351604480435,2.053301222593815,0.3861917421038416,0.4677023943293453,0.6096598100222578,0.6477375995644433,0.5972444500514024,0.5509514948484421,1.7359615954624459,0.3058816822504121;
Cross-presentation of soluble exogenous antigens (endosomes),0.3293713534384813,0.3041785410778355,0.9997493873720442,0.3068385808775283,0.6464762617962498,0.6774667045954355,0.6477375995644433,0.35082679893314456,0.37714526130064224,0.4121812366547547,0.3058816822504121;
G-protein beta:gamma signalling,1.6621284400141596,0.6949866166592567,0.8410170842254203,0.9307538981534129,0.3119959467823231,0.3506047630835153,0.6477375995644433,0.4681429621674421,0.33154605935666304,0.44065582267788694,0.3058816822504121;
Regulation of PAK-2p34 activity by PS-GAP/RHG10,0.3407996132956933,0.5254335345474912,0.6430813796130099,0.3198395805486888,0.3073643548426107,0.40025699739537474,0.6477375995644433,0.5174152264767676,0.8343263083614866,1.9819513083267213,0.3058816822504121;
Signaling by the B Cell Receptor (BCR),0.48313498722766435,0.3323755191652757,0.6433961507045527,0.39710621317627126,1.4497014587581227,0.9662702471036565,0.6477375995644433,0.3094759427026921,0.32397177416554596,1.278569614722146,0.3030467691849685;
COPII-mediated vesicle transport,0.3119979840557615,0.30814244538089003,0.40487844146094454,0.3103014479071436,0.39915625782545383,0.5040377049096719,0.6477375995644433,0.4589589677230645,0.4881499224650157,0.4180930510119524,0.3058816822504121;
Eicosanoids,0.30133470505033955,0.30136794395345357,0.48542971755829295,0.3881184602725714,0.8133814640431409,0.4300466631842503,0.6472720912254882,0.5032716605085823,0.9045344860174249,0.4748417360474539,0.3058816822504121;
Gap junction degradation,0.6575892762752841,0.3029713996082115,2.411391835264811,0.4147520762862274,0.3226140943665297,0.4095359585082957,0.6453744005251274,0.5238886509233606,0.3578586759482637,1.008836296218646,0.3058816822504121;
Classical Kir channels,0.3775870832267736,0.3667015217797265,2.2800584638170864,0.44815612351070533,0.32741484957780614,0.4306777496994055,0.6453744005251274,0.3673641876817358,0.3389374015397122,0.4625596178349653,0.3058816822504121;
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),0.38643697721258424,0.4001476370117231,0.7615455863097667,0.3881184602725714,1.1431615389490235,1.1143603888025917,0.6453744005251274,0.3425206096678787,0.48124263349989904,1.7387034335731002,0.3058816822504121;
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,0.33299551659134974,0.4828154453378415,0.3880260456385692,0.3881184602725714,0.39113834579371415,0.36504209043534924,0.6443251587244894,0.7157035988615835,3.35807944939153,0.6716459391729103,0.3058816822504121;
Glycolysis,1.1098280637652032,0.676678057295489,3.220848191015027,1.4734733037340915,0.5718721379043165,3.9580873428343493,0.6443251587244894,0.39106647252794896,0.9045344860174249,0.4540611718827999,0.3058816822504121;
Hedgehog 'on' state,0.7569119402608251,0.3393935927201346,0.4545456547511497,0.3468013020091587,0.6181909816472938,0.6983792545637864,0.6443251587244894,0.3101095001068416,0.418328270869041,0.6275550123828493,0.3058816822504121;
IRS activation,1.1098280637652032,0.36250846227187006,0.6874299491778388,0.3163292158034775,0.35830085846035925,0.30146276932778043,0.6411948420524092,0.3445040560899542,3.843945196908138,0.48863788812715925,0.3058816822504121;
NTF3 activates NTRK2 (TRKB) signaling,2.523254037657491,0.4920142274166592,0.3654193179949343,0.38650006444627144,0.4146172972667351,0.47055855225156185,0.6397211908528908,0.3207891067373377,1.016202858953107,0.4540611718827999,0.30370155596674026;
Activation of Ca-permeable Kainate Receptor,0.7720732380339349,0.334075782009426,0.36516085144117183,0.5950246338700154,0.330372459861341,0.35767155389389355,0.6397211908528908,0.3610048682403598,0.6495813182532031,0.3184671951240273,0.3030467691849685;
Transport to the Golgi and subsequent modification,0.3390466778271897,0.8294461261044188,0.6541994802932344,0.3386982920238717,0.397151474618249,0.42626866561660953,0.6391286418637736,0.37770911594983014,0.4049598252116228,0.35602166590463147,0.3030467691849685;
Activation of BIM and translocation to mitochondria ,0.3481518561848366,0.3326844125402299,0.3186523149786101,0.3861917421038416,0.3439134979171695,0.3968193348510415,0.6391286418637736,0.34311923132904953,0.33154605935666304,0.35813546395474505,0.3058816822504121;
Ionotropic activity of kainate receptors,0.7753440831935311,0.3351318903327174,0.3638088415947402,0.6028394895080141,0.330372459861341,0.359645047493023,0.6386528990964253,0.3610048682403598,0.6599543878170412,0.3192411555141251,0.3030467691849685;
Response to metal ions,2.542854621103988,0.32979575975804937,0.7181371261749155,0.36903555914521596,1.4527835083452083,0.6261490231295497,0.6370458800385651,0.46387415068046234,0.4491556453856495,0.30241267449194814,0.3058816822504121;
Regulation of RAS by GAPs,0.3910589826000372,0.30397605771269914,1.070454754960547,0.30570651231582135,0.7008282779048037,0.8191093977027304,0.6328720688769365,0.3027579187486238,0.40204508772130776,0.4030133825628864,0.3058816822504121;
ATF4 activates genes in response to endoplasmic reticulum  stress,2.7479059081461,1.8815589255708167,0.6485759415060202,2.039925222755937,0.39026309562416256,0.4654107926117023,0.6313439853975169,0.32004270639318994,0.3291793723880899,0.4540611718827999,0.3058816822504121;
Acetylcholine regulates insulin secretion,2.3170412095512583,0.3057222929869753,0.6371763478650965,0.5375314615485541,1.289087089228065,0.9055099536922643,0.6310920916496067,0.3725206349295344,0.32815084485870327,3.4449015650011026,0.3058816822504121;
BBSome-mediated cargo-targeting to cilium,1.2395545150788039,0.7623567272052943,4.842470890520244,2.2650458759999386,0.736694677490896,4.237413484234244,0.6304574654235515,0.5298150485572088,2.0125965975846594,0.41376887048902816,0.3058816822504121;
Termination of O-glycan biosynthesis,0.49291980934876795,0.3941337904584961,0.996131501942276,0.46226604486085676,0.4549475819776362,0.5588744344857842,0.6287254159882936,0.7796931658740366,0.33154605935666304,0.44480723187912163,0.3058816822504121;
Negative feedback regulation of MAPK pathway,0.4817292801788386,0.301642737608084,0.7427333755593621,0.3503872330012344,0.36291076110700615,0.35399026492638497,0.6272100880792519,0.4594542354595542,0.32562191479076025,0.5295654644999037,0.3058816822504121;
Interleukin-21 signaling,0.44498379621009987,0.4906211694986659,0.366949816375034,0.33673587927188364,1.186629245897139,0.46329118624362164,0.6262032210714549,0.3354845578006066,0.34010467491250734,1.8792239064126597,0.3058816822504121;
Erythropoietin activates Phospholipase C gamma (PLCG),1.2078137829487043,0.522282795009411,0.3222246234534123,0.36979981229449416,1.4497014587581227,1.8311672677668602,0.6262032210714549,0.3613559184988038,0.32111489806210064,1.9520731071313704,0.3058816822504121;
SHC1 events in ERBB4 signaling,0.41368428722655964,0.4179128650456059,0.366949816375034,0.3861917421038416,0.3439134979171695,0.6470773481185341,0.6253770897381131,0.5152172963006261,0.32855021388126704,0.3145341631936787,0.3024439670208732;
vRNP Assembly,1.2375457594394272,0.49023002456961257,0.4058123878935055,0.34567633947784127,0.35830085846035925,0.37279380859743294,0.6244395542888417,1.0161680515499365,0.3327832096024327,0.30377756914377746,0.3058816822504121;
Mitochondrial calcium ion transport,0.7229430398457655,0.5063312115705851,0.6765362912914509,0.5259000391854405,0.3226140943665297,0.459200286558088,0.623708776487114,0.48606186013240477,0.6625909336695316,0.33740247317007105,0.3058816822504121;
Signaling by FGFR3 in disease,0.4489840067171152,0.3090278240817252,1.4664144571942463,0.3657188180620897,0.37205774949981,0.4541009858801141,0.6233418839927014,0.31539388260432966,0.37818098826263175,0.32837788404645557,0.3058816822504121;
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,0.5087320036543982,0.3090278240817252,1.2173595814786349,0.5051382176619013,0.40172092259716147,0.4300466631842503,0.6233418839927014,0.3026882475200465,0.801610122932309,1.5147422072234873,0.3058816822504121;
Regulation of gene expression in beta cells,0.4637962833951004,0.31878267820372547,0.4244230974768862,0.3612995601475251,0.35830085846035925,0.30935821823726206,0.6227443251316185,0.3094759427026921,0.45174765924593724,0.47575535715786293,0.3058816822504121;
Amine Oxidase reactions,0.7103589167065222,0.421441415526736,1.1687960223806535,1.337137883213234,0.3226140943665297,1.406004938591317,0.6227443251316185,1.2382013029336363,2.445397666782993,1.3252235613115686,0.3058816822504121;
AKT-mediated inactivation of FOXO1A,0.3205509179075892,0.7480906320451475,0.7085898925746626,0.3074220055826222,0.46352996110646083,0.48487375011027734,0.6221066591061859,0.5389628321778192,0.3406966434873319,0.31100904921848943,0.3058816822504121;
Assembly and cell surface presentation of NMDA receptors,0.4413392197585203,0.7117440126230394,1.9365202542765205,1.181504720171942,0.7031803745821407,1.4253477582594813,0.6221066591061859,0.4147150908432823,2.5686467092452725,0.3146249156431087,0.3030467691849685;
RNA Polymerase II Transcription Elongation,1.1006572113928061,0.47698398560067923,2.993865667155949,1.6396908958083662,0.38943238328213475,0.8166208659207264,0.6207875833337954,0.5174152264767676,0.3156028200568447,0.5266784352668187,0.3058816822504121;
mRNA Editing: C to U Conversion,0.35546056252366,0.3661244522353381,1.200161912746773,0.4623887211683596,0.9073877188713215,0.609620681310484,0.6197334262306619,0.6292013533408742,0.30320189929542807,1.2561339572121097,0.3058816822504121;
Formation of RNA Pol II elongation complex ,1.1044363717623256,0.47698398560067923,2.9852707225489863,1.6396908958083662,0.3900512129307848,0.8166208659207264,0.6197334262306619,0.5174152264767676,0.31497219477514715,0.5278203201689747,0.3058816822504121;
Signaling by FGFR4,0.9895905770638133,1.0346589951790564,1.7306317027678155,0.34552125769421904,0.5203761356366514,0.312405934491624,0.6197334262306619,0.3422609258794438,0.3728343545959842,0.4256218001331623,0.3058816822504121;
Formation of the Editosome,0.35546007256282774,0.3661244522353381,1.1975164472302646,0.4588658462678318,0.9073877188713215,0.6091496236054034,0.6188348250237403,0.6292013533408742,0.30320189929542807,1.2561339572121097,0.3058816822504121;
Digestion,0.4416826026365212,0.6937041650548988,2.3392743670789615,0.5595898307253171,0.3726312003584851,0.3762215469973146,0.618766832547746,0.7178761696994983,0.554461158330871,0.39863298409526765,0.3058816822504121;
Hemostasis,2.6067777820855773,0.3650614398467666,1.6009174500429368,0.3163292158034775,1.4497014587581227,0.4306777496994055,0.6175913602706975,0.3317123913477366,0.46398019506563953,2.997892669141395,0.3058816822504121;
Scavenging of heme from plasma,0.9633412710095572,0.30844391279468925,0.3889203456174835,0.34114908780953945,1.3117371153061983,0.3111782497541377,0.6161994344295351,0.44203855648039064,0.41366042532312036,0.951176730912015,0.3024439670208732;
Activation of RAS in B cells,0.47615683619677523,0.4589854816754815,1.0271210263264698,0.4719780034210142,0.3042255279326703,0.6146134294433632,0.6154576991650971,0.4671836385857672,0.31165489437756005,0.6749467764774163,0.3058816822504121;
Signaling by FGFR1,1.1645252368847758,0.9900473145611959,2.2258969211531747,0.4377973965427679,0.4478076746337553,0.3167789875738771,0.6135925556444946,0.37363972655453026,0.3973359698996325,0.38489751646675285,0.3058816822504121;
Signaling by NOTCH1,0.7939764877875455,0.3090278240817252,0.3423293169245103,0.39718831089691875,0.30447768946963627,0.3328673103460413,0.6129435998054554,0.34398443282195684,0.3086647282719282,0.30241267449194814,0.3058816822504121;
Prolonged ERK activation events,0.382661322523146,0.3051715086707191,0.7754297360402278,0.529994372254881,0.3119959467823231,0.4902850695312733,0.6129435998054554,0.6799766290735694,0.4505231252205524,0.42581119985693494,0.3024439670208732;
Sterols are 12-hydroxylated by CYP8B1,1.0921754824570058,0.3667015217797265,0.5912408725194476,0.42674137949237534,0.3764809604369917,0.3111782497541377,0.6099143559843874,0.309018298085769,0.441266538994127,0.35352371536264976,0.3058816822504121;
Activation, translocation and oligomerization of BAX,0.3827545297476341,0.36250846227187006,1.2689601743304062,0.3754435264512781,0.3119959467823231,0.312405934491624,0.6099143559843874,0.5152172963006261,0.4881499224650157,0.514447818538236,0.3058816822504121;
Inactivation of CDC42 and RAC1,0.3734046510438084,0.9900473145611959,0.30747772415026436,0.3861917421038416,0.3119959467823231,0.4943795785364185,0.6085169415198353,0.31482486972733703,0.30320189929542807,0.31100904921848943,0.3058816822504121;
ER-Phagosome pathway,0.3757811722764317,1.2883328945183445,0.3286617056409019,0.3163292158034775,1.1550172303045425,1.0759741558630265,0.6074573323384226,0.39653028297393783,0.3080664458142234,0.4724375413774212,0.3058816822504121;
Purine catabolism,1.053977997009789,0.3659796444425064,2.446629515634509,2.2990384417973035,1.2574929567058153,4.460539542243616,0.6064500921951128,0.3040196464828374,2.617225113548886,0.30603264219956966,0.3058816822504121;
Negative regulation of MET activity,0.3971734923445716,0.3287534890243859,2.6189342360355807,0.8651694564980436,1.4497014587581227,3.6682713617479097,0.6047181655662764,0.6113856407636219,0.3522221105554151,1.6621396350243398,0.3058816822504121;
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.9962224759148058,0.33281680434913724,0.3710314070749997,0.45814106070834476,1.1550172303045425,0.5599068983002935,0.6047181655662764,0.30318050255984674,0.3190828844110016,2.7980008285229334,0.3058816822504121;
Semaphorin interactions,3.0065856196841656,1.1805460151872085,0.3648511899524546,0.3541571802879987,0.6690453106869725,0.4454136642903058,0.6047181655662764,0.524218023045207,0.3329607429278685,2.06427786660498,0.3058816822504121;
Mitochondrial biogenesis,0.34851775320695805,0.7380453821386058,0.5899768161580835,0.3816686884212616,0.3439134979171695,0.452236788425519,0.6047181655662764,0.31539388260432966,0.36494779765230456,0.30241267449194814,0.3058816822504121;
Regulation of the apoptosome activity,0.5557714001529779,0.3579101535729101,0.7461313363362247,0.3468013020091587,0.33664443463132226,0.4707131587543235,0.6047181655662764,0.6834181834101111,0.3596562854316725,0.33258796371861915,0.3058816822504121;
Aflatoxin activation and detoxification,0.3734046510438084,0.47300501140253504,3.4288675997688203,0.3163292158034775,0.531793620499492,1.6361384284798421,0.6041760619553798,0.3108923324961582,0.441266538994127,1.4816810756480672,0.3058816822504121;
Ephrin signaling,0.4018828569002947,0.35692546054244895,2.666974935369027,0.4147520762862274,0.8529634354326688,1.4869809244944705,0.6010606335982255,3.097529713339588,0.31120063727890246,1.6225454832760655,0.3058816822504121;
Activation of RAC1 downstream of NMDARs,0.4025554105549951,0.3757662919161499,0.7967758165849417,0.3503872330012344,0.48966648444849525,0.3976005671239824,0.599842167963549,0.3428250647930948,0.33154605935666304,0.3337585302705513,0.3030467691849685;
Aggrephagy,0.3971734923445716,0.5698796886264856,0.35535755172665123,0.3861917421038416,0.49397349821228864,0.5014736687538923,0.599842167963549,0.7086724457561365,0.33154605935666304,0.9286390457962913,0.3058816822504121;
Peroxisomal lipid metabolism,0.7172429252214279,0.4691874280398756,1.8607583764898603,2.1064236111950527,1.3375113665528906,3.197932235509305,0.5994516984667435,0.35971925328583354,0.31833320673388454,0.47781560131935036,0.3058816822504121;
Adaptive Immune System,0.7987175084881835,0.40402279833969024,0.8219084041657259,0.5993005284414504,1.4497014587581227,0.7611948809893043,0.5994516984667435,0.5627328227900846,0.33154605935666304,2.1733796621331583,0.3058816822504121;
Reuptake of GABA,0.3413040478985904,0.3667015217797265,0.37445075705903463,0.481639618788804,0.5352610187418227,0.49408554235057933,0.5994516984667435,0.39014468230695576,1.6715027404174745,0.4662474674102111,0.3032374359194824;
Metabolism of vitamin K,1.13506157252981,0.5892408336468945,1.6369573174202467,0.38459539265859194,0.32162569628297455,0.36863436870686955,0.5994516984667435,0.9897043482796474,0.33154605935666304,0.3084605076514881,0.3058816822504121;
Formation of apoptosome,0.5557714001529779,0.3579101535729101,0.7613149469443117,0.3468013020091587,0.3363756870848458,0.47111129867808327,0.5994516984667435,0.6849130563545062,0.3578586759482637,0.3333681131202209,0.3058816822504121;
Activation of AKT2,2.3432740989404515,0.8632208606986975,0.38880248195770517,1.1142675776635804,0.5387294385820026,0.3632803726492419,0.5989433324395058,0.479986763867055,0.8048458867956023,0.34335514650734517,0.3058816822504121;
Signaling by NOTCH3,0.44193241261666083,0.315650141649467,0.4738126440768114,0.6093374474314339,0.330372459861341,0.48342847674028183,0.5984295489726322,0.5578106790042832,0.38395097131164374,0.4540611718827999,0.3058816822504121;
Activated NTRK2 signals through FYN,0.43617467770933954,0.30844391279468925,0.6801207909144334,0.5950246338700154,0.6231688405270283,1.1536654672087028,0.5960931700861403,0.46160100481213256,0.3672196296599615,0.39091888813155207,0.3058816822504121;
Stabilization of p53,0.9050907398884578,0.3051715086707191,0.6216315506447123,0.3881184602725714,0.6692056431172262,0.8376841702460962,0.5951683171556058,0.34398443282195684,0.47514208089199056,0.5578222525509198,0.3058816822504121;
Defective ABCA1 causes Tangier disease,0.737234817812786,0.7380453821386058,0.3557042064788556,0.38741141821149655,0.6231688405270283,0.42924963491620954,0.5951683171556058,0.30371588476481126,0.33154605935666304,1.0835322007145531,0.3030467691849685;
SUMOylation of DNA damage response and repair proteins,1.8658049258015759,0.48681187573574713,1.155310283745585,2.186707813833364,0.35646676400014793,4.434155846068263,0.5951683171556058,0.8267709879840873,0.33154605935666304,0.4451611421708856,0.3030467691849685;
Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling,0.44475513774266295,0.32644608695254396,1.6961102734751214,0.3163292158034775,0.32741484957780614,0.35399026492638497,0.5951312225955632,0.4815653043880472,0.7579121765853911,0.5550265173439319,0.3058816822504121;
Signal attenuation,0.49414180652094974,0.3161945191525057,1.913854202786874,0.5691213866579543,0.7418097657992928,1.8335365294606787,0.595051239088391,0.4843159419563512,0.4141350390547139,0.44811482431034744,0.3058816822504121;
Membrane binding and targetting of GAG proteins,1.4495191117476585,18.72418895955534,0.4066047791520444,0.3163292158034775,0.37921048227433873,1.02303616349597,0.594597984630684,0.7041732959113225,0.46964083019396136,1.070876034055654,0.3058816822504121;
Synthesis And Processing Of GAG, GAGPOL Polyproteins,1.4495191117476585,18.72418895955534,0.4077557145318142,0.3163292158034775,0.37913461146889044,1.02303616349597,0.5941629696398644,0.7104780544840936,0.46964083019396136,1.070876034055654,0.3058816822504121;
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,0.7753440831935311,0.3375899397983633,3.072413482054089,0.32289368140643626,0.42845660058183616,0.5143389080186972,0.5934048865234138,0.4890921202267072,0.44204832249518705,0.3281579980837237,0.3058816822504121;
Signaling by NTRK1 (TRKA),0.44528226273191873,0.900266676388589,0.7356982690080166,0.3861917421038416,0.3252199581779007,0.4775455705323609,0.5914683312205915,0.30705368811069295,0.3944031754439474,0.4640617091673951,0.3058816822504121;
Antigen processing: Ubiquitination & Proteasome degradation,0.4246650451014949,0.46476382621388357,0.8216637342111406,0.3213115419718923,0.32741484957780614,0.3845667208434919,0.5914683312205915,0.3300822406904645,0.33154605935666304,0.30241267449194814,0.3058816822504121;
FCGR activation,0.8542844809901686,0.7834067095934737,1.1223376057532264,0.32552608200489686,1.4497014587581227,0.4902850695312733,0.5914683312205915,0.4160132539854251,0.47514208089199056,1.430203188159464,0.3058816822504121;
NOSTRIN mediated eNOS trafficking,0.6201674709820884,0.7759719336519098,0.5719252318782395,3.2052102901869066,1.1631725606936794,0.8223810311479098,0.5900398415672385,0.30371588476481126,1.2715719157772336,2.4072876984101277,0.3058816822504121;
Amino acids regulate mTORC1,0.40511607004227757,0.31575954172831694,4.7472982508105375,0.3386982920238717,0.35830085846035925,1.4210486164345306,0.5900398415672385,3.4988955953655956,1.4200398915934218,0.9348202675509376,0.3058816822504121;
Synthesis of 12-eicosatetraenoic acid derivatives,0.47476612700521587,0.35692546054244895,0.9557000940500868,0.4303767648874029,0.40817078376215093,0.38824598763600915,0.5900398415672385,0.5238886509233606,0.8148897708026148,0.6275550123828493,0.3030467691849685;
Caspase-mediated cleavage of cytoskeletal proteins,0.5017666922347023,0.3051715086707191,3.576704185968215,1.9213835140203939,1.4268786222886325,2.8366622884131485,0.5900398415672385,0.3139169205361536,5.124140824579572,2.1972219634687944,0.3058816822504121;
Biological oxidations,0.49613785187768805,0.3187355966601872,3.228445727348512,0.5649603294597292,1.4497014587581227,1.3682532712781112,0.5900398415672385,0.4313030976096779,0.32855021388126704,1.2494740913292197,0.3058816822504121;
Calcitonin-like ligand receptors,0.5352592075091925,0.4141143292009499,1.3445781099223764,1.1673887999976262,0.330372459861341,2.130924992320124,0.58816230971181,0.6370660872345657,3.2841406566513855,0.6899463049956933,0.3058816822504121;
Abacavir metabolism,2.49213647564696,0.7275175613159001,1.192546288252778,1.5123371805538774,0.35830085846035925,1.1355491154455415,0.5862008987922501,0.49240764263677456,2.2633490448862537,0.3755674202397432,0.3058816822504121;
Phospholipase C-mediated cascade; FGFR4,0.5643806122452142,0.3361553255902056,0.3327614819001198,0.5900152111207688,0.3439134979171695,0.5599068983002935,0.5856341717820197,0.4184113112236314,0.3728343545959842,0.3272584305099836,0.3058816822504121
Mitochondrial transcription initiation,0.670812212167234,0.3650614398467666,2.572810503142373,0.5879866812394244,0.4696389090763279,0.5487753153582212,0.58450892187093,0.3582339302818586,0.4326147371542654,0.47812431533965105,0.3058816822504121;
Cargo recognition for clathrin-mediated endocytosis,0.382661322523146,0.6025095823481236,0.4201686359858995,0.34114908780953945,0.30418705243734856,0.30930404734628464,0.58450892187093,0.3094759427026921,0.3329607429278685,0.37882480811887304,0.3058816822504121;
VEGFR2 mediated cell proliferation,1.2364841185841642,0.30677617522722794,2.7828355175990342,0.6093374474314339,0.6989623471272555,0.6621129724397352,0.58450892187093,0.4628527562793292,0.33154605935666304,0.572602207453692,0.3058816822504121;
Activation of PUMA and translocation to mitochondria,2.0836589221079467,0.4081569957992947,1.3055650210691319,0.34523110574342525,0.30418705243734856,3.6463143324478393,0.58450892187093,0.43044402620096184,0.37818098826263175,0.6278686644799669,0.3030467691849685;
Defective MTR causes methylmalonic aciduria and homocystinuria type cblG,0.40416822402795777,0.5226248776529049,0.8827936058609523,0.4787629375979512,0.3633380217657343,0.4462005514578704,0.58450892187093,0.4590848497960635,0.30150053284191936,0.9142395245658843,0.3058816822504121;
Synthesis of PA,1.1808570603390043,0.5261728792807606,0.35516354224109725,1.5185208073107592,0.3764809604369917,0.3321209692064086,0.58450892187093,0.5753977044168755,0.36494779765230456,0.6373351344924745,0.3058816822504121;
Downregulation of SMAD2/3:SMAD4 transcriptional activity,0.6280033938262458,0.34355423434661836,0.398930845222065,0.3271459557820616,0.32297793958928395,0.5348176763167671,0.58450892187093,0.3569622340932903,0.31952804471255203,0.30352660857733577,0.3058816822504121;
Reelin signalling pathway,2.9650636060332687,0.3699715056935029,0.9755889006351273,0.3503872330012344,1.283355176961649,0.48487375011027734,0.58450892187093,0.36371079402101386,0.46426390350807945,3.4449015650011026,0.3058816822504121;
Detoxification of Reactive Oxygen Species,1.05959797977676,0.3454297670313602,0.7832182228226636,0.3503872330012344,1.0661186522715957,0.5276431447302522,0.58450892187093,0.6298029648437563,0.44204832249518705,1.0099763115094418,0.3058816822504121;
Formation of HIV elongation complex in the absence of HIV Tat,1.5139160947299097,0.7663054886937828,2.1284016907979777,1.9777592025426907,0.30418705243734856,0.9769991092692408,0.58450892187093,0.4628527562793292,0.329509855487524,0.3160906252949544,0.3032374359194824;
Diseases of carbohydrate metabolism,0.38132131699763155,0.4081569957992947,1.5444164327986398,0.6622763101984931,0.3778170345464189,1.1516495716257158,0.583299313822173,0.5972444500514024,0.441266538994127,0.38946540392582374,0.3058816822504121;
NTRK2 activates RAC1,0.36794248948618863,0.4973390331284095,1.9878792449742015,1.0984007136001188,0.5063148250480233,0.3746954730679191,0.583299313822173,0.3272468962834211,0.32892132877066294,0.41912518944327204,0.3058816822504121;
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,0.6188386975716889,0.3368377974219193,0.47531146190153706,1.402095657048408,0.6109240307787517,0.3087936354152438,0.582849314870551,0.48606186013240477,0.6210171735684104,0.33619831583867554,0.3058816822504121;
Defective EXT2 causes exostoses 2,0.36765290593325656,0.3090278240817252,0.482378744370449,0.8204438826608905,0.3808454324985298,0.3620735944925361,0.5808697597322219,0.3323267677217555,1.7356631751023508,1.397736080653779,0.3058816822504121;
Autophagy,0.4109520095001413,0.7942545520053982,0.5441269426029018,0.3881184602725714,0.3439134979171695,0.3111782497541377,0.5808697597322219,0.4027649518660638,0.36494779765230456,0.6096568683654476,0.3032374359194824;
G alpha (q) signalling events,2.9388588202148087,0.5698796886264856,0.5918648485601009,0.5187531396662611,1.0154803251442055,0.3946222670176035,0.5808697597322219,0.5875312333581726,0.329509855487524,1.890603867424168,0.3058816822504121;
ABC transporters in lipid homeostasis,1.0700109216582754,0.48371352640443255,2.195007627689316,0.5879866812394244,1.27292890664036,1.712975075732699,0.5808697597322219,0.7808545639669524,3.582534078690718,3.314105425567513,0.3058816822504121;
TICAM1 deficiency - HSE,0.3386844483448156,0.3522313504995742,0.6196374237856637,0.4296023820159213,0.39863506445001573,0.43600447353966315,0.5796897095728246,0.41975460648763435,0.36494779765230456,0.34335514650734517,0.3058816822504121;
RUNX3 regulates BCL2L11 (BIM) transcription,0.7441795746115099,0.39450107866299366,0.35470016441665064,0.520633663964261,0.33627276072485157,0.6374443225425805,0.5787506373594129,0.4628527562793292,0.33154605935666304,0.4523752385250782,0.3058816822504121;
Mineralocorticoid biosynthesis,0.35562270700240717,0.4828154453378415,0.9579023496523752,1.6931900894072889,1.1600797188479506,0.8300173452917683,0.5784505296676542,0.6411808684018272,0.47514208089199056,0.618958085029439,0.3030467691849685;
Defective EXT1 causes exostoses 1, TRPS2 and CHDS,0.3672789551152327,0.3090254582300101,0.48346237348866605,0.8109639229343182,0.3808454324985298,0.3620735944925361,0.5779518724321794,0.3317123913477366,1.7356631751023508,1.397736080653779,0.3058816822504121;
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,0.5110806458636459,0.42941821270763025,0.3186523149786101,0.520633663964261,0.3900512129307848,0.5138249529961795,0.5779518724321794,0.37482945748292784,0.46964083019396136,0.30275000416564607,0.3058816822504121;
Regulation of KIT signaling,0.9059589856483335,0.3579101535729101,1.2779065248146315,0.3347311511299859,1.4268786222886325,2.0806635156743734,0.5767228843654125,0.8392145373470217,0.3779014763245248,3.4449015650011026,0.3058816822504121;
Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE,0.4042318912617516,0.522282795009411,0.8973268374793185,0.481639618788804,0.36405550772813533,0.4461518232477087,0.5740121033607938,0.4612616436760333,0.3013333079553526,0.9351044811737204,0.3058816822504121;
PTK6 Down-Regulation,0.9751455003165845,1.2397120796373553,1.3085168449344753,0.3347645018815191,0.3791920767944086,0.6621129724397352,0.5725737192157304,0.7316766047041314,0.37818098826263175,0.4855530989821367,0.3058816822504121;
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),2.29861419269392,0.3393935927201346,0.7654194085499344,0.3684705508289915,0.6179677922698414,0.4127644252979026,0.5722124891198251,0.32735598382599135,0.3564169901750398,1.2252955819219193,0.3058816822504121;
Class I MHC mediated antigen processing & presentation,0.40492512827144206,0.573006782175561,1.2021267699589135,0.5259000391854405,1.4268786222886325,1.5311012719780634,0.5722124891198251,0.4313030976096779,0.45174765924593724,0.8891018910311445,0.3032374359194824;
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,0.7553950797127306,0.413066088586355,1.1083805905105883,0.5076203200586503,0.3363756870848458,1.2427780864673068,0.5712012601580387,0.6370660872345657,0.3589997748361272,0.30795647085368,0.3058816822504121;
Metabolism of water-soluble vitamins and cofactors,2.9647803656121123,1.5671211051990475,1.5210966350096282,0.3874935871335183,0.9021009043939139,0.4541009858801141,0.5697494702447431,0.5693729600094288,0.32426094406474487,1.78649655390807,0.3058816822504121;
IRAK1 recruits IKK complex,0.5094261828828982,0.4309972353107969,0.3206080364786928,0.520633663964261,0.3900512129307848,0.5138249529961795,0.5695118625117668,0.37731415007330193,0.4644723627826459,0.30352660857733577,0.3058816822504121;
Physiological factors,0.3390466778271897,0.335630131897455,0.4018400955900535,0.6299656593214783,0.3439134979171695,0.3131733022391502,0.569496376481786,0.35082679893314456,0.3418975449068169,0.30110966775959974,0.3058816822504121;
Rhesus blood group biosynthesis,0.4817292801788386,0.5131391727266793,1.585507937318083,0.3881184602725714,0.4478085833375179,0.5145174956340497,0.569496376481786,0.35971925328583354,0.5533050837385294,0.4121812366547547,0.3058816822504121;
Insulin effects increased synthesis of Xylulose-5-Phosphate,0.44379773945232204,0.9048193951556922,1.322897513905359,3.0002403088913203,0.8446972605608251,1.209979639482464,0.569496376481786,0.36593959197886095,1.3755447131318355,0.6789432446755621,0.3058816822504121;
Interleukin-9 signaling,0.3117629957183809,0.34082619400820896,0.996131501942276,0.31209524242081715,0.5277268907652843,0.3028133569923738,0.569496376481786,0.5111346635224848,0.33154605935666304,1.1404565985013442,0.3058816822504121;
Negative regulation of the PI3K/AKT network,1.05959797977676,0.3375899397983633,2.585307364309015,0.8702638379415334,1.4497014587581227,1.5666239456364723,0.569496376481786,0.35082679893314456,0.33154605935666304,3.384554429792202,0.3058816822504121;
GRB7 events in ERBB2 signaling,1.1942267462802694,0.45420597324553597,0.5987697647187264,0.549035509160064,0.4393593943366305,0.7996773688617796,0.569496376481786,0.3437722064307414,13.59933018389872,0.36089186576253024,0.3058816822504121;
Signal amplification,1.2425571895325784,0.4589854816754815,0.6066943934222234,0.8930098233406037,0.3439134979171695,0.38644297502167896,0.5688547520955242,0.30299624920473567,0.3051798143030743,0.3013223548358037,0.3058816822504121;
Histamine receptors,0.572952278377859,0.47698398560067923,0.9582644958721781,0.3163170636750133,0.32162569628297455,0.5683890433722195,0.5677425861452924,0.4594542354595542,0.304022170806971,0.7558105801902364,0.3058816822504121;
MHC class II antigen presentation,1.05959797977676,0.33281680434913724,0.6231240255902294,0.5037883573514967,0.7576852196375048,0.4902850695312733,0.5677425861452924,0.32275912281066177,0.31197598096833934,1.377199030694664,0.3058816822504121;
Signaling by activated point mutants of FGFR1,0.43617467770933954,0.30402224815377643,0.363838568588565,0.5950246338700154,0.3726312003584851,0.42525182155387664,0.5677425861452924,0.8217497190823737,0.3418975449068169,0.32118391269318924,0.3058816822504121;
Vpu mediated degradation of CD4,0.38523662041238443,0.30963854390385315,0.7120241267902051,0.3462362231532854,0.6689626772894115,0.7362014428337754,0.5677425861452924,0.3300822406904645,0.8607865932569042,0.3337585302705513,0.3058816822504121;
TCR signaling,0.5929008419400837,0.4301895395995331,0.4242305594588609,0.32552608200489686,0.9699797081820802,0.5646191142917181,0.5677425861452924,0.48606186013240477,0.5264377585191584,0.9717408988765865,0.3058816822504121;
Blood group systems biosynthesis,0.6499891474814949,0.49826868931813784,1.8437272037867236,0.3156748741478961,0.3439134979171695,0.3748291066993173,0.5677425861452924,0.33990809468773525,0.5509514948484421,0.49143324866656846,0.3058816822504121;
Free fatty acids regulate insulin secretion,0.36467834019533574,0.4973390331284095,0.5956821402371679,0.39485276920195894,0.37205774949981,0.7155883661323684,0.5677425861452924,0.3610048682403598,0.31558403987910877,0.8730525531310326,0.3058816822504121;
Peroxisomal protein import,0.343981415433736,0.3351332739777284,0.8410170842254203,0.33980610064939215,0.30418705243734856,0.3666751479511771,0.5677425861452924,0.320366497401215,0.4084899821472641,0.4625596178349653,0.3058816822504121;
PTK6 Regulates Proteins Involved in RNA Processing,0.8667064535396588,0.8522925565223789,0.5428814771604668,0.39718831089691875,0.32162569628297455,0.870676636899998,0.5677425861452924,0.6652097340320369,0.378780953316455,0.46947200515560084,0.3058816822504121;
Toll Like Receptor 10 (TLR10) Cascade,0.3219535167637239,0.40402279833969024,0.48807233969871583,0.3503872330012344,0.32162569628297455,0.511477330150265,0.5664948836182203,0.37363972655453026,0.32296005032747643,0.33194577730543684,0.3030467691849685;
VEGFR2 mediated vascular permeability,4.287312178814089,0.976359290120047,1.5929326002698512,0.6933668795906172,0.5215188199488212,0.34084875043490775,0.5663891464730851,0.33696163270265517,0.31165489437756005,0.8753591799895075,0.3058816822504121;
Transcription-Coupled Nucleotide Excision Repair (TC-NER),0.40092328276644357,0.3691439136623758,0.3081915935170801,0.5899368858697199,0.3119959467823231,0.3982804413960526,0.5663891464730851,0.4018751439850773,0.3406966434873319,0.4724375413774212,0.3058816822504121;
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,0.9267563030733139,0.3918158246299093,3.0583390208778325,0.38227738456265975,0.39794629746034765,0.3111782497541377,0.5663891464730851,0.5745029716188665,0.3265506469380085,0.42606473230594233,0.3058816822504121;
Interleukin-17 signaling,0.4632713188448469,0.39450107866299366,0.49585837324710763,0.48853611966738064,0.395589721156635,0.3665801123277985,0.5663891464730851,0.4628527562793292,0.33154605935666304,0.7759878936396359,0.3058816822504121;
FOXO-mediated transcription,0.435056961084513,0.30814244538089003,1.2957633497091234,0.3183311680559162,0.3439134979171695,0.4285610224848932,0.5663891464730851,0.3251934547032587,0.40065431847947436,0.4232200116160087,0.3058816822504121;
Interleukin-15 signaling,0.9962224759148058,0.31070106152335225,0.734791934999741,0.3527496754644661,0.9768082672478035,0.6173359364348264,0.5654915029345091,0.6552415765802345,0.37721347556427365,1.9520731071313704,0.3024439670208732;
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,1.0723302102384076,0.3579101535729101,0.9288647512099875,0.34437446224392726,0.4393593943366305,0.3829935829538375,0.5654915029345091,0.43082664047868263,0.46964083019396136,1.3535894708088327,0.3058816822504121;
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,0.44631117192110686,0.4730357518880468,2.3392743670789615,0.3468013020091587,0.33627276072485157,0.4300466631842503,0.5654915029345091,0.7214872606359403,0.9074128455282108,0.33873573073084623,0.3058816822504121;
mitochondrial fatty acid beta-oxidation of saturated fatty acids,0.4163612747565755,0.6441853723194954,0.55281516121407,0.3163292158034775,0.3363756870848458,0.33792113328261064,0.5654915029345091,0.4628527562793292,0.3667930924250126,0.30245448354214916,0.3058816822504121;
Assembly of the ORC complex at the origin of replication,3.2160896901423657,0.3090278240817252,0.6680567965606966,2.086567704116142,0.32297793958928395,2.5583490586593745,0.5649865141619921,0.5065936427260506,0.40779040116016196,0.5103027601099676,0.3058816822504121;
VEGF binds to VEGFR leading to receptor dimerization,1.502358715204575,0.3661244522353381,0.39161510178558023,0.3728719702564068,0.31357570256688605,0.6565974083083047,0.5649865141619921,0.5562074498396701,0.3327832096024327,1.534402703378459,0.3058816822504121;
Defective CHSY1 causes TPBS,0.661442418419975,0.6025095823481236,1.180677839324132,2.7120106683136838,0.32297793958928395,0.5646191142917181,0.5649865141619921,0.34311923132904953,0.33154605935666304,0.3286979716130023,0.3058816822504121;
Ketone body metabolism,0.5654079179337074,0.3165159964142589,0.3186523149786101,0.38650006444627144,0.35573771241937,0.3762215469973146,0.5649865141619921,0.4018751439850773,0.32562191479076025,0.30603264219956966,0.3058816822504121;
Selective autophagy,0.8557616108455623,0.4973390331284095,0.4646964298938299,0.380333723709027,0.5820488601346345,1.3917802130409396,0.5645761866567632,0.30396128062304534,0.32855021388126704,0.33740247317007105,0.3058816822504121;
RUNX3 regulates p14-ARF,0.3357706194917672,0.43246941553297696,1.0373342112474155,0.3347645018815191,0.3130215102818571,0.3368439053375476,0.5624692163539768,0.829854390072768,0.3329607429278685,0.5278203201689747,0.3058816822504121;
Synthesis of bile acids and bile salts,1.4902736858247079,0.42498593976503624,0.4926764975294921,0.3198395805486888,0.7409373343908842,0.3861455410117313,0.5620019747758612,0.41975460648763435,0.3313549584263906,2.0333999971228023,0.3058816822504121;
Lactose synthesis,0.6790244304926514,0.32858137358249256,1.7007113797573465,1.19504725598382,0.3764809604369917,1.253892428975836,0.5619721744855252,0.7316766047041314,0.33154605935666304,0.32532264275231887,0.3058816822504121;
Neurotransmitter uptake and metabolism In glial cells,0.47453674885557934,0.30955187441848364,0.5439930076286128,0.3628766921649118,1.0423639475701816,0.6436104690705318,0.5593377059939286,0.30299624920473567,1.2578540591161071,0.622741869993541,0.3058816822504121;
Astrocytic Glutamate-Glutamine Uptake And Metabolism,0.47453674885557934,0.3090254582300101,0.5439930076286128,0.3628766921649118,1.0423639475701816,0.6434189199741671,0.5593377059939286,0.30308894197867353,1.2578540591161071,0.6136687820851401,0.3058816822504121;
PI3K/AKT activation,0.3479743390395984,0.4408812240548287,0.5017359945597698,0.39485276920195894,0.31167319664073184,0.3479832638871655,0.5593377059939286,0.3323267677217555,0.9045344860174249,0.30352660857733577,0.3058816822504121;
Translation,0.33895461643817115,0.3057534806262932,0.6528004921981475,0.3428663705227962,0.30246496029501807,0.5407089222379899,0.5593377059939286,0.4628527562793292,0.30320189929542807,0.4716648533813419,0.3058816822504121;
VEGF ligand-receptor interactions,1.502358715204575,0.3661244522353381,0.4075577494899649,0.36926780817120297,0.31351737387980566,0.6410017706458788,0.5593377059939286,0.5476577904899258,0.3322378492350531,1.534402703378459,0.3058816822504121;
Metabolic disorders of biological oxidation enzymes,0.46946449844294713,0.36305624463054287,0.7706553378908468,1.0907646901544714,1.4268786222886325,1.177864956113069,0.5593377059939286,0.31856818801142184,0.4188260016559483,1.0847504988898473,0.3058816822504121;
COPI-independent Golgi-to-ER retrograde traffic,0.30296962315825304,1.2883328945183445,0.39726083241319304,0.4602774105125744,0.43870502637389713,0.435132948930374,0.5591005997578204,0.4628527562793292,0.33154605935666304,0.3093086726264615,0.3058816822504121;
Biosynthesis of DPAn-6 SPMs,0.3672789551152327,0.8154380545274866,0.6097275555725923,0.5994221971160298,0.330372459861341,0.49243425586061645,0.5590295067439051,0.3428250647930948,0.3578586759482637,0.45956823263269403,0.30140128990347;
Chylomicron assembly,0.5259896618479669,0.4583996963357266,0.4579102813786349,0.6924045926167081,0.312768577621854,0.468029122621951,0.5590295067439051,0.30980925894012945,0.801610122932309,0.3160906252949544,0.3058816822504121;
Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1,0.31976342469705354,0.39501944315919246,0.7922759333769533,0.3691573656851328,0.5352610187418227,0.4467220717805114,0.5586147543238863,0.41975460648763435,0.5150564954008329,0.44065582267788694,0.3058816822504121;
Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2,0.31959300312778277,0.3968552970909142,0.7806341170784341,0.36926780817120297,0.5352610187418227,0.4467220717805114,0.5586147543238863,0.42864408325691356,0.5161023041844398,0.44065582267788694,0.3058816822504121;
Interleukin-3, Interleukin-5 and GM-CSF signaling,1.5575233024396238,0.3691439136623758,0.48807233969871583,0.3276978690976087,1.283355176961649,0.3829935829538375,0.5586147543238863,0.32753430183444365,0.6052596979838009,3.4449015650011026,0.3058816822504121;
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),1.4092370257446984,0.34355423434661836,0.4404769034096453,0.3213115419718923,1.2619462485978667,0.46829287577570267,0.5586147543238863,0.34771675041091515,0.8833437902205385,0.9562192771334456,0.3058816822504121;
Regulation of RUNX3 expression and activity,0.40416822402795777,0.31407750847502913,0.6371824077338354,0.3411192642224706,0.6740428384514924,0.7789091002105214,0.5586147543238863,0.30318050255984674,0.3973359698996325,0.4167336646038495,0.3058816822504121;
RAS signaling downstream of NF1 loss-of-function variants,0.3390466778271897,0.4081569957992947,0.30747772415026436,0.3232519888569888,0.35646676400014793,0.663366935019738,0.5586147543238863,0.3167418100550727,1.1611052484665474,0.35352371536264976,0.3058816822504121;
Basigin interactions,0.43474740894302966,0.4081569957992947,2.545746711814005,2.619139100227427,1.2744774780800556,2.9808766599588936,0.5586147543238863,0.4671836385857672,2.3977188328456367,1.8079973059073053,0.3058816822504121;
Prolactin receptor signaling,0.33991984304289263,0.31407750847502913,1.8138294843570146,0.33564575743536246,0.6233868947514392,2.8366622884131485,0.5586147543238863,0.6652097340320369,0.3086647282719282,1.7106826162149802,0.3058816822504121;
Synthesis of glycosylphosphatidylinositol (GPI),0.3361383259572482,0.964165667994885,0.40487844146094454,0.7312542504569594,0.39310591820871404,0.46829287577570267,0.5586147543238863,0.5389628321778192,0.3181712228862701,0.6335858605331677,0.3058816822504121;
Pregnenolone biosynthesis,2.346798702124567,0.3294175279576714,0.3186523149786101,0.33078324903982564,0.3977920397900884,0.3410850662423667,0.5586147543238863,0.4147150908432823,0.33154605935666304,0.8406988549530048,0.3058816822504121;
MyD88 cascade initiated on plasma membrane,0.3219535167637239,0.40402279833969024,0.48028659463326695,0.3503872330012344,0.3149984710890399,0.510460930321094,0.5586147543238863,0.37482945748292784,0.3231340566037976,0.33136141337096764,0.3030467691849685;
Toll Like Receptor 5 (TLR5) Cascade,0.3219535167637239,0.40402279833969024,0.47818504531566963,0.3503872330012344,0.32162569628297455,0.5070970648694568,0.5586147543238863,0.3751809727502707,0.32296005032747643,0.3306556298996619,0.3030467691849685;
Histidine catabolism,0.3971734923445716,0.31575954172831694,0.6066943934222234,1.7149205288296088,0.3764809604369917,0.3111782497541377,0.5586147543238863,0.5389628321778192,0.441266538994127,0.3286979716130023,0.3058816822504121;
Sema4D mediated inhibition of cell attachment and migration,0.3833773909436085,0.9394394484219818,0.9420434623734547,0.3881184602725714,0.3682477132294071,0.6051375835311831,0.5586147543238863,0.3918075842280902,0.36494779765230456,0.4232200116160087,0.3058816822504121;
Nef Mediated CD4 Down-regulation,0.8320370635605948,0.413066088586355,2.359926286467173,0.5874431926211804,0.39794629746034765,0.4214928495246554,0.5586147543238863,0.3873399681862305,0.3017463573232267,0.5280321394999583,0.3058816822504121;
TFAP2 (AP-2) family regulates transcription of cell cycle factors,2.7502552151057027,0.311151884547695,2.4335850565322814,0.3861917421038416,1.4353727597575503,0.3027894244324539,0.5586147543238863,0.3909454933235953,1.926502301917846,1.31566242757387,0.3058816822504121;
Calcineurin activates NFAT,0.9053507140392372,0.5825284386456702,1.7007295092476231,0.5043782219039552,0.3540024647605433,0.315085039913656,0.5586147543238863,0.309018298085769,0.3156659602261388,0.8618477111312528,0.3058816822504121;
Eicosanoid ligand-binding receptors,0.3957341132721857,0.4516995018455257,1.6871466656300826,0.4823062979997039,0.4146172972667351,0.5646191142917181,0.5573082282652562,0.4849021760868862,0.33154605935666304,0.30112320951753413,0.3058816822504121;
Toll Like Receptor 3 (TLR3) Cascade,0.7293809381687382,0.671007123935896,0.7950820635273264,0.4461636818038182,0.3824048831138682,0.3028133569923738,0.5552388697370142,0.3317123913477366,0.31197598096833934,0.41104584371777314,0.3058816822504121;
RHO GTPases activate IQGAPs,0.350054313306344,0.6400399366779007,0.3180102748962083,0.3350938995998829,0.34597679685845784,0.44569311077594786,0.555139399243918,0.3317123913477366,0.42563818276787846,0.3866317659379911,0.3058816822504121;
Molybdenum cofactor biosynthesis,0.6028468264166759,0.4358630027633813,1.7133650859540934,0.35457616746105136,0.3535867649444133,0.8398834316151859,0.5540674820608583,0.31539388260432966,0.5925824442312864,0.3286979716130023,0.3058816822504121;
Pentose phosphate pathway,0.4008627414888737,0.3202461238622649,1.994936069801295,0.4173616297592498,0.5905879164149995,2.9753587102600263,0.5521903213454883,0.3610048682403598,0.3300924222434923,0.3655997505279174,0.3058816822504121;
Regulation of innate immune responses to cytosolic DNA,0.30814360877310026,0.314824977833682,2.329820372190607,0.5037883573514967,0.41200215293113845,0.34084875043490775,0.5521903213454883,0.3094759427026921,0.45174765924593724,0.5934269043789591,0.3058816822504121;
PTK6 Activates STAT3,2.100626821058894,0.3659796444425064,1.4937353575819188,0.5016914801173993,0.3900512129307848,0.3632803726492419,0.5521903213454883,0.3356960773573929,0.6459758662785066,0.3086577387734625,0.3030467691849685;
Trafficking of myristoylated proteins to the cilium,0.31186750211813125,0.3393935927201346,1.0277586651572874,0.3922480685341312,0.3119959467823231,0.30146276932778043,0.5521903213454883,0.5347685416390742,2.5686467092452725,0.4523752385250782,0.3058816822504121;
Diseases associated with visual transduction,0.4068071496796083,0.652403918986381,3.7653157021786905,0.9866419833135416,0.3560720414244286,0.5498082464947072,0.5521903213454883,0.31539388260432966,1.016202858953107,0.30241267449194814,0.3058816822504121;
Reduction of cytosolic Ca++ levels,0.4029927195800096,0.4916469925647314,1.4509741794713948,0.49786442742870163,0.3791920767944086,0.4794000133923282,0.5521903213454883,0.36046186142273234,0.41645333857825007,0.4121812366547547,0.3058816822504121;
SOS-mediated signalling,0.3288559388871276,0.3214902380011182,0.9127868378715198,0.4126957922775283,0.3073643548426107,0.7260394740526817,0.5521903213454883,0.5972444500514024,0.37714526130064224,0.3911991709688112,0.3058816822504121;
Activation of NF-kappaB in B cells,0.469082934340401,0.3508263610994628,1.6023323837370131,0.3881184602725714,0.6732191070579637,0.8205962637560629,0.5521903213454883,0.3015161787323837,0.5843054969729731,0.30979469541785326,0.3058816822504121;
LDL remodeling,0.7978798310385139,0.5928485645407497,0.3538601237188543,0.3816686884212616,0.30447768946963627,0.3118750406862754,0.5512764926071008,0.48606186013240477,0.6206278086719139,0.30621433275255217,0.3058816822504121;
Defective MUT causes methylmalonic aciduria mut type,0.30554816552217945,0.3661244522353381,1.2020317108771463,0.3220708023044529,0.33261410504422656,0.3620735944925361,0.5512764926071008,0.36593959197886095,0.39644386094447553,0.4640617091673951,0.3058816822504121;
Nicotinamide salvaging,1.2539408448910911,1.8918086097467384,0.40128275093480864,0.9324881692464166,0.5254209537315264,0.3367022346185409,0.5489561165693235,0.6912688391345757,0.30150053284191936,1.0311558872936442,0.3058816822504121;
Downstream signaling of activated FGFR4,0.670812212167234,0.7176299670015546,0.7332120241169651,0.7521841837642104,0.3560720414244286,0.30701965150343463,0.5489561165693235,0.378954871891739,0.3061107917419532,0.4353740121305991,0.3058816822504121;
Defective MMAA causes methylmalonic aciduria type cblA,0.30373747758655945,0.3661244522353381,1.2020317108771463,0.3220708023044529,0.33627276072485157,0.3632803726492419,0.5489561165693235,0.36593959197886095,0.3973359698996325,0.4640617091673951,0.3058816822504121;
Metabolism of porphyrins,0.4370550442414825,0.5739278441172219,1.1841713365801751,0.33980610064939215,0.7799208320691424,0.4902850695312733,0.5489561165693235,1.0950377771587994,0.3693665271664583,0.47469881290334454,0.3058816822504121;
Interleukin-2 family signaling,1.2127446810691964,0.6374063636494343,1.2020317108771463,0.3142325622507859,1.263262560339818,0.34084875043490775,0.5489561165693235,0.44203855648039064,0.30320189929542807,2.941907485952989,0.3058816822504121;
Metabolism of proteins,0.5010655922836115,0.3393935927201346,0.3206195074938858,0.39485276920195894,0.4336556952074095,0.34084875043490775,0.5487339858738199,0.46153279637333866,0.33154605935666304,0.33345674932317276,0.3058816822504121;
Retinoid cycle disease events,0.4119904897944984,0.6539777764191337,4.116345100787422,0.9914308948078334,0.35573771241937,0.5409571700416974,0.5487339858738199,0.31539388260432966,1.0151134693501873,0.30241267449194814,0.3058816822504121;
Neurexins and neuroligins,0.469082934340401,0.6161081789146999,2.0283748895580045,0.3468013020091587,0.39026309562416256,0.33289973183375743,0.5487339858738199,0.5918767786718077,0.38395097131164374,1.2659926244198663,0.3058816822504121;
Tat-mediated elongation of the HIV-1 transcript,1.5345670566679266,0.784862753223625,2.114585589807809,2.0363512847631333,0.30418705243734856,0.9945345766707561,0.5487339858738199,0.4589589677230645,0.33154605935666304,0.33740247317007105,0.3058816822504121;
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,0.4416826026365212,0.3351332739777284,0.6066943934222234,0.6924045926167081,0.49397349821228864,4.460539542243616,0.5487339858738199,0.4671836385857672,0.7283839345834368,0.9064061091606519,0.3030467691849685;
Defective CD320 causes methylmalonic aciduria,1.4362206053945392,0.3922542300893332,0.4728389425664053,0.9673835150892642,0.8446972605608251,0.7370930606339963,0.5486832394780494,0.6121973354446032,0.3406966434873319,0.5231412627684151,0.3024439670208732;
Signaling by FGFR4 in disease,0.3672789551152327,0.3051715086707191,0.3528845675322629,0.3156748741478961,0.35573771241937,0.557960372657444,0.5486832394780494,0.6303443794140307,0.33154605935666304,0.3109481832046546,0.3058816822504121;
Regulation of TP53 Activity through Acetylation,0.3016763054275278,0.47698398560067923,1.8634477644547396,0.3163292158034775,0.33664443463132226,0.4285610224848932,0.5482379095828034,0.6370660872345657,0.3404697512215013,0.572602207453692,0.3034996034775484;
Rap1 signalling,0.42992726818516147,0.4920142274166592,0.4760528568967101,0.481639618788804,0.4087838908102159,0.6783029258638603,0.5467843854479838,0.37770911594983014,0.33154605935666304,0.45032973087605116,0.3058816822504121;
Defective Mismatch Repair Associated With MSH6,0.44782790628522195,0.40577227024084006,4.043873705123747,0.9039108135229567,0.37205774949981,0.4306777496994055,0.5449693486898921,0.5174152264767676,0.33154605935666304,0.34032309265129573,0.3058816822504121;
Metabolism of steroids,0.47453674885557934,0.4081569957992947,1.2533013848274954,0.3386982920238717,0.7962633357453084,0.7072001173174037,0.5449693486898921,0.43082664047868263,0.42332031869678155,0.3286979716130023,0.3058816822504121;
Defensins,0.3288559388871276,0.3667015217797265,1.1611221759179944,0.4679155083230611,0.40431063241202125,0.44126024644852563,0.5449693486898921,0.32753430183444365,0.441266538994127,0.5992126942583009,0.3032374359194824;
O-linked glycosylation of mucins,0.3494356728052213,0.301642737608084,0.4043610808977015,0.6976391796178689,0.6899473180595564,0.4306777496994055,0.5432321960506836,0.3317123913477366,0.33154605935666304,0.4569839190337219,0.3058816822504121;
RUNX2 regulates osteoblast differentiation,0.4890337317917532,0.6947337878577814,1.6966067461257508,0.350714016868682,0.7576852196375048,1.5480222055598936,0.5432321960506836,0.9897043482796474,0.36419136224313775,0.8508810323424288,0.3058816822504121;
Cargo trafficking to the periciliary membrane,0.7145209043157006,0.3691439136623758,5.021904651581653,0.7692246943661192,0.6625353621448575,1.7481318626952564,0.5430879243937501,0.33696163270265517,0.34050073667628167,0.32429151923420935,0.3058816822504121;
Formation of HIV-1 elongation complex containing HIV-1 Tat,1.5345670566679266,0.7879202867763312,2.1095400172146657,2.0363512847631333,0.30418705243734856,0.9945345766707561,0.5430879243937501,0.4589589677230645,0.33154605935666304,0.33740247317007105,0.3058816822504121;
Digestion and absorption,0.5683227877103033,0.580426989156841,2.0158468564560423,0.45587125330310274,0.3791920767944086,0.34570385066231185,0.5430879243937501,0.682677286879512,0.40728486195669966,0.30738279210111424,0.3058816822504121;
HIV Transcription Elongation,1.5345670566679266,0.7919173621533518,2.1136898319298996,2.0363512847631333,0.30418705243734856,0.9945345766707561,0.5423681290104425,0.4582847620118485,0.33154605935666304,0.33740247317007105,0.3058816822504121;
MAPK family signaling cascades,1.173248810608057,0.43246941553297696,0.7215128144789571,0.3228589977337532,0.3590225224597753,0.5312410536886313,0.5423681290104425,0.8986880030650579,0.41922428215661073,0.429118783483402,0.3058816822504121;
Neuronal System,0.44766682252123474,0.5392059240522732,3.3949397107439645,0.49786442742870163,1.27292890664036,2.035424508829746,0.5423681290104425,0.5152172963006261,0.33154605935666304,1.658587024963112,0.3058816822504121;
PKA-mediated phosphorylation of key metabolic factors,0.30554816552217945,0.49882509403717307,0.5713673750844409,0.3816686884212616,0.3535867649444133,0.3111782497541377,0.5423681290104425,0.5745029716188665,0.3611519215597742,0.30621433275255217,0.3058816822504121;
Interleukin receptor SHC signaling,1.4773091429658018,0.3393935927201346,0.33804747449655886,0.835018497409793,1.2231594787911602,0.34084875043490775,0.540571754498851,0.7829940306421141,0.37721347556427365,3.2192347163003254,0.3058816822504121;
Abacavir transport and metabolism,5.133367885982449,1.2567397901919064,0.38239861593688573,2.05197241851647,0.3726312003584851,0.7288840913587475,0.5388816280037092,0.41402764427788524,1.548245642681925,0.3890263489050837,0.3058816822504121;
Reactions specific to the complex N-glycan synthesis pathway,0.44475513774266295,0.8500810538403776,0.4018400955900535,3.3156221215320296,0.3603490398370773,1.525595498656345,0.5388816280037092,0.35200545937489847,3.7332482366594273,0.4523752385250782,0.3030467691849685;
Signaling by NOTCH2,0.4892930819819199,0.6947337878577814,1.8138294843570146,0.3861917421038416,0.3170491578203832,0.30836634995479767,0.5388816280037092,0.34311923132904953,0.3329607429278685,0.38486707233306083,0.3058816822504121;
Phase 1 - inactivation of fast Na+ channels,3.0059865578560743,0.8416242911325119,0.4760528568967101,0.3861917421038416,0.36125084206021507,0.3420003235500663,0.5388816280037092,0.37731415007330193,0.31075100083854396,0.6749467764774163,0.3058816822504121;
Thrombin signalling through proteinase activated receptors (PARs),0.8419567459527204,0.7834004270680736,0.6066943934222234,1.3413460780257314,0.3764809604369917,0.4453298839223913,0.5385966068348199,0.6175042069029268,0.5509514948484421,0.5278203201689747,0.3058816822504121;
Adherens junctions interactions,1.3482789970068219,0.3650614398467666,1.7007113797573465,1.4352500914830828,0.30985369422832876,0.6697244425992687,0.5380681311634249,0.35357383253505825,0.33154605935666304,0.30241267449194814,0.3058816822504121;
Agmatine biosynthesis,0.4134991322625479,0.30402224815377643,1.5237724238919494,1.0131714658015387,0.3824048831138682,0.8214675571170547,0.5378662540431114,0.6080592305607659,1.0113999391816824,0.4121812366547547,0.3058816822504121;
Binding and Uptake of Ligands by Scavenger Receptors,1.364218575636549,0.642037538389264,0.46299827936706456,0.48394439185316723,1.4291123758763953,0.34084875043490775,0.537694119502759,0.4160132539854251,0.4066299711850315,1.209522641855594,0.3058816822504121;
Conjugation of benzoate with glycine,0.3439432282083857,0.32979575975804937,2.8037501948472294,0.38650006444627144,0.33627276072485157,0.47055855225156185,0.5344891531040212,0.6113856407636219,0.3564169901750398,0.8338588690146164,0.3058816822504121;
Regulation of TP53 Activity through Methylation,1.3428996436296396,0.30844391279468925,0.392980112613742,0.3156748741478961,0.3726312003584851,0.4511070166599102,0.5329395671216145,0.3317123913477366,0.37721347556427365,0.4404591951700404,0.3058816822504121;
MyD88-independent TLR4 cascade ,0.31186750211813125,0.9900473145611959,1.0193284028017302,0.32711765119734587,0.3073643548426107,0.5487753153582212,0.5327469992775279,0.4854973456410397,0.42933067375325595,0.7164596722064461,0.3058816822504121;
Signaling by EGFR,0.3775870832267736,0.5206233125246345,2.318192736579381,0.3163292158034775,1.1217474271878223,1.7726101787659474,0.5327017907388784,0.35971925328583354,0.3589997748361272,1.0724163704412397,0.3058816822504121;
G alpha (12/13) signalling events,0.38878474410551483,0.47603833299323217,0.33878611882482,0.32562057663775773,0.4099884398602422,0.5143389080186972,0.5322040493013964,0.35971925328583354,0.3061329461218883,0.4121812366547547,0.3058816822504121;
Serine biosynthesis,0.33195778577326673,0.395288078616132,3.2598334068524863,1.1135907170958188,1.0717872712671177,4.59237553220225,0.5320271452125783,0.4254503482315462,2.3305154185771806,1.1534204069277305,0.3058816822504121;
TRIF(TICAM1)-mediated TLR4 signaling ,0.31186750211813125,0.9864467409131318,1.0394768555096892,0.32680654790973906,0.3074022772531135,0.552499617515074,0.5320271452125783,0.48606186013240477,0.42933067375325595,0.7164596722064461,0.3058816822504121;
Mucopolysaccharidoses,0.35546007256282774,0.3998527053714512,0.3186523149786101,0.32289368140643626,0.397151474618249,1.423921297032927,0.5310940459092175,0.4467806963553069,0.328101835849978,0.51104279764138,0.3058816822504121;
Downstream signaling events of B Cell Receptor (BCR),0.40089828063803934,0.4358630027633813,0.3648511899524546,0.44423826766513785,0.7433781605289134,0.9226901353501089,0.530407104165878,0.30982906409707045,0.38395097131164374,0.3451238691514368,0.3058816822504121;
Centrosome maturation,2.2002493761328745,0.4995829547349528,2.2129383565812737,3.093200608811175,0.33140832466933967,0.9768985359491579,0.530057597101271,0.33030236244002353,1.2632929927009808,0.4209700519911368,0.3058816822504121;
Beta-catenin independent WNT signaling,0.375817106410999,0.3351332739777284,0.48379232873396233,0.3503872330012344,0.5705700121496526,0.36980007246190394,0.530057597101271,0.5856301026206966,0.32397177416554596,0.5637148753815774,0.3058816822504121;
Antigen processing-Cross presentation,0.3118854532837041,0.6632010765904364,0.9079229255243332,0.3628766921649118,1.2168620188986268,1.102098315814885,0.530057597101271,0.37363972655453026,0.32562191479076025,0.661829187469421,0.3058816822504121;
Gluconeogenesis,0.3851513712885939,0.46476382621388357,2.599818722505972,0.3213115419718923,0.8663173673384363,1.6024213076807978,0.5287400847198466,0.37770911594983014,2.208785706392964,0.30738279210111424,0.3058816822504121;
Proton-coupled neutral amino acid transporters,0.6153813595862411,0.6161081789146999,0.6572321378897701,0.5950246338700154,0.3874726764872815,0.4229789398482754,0.5287400847198466,0.41811200490375733,0.3728343545959842,0.5278203201689747,0.3058816822504121;
Recruitment of mitotic centrosome proteins and complexes,2.2002493761328745,0.501568677588103,2.1968124120557433,3.093200608811175,0.33140832466933967,0.9768985359491579,0.5287400847198466,0.3301441399438418,1.2632929927009808,0.4209700519911368,0.3058816822504121;
SDK interactions,1.159865218448597,0.3680173532856128,1.0176927606776371,0.3541571802879987,0.33664443463132226,0.3976005671239824,0.5287400847198466,0.6370660872345657,0.33154605935666304,0.6351714656837537,0.3058816822504121;
Immune System,0.8323775981906836,0.4973390331284095,1.1841713365801751,0.3115144235208682,1.4527835083452083,1.0602136380537837,0.5287400847198466,0.30676358637777745,0.5219908068330215,2.5931954325193787,0.3058816822504121;
NIK-->noncanonical NF-kB signaling,0.5207997001917796,0.4055765767391985,0.530089235023403,0.3163292158034775,0.6197867756829976,0.7579644155851439,0.5242944692978341,0.3272468962834211,0.39328194195957444,0.46793777455222346,0.3058816822504121;
DDX58/IFIH1-mediated induction of interferon-alpha/beta,0.31186750211813125,0.7052414227406532,0.4242734810959642,0.42490532591127567,0.3119959467823231,0.48717144573263077,0.5225801543525144,0.3279426044526268,0.3033805754814556,0.33443076555210144,0.3058816822504121;
Nucleobase catabolism,0.5783611683049584,0.30814244538089003,2.413345267455609,0.7314997931615257,1.5828289611196062,2.2293558088262206,0.5225801543525144,0.39361440195896213,1.548245642681925,1.5147422072234873,0.3030467691849685;
Inhibition of nitric oxide production,2.0393332196216494,0.9722026967614994,1.3839043179883173,0.3271459557820616,0.3764809604369917,0.5164552249632212,0.5216454149643387,0.4310819043285157,0.33154605935666304,0.35947978844318385,0.3058816822504121;
Heparan sulfate/heparin (HS-GAG) metabolism,0.43486369648632767,0.3987793773700789,1.585507937318083,0.4296023820159213,0.6231688405270283,0.47055855225156185,0.5216454149643387,0.6175042069029268,0.4892423191611282,0.7210601512791815,0.3058816822504121;
Integration of provirus,0.41368428722655964,0.3393935927201346,0.5111303216523466,0.47632588316774416,0.31579531127581695,0.3698556846412857,0.5216454149643387,0.32735598382599135,0.4211719884904539,0.39091888813155207,0.3058816822504121;
Elevation of cytosolic Ca2+ levels,0.48313498722766435,0.9335755091221253,0.30134832367833375,2.0680816753341893,0.7093136373245287,1.3283942575509875,0.5216454149643387,0.3885445788445926,1.4730239173931012,2.7655131538232336,0.3058816822504121;
Negative regulation of activity of TFAP2 (AP-2) family transcription factors,0.32547764111405103,0.576173559427021,0.3538601237188543,0.7188771784227584,0.3439134979171695,0.5722975276722293,0.5216454149643387,0.43850102816878783,0.6606921149715522,0.32532264275231887,0.3058816822504121;
FLT3 Signaling,0.6313559218678279,0.31407750847502913,0.8766094637153571,0.33742237989027085,0.7649116976674908,0.6355860224373221,0.5216454149643387,0.5795150420091576,0.33154605935666304,0.4327164396326923,0.3024439670208732;
Transport of Mature mRNAs Derived from Intronless Transcripts,2.6425765986651544,0.5698796886264856,1.7464491825945954,1.8985378773530517,0.3119959467823231,4.21333661183497,0.5208150226027216,0.44203855648039064,0.3418975449068169,0.8468551764211115,0.3058816822504121;
Mitochondrial iron-sulfur cluster biogenesis,0.40416822402795777,0.4916469925647314,3.0567135543495803,0.34114908780953945,0.3726312003584851,0.35399026492638497,0.5208150226027216,0.4045210707684523,0.4399657892714404,0.3172734172535683,0.3058816822504121;
Biosynthesis of A2E, implicated in retinal degradation,0.4029927195800096,0.4386912358120347,1.741137619829172,0.350714016868682,0.3929647250895019,0.4838797903392124,0.5199726286421501,0.34398443282195684,0.6052596979838009,0.4517256911014107,0.3058816822504121;
Keratan sulfate degradation,1.9874385417664953,1.294694436611799,0.4978925854600094,2.027018582292917,0.44190872554450233,0.3946222670176035,0.5199726286421501,0.4184113112236314,0.33154605935666304,0.4209700519911368,0.3058816822504121;
Activated NTRK2 signals through RAS,0.336169237894673,0.36231980452174045,0.5111303216523466,0.41581161145612344,0.41200215293113845,0.6494417602692866,0.5199726286421501,0.4160397494096559,0.3063901120454567,0.4404591951700404,0.3058816822504121;
Downstream signaling of activated FGFR1,0.6654831220501027,0.39346922355107966,0.3025960133980849,0.42070290156521034,0.30246496029501807,0.571271532995407,0.5199726286421501,0.3822363263756954,0.33154605935666304,0.30352660857733577,0.3030467691849685;
Toll Like Receptor 7/8 (TLR7/8) Cascade,0.3390466778271897,0.35463206527573876,1.3839043179883173,0.3503872330012344,0.7448001569816128,0.727804073060917,0.5199726286421501,0.7365736838947909,0.33154605935666304,0.7840023142261238,0.3058816822504121;
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),0.3390466778271897,0.5698796886264856,1.4746456317007623,0.3228589977337532,0.3119959467823231,0.468029122621951,0.5199726286421501,0.3120922108743096,0.3846559724410146,0.4232200116160087,0.3058816822504121;
MyD88 dependent cascade initiated on endosome,0.33991984304289263,0.35463206527573876,1.3846469675757105,0.3503872330012344,0.7448001569816128,0.727804073060917,0.5199726286421501,0.7494624759764011,0.33154605935666304,0.7975169865988863,0.3058816822504121;
Autointegration results in viral DNA circles,1.893539545130151,1.8918086097467384,0.5454266487560718,1.789559069129922,0.4829239057523196,1.2165962246500301,0.5199726286421501,0.38406337630046994,1.2218495858429155,0.37228578428448916,0.3058816822504121;
Nonsense-Mediated Decay (NMD),0.3390466778271897,0.5698796886264856,1.477502551184969,0.3213115419718923,0.31167319664073184,0.468029122621951,0.5199726286421501,0.3117697514900949,0.3842215783855741,0.4232200116160087,0.3058816822504121;
The NLRP1 inflammasome,0.44782790628522195,0.421441415526736,3.656523061934539,0.6039833361262053,0.6109240307787517,2.3045252499338793,0.5199726286421501,0.5918767786718077,0.8511998978877712,1.748177700993418,0.3058816822504121;
Acetylation,0.4300642653083229,0.3278436372594612,0.8219084041657259,2.3518461040317087,1.0612975010678298,0.39579425561555787,0.5199726286421501,0.3207891067373377,0.7283839345834368,0.4327164396326923,0.3058816822504121;
Metabolism of lipids,0.5783611683049584,0.3173693456155217,3.356824672198266,0.34242551078476546,1.4120256619524758,2.2894016663815893,0.5199726286421501,0.48606186013240477,0.33154605935666304,1.534402703378459,0.3058816822504121;
Proton-coupled monocarboxylate transport,0.7103589167065222,0.6255863960340599,2.2483234071619544,0.39485276920195894,0.4696389090763279,0.6158886095942938,0.5199726286421501,0.5753977044168755,0.3074603287870551,0.36956882019668214,0.3058816822504121;
Enzymatic degradation of Dopamine by monoamine oxidase,1.7874104207120947,0.7816596912323202,0.6272223073750346,0.8452387558632973,0.5442360620589024,0.36504209043534924,0.5179593336379549,0.4849021760868862,0.4904318320906067,0.31613944815052264,0.3058816822504121;
Nucleotide-like (purinergic) receptors,2.6980790236854832,0.8382224653109192,0.5958918847559157,0.3503872330012344,0.3726312003584851,0.44569311077594786,0.5178664466173247,0.5080864360471277,0.32577132484347926,0.7131212844176323,0.3058816822504121;
GPCR downstream signalling,1.1505183638246546,0.30641678157489305,1.6717130356550312,0.9039108135229567,1.4497014587581227,0.8243783587208424,0.5178664466173247,0.5856301026206966,0.36494779765230456,2.1973600892666885,0.3058816822504121;
Threonine catabolism,0.47615683619677523,0.49235411393427414,0.30747772415026436,0.33741769099486835,0.4342883715633839,0.3383257531684057,0.5178664466173247,0.35971925328583354,1.016202858953107,0.4540611718827999,0.3058816822504121;
Plasma lipoprotein clearance,0.35395902962098935,0.4594930053265428,1.2613925183389425,0.7498604288963968,0.3073643548426107,0.4008567504272784,0.517802186209024,0.36371079402101386,0.4904318320906067,0.30603264219956966,0.3058816822504121;
Glucuronidation,0.6114846292543552,0.35463206527573876,2.117444700008685,0.3468013020091587,0.32297793958928395,0.524085852020183,0.5176062889092149,0.45482312314956885,0.3484005984762255,0.5026703144243176,0.3058816822504121;
SUMOylation of RNA binding proteins,1.1365783624670363,0.30188327596459563,0.3408033222139188,1.170860276373838,0.3791920767944086,2.1868068650400994,0.517474435676392,0.3267225039151543,0.33154605935666304,0.3811579239158923,0.3058816822504121;
Prostacyclin signalling through prostacyclin receptor,1.5241749246825715,0.9285413398621923,1.216849691457369,2.0093749167695414,0.3726312003584851,0.4467220717805114,0.517474435676392,0.34311923132904953,0.3693665271664583,0.5281095055314579,0.3058816822504121;
HHAT G278V abrogates palmitoylation of Hh-Np,0.6228686233239953,0.3041785410778355,0.4744257747994897,1.518409133779803,3.116145277307852,1.3975417920589324,0.517474435676392,0.5012508880889713,0.3227320418931485,1.4573703115894694,0.3058816822504121;
Metabolism,0.568833034590594,0.33875335399120593,0.730308954681951,0.7323545191286396,0.35830085846035925,0.3976005671239824,0.517474435676392,0.38454701793058893,0.3443921572946001,0.3396035592964414,0.3058816822504121;
Interleukin-1 family signaling,0.888578702258258,0.41268909257052344,0.6468125906699718,0.4123123107885862,0.9206248933499372,1.423990258998822,0.517474435676392,0.34535509827064254,0.32397177416554596,0.4209700519911368,0.3058816822504121;
GRB2:SOS provides linkage to MAPK signaling for Integrins ,0.614032600761316,0.31070106152335225,0.5448232712320172,0.48995508415449784,0.330372459861341,0.4095359585082957,0.517474435676392,0.3317123913477366,5.921107550491273,0.7302267570893407,0.3058816822504121;
Tryptophan catabolism,1.0189178209461276,0.3326844125402299,2.7601178302984697,3.1714969765499426,0.9494636929508514,0.880118817711989,0.5156890488245138,0.30222076309715623,9.335447325598414,2.839890518347915,0.304314835196113;
Cellular hexose transport,0.33178253971534694,0.5324309296314834,0.5936519282516582,1.5185208073107592,0.8890740651874032,2.0875860491814384,0.5151466589078909,0.3404366042983231,0.4156689500982106,1.658587024963112,0.3058816822504121;
Integration of viral DNA into host genomic DNA,1.893539545130151,1.8918086097467384,0.5349670287033231,1.789559069129922,0.48046633727165955,1.2165962246500301,0.5151466589078909,0.38454701793058893,1.2218495858429155,0.3755674202397432,0.3058816822504121;
NR1H2 and NR1H3-mediated signaling,0.388101869376657,0.3659796444425064,1.6969458827082358,0.34114908780953945,0.3328422870630962,0.3111782497541377,0.5141583244370835,0.37363972655453026,0.6606921149715522,0.34032309265129573,0.3058816822504121;
Transcription from mitochondrial promoters,0.7753440831935311,0.301642737608084,2.3570706198998224,0.543500529637991,0.4240050290751324,0.47677687539221214,0.5141583244370835,0.3094759427026921,0.4881499224650157,0.44022807337003683,0.3058816822504121;
Bicarbonate transporters,1.012327603540305,0.3167546157875405,0.3186523149786101,0.6739582054110552,0.4620026084881862,0.4229789398482754,0.5141583244370835,0.30883045339476317,0.9792113184900886,0.34769688484195377,0.3030467691849685;
ERBB2 Regulates Cell Motility,0.6065438077322955,0.6157618001620583,0.47620779881555453,1.3812324496768316,0.3119959467823231,1.2165962246500301,0.5141583244370835,0.5795150420091576,0.4141350390547139,0.7164596722064461,0.3058816822504121;
Cellular responses to stress,0.4146405080672999,0.673328207235526,0.4760528568967101,0.34552125769421904,0.3542809798398846,0.32379424092724673,0.5132018246307443,0.8777224198746281,0.36494779765230456,0.8529629531955053,0.3030467691849685;
HIV Infection,0.44498379621009987,0.36189234081749233,0.5111303216523466,0.6174056523891611,0.4898488404558619,0.4399866167593563,0.5121842323018949,0.3030828004188756,0.31808512104917774,0.4209700519911368,0.3030467691849685;
Adrenaline signalling through Alpha-2 adrenergic receptor,0.34363739714129227,0.39346922355107966,0.3327614819001198,1.9392124417431353,0.35652570087271857,0.3762215469973146,0.5120878828807008,0.3834916181466995,0.6210171735684104,0.4121812366547547,0.3058816822504121;
FGFR2c ligand binding and activation,0.33991984304289263,0.4697451878114334,0.3512635275580232,0.6432246813744723,0.6363388716912172,0.41186476367059427,0.5113613756681872,0.30396128062304534,0.3322378492350531,0.30738279210111424,0.3058816822504121;
Uptake and actions of bacterial toxins,0.3697786288314644,0.36231980452174045,0.4398876401776831,0.37145838041192264,0.3014212581253249,0.3778854454032035,0.5113613756681872,0.4628527562793292,0.3406966434873319,0.47469881290334454,0.3058816822504121;
Triglyceride catabolism,3.52947896464443,0.9285413398621923,0.6589612821720894,1.3156873453985993,0.397151474618249,0.33664035924109287,0.5113613756681872,0.5238886509233606,0.31122200488443763,0.3281579980837237,0.3058816822504121;
Biosynthesis of DHA-derived SPMs,0.8881699497817103,1.2567397901919064,0.3222246234534123,0.33741769099486835,0.6776561166140836,0.5143389080186972,0.5088584499963338,0.3727510515670385,0.3061107917419532,1.008144593045361,0.3058816822504121;
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.5654079179337074,0.36250846227187006,1.2269629978401315,0.8109639229343182,0.3396325673262649,0.5770301804297325,0.5088584499963338,0.5795150420091576,0.32562191479076025,0.4540611718827999,0.3058816822504121;
Regulation by c-FLIP,0.5394487408204015,0.3142762591661267,1.0810554295898598,0.3163292158034775,0.330372459861341,0.468029122621951,0.5068614491298019,0.35082679893314456,0.3156659602261388,0.35749355813041916,0.3058816822504121;
G beta:gamma signalling through PI3Kgamma,1.5970665700975755,0.8707342184525757,0.363838568588565,1.6381633145521644,0.35830085846035925,0.3636895842323911,0.5058434167522426,0.35611209963871854,0.42382662266091486,0.6899463049956933,0.3058816822504121;
Electron transport from NADPH to Ferredoxin,1.2825318313219114,0.7083061017751114,0.7936710550782053,0.8603605251881427,0.330372459861341,0.5646191142917181,0.5058434167522426,0.5856301026206966,0.7209288851344792,0.4523752385250782,0.3058816822504121;
Generic Transcription Pathway,0.3117629957183809,0.36231980452174045,0.4174243402144895,0.380333723709027,0.33406583255714095,0.4641092916342805,0.5058434167522426,0.3207891067373377,0.33154605935666304,0.46098438219063703,0.3058816822504121;
CASP8 activity is inhibited,0.5399644385843695,0.3142762591661267,1.0970230461575994,0.3163292158034775,0.32297793958928395,0.468029122621951,0.5058220008266869,0.35082679893314456,0.3156659602261388,0.3576703241970742,0.3058816822504121;
RUNX2 regulates genes involved in cell migration,0.737234817812786,0.34088690059804977,0.33878611882482,0.6556432817821373,0.33910487705697223,0.4541009858801141,0.5051357996998651,0.5053548155512009,0.33154605935666304,0.47469881290334454,0.3030467691849685;
Post-transcriptional silencing by small RNAs,0.5458928984146456,0.806942733657417,2.6098424911432305,1.923007995777711,0.4929397770449673,1.2205911733122583,0.5047011010500622,0.46950761507088173,0.4066299711850315,0.3281579980837237,0.3058816822504121;
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,0.6028468264166759,0.3010748960204856,2.128780127984899,0.36311486150506656,0.46152238547560237,0.321223791693833,0.5047011010500622,0.8890094092459607,0.3693665271664583,0.6482748595064046,0.3058816822504121;
Recycling of eIF2:GDP,0.4805100160050987,0.3335517647086268,0.3196134621449584,0.6214267086654077,0.3073643548426107,0.30410402879652054,0.5047011010500622,0.4890921202267072,0.6606921149715522,0.5590053037298347,0.3058816822504121;
Glucocorticoid biosynthesis,0.5823479756516419,0.4081569957992947,0.47742800113506856,1.5840995333594994,1.24988939967765,0.9125813387362648,0.5047011010500622,0.35082679893314456,0.35739478096045746,0.8677319188842189,0.3058816822504121;
Synthesis of GDP-mannose,0.5338757743243644,0.5276408618205516,0.4702734346865812,0.3861917421038416,0.4620026084881862,0.4900714565162325,0.5028955031529247,0.35971925328583354,0.6625909336695316,0.3641262916570064,0.3058816822504121;
mRNA Splicing,0.49613785187768805,0.7380453821386058,0.3780694700450378,0.3881184602725714,0.3726312003584851,0.3061210216620263,0.5019188707573919,0.37363972655453026,0.36494779765230456,0.572602207453692,0.3058816822504121;
Breakdown of the nuclear lamina,0.3791445346939466,0.3513392212488015,0.4763371513150519,0.5875124415270933,0.34604507203067597,0.42768236538017645,0.5019188707573919,0.6303443794140307,0.9799404551560605,0.4307830798707323,0.3058816822504121;
G beta:gamma signalling through PLC beta,1.05959797977676,0.6753629744360657,0.9529328859520616,1.900992698620638,0.3396325673262649,0.5138249529961795,0.5019188707573919,0.9221426572870339,0.36494779765230456,0.32315653939736994,0.3058816822504121;
MicroRNA (miRNA) biogenesis,0.5661485660170688,0.3250759886945429,0.3465327570087948,0.8351261394069595,0.3439134979171695,1.081709310734316,0.5019188707573919,0.6370660872345657,0.5509514948484421,0.4058203428294384,0.3058816822504121;
STING mediated induction of host immune responses,0.44498379621009987,0.6303418817141294,0.5016034104344255,0.39485276920195894,0.5484067350908636,0.42626866561660953,0.501711612823495,0.39688813005863777,0.5782895603044629,0.32532264275231887,0.3058816822504121;
Frs2-mediated activation,0.382661322523146,0.311151884547695,0.5123197760698118,0.322985779213323,0.37800717335912154,0.5487753153582212,0.5004470869475673,0.6285814395938571,0.36419136224313775,0.47469881290334454,0.3032374359194824;
Ethanol oxidation,4.287312178814089,0.7480906320451475,0.6765362912914509,1.2879525648742005,0.3764809604369917,0.3826018744696143,0.5004470869475673,0.4018372923384269,0.3329607429278685,0.44297218450032194,0.3058816822504121;
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,0.4487785674437691,0.3051715086707191,2.2550488085214284,0.3213115419718923,0.46152238547560237,0.35399026492638497,0.5004470869475673,0.6834181834101111,0.4156689500982106,0.5124302984800859,0.3058816822504121;
mRNA Capping,0.8866343934354561,0.31070106152335225,0.8309627655875346,0.45814106070834476,0.3119959467823231,0.9945345766707561,0.5004470869475673,0.4628527562793292,0.36272015169669014,0.41104584371777314,0.3058816822504121;
RORA activates gene expression,0.6188386975716889,0.30402224815377643,0.4846102376278911,0.42061976167530685,0.306397614617226,0.339370993914336,0.5004470869475673,0.5238886509233606,0.3243765987517343,0.47728954306028143,0.3058816822504121;
Neurophilin interactions with VEGF and VEGFR,1.6175554593819317,1.1137344189391158,0.37790418838358186,0.4030142853102931,0.33664443463132226,0.4128019203312433,0.5004470869475673,0.30762701980706253,0.33559887803413757,1.2383177022618577,0.3058816822504121;
Interaction between L1 and Ankyrins,4.793465774230655,1.7291076827125254,2.4887017770108586,2.096770311365312,0.42272067676020203,0.35399026492638497,0.5004470869475673,0.352994800586426,1.9040404129500301,0.33393281231497723,0.3058816822504121;
rRNA processing in the nucleus and cytosol,0.4093424622751112,0.3864631808225056,0.5017359945597698,0.39485276920195894,0.41709375049548464,0.3131733022391502,0.5004470869475673,0.30222076309715623,0.33154605935666304,0.3109481832046546,0.3058816822504121;
Bile acid and bile salt metabolism,1.375224842448649,0.41653771035597,0.7613149469443117,0.4303767648874029,0.7668371077295931,0.5423918303447901,0.5004470869475673,0.35971925328583354,0.3728343545959842,2.060391253572664,0.3058816822504121;
Dimerization of procaspase-8,0.5437888218575485,0.3142762591661267,1.1639187855194855,0.31471394031514205,0.330372459861341,0.46829287577570267,0.5003242557742834,0.35082679893314456,0.3156659602261388,0.3576998859508197,0.3058816822504121;
G beta:gamma signalling through CDC42,1.1238275055586244,0.6161081789146999,0.509360240043381,1.4562188067639485,0.3115859300677829,0.3676748767985349,0.5003242557742834,0.33030236244002353,0.3227320418931485,0.4504612986701036,0.3032374359194824;
ER to Golgi Anterograde Transport,0.7103589167065222,0.5698796886264856,1.0194807098411316,0.330334113068339,0.30418705243734856,0.468029122621951,0.5003242557742834,0.41975460648763435,0.33154605935666304,0.46558104855788673,0.3058816822504121;
Chemokine receptors bind chemokines,0.9739411088375305,0.4081569957992947,0.5439930076286128,0.6214267086654077,1.1806819119783158,0.47055855225156185,0.5003242557742834,0.4849021760868862,0.3061107917419532,1.4614751638835521,0.3058816822504121;
Misspliced GSK3beta mutants stabilize beta-catenin,0.7569293556763195,0.36235197233888794,1.3051619198303333,1.1578910544844385,0.3338790911936934,0.4300466631842503,0.49907063417047903,0.3646829165254219,0.5296096740034458,0.41932959571843376,0.3058816822504121;
Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia,0.4416826026365212,0.4081569957992947,1.1081772974668507,0.3542850324339428,0.3073643548426107,0.46482789085001164,0.4986303955918365,0.31482486972733703,0.5009692397247629,0.9189824627807782,0.3058816822504121;
Neddylation,0.3195134583854903,0.4081569957992947,0.32128032433747655,0.40508555541811875,0.33627276072485157,0.3041189807879212,0.4986303955918365,0.9674975239409703,0.3413587699374491,0.38871869748586235,0.3058816822504121;
Protein localization,0.35546056252366,0.3142762591661267,0.3081915935170801,0.5043782219039552,0.4118967113859953,0.4992825294086943,0.4981117234122626,0.4467806963553069,0.5140766613827893,0.4640617091673951,0.3058816822504121;
Intracellular signaling by second messengers,0.3295920706872582,0.39027423656448595,1.4462954737990017,0.3142325622507859,0.6881908609437631,0.7305728899620716,0.49786427486267554,0.34311923132904953,0.37818098826263175,0.3811579239158923,0.3058816822504121;
RHO GTPases activate KTN1,0.33991984304289263,0.642037538389264,0.556917742662055,0.3861917421038416,0.43593317304740314,0.31443764912308014,0.49763234194347616,0.37363972655453026,0.3329607429278685,0.4404591951700404,0.3058816822504121;
The phototransduction cascade,0.3794194863285861,0.355263564343029,2.2862105325436706,1.1265222948060511,1.1180128104184908,2.014541245564624,0.49763234194347616,0.32915173875632203,0.30150053284191936,0.3641262916570064,0.3030467691849685;
RUNX3 regulates NOTCH signaling,0.6068259797679076,0.4001476370117231,0.7613149469443117,0.3163292158034775,0.3791920767944086,0.3748291066993173,0.49763234194347616,0.4467806963553069,0.42563818276787846,0.5612321401469508,0.3058816822504121;
Signaling by ERBB2,0.5065318103776832,0.6333040920696568,3.5150709777121802,0.5016914801173993,0.9381079498078779,3.0941830284042084,0.49763234194347616,0.6834181834101111,0.36494779765230456,1.21219404816517,0.3058816822504121;
TRAF3-dependent IRF activation pathway,0.5086090191266497,0.4666031335031772,1.312374881309379,0.30583657714524676,0.3542809798398846,0.32379424092724673,0.49763234194347616,0.3617517012302228,0.3384177868520018,0.3109481832046546,0.3058816822504121;
Conjugation of salicylate with glycine,0.382661322523146,0.5254335345474912,1.982134437236759,0.3657188180620897,0.3394918967507969,0.42559684233977757,0.49763234194347616,0.3300822406904645,0.37489773248453867,0.4540611718827999,0.3058816822504121;
NTF3 activates NTRK3 signaling,1.2687883925486538,0.7083061017751114,1.405432806416354,0.3781533650620131,0.3130215102818571,0.30146276932778043,0.49743233470824116,0.46499980428471527,0.9636411855716062,0.5016911901526382,0.3058816822504121;
Regulation of beta-cell development,1.1734224141268843,0.4916469925647314,0.5439930076286128,0.7756836872344526,0.3372491920031881,0.6702561517274862,0.49421145085197077,0.6652097340320369,0.4066299711850315,0.9562192771334456,0.3058816822504121;
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),2.7632502486475112,0.8410357410402534,0.6823870535731308,3.419002188152002,0.3764809604369917,2.309042166255767,0.4938985274924783,0.39504606361807143,0.31837078236812505,0.41104584371777314,0.3058816822504121;
Nuclear signaling by ERBB4,2.2338560538875876,0.6617160530759545,0.844470663710365,0.3881184602725714,1.5061060989817545,0.4229789398482754,0.4938985274924783,0.5174152264767676,0.3156659602261388,2.5550110864105697,0.3058816822504121;
Pyrimidine catabolism,1.217579621325727,0.301642737608084,1.960759995839302,0.33629937585789416,1.27292890664036,0.3676748767985349,0.4938985274924783,0.39014468230695576,0.9215145356872653,2.3025086199518525,0.3058816822504121;
Lectin pathway of complement activation,0.6721148538043277,0.34903960726753813,1.0883057006766685,0.39485276920195894,0.3439134979171695,0.3907944214595881,0.4935082085409399,0.40342728894670354,0.32855021388126704,0.46947200515560084,0.30370155596674026;
Metal ion SLC transporters,0.40324195892511366,0.5717648254254253,1.982134437236759,0.8534871045546273,0.3701740018252065,0.3287334607648631,0.4934683986679046,0.4160132539854251,0.9262719583570862,0.30669710771625813,0.3058816822504121;
WNT mediated activation of DVL,0.3672789551152327,0.576173559427021,0.48346237348866605,0.3861917421038416,0.33627276072485157,0.44945556701622913,0.4933072608260389,0.7214872606359403,0.3728343545959842,0.3172734172535683,0.3058816822504121;
Keratan sulfate/keratin metabolism,1.403290665938957,1.7291076827125254,0.7809287109776725,0.9266982369643003,0.311114601116272,0.4253316158697854,0.4933072608260389,0.39014468230695576,0.36817134660308426,0.6275550123828493,0.3058816822504121;
Activation of NOXA and translocation to mitochondria,0.8052861038989163,0.421441415526736,0.6371763478650965,0.3739887061075729,0.330372459861341,1.429074647254128,0.4931981310695763,0.7214872606359403,0.5493482026354087,0.32429151923420935,0.3024439670208732;
Activation of BH3-only proteins,1.6730961236204605,0.44979020246864093,1.858161098708219,0.5259000391854405,0.30447768946963627,3.170706288698325,0.4903216663662132,0.5758406932633269,0.33154605935666304,0.3286979716130023,0.3058816822504121;
Other interleukin signaling,0.9962224759148058,0.3105836898586958,0.899877810071458,0.3881184602725714,1.0192124260773991,0.5646191142917181,0.4894242734916182,0.37363972655453026,0.36494779765230456,2.983079223253192,0.3058816822504121;
NOTCH3 Intracellular Domain Regulates Transcription,0.335368352224608,0.3667015217797265,0.4019342432581008,0.3503872330012344,0.4144015923110133,0.3111782497541377,0.4887391008009517,0.5174152264767676,0.3728343545959842,0.38295181979759085,0.3058816822504121;
Endogenous sterols,0.4416826026365212,0.32979575975804937,0.4139899050033227,1.6827512678567813,1.338063731292969,1.2266820738215025,0.4887391008009517,0.48606186013240477,0.4917345000954562,0.9717408988765865,0.3058816822504121;
RUNX1 regulates transcription of genes involved in WNT signaling,2.455478314331589,0.4179128650456059,4.7103758117704615,0.3163292158034775,1.5061060989817545,0.6702561517274862,0.4887391008009517,0.3578253404952037,1.4856470946987632,3.088857142578697,0.3058816822504121;
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,0.3957341132721857,0.5199119484690351,0.8833146903713517,0.3881184602725714,1.1380648165882117,0.5646191142917181,0.486843063046879,0.31950585589685954,0.33154605935666304,1.278569614722146,0.3058816822504121;
S33 mutants of beta-catenin aren't phosphorylated,0.7569119402608251,0.36231980452174045,1.2957633497091234,1.1578910544844385,0.33627276072485157,0.43075902825616436,0.486843063046879,0.3646829165254219,0.5161023041844398,0.4171509897051396,0.3058816822504121;
PTK6 Expression,3.744795482399178,0.41933177387997705,0.455280490134858,0.45025906807447985,0.4549475819776362,0.40857645150366523,0.486590984656632,0.352267490683119,0.8773874018157881,1.483370356290762,0.3058816822504121;
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,0.7476655254087891,0.36231980452174045,1.2957633497091234,1.1578910544844385,0.33627276072485157,0.43075902825616436,0.486590984656632,0.3646829165254219,0.5150564954008329,0.4189205258768189,0.3058816822504121;
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,0.3975156023891009,0.3667015217797265,2.6189342360355807,1.2093445819168447,0.3764809604369917,1.1206479727280203,0.486590984656632,0.48606186013240477,6.487449302920633,1.748177700993418,0.3058816822504121;
p38MAPK events,0.3672789551152327,0.9398134822000689,0.3554138575034153,0.5198656665604607,0.3764809604369917,0.3111782497541377,0.486590984656632,0.5327910439846112,0.3315899341674589,0.5484182344642704,0.3058816822504121;
Regulation of RUNX1 Expression and Activity,0.4221864504607768,0.32010506335144423,0.39679477643070366,1.2493853807088562,1.27292890664036,2.0495596120072412,0.486590984656632,0.7086724457561365,0.3327832096024327,1.5049899936006637,0.3058816822504121;
Translesion synthesis by REV1,1.5838329768184043,0.3393935927201346,0.4134699577910062,0.4296023820159213,0.3535867649444133,1.5869323539619207,0.486590984656632,0.5238886509233606,0.33154605935666304,0.33443521061762477,0.3058816822504121;
HS-GAG degradation,0.9275454020449196,0.3650614398467666,0.8292412231221908,1.2176279316935101,1.1073522751388227,2.6999617740847346,0.4862446663435915,0.39014468230695576,1.2134694198716163,0.30212584039343277,0.3058816822504121;
Degradation of beta-catenin by the destruction complex,0.3131846682126686,0.4752707412624548,0.5196560187410272,0.33980610064939215,0.697971698746192,0.8205962637560629,0.4845045543357206,0.34680976678403747,0.423716321008238,0.39891851694034464,0.3058816822504121;
T41 mutants of beta-catenin aren't phosphorylated,0.7427303811561812,0.36231980452174045,1.2957633497091234,1.1578910544844385,0.33140832466933967,0.43075902825616436,0.4845045543357206,0.36434155364310694,0.5296096740034458,0.41912518944327204,0.3058816822504121;
Defects in vitamin and cofactor metabolism,1.306197047981217,0.49882509403717307,0.4410475186133065,0.5879866812394244,0.3226140943665297,0.6063265940174721,0.48417870656159584,0.6834181834101111,0.5095929877456744,0.3160906252949544,0.3058816822504121;
Collagen degradation,0.42992726818516147,0.301642737608084,0.6322208994653702,0.5950246338700154,0.32297793958928395,0.5646191142917181,0.48417870656159584,0.5594683711508179,0.3187254357066004,0.3370467040211229,0.3058816822504121;
Constitutive Signaling by Aberrant PI3K in Cancer,0.9464944377933072,0.576173559427021,1.2957633497091234,0.5879866812394244,1.4353727597575503,0.9470898334811291,0.48417870656159584,0.4164315502421382,0.33482577791173423,3.4449015650011026,0.3058816822504121;
Reversal of alkylation damage by DNA dioxygenases,1.9428843081434788,1.2567397901919064,0.30734867613921363,1.1673887999976262,0.35646676400014793,0.42626866561660953,0.48333579395382825,0.3693631048944899,0.3089310108463698,0.8356116063721268,0.3058816822504121;
S37 mutants of beta-catenin aren't phosphorylated,0.7536607705215023,0.36231980452174045,1.3001535375668734,1.1578910544844385,0.33406583255714095,0.4300466631842503,0.48277315639974566,0.3646829165254219,0.5168436383523363,0.41983653668333754,0.3058816822504121;
PKB-mediated events,0.9370609571077493,0.42498593976503624,0.45223816956965585,0.41179614815947363,0.3439134979171695,0.3420003235500663,0.48136934690807914,0.33990809468773525,0.3406966434873319,0.688103773185247,0.3058816822504121;
Platelet homeostasis,2.7300161653613166,0.8380869200878739,0.7613149469443117,1.4117478790949058,0.46163953884057446,0.31386541612384017,0.48136934690807914,0.7214872606359403,0.3406966434873319,0.4569839190337219,0.3058816822504121;
Mismatch Repair,2.7003189050641927,0.8410357410402534,0.44896251260719916,3.5248810730111386,0.33627276072485157,2.5921931447370117,0.48059807795645954,0.7441213175540436,0.3127264994826523,0.30245448354214916,0.3058816822504121;
Pyruvate metabolism,0.3501378526710248,0.30188327596459563,0.3208535148713935,0.8513061050747608,0.30320248709849507,0.887962512340968,0.47893911861439475,0.48606186013240477,0.3248635531929545,0.38300722113202923,0.3058816822504121;
CREB phosphorylation,0.41333274690186717,0.47603833299323217,1.2149703771791165,0.3428663705227962,0.3764809604369917,0.3111782497541377,0.47890752614513343,0.3404366042983231,0.3329607429278685,0.32204584831205535,0.3058816822504121;
Interleukin-10 signaling,0.6381758284260755,0.3170649431462248,0.5439930076286128,0.3874935871335183,0.9200438033952797,0.7155883661323684,0.47842120857441806,0.3571372583019324,0.3156659602261388,1.0597407328998516,0.3058816822504121;
Vitamins,0.5695885041755652,0.6142135513007515,0.4760528568967101,0.3816686884212616,0.5555629456114858,0.47055855225156185,0.4781076300714729,0.6325337641428745,0.6052596979838009,0.4232200116160087,0.3058816822504121;
Sialic acid metabolism,0.3219535167637239,0.41268909257052344,0.382632944164255,3.1436752331273836,1.5061060989817545,4.268973585466074,0.4781076300714729,0.3931219998955243,0.3065164849314509,1.7736758732019013,0.3030467691849685;
S45 mutants of beta-catenin aren't phosphorylated,0.7557862538575085,0.36231980452174045,1.3051619198303333,1.1578910544844385,0.330372459861341,0.4300466631842503,0.4781076300714729,0.36593959197886095,0.5296096740034458,0.4203831368394754,0.3058816822504121;
DCC mediated attractive signaling,0.8716519885708844,0.32979575975804937,2.3238524025629204,0.5148512183686544,1.263262560339818,1.430721753260754,0.47765378052892143,0.44770267919471923,1.0949631728026215,0.739829295563816,0.3058816822504121;
alpha-linolenic acid (ALA) metabolism,0.32648569807719524,0.8149688586752587,1.1458569171858222,5.677792461818851,1.007071052446887,2.4175493561626946,0.47765378052892143,0.33847917930687405,4.097646175707529,0.8338588690146164,0.3058816822504121;
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,0.32648569807719524,0.8149688586752587,1.1414164345205433,5.677792461818851,1.007071052446887,2.4175493561626946,0.47765378052892143,0.33838150094469,4.097646175707529,0.8368997031223852,0.3058816822504121;
Stimuli-sensing channels,0.335368352224608,0.5631968708467756,4.043873705123747,0.3861917421038416,1.136888493800863,3.7920251266695986,0.47765378052892143,0.4733768846338477,0.39328194195957444,1.1480729271559689,0.3058816822504121;
CD209 (DC-SIGN) signaling,1.603124623320052,0.438351604480435,1.052594944937501,0.3881184602725714,1.136888493800863,1.036807842015328,0.47765378052892143,0.30676358637777745,0.7441222546207356,2.4472617310244527,0.3058816822504121;
Insulin receptor recycling,0.335368352224608,0.5272421300721946,3.384487110052987,0.5874431926211804,0.384241151119403,0.7072001173174037,0.47765378052892143,3.5793220696144203,0.9165201415367404,0.3337585302705513,0.3058816822504121;
PI3K events in ERBB4 signaling,0.44498379621009987,0.3667015217797265,1.1879585187559678,1.0545185283548835,0.330372459861341,0.416812166468743,0.4776313006608395,0.35082679893314456,0.37493058443204597,0.4523752385250782,0.3058816822504121;
Cilium Assembly,0.45157137268716835,0.4730357518880468,2.5759157192245343,0.3881184602725714,0.48365622352261173,0.5245047266062759,0.4776313006608395,0.6758900339821093,0.43407027552478483,0.41932959571843376,0.3058816822504121;
Influenza Infection,0.33895461643817115,0.31878267820372547,0.7663667792126356,0.4208562954813837,0.35573771241937,0.3158212132785428,0.4753217921706432,0.34398443282195684,0.32855021388126704,0.30352660857733577,0.3058816822504121;
Trafficking of GluR2-containing AMPA receptors,0.5038902867280486,0.5825284386456702,2.257931789270169,0.3067748912708138,0.3540024647605433,0.3260350496628621,0.4753217921706432,0.5283469793061432,0.3327832096024327,0.35813546395474505,0.3058816822504121;
Carboxyterminal post-translational modifications of tubulin,0.8121277182997256,0.30713105125946294,4.167943464902951,1.3345477935938186,1.4527835083452083,3.4156031801499713,0.4753217921706432,0.5918767786718077,2.0125965975846594,0.32837788404645557,0.3058816822504121;
PDE3B signalling,0.935961776654062,0.42498593976503624,0.4513554156734343,0.41143170833275283,0.3439134979171695,0.34220669868726283,0.4753217921706432,0.33990809468773525,0.3406966434873319,0.6857888430279614,0.3058816822504121;
Association of TriC/CCT with target proteins during biosynthesis,0.4826960453306865,0.4957100378737323,1.0619460329506734,0.3228589977337532,0.3119959467823231,0.3730690317561491,0.4753217921706432,0.3251934547032587,0.7574177165397277,0.44616573641289636,0.3058816822504121;
Signaling by FGFR2,0.3119979840557615,0.6157618001620583,0.9557536004612296,0.3657188180620897,0.3764809604369917,0.8134374922184098,0.4753217921706432,0.35188495600616115,0.3265506469380085,0.9985947415677143,0.3058816822504121;
Interleukin-1 processing,0.887690418569833,0.47698398560067923,0.3288722024330404,0.38741141821149655,0.3076326161437668,0.6051375835311831,0.4753217921706432,0.3317123913477366,0.40728486195669966,0.572664940565834,0.3058816822504121;
Activation of AMPA receptors,0.3136107765403995,0.3659796444425064,0.6231240255902294,0.32552608200489686,0.3439134979171695,0.5333671736672642,0.4753217921706432,0.3363632797967757,0.7072860466629798,0.4448245137365865,0.3058816822504121;
Class I peroxisomal membrane protein import,0.3390466778271897,0.421441415526736,0.31662508962588515,0.3861917421038416,0.6181909816472938,0.4838797903392124,0.47471752381853194,0.44770267919471923,1.5688410743164674,2.5550110864105697,0.3058816822504121;
Activated point mutants of FGFR2,0.4397502331886933,0.601299658616172,0.5220164126287496,0.6914851560917501,0.6776561166140836,0.39254468660396336,0.47435889999706843,0.31539388260432966,0.33154605935666304,0.39091888813155207,0.3030467691849685;
Signal transduction by L1,0.606635513897259,0.551949046739447,0.6066943934222234,0.3503872330012344,0.3439134979171695,0.47361860684248014,0.47430079168158523,0.5972444500514024,0.31497219477514715,0.6108217978378385,0.3058816822504121;
TWIK-related alkaline pH activated K+ channel (TALK),0.5367193506170276,0.4405300811880554,1.8124395980745798,0.3428663705227962,0.3394918967507969,0.4126833593188166,0.47430079168158523,0.31080172654221816,0.36494779765230456,0.44065582267788694,0.3058816822504121;
Estrogen biosynthesis,0.42992726818516147,0.30955187441848364,0.7635003516328472,0.4296023820159213,0.30246496029501807,0.46329118624362164,0.47430079168158523,0.6165161116191114,3.7301894943733327,2.802341362090072,0.3058816822504121;
PLC beta mediated events,0.44317443112510646,0.33281680434913724,4.7103758117704615,0.39026723080694775,1.4497014587581227,3.3752407581580246,0.47430079168158523,0.7214872606359403,0.8059290852393105,3.4449015650011026,0.3058816822504121;
GRB2 events in ERBB2 signaling,0.3485280504925926,0.4730357518880468,0.34733542328568157,1.1290363632586324,0.33664443463132226,0.8205962637560629,0.47430079168158523,0.39048239961549064,0.36494779765230456,0.532096178369972,0.3058816822504121;
Cap-dependent Translation Initiation,0.32811464063720513,0.6161081789146999,1.2332620270716799,0.3454633916917074,0.3119959467823231,0.5588744344857842,0.47430079168158523,0.30318050255984674,0.6052596979838009,0.622741869993541,0.3024439670208732;
Synthesis of UDP-N-acetyl-glucosamine,2.226195941366306,0.4155240941545764,0.4173066784472562,0.3232519888569888,0.3726312003584851,0.3695405452782485,0.47387972900025127,0.31539388260432966,0.37714526130064224,1.7889291130233775,0.3058816822504121;
RNA Polymerase I Transcription Initiation,0.6284918354782628,0.6667335201465007,1.5875048741766733,0.39992247154050303,0.330372459861341,0.416812166468743,0.472422262226759,0.33102140044232475,0.3106584475526706,0.3460910784833522,0.3058816822504121;
TNFR1-induced NFkappaB signaling pathway,0.3117629957183809,0.32644608695254396,0.6331606985702882,0.49786442742870163,0.42272067676020203,0.651553621145545,0.472422262226759,0.5300187576686016,0.33154605935666304,0.3845950755081606,0.3058816822504121;
Activation of Na-permeable kainate receptors,0.36765290593325656,0.3897456937069698,1.738007687702123,0.4679155083230611,0.3223947354494506,0.47677687539221214,0.472422262226759,0.32008659068880624,0.42782578452573555,0.5026703144243176,0.3058816822504121;
Ca-dependent events,0.3892389944485352,0.7678534252093862,4.842470890520244,0.4751568544371663,1.4497014587581227,3.645811997377063,0.472422262226759,0.5174152264767676,0.33154605935666304,2.918220327306432,0.3058816822504121;
Regulation of localization of FOXO transcription factors,0.47959881088156225,0.39346922355107966,0.3522091894431383,0.4697453280545078,0.330372459861341,0.9645603131595664,0.472422262226759,0.42864408325691356,0.35612183817226384,0.5323145474341873,0.3058816822504121;
Activation of GABAB receptors,0.41955155407635125,0.5073445985405695,0.5782532957107175,0.3163292158034775,0.5630974666556423,0.45670913707475397,0.472422262226759,0.319929158053878,0.33154605935666304,0.6343528131464561,0.3030467691849685;
Sodium-coupled phosphate cotransporters,0.3957341132721857,0.923842783530003,0.7045131215857201,0.3163292158034775,0.3652904863488216,0.7464617740472214,0.472422262226759,1.036298778402231,0.3156659602261388,0.37636770226551464,0.3030467691849685;
GABA B receptor activation,0.42086888736119815,0.5067139839757604,0.5798296840686574,0.3163292158034775,0.5669614829417398,0.4590919226290376,0.472422262226759,0.3239716014333915,0.33154605935666304,0.6343528131464561,0.3030467691849685;
Formation of the active cofactor, UDP-glucuronate,0.8090237191460051,0.33402483609309025,2.359926286467173,0.39485276920195894,0.5973746507494396,0.474224940380697,0.4712812844238908,0.31319485378598494,0.4564353693270964,0.3275982714052055,0.3058816822504121;
Unfolded Protein Response (UPR),0.4285257794946782,0.6667335201465007,2.357429115642457,0.5899368858697199,0.35952474696705994,0.8353012895207585,0.4712812844238908,0.30222076309715623,0.3293878277257215,0.3586349562682923,0.3030467691849685;
Signaling by ERBB2 KD Mutants,0.8765791421228779,0.34441575692295656,1.073527017168443,0.3861917421038416,0.3764809604369917,0.8252260363006858,0.4712812844238908,0.35971925328583354,0.32397177416554596,0.35352371536264976,0.3058816822504121;
LDL clearance,0.32400304823221204,0.4916469925647314,0.3557042064788556,0.4339948646037047,0.3012749188645074,0.4219367177964331,0.4712812844238908,0.3425206096678787,0.3329607429278685,0.4451611421708856,0.3030467691849685;
Eukaryotic Translation Initiation,0.32811464063720513,0.6161081789146999,1.2346712003995064,0.3454633916917074,0.3119959467823231,0.5646191142917181,0.4712812844238908,0.30308894197867353,0.6052596979838009,0.6233783326264207,0.3024439670208732;
RNA Polymerase III Transcription,0.7432242533096001,0.3090278240817252,1.0193284028017302,0.3265325825462171,0.3439134979171695,0.3946222670176035,0.4712812844238908,0.40342728894670354,0.3693665271664583,0.3109481832046546,0.3032374359194824;
FGFR3 ligand binding and activation,0.36408810510314893,0.39814946840836085,0.8448730873518618,0.5120370352239828,0.35573771241937,0.3632803726492419,0.4712812844238908,0.37816616888872967,0.3074634276468475,0.3524418164773709,0.3058816822504121;
Disinhibition of SNARE formation,2.171295521471604,0.3029713996082115,1.4551918751426052,0.3347645018815191,1.0702835859303041,0.4300466631842503,0.4712812844238908,0.3300822406904645,0.46309482125230866,0.5101211329757073,0.3058816822504121;
Miscellaneous transport and binding events,0.5449293344335326,0.3299417989905663,2.3392743670789615,1.4599914308140092,1.0102546585812715,4.460539542243616,0.4712812844238908,0.36073163167381794,0.3329607429278685,0.3337585302705513,0.3058816822504121;
Peptide hormone metabolism,0.6188386975716889,0.30136794395345357,0.7635003516328472,0.34115852730494867,0.3439134979171695,0.4306777496994055,0.4712812844238908,0.350379041909501,0.3125976105473822,0.4523752385250782,0.3058816822504121;
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,0.35031899134905103,0.38922267012244505,0.7967758165849417,0.5037883573514967,0.3082126526753394,0.41548903650203944,0.47077984446449106,0.30318050255984674,0.34010467491250734,0.5395292439805308,0.3058816822504121;
RNA Polymerase III Transcription Initiation From Type 1 Promoter,0.4524815885910299,0.3351332739777284,1.7722808994134962,0.3343959421279304,0.3439134979171695,1.240457662602838,0.4687175974098913,0.3909454933235953,0.3418975449068169,0.6492080770480536,0.3058816822504121;
Interleukin-6 family signaling,1.2840117355802898,0.9363641915722525,0.3617239240045207,0.34114908780953945,0.39026309562416256,0.4107256546615841,0.4687175974098913,0.638700226611994,0.3564169901750398,1.6013076041885623,0.3058816822504121;
RNA Polymerase III Abortive And Retractive Initiation,0.737234817812786,0.3090254582300101,1.0193284028017302,0.32674678664545054,0.3439134979171695,0.3946222670176035,0.4687175974098913,0.40342728894670354,0.3693665271664583,0.3105472018765112,0.3032374359194824;
Regulation of signaling by NODAL,0.3672789551152327,0.33580448813743125,0.8263536960792152,0.4296023820159213,0.41915543431295504,0.5214535874144981,0.4687175974098913,0.3207891067373377,0.3061329461218883,0.7325121903592762,0.3058816822504121;
Synthesis of PI,1.05959797977676,0.6290502125044155,2.612080435887825,0.330334113068339,0.9494636929508514,0.312405934491624,0.4687175974098913,0.5327910439846112,0.7782429355668223,3.088857142578697,0.3058816822504121;
Sphingolipid de novo biosynthesis,1.928483561668115,0.41341873352266867,2.2738241139471578,0.45814106070834476,1.239479955932051,0.8116488067643249,0.4687175974098913,0.35971925328583354,0.4459533977710523,2.1973600892666885,0.3058816822504121;
Signaling by activated point mutants of FGFR3,0.36439308070393406,0.40047440567304926,0.820579901647453,0.5192747265799554,0.35573771241937,0.36357692884379,0.4687175974098913,0.37816616888872967,0.3093454784028885,0.3499554559816128,0.3058816822504121;
Metabolism of serotonin,2.021217296795734,0.33958084202876593,0.47620779881555453,1.0001697724579797,0.4224421407412922,0.3111782497541377,0.4687175974098913,0.30299624920473567,0.3779014763245248,0.5231412627684151,0.3024439670208732;
Activation and oligomerization of BAK protein,0.3162862152926333,0.479523222979618,0.8018893713477384,0.34115852730494867,0.3726312003584851,0.46829287577570267,0.46773518445860446,0.33030236244002353,0.33852055572539486,0.5323145474341873,0.3058816822504121;
Translesion synthesis by POLK,1.5850012321335474,0.335630131897455,0.36743428113510346,0.4609306983002966,0.33947615435300504,1.5945953640146877,0.46676547595016665,0.5693729600094288,0.30150053284191936,0.34303382656163733,0.3058816822504121;
HDL remodeling,1.2539408448910911,0.33429339400368174,1.5375010889535694,0.3654174844613779,1.239479955932051,0.6309656636215836,0.46562006586021537,0.37482945748292784,0.6052596979838009,2.6239804783313474,0.3058816822504121;
UNC93B1 deficiency - HSE,0.7753440831935311,0.6632010765904364,1.858161098708219,2.1959705259269473,0.3439134979171695,0.4127644252979026,0.46535962008636683,0.31153241212058264,1.0440800124954295,0.5209613107182163,0.3058816822504121;
Conjugation of phenylacetate with glutamine,0.45668967406434435,0.642037538389264,2.517592523588584,0.3881184602725714,0.40011734818170236,0.4000864393565479,0.4640478435647773,0.4671836385857672,0.30458685905162125,1.483370356290762,0.3032374359194824;
Beta oxidation of myristoyl-CoA to lauroyl-CoA,0.5900450371029411,0.49882509403717307,1.982134437236759,0.3198395805486888,0.31425684010309535,0.46297556448329885,0.46401018969133195,0.34680976678403747,0.3156659602261388,0.3410047920540425,0.3058816822504121;
Insulin receptor signalling cascade,0.8072884376667768,0.5825284386456702,1.5367409836438426,0.34571014914919185,0.3226140943665297,0.35399026492638497,0.46361729821021025,0.515231060699031,0.45174765924593724,0.510128109772137,0.3058816822504121;
Glutathione synthesis and recycling,1.502358715204575,0.3351332739777284,0.7658314545832369,0.3881184602725714,0.32162569628297455,0.38644297502167896,0.46361729821021025,0.42426681188822685,3.582534078690718,0.3109481832046546,0.3058816822504121;
NOTCH1 Intracellular Domain Regulates Transcription,0.44351687530887374,0.4785132458736432,2.585307364309015,0.5158311239983016,0.697971698746192,1.3027480042124746,0.4628072801432424,0.5226955554832011,0.5380488165948838,0.4353740121305991,0.3058816822504121;
Listeria monocytogenes entry into host cells,0.33195778577326673,0.3057534806262932,0.3538601237188543,0.5259000391854405,0.5343252231455516,0.3111782497541377,0.4628072801432424,0.6652097340320369,0.418328270869041,0.37636770226551464,0.3058816822504121;
LGI-ADAM interactions,0.5587013765220952,0.32979575975804937,2.123183035424456,0.6197330358455396,0.39841886726404796,0.40268367579666303,0.4628072801432424,0.3094759427026921,0.35498837673230227,0.669644009748287,0.3058816822504121;
FCERI mediated NF-kB activation,0.3052983521599139,0.5254335345474912,0.7391101653549697,0.32100808197395886,1.3011770376809937,0.70206723630419,0.4628072801432424,0.6113856407636219,0.3327832096024327,0.39807543893028463,0.3058816822504121;
NEP/NS2 Interacts with the Cellular Export Machinery,2.547108532706971,0.7380453821386058,1.4499285308620922,1.5123371805538774,0.35573771241937,4.048180206970717,0.4628072801432424,0.4467806963553069,0.3121738255632173,0.3109481832046546,0.3058816822504121;
Glycogen storage disease type IV (GBE1),0.495644558835117,0.3818530794945164,1.299736166825633,0.4147520762862274,0.3764809604369917,0.3676748767985349,0.4628072801432424,0.4540751851007829,0.34050073667628167,0.7147958524686185,0.3058816822504121;
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,0.3117629957183809,0.3041785410778355,1.405432806416354,0.3163292158034775,0.779873055131759,0.7659191921406994,0.46252515237241304,0.6365288301479024,0.31120063727890246,0.8682301719181825,0.3058816822504121;
Transcriptional regulation by RUNX3,0.3338779305607098,0.3667015217797265,0.42507367602014473,0.3163292158034775,0.631676288554392,0.8813681710037167,0.46215837328112996,0.4890921202267072,0.5935159742610949,0.38486707233306083,0.3058816822504121;
Myogenesis,0.4451629103662902,0.3667015217797265,1.5977118412502447,1.115562684767983,0.35830085846035925,0.3071425190433953,0.46154911800074344,0.8986880030650579,0.42332031869678155,0.4232200116160087,0.3058816822504121;
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP),0.6635617905334938,0.6617160530759545,0.3671298580499003,0.5358939466297958,0.39026309562416256,0.35399026492638497,0.46154911800074344,0.3710643393795012,0.6175389953182515,0.30603264219956966,0.3058816822504121;
FGFR1 ligand binding and activation,1.306197047981217,0.4284698207307233,0.3114561128294983,0.38977595796733894,0.311114601116272,0.4469459782732627,0.46133044240944726,0.3658203974216597,0.3126560962541032,0.8170898715095123,0.3058816822504121;
Ficolins bind to repetitive carbohydrate structures on the target cell surface,0.30735682749868515,0.33875335399120593,0.5494530568571484,0.3861917421038416,0.3764809604369917,0.524085852020183,0.46133044240944726,0.32753430183444365,0.36494779765230456,0.31100904921848943,0.3058816822504121;
HDL clearance,0.38523662041238443,0.4386912358120347,1.2445841882295585,0.34493403884766827,0.3147704613843775,0.4408110119089345,0.46133044240944726,0.6537880606010806,0.3522221105554151,0.4030133825628864,0.3058816822504121;
FGFR3 mutant receptor activation,0.3637587916540856,0.39701699993581774,0.9964277710234618,0.5093368965319863,0.3560720414244286,0.3620735944925361,0.46081415678207305,0.3784754571208943,0.3075199522833463,0.35352371536264976,0.3058816822504121;
Complement cascade,1.3567582193901935,0.44724438401219935,0.824931137133459,0.3283439964211864,1.5828289611196062,0.3727191734928265,0.46081415678207305,0.30481780719897456,0.6052596979838009,2.274202032700971,0.3058816822504121;
RUNX1 regulates estrogen receptor mediated transcription,0.3295920706872582,0.3351332739777284,5.015737199730612,0.5900152111207688,1.3241905080609873,3.4797584798038175,0.45909928180314313,0.8261221892681899,4.492296970246937,3.4449015650011026,0.3058816822504121;
FOXO-mediated transcription of cell death genes,0.7669120937190577,0.5324309296314834,1.2149703771791165,0.9095489031696933,0.3439134979171695,0.3665758794553794,0.4586653234791756,0.33030236244002353,0.3692084556559849,0.30460299844595456,0.3058816822504121;
Transcriptional activation of mitochondrial biogenesis,0.4397502331886933,0.301642737608084,0.3897040218281641,0.6408716818388634,0.5284597186854141,0.31776991236841967,0.4586653234791756,0.5036309725177871,0.45644750223509717,0.5798185263650673,0.3058816822504121;
Neurotoxicity of clostridium toxins,0.8076155113100113,0.45199084089717,0.597165898101263,0.48853611966738064,0.35830085846035925,0.32582525152199426,0.4581012543891677,0.34398443282195684,0.37714526130064224,0.4404591951700404,0.3058816822504121;
Gap junction trafficking and regulation,0.6098863292854918,0.4081569957992947,0.7613149469443117,0.3265325825462171,0.6818387521124429,0.9263794319903491,0.4571815530538436,0.46020637526382446,0.4644723627826459,0.3117369630687721,0.3058816822504121;
Vasopressin regulates renal water homeostasis via Aquaporins,2.8464937374289456,1.0352787328432593,0.4018400955900535,0.8651694564980436,0.34326141804925875,0.3454369423490266,0.45713632475004395,0.3251934547032587,0.37771151139769193,0.572602207453692,0.3058816822504121;
Synthesis of substrates in N-glycan biosythesis,0.31186750211813125,0.3392192110836122,1.2020317108771463,2.5587379297236894,1.5828289611196062,4.192333372904334,0.45616045703912467,0.35082679893314456,0.4881499224650157,2.4072876984101277,0.3058816822504121;
Peptide chain elongation,0.38132131699763155,0.4631345202388002,1.5753594462620744,0.322985779213323,0.38442268773206284,0.4641092916342805,0.45616045703912467,0.3272468962834211,0.37714526130064224,0.38820904859778893,0.30249811228335877;
Linoleic acid (LA) metabolism,0.3195134583854903,0.30713105125946294,0.7967758165849417,3.3403030746676428,0.7460829399514947,1.2349852244576813,0.4551020304496021,0.4836965380079519,4.204788547537598,1.2128632227613605,0.3058816822504121;
Glycogen storage disease type II (GAA),0.3136107765403995,0.7560598382503433,0.4077557145318142,0.3861917421038416,0.3918027183993316,0.46829287577570267,0.4550179127633811,0.5389628321778192,0.3728343545959842,0.4678954462589095,0.3058816822504121;
Fatty acid metabolism,0.3131846682126686,0.36231980452174045,3.5936623015962224,0.8238790622019743,1.4497014587581227,3.5894551210514725,0.454966152459563,0.5613944991412845,0.6669914040927446,2.147656821886492,0.3058816822504121;
p75NTR recruits signalling complexes,0.40511607004227757,0.30641678157489305,0.31244482358060083,1.2904046964004916,0.7433781605289134,2.979546248499804,0.454966152459563,0.5389628321778192,0.3017463573232267,0.998516810697719,0.3058816822504121;
SUMOylation of transcription factors,0.4304054585981739,0.3393935927201346,0.3327614819001198,0.3836697831767265,0.6736357056346454,0.9134979803271983,0.454966152459563,0.6121973354446032,0.3156659602261388,0.41376887048902816,0.3058816822504121;
Activated NTRK2 signals through FRS2 and FRS3,0.5746746201572204,0.38415246703004036,0.5230733200949161,0.32289368140643626,0.4146172972667351,0.4541009858801141,0.454966152459563,0.35971925328583354,0.3293878277257215,0.5323145474341873,0.3058816822504121;
VxPx cargo-targeting to cilium,0.3914332839728542,0.3659796444425064,3.452337414547906,0.39144877960498997,0.6278261191361808,0.6416953454529292,0.454966152459563,0.30705368811069295,0.33154605935666304,0.4404591951700404,0.3034996034775484;
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,0.42506882085756453,0.31903362697909327,1.3106624219521872,0.46898504590813767,0.3808454324985298,0.46329118624362164,0.454966152459563,0.35082679893314456,0.569721328093352,2.0007560205265067,0.3058816822504121;
OAS antiviral response,0.33137564217830273,0.5134678000949939,2.4677521763391383,0.3163292158034775,0.4130708040105258,0.3479832638871655,0.454966152459563,0.437610754516171,0.3522221105554151,0.4625596178349653,0.3058816822504121;
Aryl hydrocarbon receptor signalling,0.32213490899676,0.315650141649467,0.7045131215857201,0.3861917421038416,0.48046633727165955,0.4306777496994055,0.453856316849635,0.6652097340320369,0.3065164849314509,0.8678273610123992,0.3058816822504121;
2-LTR circle formation,0.638805214557159,0.46050058308477193,0.6371763478650965,0.3536741872163679,0.4161067193317774,0.38644297502167896,0.453856316849635,0.4589589677230645,0.32855021388126704,0.3822388643311611,0.3058816822504121;
Erythropoietin activates RAS,0.8072884376667768,0.5357174180674569,1.4395540187364995,0.3503872330012344,1.1881095655489549,1.4443143830942757,0.453856316849635,0.5613944991412845,0.40204508772130776,1.7531485862030827,0.3058816822504121;
FGFR3c ligand binding and activation,0.3599360603194696,0.39501944315919246,0.969339437530591,0.5084365731528091,0.3560720414244286,0.3620735944925361,0.453856316849635,0.3784754571208943,0.30776308796617835,0.35352371536264976,0.3058816822504121;
Axon guidance,0.7518518916541688,0.301642737608084,0.5130503622174319,0.39485276920195894,0.330372459861341,0.32379424092724673,0.453856316849635,0.3873399681862305,0.34050073667628167,0.3451238691514368,0.3058816822504121;
Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4),0.3119979840557615,0.5073445985405695,0.3081915935170801,0.3881184602725714,0.4880981010804869,0.6374443225425805,0.453856316849635,0.3419488235161132,0.4682047298447594,1.1185774179386265,0.3058816822504121;
Loss of proteins required for interphase microtubule organization from the centrosome,2.89072583416433,0.5160538865147885,0.7967758165849417,3.3156221215320296,0.33406583255714095,1.4913294770057988,0.453856316849635,0.309018298085769,1.6481131610047546,0.6566377434606885,0.3058816822504121;
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),0.8072884376667768,0.4155240941545764,0.5839126285149882,0.3198395805486888,0.3073643548426107,0.3762215469973146,0.45323528915453365,0.3363632797967757,0.7400732280100476,0.5278203201689747,0.3058816822504121;
TYSND1 cleaves peroxisomal proteins,0.48052176933701835,0.36734545489144443,0.4322549751498343,2.2108397880598227,0.330372459861341,1.102098315814885,0.45289313218443833,0.7214872606359403,0.7945700729668096,0.6081611140532585,0.3058816822504121;
Loss of Nlp from mitotic centrosomes,2.89072583416433,0.5160538865147885,0.7967758165849417,3.3156221215320296,0.33140832466933967,1.4913294770057988,0.45289313218443833,0.309018298085769,1.6481131610047546,0.6568066265367332,0.3058816822504121;
Keratan sulfate biosynthesis,1.1259571148530627,1.8815589255708167,0.5135324116895287,1.2230266050966954,0.34063624591886615,0.4306777496994055,0.45289313218443833,0.32735598382599135,0.37714526130064224,0.3109481832046546,0.3058816822504121;
Post-translational protein modification,0.3794194863285861,0.30844391279468925,0.6273178275096073,0.44798064657680453,0.33664443463132226,0.38644297502167896,0.4528813748839948,0.4849021760868862,0.3063901120454567,0.31613944815052264,0.3058816822504121;
Mitochondrial Fatty Acid Beta-Oxidation,0.335368352224608,0.36231980452174045,1.1071248507213265,0.32289368140643626,0.3439134979171695,0.45182304898127246,0.4528813748839948,0.4589589677230645,0.418328270869041,0.30352660857733577,0.3058816822504121;
Cholesterol biosynthesis,2.5300786564207183,0.3486664547515465,0.47160753149999735,1.7592356223195151,0.30246496029501807,0.32379424092724673,0.45257289741517553,0.48606186013240477,5.933991275033519,0.32532264275231887,0.3058816822504121;
Transmission across Chemical Synapses,0.3603728060987278,0.3659796444425064,3.4801072213110906,0.38834181595987294,1.385141847474294,2.083530125044517,0.45257289741517553,0.39635815751768927,0.4574971964982196,1.3795353370639227,0.3058816822504121;
Cytokine Signaling in Immune system,0.6558037141499062,0.3864631808225056,0.3366102940742713,0.37851270714961555,1.4497014587581227,0.9945345766707561,0.45257289741517553,0.4018372923384269,0.3089310108463698,1.9633837456177656,0.3058816822504121;
Catecholamine biosynthesis,0.5557714001529779,0.39345866018991343,0.926894255266249,0.9849589810571827,0.3824048831138682,0.38644297502167896,0.45257289741517553,0.8392145373470217,16.3406761094273,0.59909883417329,0.3058816822504121;
Defects in biotin (Btn) metabolism,0.46161854092936455,0.49023002456961257,1.070454754960547,0.5261277469989963,0.37205774949981,0.45383436213121164,0.45257289741517553,0.4467806963553069,0.34010467491250734,0.4279876382867682,0.3058816822504121;
Phase 4 - resting membrane potential,0.574253986837501,0.3287763939899654,3.0717146287933357,0.45814106070834476,0.7706141885413044,2.785860240774788,0.45257289741517553,1.2382013029336363,1.1033715792095793,1.3417327277549957,0.3058816822504121;
Platelet degranulation ,3.744795482399178,0.6748754522273666,0.7695585986948226,0.3067748912708138,1.1631725606936794,0.609620681310484,0.45257289741517553,0.3998593960551724,0.3418975449068169,2.3053667390193406,0.3058816822504121;
L1CAM interactions,0.5616787261605595,0.3667015217797265,2.2276406502899304,0.36926780817120297,0.6707343576859068,0.6234524920206473,0.4521222213679171,0.36710932947589353,0.4904318320906067,0.3286979716130023,0.3030467691849685;
PKA-mediated phosphorylation of CREB,0.32648569807719524,0.315650141649467,3.842756560222099,0.7628528203458588,1.4120256619524758,4.165285200589449,0.4521222213679171,0.33696163270265517,0.3729062334678565,2.2500527373668495,0.3058816822504121;
Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5),0.3118854532837041,0.5073445985405695,0.30134832367833375,0.38834181595987294,0.4863867848397038,0.6434189199741671,0.4508106135646171,0.3404366042983231,0.46964083019396136,1.1185774179386265,0.3058816822504121;
Transport of fatty acids,0.3672789551152327,0.6663735102025011,0.5669713911895651,0.3454633916917074,0.30142164052271936,0.7284869631520305,0.4508106135646171,0.32735598382599135,0.3728343545959842,0.32837788404645557,0.3036587911860299;
Metabolism of nitric oxide: eNOS activation and regulation,0.5032828338856044,0.37261707238678665,0.8833146903713517,0.3503872330012344,0.3726312003584851,0.51333672425214,0.4502647423263445,0.5389628321778192,0.3515439172895968,0.4232200116160087,0.3058816822504121;
Translesion synthesis by POLI,1.5850012321335474,0.3351332739777284,0.7356982690080166,0.39485276920195894,0.3722027189435112,1.5541986739104443,0.44922153713617535,0.548862228854724,0.3418975449068169,0.3206530510344374,0.3058816822504121;
Abortive elongation of HIV-1 transcript in the absence of Tat,1.8467552961985725,2.0049114338084766,2.4273005206431555,4.222866572356169,0.4829239057523196,0.9363108009582594,0.4484969096769902,0.3174126423874192,0.3115924460534767,0.4451611421708856,0.3058816822504121;
SHC-mediated cascade:FGFR3,0.47453674885557934,0.30590329751427836,1.5216687561972464,0.3503872330012344,0.39113834579371415,0.4900714565162325,0.4484969096769902,0.32753430183444365,0.46973565379933857,0.3109481832046546,0.3058816822504121;
Activated NTRK3 signals through PI3K,1.15357921159607,0.3010748960204856,0.33878611882482,0.5259000391854405,0.39794629746034765,0.47055855225156185,0.4484969096769902,0.43230554090872725,2.9476893090454395,0.4121812366547547,0.3058816822504121;
TNFR1-mediated ceramide production,0.4385293402931951,0.3659796444425064,0.5897840382707876,0.3114867792687908,0.3645583937901488,0.8205962637560629,0.4484969096769902,0.33696163270265517,0.31075100083854396,0.39863298409526765,0.3058816822504121;
Dual Incision in GG-NER,1.542607112490525,0.5588980041062537,1.1611221759179944,0.5602924944528066,0.56267084582879,0.902886238405665,0.4480216876297408,0.5627328227900846,0.3266862348880042,0.8203447446361902,0.3058816822504121;
Formation of editosomes by ADAR proteins,1.8450168225225432,0.3667015217797265,0.7950820635273264,0.543500529637991,0.3439134979171695,0.49516020035421604,0.4479128177676394,0.7808545639669524,0.41922428215661073,0.31254422204098564,0.3058816822504121;
Lysosomal oligosaccharide catabolism,0.6875281949141528,0.3691439136623758,0.3092052383887742,0.4823062979997039,0.3764809604369917,0.315085039913656,0.4479128177676394,0.36013197279316866,0.4881499224650157,0.9562192771334456,0.3058816822504121;
Beta oxidation of butanoyl-CoA to acetyl-CoA,0.5063094652344134,0.3278049526398883,0.996131501942276,0.49938313248528654,0.33627276072485157,0.3017544392101771,0.44784293657214597,0.4815653043880472,0.39838117936895323,0.3109481832046546,0.3058816822504121;
Class C/3 (Metabotropic glutamate/pheromone receptors),0.6228686233239953,0.30402224815377643,0.39066099676090016,0.3327284474992245,0.311422158602307,0.3976005671239824,0.44784293657214597,0.35971925328583354,0.34010467491250734,0.31613944815052264,0.3058816822504121;
GRB2 events in EGFR signaling,0.3119979840557615,0.3051715086707191,1.5621779857084854,0.3163292158034775,0.7409373343908842,1.8779020410390956,0.44784293657214597,0.5174152264767676,0.31075100083854396,0.5100898491572277,0.3058816822504121;
Reversible hydration of carbon dioxide,0.5557714001529779,0.34355423434661836,2.237538539530494,0.8182391893769537,0.9200438033952797,4.170257495204747,0.44682433953022976,0.4717915099738133,0.9291847867621535,1.5989857264412672,0.3058816822504121;
DARPP-32 events,1.7616003058901537,0.30397605771269914,0.9868026812162809,0.3256228293422544,0.3396325673262649,0.416812166468743,0.44682433953022976,0.6165161116191114,0.36494779765230456,0.32837788404645557,0.3058816822504121;
Opioid Signalling,2.931225983477916,0.9394394484219818,1.2347702357212416,0.3503872330012344,0.5358107092946165,0.3635437582043762,0.44647821235836693,0.9221426572870339,0.3326837406564544,1.1466822619693087,0.3030467691849685;
Response of EIF2AK1 (HRI) to heme deficiency,1.52923317523598,1.074569692527948,0.4426141841101584,4.099124446419689,0.9085949067020295,1.5541986739104443,0.44639580110479105,0.5578106790042832,3.577673173252147,0.3115470929760852,0.3058816822504121;
Sodium-coupled sulphate, di- and tri-carboxylate transporters,0.4416826026365212,0.4081569957992947,2.114585589807809,0.46614281375376615,0.43870502637389713,0.3235313818318902,0.4462100775758948,0.45209511687783316,0.7066938861268142,0.5102475295262496,0.3058816822504121;
Synthesis of very long-chain fatty acyl-CoAs,0.469082934340401,0.601299658616172,1.5459410778839082,0.4147520762862274,0.9078860349641316,2.5291999895757384,0.4462100775758948,0.4849021760868862,0.4084899821472641,1.0394259440247136,0.3058816822504121;
C6 deamination of adenosine,1.8450168225225432,0.3667015217797265,0.8017891949040372,0.543500529637991,0.3439134979171695,0.49267270361802806,0.4462100775758948,0.7808545639669524,0.42165490530340993,0.3126363644087619,0.3058816822504121;
Glycogen storage disease type 0 (liver GYS2),0.6965908886977157,0.5324309296314834,1.45366218336228,0.329897791700562,0.30246496029501807,0.35399026492638497,0.4462100775758948,0.5578106790042832,0.34050073667628167,0.45624654297268663,0.3058816822504121;
Hydrolysis of LPC,0.4385293402931951,0.4828154453378415,0.31713424437660603,0.40163249982414734,0.6776561166140836,1.1143603888025917,0.4462100775758948,0.8253612893047934,0.37714526130064224,0.700096020022996,0.3058816822504121;
Cohesin Loading onto Chromatin,0.3154373953176946,0.5160538865147885,1.4132915985086576,0.6830590249119001,0.3439134979171695,0.727804073060917,0.44576981922469117,0.6121973354446032,0.7574177165397277,0.5100898491572277,0.3058816822504121;
mRNA Editing: A to I Conversion,1.8450168225225432,0.3667015217797265,0.8058702959459212,0.5488067463935579,0.3439134979171695,0.4902850695312733,0.44576981922469117,0.7808545639669524,0.423716321008238,0.3126363644087619,0.3058816822504121;
Lysine catabolism,0.5954492320468132,0.4081569957992947,0.7615455863097667,0.45318152334723316,0.3082126526753394,0.46101187408142824,0.44576981922469117,0.3445913271108731,1.974933289915886,0.4540611718827999,0.3058816822504121;
RIP-mediated NFkB activation via ZBP1,0.4397502331886933,0.3173693456155217,0.5196560187410272,0.3503872330012344,0.3439134979171695,0.6928943061340497,0.44562840201462767,0.479986763867055,0.3121738255632173,0.4727905293493389,0.3030467691849685;
Generation of second messenger molecules,0.9272564687137639,0.3067409288727,0.5111303216523466,0.9360806391385281,0.7649116976674908,0.6339686800252128,0.44562840201462767,0.3094759427026921,0.33154605935666304,0.9930461633126723,0.3058816822504121;
HIV Life Cycle,0.4029927195800096,0.576173559427021,1.178127480809313,0.4074955743352819,0.30418705243734856,0.5555984606532605,0.44509848228879206,0.3317123913477366,0.3181712228862701,0.32837788404645557,0.3058816822504121;
TLR3-mediated TICAM1-dependent programmed cell death,0.5954492320468132,0.5884097883583718,0.5017359945597698,0.45025906807447985,0.5718721379043165,0.609620681310484,0.44383130387647823,0.4890921202267072,0.3944031754439474,0.35352371536264976,0.3058816822504121;
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,0.3914332839728542,0.44979020246864093,0.4322549751498343,0.5109471607838141,1.4497014587581227,0.31386541612384017,0.44383130387647823,0.5918767786718077,0.8093683332048278,0.44811482431034744,0.3058816822504121;
Ion homeostasis,1.1098280637652032,0.413066088586355,2.2805929725509984,0.3628766921649118,0.9989839361691158,0.6263653397241001,0.44383130387647823,0.4478369225572017,0.32397177416554596,1.528324873079311,0.3058816822504121;
Processing of Intronless Pre-mRNAs,2.4157043501620223,3.696614539228338,2.4887017770108586,3.1065384631865065,0.3394918967507969,1.0323535312082575,0.44350792881517126,0.5627095985093976,0.3061329461218883,0.5755917057901333,0.3058816822504121;
MET activates STAT3,1.1734224141268843,0.3105836898586958,0.5785913371395999,0.39144877960498997,0.6776561166140836,0.36504209043534924,0.44254767184168753,0.6665031139237775,0.536884289765251,0.3672727022722716,0.3058816822504121;
Receptor Mediated Mitophagy,0.4965830528827928,0.5131391727266793,0.3213389630759881,0.3874935871335183,0.35290876980663655,0.44836832077940414,0.4418175250280188,0.7808545639669524,0.37721347556427365,0.35352371536264976,0.3058816822504121;
Glucagon-type ligand receptors,1.2784081288862559,0.59842826146496,0.5226661205165584,1.1778410748784354,0.32297793958928395,0.3620735944925361,0.44170308303322703,0.35524193396628306,0.39047907840646395,0.34816200195549196,0.3058816822504121;
Late endosomal microautophagy,0.4632713188448469,1.3570134356717731,0.7552500465933367,0.518409827601242,0.3385368315518125,0.35765380914162076,0.44170308303322703,0.34311923132904953,0.37818098826263175,0.3641262916570064,0.3058816822504121;
Insulin processing,0.3757811722764317,0.4798917148825528,0.7654194085499344,0.380333723709027,0.5442360620589024,0.3491683136349247,0.441429931778153,0.31482486972733703,0.33985218265693556,0.3527755914843758,0.3058816822504121;
PI-3K cascade:FGFR4,0.45031287653699437,0.6441853723194954,0.498071154827163,0.5954683647755179,0.433323819297691,0.3111782497541377,0.441429931778153,0.7808545639669524,0.31837078236812505,0.7028263161348234,0.3058816822504121;
RNA Polymerase III Transcription Initiation From Type 3 Promoter,0.48313498722766435,0.35817300272844155,0.3925098753478222,0.4713179984058352,0.3439134979171695,0.48487375011027734,0.441429931778153,0.638700226611994,0.4040687910405057,0.3286979716130023,0.3058816822504121;
Oligomerization of connexins into connexons,0.5303815396723062,0.5550410065029113,0.5439930076286128,0.3063319847788688,0.32162569628297455,0.6002867425486573,0.4405021671650462,0.3909454933235953,0.6459758662785066,0.697425008539117,0.3058816822504121;
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism,1.3854551577291125,1.5177742100176006,0.6826035945216478,1.2097778019785008,0.30418705243734856,0.5599068983002935,0.4405021671650462,0.4147150908432823,0.5424034113042814,0.5798185263650673,0.3058816822504121;
tRNA Aminoacylation,1.8658049258015759,0.39264274682216194,0.8517982647455866,2.352614944859006,0.3226140943665297,1.776798529138074,0.44047396306035724,0.3841922058752813,1.042470285322291,0.3275771061088942,0.3024439670208732;
Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD),0.47453674885557934,0.301642737608084,0.35275308129702004,0.8452387558632973,0.3363756870848458,0.3420003235500663,0.44047396306035724,0.30980925894012945,0.31837078236812505,0.43313205522532416,0.3058816822504121;
Norepinephrine Neurotransmitter Release Cycle,0.9434026314434367,0.3918158246299093,0.3081915935170801,0.380333723709027,0.3500419343212808,0.6436104690705318,0.44047396306035724,0.5918767786718077,1.38416838586673,0.35815713029086216,0.3032374359194824;
Dectin-1 mediated noncanonical NF-kB signaling,0.48313498722766435,0.4081569957992947,1.585507937318083,0.3163292158034775,0.6278261191361808,0.7659191921406994,0.44047396306035724,0.3251934547032587,0.9874978175548073,0.3806709461682284,0.3058816822504121;
Signaling by NTRKs,0.6959881424282498,0.39853428626325116,0.6547727419832847,0.9950322238627654,0.35573771241937,0.4541009858801141,0.44030848238246667,0.32753430183444365,0.3170116103066843,0.3133010171588978,0.3058816822504121;
Transport of connexins along the secretory pathway,0.5292106765047301,0.5550410065029113,0.5494530568571484,0.30583657714524676,0.32162569628297455,0.6091496236054034,0.4402190764915039,0.3909454933235953,0.6606921149715522,0.697425008539117,0.3058816822504121;
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),4.169914729869479,0.34355423434661836,0.3186523149786101,0.38741141821149655,0.8663173673384363,0.31776991236841967,0.4401300773330518,0.46237839526257996,0.4881499224650157,2.3654295100220923,0.3058816822504121;
Glycosaminoglycan metabolism,1.0077100110463826,0.9469106376542266,0.30734867613921363,0.4296023820159213,0.3726312003584851,0.3620735944925361,0.43970589210464095,0.36593959197886095,0.3515439172895968,0.9570457154696246,0.3030467691849685;
Caspase activation via Death Receptors in the presence of ligand,2.114099835737413,0.36231980452174045,1.405432806416354,0.4609306983002966,0.7825047167930168,0.35384340849436446,0.4394060684670128,0.36593959197886095,0.37714526130064224,1.9855723150810611,0.3058816822504121;
Unblocking of NMDA receptors, glutamate binding and activation,0.8072884376667768,0.5324309296314834,0.9420434623734547,0.5950246338700154,0.38397908613243154,0.5175419987834062,0.4388902044247127,0.5519274911949776,1.548245642681925,0.5194472297578587,0.3058816822504121;
Activation, myristolyation of BID and translocation to mitochondria,0.3208413612620982,0.4081569957992947,0.30134832367833375,0.4008054562646203,0.41200215293113845,0.3111782497541377,0.4386318112674665,0.3693631048944899,1.1033715792095793,0.6967946078261547,0.3058816822504121;
Synthesis of wybutosine at G37 of tRNA(Phe),0.31443702792310463,0.46476382621388357,0.9063871686154971,0.3503872330012344,0.3073643548426107,0.35620887378061067,0.43858787989208126,0.6121973354446032,0.3414062616665845,1.0847504988898473,0.3058816822504121;
Pyrophosphate hydrolysis,0.3390466778271897,0.3351332739777284,0.3180102748962083,0.55939732041043,0.3590225224597753,0.38644297502167896,0.43814151138592483,0.30396128062304534,0.32819706770507,0.3302665829120577,0.3058816822504121;
Lipophagy,0.3165446042742289,1.1303015295445231,1.6421343307085574,0.3388488933313274,0.5358107092946165,0.6606059318480162,0.43808021422218313,0.4898399187883028,0.7378373462993497,0.32532264275231887,0.3058816822504121;
CS/DS degradation,1.1259571148530627,0.33958084202876593,0.3408790815282517,1.3253923471714513,0.43870502637389713,0.3804564941715372,0.4360829938806437,0.30222076309715623,0.32325228003675216,0.4170778848741611,0.3058816822504121;
Apoptotic execution phase,0.48703880564889745,0.3041785410778355,1.2898911462912885,0.4823062979997039,0.6707343576859068,1.7413511542440867,0.4360829938806437,0.7178761696994983,0.38395097131164374,0.3527755914843758,0.3058816822504121;
Transport of organic anions,0.3914332839728542,0.4582438890954255,0.5899768161580835,0.3237979394113036,0.6818387521124429,0.38644297502167896,0.4360829938806437,0.32753430183444365,0.3293878277257215,0.697425008539117,0.3030467691849685;
RNA Polymerase III Transcription Termination,1.7976209056623353,1.9293920978411963,0.9432926487377382,2.352614944859006,0.6947469905067896,4.324517915897413,0.4360829938806437,0.37770911594983014,0.3051798143030743,0.3117369630687721,0.3058816822504121;
Regulation of TNFR1 signaling,0.3165446042742289,0.39701699993581774,0.5206607413766151,1.0001697724579797,0.40431063241202125,0.6614424948240106,0.4352918851581655,0.5795150420091576,0.3733674433073597,0.4232200116160087,0.3058816822504121;
EGFR interacts with phospholipase C-gamma,0.32724507574765255,0.5910796270007741,0.800104277397364,2.080044894889779,1.4356539991419839,2.859461390118346,0.4352918851581655,0.5065936427260506,0.6459758662785066,1.5147422072234873,0.3058816822504121;
Transfer of LPS from LBP carrier to CD14,0.3833773909436085,0.3351332739777284,0.4686749892684955,0.3419116764261123,0.9240064663944481,0.41241588958501557,0.43520150936986685,0.7086724457561365,1.846515403629212,3.4449015650011026,0.3058816822504121;
IKK complex recruitment mediated by RIP1,0.382661322523146,0.4358630027633813,0.3682266871350676,0.39144877960498997,0.7433781605289134,0.3549954513766429,0.4350446548396555,0.352267490683119,0.39328194195957444,0.30738279210111424,0.3058816822504121;
Regulation of TP53 Activity through Association with Co-factors,0.3672789551152327,0.3667015217797265,1.7846550304747826,0.4296023820159213,0.330372459861341,2.7527510053106834,0.4350347062352968,0.4018751439850773,0.441266538994127,0.3062654297221931,0.3058816822504121;
Caspase activation via extrinsic apoptotic signalling pathway,1.1954583367573863,0.3393935927201346,0.9443850209880829,0.3503872330012344,1.1431615389490235,0.3145723753771386,0.4350347062352968,0.30705368811069295,0.3484005984762255,2.0822524348905262,0.3058816822504121;
RUNX1 regulates transcription of genes involved in interleukin signaling,0.7753440831935311,1.7818542576584766,0.4065906431250117,0.5934319195341671,0.40185636083147025,0.3400585084882708,0.4332896946094702,0.5921537599898707,0.3227320418931485,0.456986264226675,0.3058816822504121;
NFG and proNGF binds to p75NTR,1.5850012321335474,0.9900473145611959,0.4978925854600094,0.4924293701949291,0.3824048831138682,0.4306777496994055,0.4332896946094702,0.559800260443346,0.3729062334678565,0.7364624317206159,0.3058816822504121;
Peptide ligand-binding receptors,1.0837802485733614,0.6667335201465007,1.4425466931289612,0.3503872330012344,1.4353727597575503,0.8459312116920314,0.43321858800470137,0.3029001293088984,0.33154605935666304,2.051687776345235,0.3058816822504121;
VLDL assembly,0.44351687530887374,0.6735631991464341,0.32514167031236674,0.3861917421038416,0.4393593943366305,0.4273856742454938,0.433153250606878,0.35082679893314456,0.7209288851344792,0.41104584371777314,0.3058816822504121;
Regulation of TLR by endogenous ligand,0.33137564217830273,0.3667015217797265,1.0970230461575994,0.4627629005323368,0.9494636929508514,0.3620735944925361,0.430686226725833,0.524218023045207,2.812328088288455,2.839890518347915,0.3058816822504121;
RAS GTPase cycle mutants,0.661442418419975,0.3214902380011182,0.5017359945597698,0.33925035064181597,0.3076326161437668,0.3111782497541377,0.430686226725833,0.6000060832308047,0.33154605935666304,0.4540611718827999,0.3058816822504121;
Creatine metabolism,0.30814360877310026,0.4358630027633813,0.5336487132370172,1.1216479692948012,0.31157117856664596,0.46829287577570267,0.430686226725833,0.9521400088762076,1.231500012211471,0.3533672437172829,0.3058816822504121;
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation,0.329232717129869,0.42498593976503624,0.6278381825267022,0.964266055070458,0.3439134979171695,0.46329118624362164,0.4295335229336273,0.4478369225572017,0.3670929745469339,0.44297218450032194,0.3058816822504121;
The canonical retinoid cycle in rods (twilight vision),0.4552598452590548,0.5698796886264856,2.599818722505972,0.32978641818617105,0.34456538471876236,0.6261490231295497,0.42932491236279735,0.4488400297962748,0.7209288851344792,0.38630092353663426,0.3058816822504121;
Activation of BAD and translocation to mitochondria ,1.4362206053945392,0.46633846452847055,1.405432806416354,1.0821754554936984,0.3764809604369917,2.7496598154863165,0.4290069893376999,0.4628527562793292,1.231500012211471,0.403325320583016,0.3058816822504121;
Propionyl-CoA catabolism,0.35546007256282774,0.41868856838297025,0.7117191178668506,0.38725003842407885,0.3764809604369917,0.3976005671239824,0.4290069893376999,0.35971925328583354,0.33154605935666304,0.30738279210111424,0.3024439670208732;
NF-kB is activated and signals survival,0.31186750211813125,0.3278436372594612,2.87433481874463,0.3881184602725714,0.3791920767944086,0.5164552249632212,0.4272364657558661,0.32008659068880624,0.3156659602261388,0.3566887822435721,0.3058816822504121;
Purine salvage,0.681580828332252,1.0132413173834718,1.477502551184969,5.15441414207913,1.23169244745567,2.5586337141015805,0.42636560579312205,0.4310819043285157,1.833986469505093,0.9785696515847591,0.3030467691849685;
Diseases of Programmed Cell Death,0.670812212167234,0.576173559427021,0.8490978546174842,0.38459539265859194,0.3073643548426107,4.316479479523637,0.42636560579312205,0.7214872606359403,0.4502323698043533,0.728520522915135,0.3058816822504121;
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,0.670812212167234,0.576173559427021,0.8517982647455866,0.38227738456265975,0.3074022772531135,4.316479479523637,0.42524563501684454,0.7214872606359403,0.4505231252205524,0.728520522915135,0.3058816822504121;
SRP-dependent cotranslational protein targeting to membrane,0.5502992749902631,0.47300501140253504,1.2699638742658215,0.3241214549251675,0.43914698688161125,0.46032187987363854,0.42512194383918417,0.43082664047868263,0.35124371693489065,0.31100904921848943,0.3058816822504121;
RNF mutants show enhanced WNT signaling and proliferation,0.4146405080672999,0.8294461261044188,0.5255761054415311,0.38725003842407885,0.35830085846035925,0.47533127791853086,0.42512194383918417,0.6162943241566933,0.418328270869041,0.3413952918045016,0.3058816822504121;
The fatty acid cycling model,0.4300642653083229,0.3103336721805107,1.0394768555096892,0.39994270381988545,0.3381607900325233,0.3845667208434919,0.42512194383918417,0.5272611619074571,2.9263999307496014,0.35602166590463147,0.3058816822504121;
The proton buffering model,0.4310355014132514,0.30963854390385315,1.0394768555096892,0.39994270381988545,0.3381607900325233,0.38459112699667636,0.42512194383918417,0.524218023045207,2.9263999307496014,0.35602166590463147,0.3058816822504121;
Post NMDA receptor activation events,0.4654296955229644,0.6667335201465007,5.021904651581653,0.9508528739611771,1.4497014587581227,3.5196408893793687,0.42512194383918417,0.32253254794436587,2.456954019061541,1.0736363732000191,0.3058816822504121;
Regulation of PTEN mRNA translation,0.4093424622751112,1.7291076827125254,0.8999298063049906,1.5989244825746418,0.46163953884057446,0.8025627105905814,0.42436529760290215,0.44448953253707935,0.33154605935666304,0.5100898491572277,0.3058816822504121;
Mitochondrial Uncoupling Proteins,0.4312001447245551,0.30974721334600447,1.0394768555096892,0.4013497646513058,0.33664443463132226,0.3864143810579853,0.42436529760290215,0.5283469793061432,2.9263999307496014,0.3566887822435721,0.3058816822504121;
G-protein mediated events,0.36461945558480086,0.336539764993978,4.581743536736562,0.39485276920195894,1.4497014587581227,3.3546624646740075,0.4243425143732002,0.7214872606359403,0.7283839345834368,3.4449015650011026,0.3058816822504121;
Defective NEU1 causes sialidosis,0.3119979840557615,0.5631968708467756,0.3528845675322629,3.2147653118048156,1.4497014587581227,3.9580873428343493,0.4242980929743099,0.3582339302818586,0.35373719637803136,1.146885316920783,0.3058816822504121;
FRS-mediated FGFR1 signaling,0.47061787251554776,0.30955187441848364,0.47620779881555453,0.3063319847788688,0.48104758683230714,0.4300466631842503,0.42378387102422865,0.35231647076248385,0.35498837673230227,0.3206530510344374,0.3058816822504121;
Plasmalogen biosynthesis,1.306197047981217,0.32979575975804937,1.0148347784200469,0.3874935871335183,0.8931051707108614,0.3778854454032035,0.42300004616299147,0.31539388260432966,0.5843054969729731,0.7247574174502829,0.3058816822504121;
GABA receptor activation,0.5557714001529779,0.45199084089717,0.3638088415947402,0.34493403884766827,0.5342874618581906,0.5646191142917181,0.42300004616299147,0.35082679893314456,0.3729062334678565,0.5278203201689747,0.3035709016788323;
RNA Polymerase II Pre-transcription Events,0.610132107697063,0.3051715086707191,1.8718226839668777,1.1142675776635804,0.33664443463132226,0.3665758794553794,0.42300004616299147,0.3207891067373377,0.31966777048058687,0.32837788404645557,0.3058816822504121;
Transcriptional Regulation by MECP2,0.5654079179337074,0.3165159964142589,3.399186057494835,1.7672605162003094,1.2845433606727839,6.036710519580195,0.42294431837740387,0.7494624759764011,2.3977188328456367,1.2454217687120142,0.3058816822504121;
Gamma-carboxylation of protein precursors,6.781528579055216,1.2057201578783334,0.61998699678518,0.39485276920195894,0.8165609098751256,0.42264146081960646,0.42294431837740387,0.33044532547684075,0.3265506469380085,1.21219404816517,0.3058816822504121;
Activation of TRKA receptors,3.182776335996717,0.3041785410778355,2.0278949290607344,0.36360503738442823,0.33140832466933967,0.461038760471906,0.422873069799046,0.3061433701205603,0.7719128939237742,0.3160906252949544,0.3030467691849685;
Sodium/Proton exchangers,1.0721618127551689,0.36250846227187006,1.4355280646143322,0.34049658036688124,0.6154136651238976,0.36412558352903635,0.42265074046163714,0.6834181834101111,0.3265506469380085,0.572602207453692,0.3058816822504121;
Adrenaline,noradrenaline inhibits insulin secretion,0.4320545812171227,0.34832675318449347,0.35535755172665123,0.3503872330012344,0.46222000596710305,0.42581828392550103,0.42265074046163714,0.515231060699031,0.5782895603044629,0.4121812366547547,0.3058816822504121;
Glycogen storage disease type 0 (muscle GYS1),0.5557714001529779,0.37739375026177774,0.3081915935170801,0.38583914709932715,0.33602180273490345,0.32860130936304466,0.42265074046163714,0.37363972655453026,0.3170116103066843,0.8135490237192949,0.3058816822504121;
Glycogen storage disease type XV (GYG1),0.5557714001529779,0.3781199716262593,0.30706672728818135,0.38583914709932715,0.33406583255714095,0.32860130936304466,0.42265074046163714,0.37363972655453026,0.3170116103066843,0.8368997031223852,0.3058816822504121;
TWIK-releated acid-sensitive K+ channel (TASK),0.36765290593325656,0.3057534806262932,2.525055825356805,0.3163292158034775,0.43228930341186067,0.4130991002355062,0.42265074046163714,0.30299624920473567,0.31837078236812505,0.45956823263269403,0.3058816822504121;
SUMOylation of intracellular receptors,1.190418935806063,0.6937041650548988,0.43530188942325104,0.4863905316506313,0.3439134979171695,0.30930404734628464,0.42265074046163714,0.5226955554832011,0.4748157664261176,0.5973478083216586,0.3024439670208732;
Gap junction trafficking,0.9972316535966268,0.39346922355107966,0.8687944075705256,0.44798489210058173,0.7545067537691059,1.0602136380537837,0.42265074046163714,0.5238886509233606,0.5493482026354087,0.3240658633672765,0.3058816822504121;
PD-1 signaling,0.8419567459527204,0.3057534806262932,0.5257917995352324,0.3388488933313274,0.6630413295381337,0.3362870662398766,0.42265074046163714,0.5174152264767676,0.312143734575034,0.7798513078995691,0.3058816822504121;
Antimicrobial peptides,0.37849811784363335,0.3798876843365051,1.9640434283118346,0.4921828466849897,0.6776561166140836,1.2343613246711145,0.42265074046163714,0.6179106924101939,2.8785594584092022,2.839890518347915,0.3058816822504121;
Glucose metabolism,0.7987175084881835,0.4753617019431409,3.4713342929134536,0.9358640275879555,0.6718297994418723,3.730850061680873,0.42265074046163714,0.4969780311601389,0.9136804718962209,0.4782004276053091,0.3058816822504121;
G beta:gamma signalling through BTK,1.4005768883880516,0.7083061017751114,0.3534742947552572,1.6247993965704888,0.7248348886290465,0.31776991236841967,0.42265074046163714,0.46802009806455497,0.3293878277257215,0.3925202283025478,0.3058816822504121;
Recycling of bile acids and salts,0.7118548573524106,0.4081569957992947,1.0308229223355851,0.34114908780953945,0.32741484957780614,0.6606059318480162,0.42257839373920975,0.37363972655453026,0.3667930924250126,0.5278203201689747,0.3058816822504121;
Receptor-type tyrosine-protein phosphatases,0.727768550865018,0.6153450361207902,1.2296501162697646,0.9632133077991313,0.37572915566633974,0.4126833593188166,0.42257839373920975,0.6179106924101939,0.33154605935666304,0.5819951510366843,0.3058816822504121;
Death Receptor Signalling,0.3195134583854903,0.5294442260322686,1.4355280646143322,0.7624437679548713,0.3629943032542542,0.6348703355574064,0.42257839373920975,0.3452626441013441,0.3265506469380085,0.5637148753815774,0.3058816822504121;
Oncogenic MAPK signaling,0.335368352224608,0.35102878445295077,2.0514920935337404,0.3213115419718923,0.32297793958928395,0.6415844798433851,0.4221014857873192,0.32753430183444365,0.3828268894890131,0.4232200116160087,0.3058816822504121;
Synthesis of PC,0.3990299242859436,0.49023002456961257,0.3222246234534123,3.7661927098391508,1.5061060989817545,4.556615801058071,0.4215891407401166,0.3317123913477366,0.3388777404003391,1.0782287355523688,0.30540190655612415;
Interleukin-6 signaling,1.477583728533899,0.5294442260322686,0.30134832367833375,0.3265325825462171,0.39794629746034765,0.3976005671239824,0.42123827633979155,0.5753977044168755,0.3327832096024327,0.8084765055104299,0.3058816822504121;
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation,0.5578026495840487,0.3393935927201346,0.47470369218909914,0.4008054562646203,0.3791920767944086,0.43788656557444844,0.4203024819271315,0.44770267919471923,2.5686467092452725,0.4327164396326923,0.3058816822504121;
betaKlotho-mediated ligand binding,0.3378889184589506,0.4081569957992947,1.65786800916288,0.3537288855756918,0.3918027183993316,0.416812166468743,0.4203024819271315,0.8392145373470217,3.0610445666333583,0.4012251061157768,0.3058816822504121;
Truncations of AMER1 destabilize the destruction complex,1.0225898661417487,0.44979020246864093,3.0140680442804078,1.5852347381666423,0.3764809604369917,0.32860130936304466,0.4201702425266415,0.4488400297962748,0.8720429629292876,0.4451611421708856,0.3058816822504121;
IRS-related events triggered by IGF1R,1.4827047521793275,0.7989919069312121,0.6357182993488588,0.3271459557820616,0.3439134979171695,0.31790515390276775,0.4201702425266415,0.35971925328583354,1.0596668568280576,0.532096178369972,0.3058816822504121;
Cell surface interactions at the vascular wall,2.0568280750905874,0.6480302479451411,0.7337159148750858,0.31135497241990473,1.4497014587581227,0.5683890433722195,0.4201702425266415,0.5918767786718077,0.4881499224650157,2.5866465158846497,0.3058816822504121;
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways,0.3165446042742289,0.30397605771269914,1.8138294843570146,0.4651563886106466,0.9989839361691158,1.4432349637978412,0.41858104369150206,0.43791357279423887,0.3061329461218883,2.3096571630153337,0.3058816822504121;
AMER1 mutants destabilize the destruction complex,1.0354848986576854,0.45199084089717,3.0012774409827094,1.5852347381666423,0.377484511377512,0.3314791681136684,0.41845736969123165,0.44786177552608863,0.8833437902205385,0.45206131470617195,0.3058816822504121;
Recycling pathway of L1,0.3119979840557615,0.49023002456961257,1.9852276445527628,0.3654174844613779,0.9394389502032432,1.7186405204842001,0.41845736969123165,0.7214872606359403,0.32562191479076025,0.5026703144243176,0.3058816822504121;
Ubiquinol biosynthesis,0.6228686233239953,0.3187355966601872,5.021904651581653,1.5723526161464592,1.5061060989817545,4.324517915897413,0.418395952718247,0.4849021760868862,2.7323640632263615,0.30603264219956966,0.3058816822504121;
Fcgamma receptor (FCGR) dependent phagocytosis,0.9279970515211201,0.5836602111607674,1.279186926800737,0.5104277075533418,1.4527835083452083,0.5646191142917181,0.418395952718247,0.5006853473702976,0.6459758662785066,2.200514850158736,0.3058816822504121;
Influenza Life Cycle,0.34566408227514456,0.3010748960204856,0.8904715042964058,0.4246158572684502,0.3726312003584851,0.3131733022391502,0.418395952718247,0.3472764440688459,0.33154605935666304,0.30603264219956966,0.3058816822504121;
Interactions of Rev with host cellular proteins,2.2455083828528766,0.6937041650548988,1.405432806416354,1.3505359792683045,0.4620026084881862,3.7151181430122495,0.418395952718247,0.33696163270265517,0.31197598096833934,0.3012973917842152,0.3058816822504121;
FRS-mediated FGFR3 signaling,0.5087320036543982,0.30844391279468925,1.4686089025013336,0.897083762637248,0.5669614829417398,0.3111782497541377,0.418395952718247,0.33696163270265517,0.4170008088774537,0.31100904921848943,0.3030467691849685;
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,0.40416822402795777,0.4081569957992947,0.8578583194692329,0.3213115419718923,1.2151977948445911,0.3111782497541377,0.418372618861702,0.4849021760868862,0.3170116103066843,1.915343838461115,0.3030467691849685;
Lipid particle organization,0.3459397693982883,0.696503281480864,3.854298625518857,0.3628766921649118,0.375988320392497,0.3028133569923738,0.4175668755470559,0.44770267919471923,0.33154605935666304,0.4121812366547547,0.3058816822504121;
AXIN mutants destabilize the destruction complex, activating WNT signaling,1.0189178209461276,0.45420597324553597,2.9983005805788268,1.5852347381666423,0.3764809604369917,0.32860130936304466,0.4175668755470559,0.45371620148804614,0.8992965617758403,0.44811482431034744,0.3058816822504121;
Diseases of signal transduction,0.8546910920022099,0.4973390331284095,1.1869347139616222,0.6278959738920488,0.6194917578984216,0.6638984904578509,0.4175668755470559,0.33696163270265517,0.5509514948484421,0.7131212844176323,0.3058816822504121;
DAP12 interactions,1.2418015582911264,0.4081569957992947,0.3081915935170801,0.4713179984058352,1.4497014587581227,0.47055855225156185,0.4175668755470559,0.3582339302818586,0.5161023041844398,1.8146048902386758,0.3030467691849685;
Signaling by FGFR3 fusions in cancer,0.4025554105549951,0.5324309296314834,1.4078528827358816,0.4823062979997039,0.3879995418920927,0.8136558257463797,0.4173427538329647,0.34398443282195684,0.34010467491250734,0.7247574174502829,0.3058816822504121;
Constitutive Signaling by NOTCH1 PEST Domain Mutants,0.4489840067171152,0.8410357410402534,0.3067161466326659,0.3881184602725714,0.31100148614565254,0.35399026492638497,0.417154126523415,0.37731415007330193,0.4904318320906067,0.3337452048421423,0.3030467691849685;
AXIN missense mutants destabilize the destruction complex,1.015455955659931,0.44979020246864093,3.0350420353683805,1.5852347381666423,0.3764809604369917,0.3338497085090671,0.41696423030098434,0.4518495329376567,0.8720429629292876,0.4451611421708856,0.3058816822504121;
Interactions of Tat with host cellular proteins,0.3131846682126686,0.3351332739777284,0.5257917995352324,0.3881184602725714,0.45126331512769713,0.5163579268941797,0.41696423030098434,0.4849021760868862,0.46964083019396136,0.37557521691711987,0.3058816822504121;
Signaling by VEGF,1.3922770579862402,0.3029713996082115,1.6023323837370131,0.3163292158034775,0.6281740643568575,0.33395938652848917,0.41696423030098434,0.8821346624304645,0.33154605935666304,0.5209613107182163,0.3058816822504121;
Removal of aminoterminal propeptides from gamma-carboxylated proteins,6.183696341690816,1.0465409745822256,0.5488460572713554,0.44798489210058173,0.7723122647336258,0.5540811364413537,0.41696423030098434,0.32735598382599135,0.304022170806971,1.1857208932300791,0.3030467691849685;
Processing of Capped Intron-Containing Pre-mRNA,0.48313498722766435,0.3864631808225056,0.4334779777342954,0.4147520762862274,0.33627276072485157,0.3548365526403741,0.41696423030098434,0.5238886509233606,0.4881499224650157,0.4307830798707323,0.3058816822504121;
Diseases of metabolism,0.5119271970064379,0.30159417718501097,2.2483234071619544,0.3654174844613779,1.3472174980157166,1.474631408955118,0.41693947830443606,0.8392145373470217,0.4967986514981886,0.7257968543160326,0.3058816822504121;
Glycogen synthesis,0.3306202636585529,0.3579101535729101,0.36097747802281666,0.5879866812394244,0.330372459861341,0.32139120730383397,0.41693947830443606,0.3148620432933206,0.32855021388126704,0.661829187469421,0.3058816822504121;
Interferon Signaling,0.4373746700048119,0.34832675318449347,0.7366702160829421,0.39718831089691875,1.239479955932051,0.579728560293359,0.41634907812247524,0.7214872606359403,0.3389374015397122,0.8672178481874911,0.30276807564634967;
CHL1 interactions,0.5415759740759772,0.9002960207629139,0.39054000387706195,0.3208009770365678,0.3439134979171695,0.4902850695312733,0.41629904195170636,0.4849021760868862,0.34010467491250734,0.8495545835296169,0.3058816822504121;
Proton/oligopeptide cotransporters,0.5793064620356686,0.32979575975804937,0.3196134621449584,0.5016914801173993,1.1550172303045425,0.40055152632578883,0.41629904195170636,0.6776389315020124,1.231500012211471,2.4072876984101277,0.3058816822504121;
CREB3 factors activate genes,2.404755710013175,0.421441415526736,0.3222246234534123,0.6492541105721789,1.4497014587581227,0.9440366080745074,0.41581278578214026,0.7808545639669524,0.3973359698996325,2.5682270669616347,0.3058816822504121;
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,0.4524815885910299,0.9285413398621923,0.30726204755336484,0.3881184602725714,0.3082126526753394,0.3540970261426587,0.4155470811566938,0.37596884782192064,0.5140766613827893,0.33239293645350926,0.3030467691849685;
Global Genome Nucleotide Excision Repair (GG-NER),0.3081642843377598,0.3519808958748297,1.879272483096239,0.3881184602725714,0.3073643548426107,0.7305728899620716,0.41444036764609876,0.5238886509233606,0.3384177868520018,0.35882421529420916,0.3058816822504121;
Transcriptional regulation of pluripotent stem cells,0.63364182433652,0.3864631808225056,0.39161510178558023,0.34114908780953945,0.3764809604369917,0.31776991236841967,0.41435890897499983,0.32753430183444365,0.3266862348880042,0.5214944368814872,0.3030467691849685;
Platelet Adhesion to exposed collagen,0.767327773499264,0.3659796444425064,1.098555463664213,0.543500529637991,0.30985369422832876,0.3620735944925361,0.41435890897499983,0.3422609258794438,0.5527307274968848,0.3286979716130023,0.3058816822504121;
Pyrimidine biosynthesis,0.3967336297876465,0.33402483609309025,0.3772774396947736,0.4679155083230611,0.33627276072485157,0.4126833593188166,0.41435890897499983,0.42600919707224844,0.441266538994127,0.38933508734286015,0.3058816822504121;
Glutamate binding, activation of AMPA receptors and synaptic plasticity,0.3031856058603267,0.3368377974219193,1.4509741794713948,0.5016914801173993,0.3240515057123824,0.47055855225156185,0.41434481673454965,0.30676358637777745,0.33154605935666304,0.3878945009222701,0.3058816822504121;
Regulation of gene expression by Hypoxia-inducible Factor,0.32929730784058775,0.6899363569587909,0.9582644958721781,0.6432246813744723,0.3226140943665297,0.8294151074065859,0.41038774533971023,0.35971925328583354,1.2632929927009808,0.6343528131464561,0.3058816822504121;
APC truncation mutants have impaired AXIN binding,1.020723918435518,0.45199084089717,2.9983005805788268,1.5852347381666423,0.3764809604369917,0.32582525152199426,0.41038774533971023,0.45209511687783316,0.8919849530428398,0.44811482431034744,0.3058816822504121;
Phase II - Conjugation of compounds,0.3969035777499636,0.3667015217797265,2.124707996289505,0.5649603294597292,0.37205774949981,0.4467220717805114,0.41038774533971023,0.3317123913477366,0.33154605935666304,0.30603264219956966,0.3058816822504121;
FGFR1c and Klotho ligand binding and activation,0.378064225064369,0.4916469925647314,1.9324132947128798,0.39026723080694775,0.33910487705697223,0.3730690317561491,0.41038774533971023,0.3425206096678787,0.3326837406564544,0.47469881290334454,2.0172877050119666;
truncated APC mutants destabilize the destruction complex,1.0204424358115218,0.44979020246864093,2.9983005805788268,1.5852347381666423,0.377484511377512,0.3314791681136684,0.4097305382542743,0.4488400297962748,0.8617035124510027,0.45206131470617195,0.3058816822504121;
Diseases of Immune System,1.2972114744366496,0.6869372624427206,1.0155217108103751,0.3503872330012344,0.8200654672397518,0.3491683136349247,0.4097305382542743,0.3323267677217555,0.37714526130064224,2.4447012532792813,0.3058816822504121;
FGFR2b ligand binding and activation,0.41932664382931056,0.32191146796407205,0.6172708435869365,0.3428663705227962,0.3764809604369917,1.4988110992710673,0.40952018152079966,0.4589589677230645,0.3412694767583051,0.6062413694017484,0.3032374359194824;
Vpr-mediated nuclear import of PICs,3.0892516933485332,0.3090278240817252,1.7236398388371843,2.038326426717599,0.35830085846035925,4.460539542243616,0.40952018152079966,0.5594683711508179,0.33154605935666304,0.49771037728506584,0.3058816822504121;
Myoclonic epilepsy of Lafora,0.3052983521599139,0.3518599213100919,1.838491459878411,0.7336648671602999,0.34278026633975034,0.36504209043534924,0.40952018152079966,0.5686274956046705,0.3443921572946001,0.3184671951240273,0.3030467691849685;
p75NTR signals via NF-kB,0.3957341132721857,0.4583996963357266,0.35275308129702004,1.5014661879762816,0.7723122647336258,3.169203958458751,0.40952018152079966,0.5174152264767676,0.31702718034113764,0.7247574174502829,0.3032374359194824;
Choline catabolism,0.3390466778271897,0.5129008496943859,0.7765738182938368,1.33044283200921,0.8863326765335747,0.43542751860299406,0.40952018152079966,0.3030615030174226,3.061866866192844,0.8600824733085335,0.3058816822504121;
Sphingolipid metabolism,0.31696645752904035,0.9285413398621923,1.7509024316502704,2.082850605925484,1.6800929462945378,4.556615801058071,0.4094627965514733,0.6652097340320369,0.3078845408318954,2.3158211287109594,0.3058816822504121;
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,0.45373426076904677,0.8627901050786347,0.3222246234534123,0.3881184602725714,0.309110606499298,0.3542943274052089,0.4090185449616754,0.3763909172804356,0.5073365773596573,0.33210750061061056,0.3030467691849685;
Scavenging by Class A Receptors,0.40089828063803934,0.4589854816754815,0.4429063563060603,0.34523110574342525,0.311422158602307,0.3829935829538375,0.4090185449616754,0.9652238352966773,0.36401522101493045,0.37636770226551464,0.3058816822504121;
Trafficking of AMPA receptors,0.3030499823510086,0.3375899397983633,1.4509741794713948,0.5016914801173993,0.3240515057123824,0.47055855225156185,0.4089395601037436,0.30676358637777745,0.33154605935666304,0.3866317659379911,0.3058816822504121;
Gastrin-CREB signalling pathway via PKC and MAPK,0.6535388372924742,0.5970863486007664,3.4801072213110906,0.683554357476519,0.8890740651874032,2.2500643401401397,0.4089395601037436,0.3280402703349836,0.32562191479076025,1.0847504988898473,0.3058816822504121;
Regulated proteolysis of p75NTR,0.47774434942214644,0.3090278240817252,0.32614184856686745,0.44798489210058173,0.3119959467823231,0.621465359678387,0.4089395601037436,0.31539388260432966,0.5140766613827893,0.641699493430441,0.3058816822504121;
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.46066971883957947,0.9494276736079174,0.3186523149786101,0.3881184602725714,0.309110606499298,0.3540970261426587,0.4089395601037436,0.3763909172804356,0.4986012137585299,0.33345674932317276,0.3030467691849685;
Branched-chain amino acid catabolism,0.7848146562853118,0.6349514821997202,0.6496096761988198,1.1095407795139778,0.8460285966547827,0.6256906647540497,0.4089395601037436,0.6370660872345657,1.7356631751023508,0.5124302984800859,0.3058816822504121;
Interleukin-35 Signalling,0.4811023888441185,0.5160538865147885,0.3471380490000285,0.4921828466849897,1.1327880741953849,0.8813681710037167,0.4089395601037436,0.31900465938053235,0.31122200488443763,1.8022021049773458,0.3058816822504121;
Signaling by ROBO receptors,0.44376278251035534,0.5392059240522732,0.7594854514355904,0.3881184602725714,0.32162569628297455,0.3420003235500663,0.4089395601037436,0.4160132539854251,0.30150053284191936,0.4540611718827999,0.3032374359194824;
Netrin-1 signaling,0.9442235379130722,0.40402279833969024,2.124707996289505,1.685748483461129,1.4497014587581227,2.5339615944161737,0.4075780975696397,0.30481780719897456,0.6495813182532031,0.5550265173439319,0.3058816822504121;
MECP2 regulates neuronal receptors and channels,0.3485280504925926,0.6748639225787441,3.675974566700656,0.322985779213323,0.6231688405270283,3.191537085884803,0.4064170149975493,0.8253612893047934,2.1772254693235484,1.1740170408257433,0.3058816822504121;
Nuclear Events (kinase and transcription factor activation),0.618211570078509,0.3650614398467666,0.6422913254813731,0.4296023820159213,0.3540024647605433,0.435132948930374,0.40507127098894696,0.6552415765802345,0.3728343545959842,0.30776221481615806,0.3058816822504121;
WNT5A-dependent internalization of FZD4,0.4632713188448469,0.3351332739777284,0.554718044662669,0.8233348958167344,0.46163953884057446,0.3400585084882708,0.40507127098894696,0.35082886539396996,0.32397177416554596,0.3866317659379911,0.3024439670208732;
Platelet calcium homeostasis,0.359541013362919,0.36250846227187006,0.3648511899524546,0.7675225401008293,0.32162569628297455,0.8770335175879989,0.40507127098894696,0.5918767786718077,0.4066299711850315,1.6755272171103741,0.3058816822504121;
FGFR4 ligand binding and activation,0.6115784758183496,0.3351332739777284,0.3355219527266201,0.5556251626561034,0.35952474696705994,0.5266749632029869,0.4046516082689275,0.41811200490375733,0.3667930924250126,0.3286979716130023,0.3058816822504121;
Vitamin C (ascorbate) metabolism,0.49667803178059367,0.7759719336519098,1.3053634210561158,1.0907646901544714,1.4268786222886325,3.164306400741602,0.4039632912028973,0.48606186013240477,0.33154605935666304,2.6919240583465,0.3058816822504121;
eNOS activation,0.5063018660714965,0.3897456937069698,0.3408790815282517,0.3503872330012344,0.3560720414244286,0.474224940380697,0.4035676960049676,0.5918767786718077,0.3406966434873319,0.47728954306028143,0.3030467691849685;
Transport of bile salts and organic acids, metal ions and amine compounds,0.3775870832267736,0.3667015217797265,1.0458807195359592,3.5395915370066713,1.5260476677623513,5.0393301483409,0.4035676960049676,0.352267490683119,0.5843054969729731,1.9200207073036626,0.3030467691849685;
Selenocysteine synthesis,0.3775870832267736,0.47698398560067923,1.5708737986177486,0.32100808197395886,0.33664443463132226,0.5014736687538923,0.4035676960049676,0.352267490683119,0.3900183977157809,0.40209386013734333,0.3030467691849685;
Gene expression (Transcription),0.3942389363792282,0.7083061017751114,0.5899768161580835,0.7301616673985576,0.3629943032542542,0.45249705888843045,0.4035276618609153,0.3610879282924264,0.32855021388126704,0.41912518944327204,0.3058816822504121;
Interleukin-20 family signaling,0.4738283916537067,0.3225436828039846,0.6765362912914509,0.3399804683290169,1.283355176961649,0.48787895451176083,0.40345466304593597,0.3317123913477366,0.5843054969729731,1.8907399955166275,0.3030467691849685;
Regulation of insulin secretion,0.47476612700521587,0.7759719336519098,0.6891963100031729,0.3915426758022891,0.5669614829417398,0.5646191142917181,0.40245724247832565,0.35971925328583354,0.3061107917419532,0.7257968543160326,0.3024439670208732;
Interleukin-36 pathway,0.3165446042742289,0.3010748960204856,2.266960484024638,0.5259000391854405,0.3223947354494506,0.4300466631842503,0.40245724247832565,0.33696163270265517,0.4399657892714404,0.4540611718827999,0.3030467691849685;
Interleukin-38 signaling,0.5259896618479669,0.49882509403717307,0.7320923959849781,0.41480404459912024,0.35830085846035925,0.41731735971283784,0.40245724247832565,0.3348159503392942,0.44204832249518705,0.38255419212893865,0.3058816822504121;
Muscarinic acetylcholine receptors,0.4829104392658238,0.35463206527573876,1.9308829881164158,0.5425344887045433,0.5130460274919545,0.3709422723379626,0.40245724247832565,0.31950585589685954,0.3074634276468475,0.4625596178349653,0.3058816822504121;
Signaling by ERBB4,0.3119979840557615,0.4973390331284095,2.379833639181064,0.3657188180620897,1.4497014587581227,2.3629382126321685,0.40236468782434637,0.8217497190823737,0.9045344860174249,2.086220253896082,0.3058816822504121;
Constitutive Signaling by Overexpressed ERBB2,0.41368428722655964,0.3229474247766884,0.3081915935170801,0.5934319195341671,0.35573771241937,0.6452917380161541,0.40236468782434637,0.371248279207672,0.3384177868520018,0.38255419212893865,0.3030467691849685;
Anchoring of the basal body to the plasma membrane,2.683965885202445,0.3897456937069698,0.8824343576034807,3.114144262745647,0.3868892941028258,1.4311633120329155,0.40236468782434637,0.36371079402101386,1.5320357590303115,0.38255419212893865,0.3058816822504121;
Ion transport by P-type ATPases,0.7602651915053373,0.36250846227187006,3.0717146287933357,0.48394439185316723,0.9553950326482782,1.2507678054496671,0.40236468782434637,0.5795150420091576,0.5487340163011186,1.908981336294421,0.3058816822504121;
TP53 Regulates Transcription of Cell Death Genes,0.47785491858863993,1.1239221042573406,1.8124395980745798,0.35607005789003415,0.6223309115427085,0.6621129724397352,0.40236468782434637,0.5675417635545577,0.58712505728644,0.669644009748287,0.3058816822504121;
FRS-mediated FGFR4 signaling,0.3827545297476341,0.5160538865147885,1.0006984045453402,0.5187531396662611,0.30842274149796467,0.30146276932778043,0.40236468782434637,0.37363972655453026,0.5101334155056853,0.44227835908400215,0.3058816822504121;
Inhibition of TSC complex formation by PKB,0.6080489904843976,0.34355423434661836,2.275380170896083,1.101466934316679,0.37205774949981,0.6240899428585395,0.40236468782434637,0.34535509827064254,0.441266538994127,0.41376887048902816,0.3058816822504121;
Protein folding,0.41368428722655964,0.4753617019431409,1.8138294843570146,0.5043782219039552,0.45810052203947244,0.43075902825616436,0.40236468782434637,0.42864408325691356,0.5161023041844398,0.4121812366547547,0.3058816822504121;
RNA Polymerase I Transcription Termination,0.4451629103662902,0.5963107939690385,2.394934103324407,0.3881184602725714,0.35830085846035925,0.30262206950922643,0.40236468782434637,0.33696163270265517,0.36494779765230456,0.524324692113882,0.3058816822504121;
Hormone ligand-binding receptors,0.4416826026365212,0.642037538389264,1.982134437236759,0.36353754930227056,0.330372459861341,0.34084875043490775,0.40236468782434637,0.3445933650653508,0.37818098826263175,0.572602207453692,0.3058816822504121;
TICAM1-dependent activation of IRF3/IRF7,0.34931056341840394,0.4171450187833146,0.927211691757386,0.42329081273942404,0.32162569628297455,0.31776991236841967,0.40138103353362947,0.3117697514900949,0.3973359698996325,0.33443076555210144,0.3058816822504121;
Signaling by NOTCH1 in Cancer,0.44991269397751044,1.2704541370857034,0.3081915935170801,0.3881184602725714,0.3106817047442599,0.3542943274052089,0.40138103353362947,0.37731415007330193,0.4986012137585299,0.33210750061061056,0.3030467691849685;
Beta defensins,0.43458744757661255,0.421441415526736,0.5111303216523466,0.36903555914521596,0.5130460274919545,0.4325854200442574,0.40138103353362947,0.44770267919471923,0.3340537124683427,0.4209700519911368,0.3058816822504121;
Organic cation/anion/zwitterion transport,0.3775870832267736,0.4386912358120347,2.7451151970855983,0.34493403884766827,1.4497014587581227,2.522969572053542,0.40138103353362947,0.9897043482796474,1.186053264888989,0.9584898257112828,0.3030467691849685;
Interleukin-4 and Interleukin-13 signaling,1.5889784800454192,0.30397605771269914,0.36743428113510346,0.3881184602725714,1.4353727597575503,0.9021051111909641,0.40138103353362947,0.3404366042983231,0.3389374015397122,3.024230275716994,0.3058816822504121;
Glycine degradation,0.6620012902173371,0.33958084202876593,0.7613149469443117,0.8527374837073514,0.7113347026938827,0.41534326566252305,0.40024991358397244,0.3452626441013441,0.6916971426918018,0.4523752385250782,0.3058816822504121;
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,0.5804731401987626,0.49882509403717307,0.8438685221695885,0.6050561062011094,0.6330786994542528,0.3608333343196273,0.40024991358397244,0.5613944991412845,0.418328270869041,0.9007292583478218,0.3030467691849685;
Diseases associated with the TLR signaling cascade,1.2952552040968606,0.6753629744360657,1.004331914546519,0.3503872330012344,0.8200654672397518,0.34699522989044684,0.40024991358397244,0.33408284733090976,0.37714526130064224,2.4447012532792813,0.3058816822504121;
FGFR2 ligand binding and activation,0.4285257794946782,0.3299417989905663,1.5459410778839082,0.330334113068339,0.35573771241937,0.43075902825616436,0.40024991358397244,0.31539388260432966,0.34130316986521125,0.4540611718827999,0.3058816822504121;
phospho-PLA2 pathway,0.8419567459527204,0.4973390331284095,1.2332620270716799,0.39901054280466575,0.3119959467823231,0.3158212132785428,0.3981028402695712,0.6758900339821093,0.36272015169669014,0.6278686644799669,0.3058816822504121;
Signal regulatory protein family interactions,1.8571999224799782,0.5074171259088994,0.39270315707408476,0.3271459557820616,1.263262560339818,0.34699522989044684,0.39803744255473755,0.43900140608273536,0.48872304360099805,2.802341362090072,0.3058816822504121;
Butyrophilin (BTN) family interactions,0.8866343934354561,0.30402224815377643,0.3288722024330404,0.5095060637041408,0.3764809604369917,1.3637384618044843,0.39803744255473755,0.34311923132904953,0.8379360170858978,0.8067966244509088,0.3058816822504121;
PPARA activates gene expression,0.32800424160725483,0.6753629744360657,0.4882880149338799,0.6675991867173691,0.3916174297412545,0.4008567504272784,0.39608034907779344,0.3239555711055185,0.36912070063627533,0.5124302984800859,0.3058816822504121;
RHO GTPases Activate WASPs and WAVEs,0.4109520095001413,0.6684810088964953,2.40932766712558,0.5336981133324132,0.6740428384514924,0.7284869631520305,0.3937502644152025,0.30676358637777745,0.30150053284191936,0.51104279764138,0.3058816822504121;
Regulation of TP53 Expression and Degradation,0.37821001808340465,0.31070106152335225,0.5800952154469378,0.3115144235208682,0.4313244288305069,0.3575170010051916,0.392930285206226,0.5795150420091576,0.33154605935666304,0.4404591951700404,0.3058816822504121;
IGF1R signaling cascade,1.502358715204575,0.8154380545274866,0.5135324116895287,0.32562057663775773,0.3439134979171695,0.3230249013430313,0.39285660427780117,0.35971925328583354,1.0867742081767566,0.5529343956742313,0.3058816822504121;
RNA Polymerase III Chain Elongation,2.851250694860466,2.455965805727763,0.7615455863097667,2.25165528157364,0.3764809604369917,3.379280563329107,0.39285660427780117,0.3582339302818586,0.33154605935666304,0.45450619732509584,0.3058816822504121;
Sulfur amino acid metabolism,2.4817593609338924,1.9505556825001291,1.0801688475148632,4.496976097550863,0.30355398244324916,1.4331724897065152,0.3919314818523035,0.3101095001068416,1.7594470605705916,0.5101211329757073,0.3058816822504121;
Nef Mediated CD8 Down-regulation,0.3250327858327181,0.31407750847502913,0.9443850209880829,0.3503872330012344,0.3726312003584851,0.4141701923235453,0.39144079202839605,0.4815653043880472,0.34050073667628167,0.669644009748287,0.3058816822504121;
mRNA Splicing - Minor Pathway,2.547108532706971,0.9722026967614994,0.6227553073220706,2.893496962648954,0.6503559917182676,4.672309930071232,0.3911744647985603,0.3122174161886404,0.7283839345834368,0.30738279210111424,0.3058816822504121;
PI3K Cascade,0.36912065892920626,0.36734545489144443,0.4978925854600094,0.34114908780953945,0.6047084457534433,0.34084875043490775,0.39071442164564435,0.3367084026894726,3.818346982569422,0.4382668869405125,0.3058816822504121;
Metabolism of folate and pterines,1.886507423787165,1.6889005897880514,0.9458211769379873,4.273548385985072,1.0325030014591006,3.455836115267905,0.39071442164564435,0.3389422839235165,3.7332482366594273,0.3321330512604211,0.3058816822504121;
Influenza Viral RNA Transcription and Replication,0.38232763216433213,0.3090278240817252,0.9394644441024399,0.38977595796733894,0.3439134979171695,0.3247733431537802,0.39071442164564435,0.3094759427026921,0.33154605935666304,0.30738279210111424,0.3058816822504121;
Formation of Senescence-Associated Heterochromatin Foci (SAHF),0.33444767886969035,0.9874628953643209,0.5213485437023118,0.3388488933313274,0.5352610187418227,0.3952105828164689,0.39069522266123735,0.30705368811069295,0.5099042580864737,0.3286979716130023,0.3058816822504121;
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,0.3479743390395984,0.33875335399120593,0.3180102748962083,0.49467446897599027,0.41200215293113845,0.7377687966015078,0.38976769607250455,0.5856301026206966,0.31837078236812505,0.5280321394999583,0.3058816822504121;
Coenzyme A biosynthesis,0.5375980675526403,0.4973390331284095,0.43068441469191265,0.5837403236847422,0.3226140943665297,0.32139120730383397,0.38976769607250455,0.3999878562041873,0.6067524848790573,0.4502976898301002,0.3058816822504121;
Intracellular metabolism of fatty acids regulates insulin secretion,0.6098863292854918,0.33402483609309025,0.451301273526655,0.38459539265859194,0.3439134979171695,0.3762215469973146,0.3895129734079006,1.2050354574082274,0.8048458867956023,0.30377756914377746,0.3058816822504121;
IL-6-type cytokine receptor ligand interactions,0.44766682252123474,0.8410357410402534,0.3538601237188543,0.3156748741478961,0.39841886726404796,0.46207977992285076,0.3893402436236327,0.515231060699031,0.8059290852393105,0.3206530510344374,0.3058816822504121;
TNFs bind their physiological receptors,0.7320559335945117,0.6025095823481236,0.9127868378715198,0.8615225603717628,1.1777384810077287,0.5736247228917777,0.38927022904359543,0.45374902011684204,0.3061329461218883,2.7980008285229334,0.3058816822504121;
Inwardly rectifying K+ channels,0.3081642843377598,0.5698796886264856,0.912577053923126,0.34114908780953945,0.46163953884057446,0.3288789691424465,0.38882812943762113,0.4786707687617883,0.46812254491648775,0.32876304540081414,0.3058816822504121;
Regulation of thyroid hormone activity,0.43154423820229537,0.36305624463054287,0.7967758165849417,0.5213340061596343,0.3393300996545799,0.44569311077594786,0.3881061595405461,0.3356960773573929,0.3900183977157809,0.7302267570893407,0.3058816822504121;
Condensation of Prometaphase Chromosomes,0.6313559218678279,0.3667015217797265,0.4613423893603983,1.0026934778203878,0.3900512129307848,1.2353885175641102,0.3881061595405461,0.4595775962539899,0.3900183977157809,0.6789432446755621,0.3030467691849685;
C-type lectin receptors (CLRs),0.382661322523146,0.5698796886264856,0.734791934999741,0.3536741872163679,1.0163102633497894,1.039664540531312,0.3878502359912982,0.3931219998955243,0.5501674638729319,0.30585742098687774,0.3030467691849685;
RHO GTPases regulate CFTR trafficking,0.3392216909044848,0.3165159964142589,2.8158517732485686,0.33514450305737103,0.3535867649444133,0.3111782497541377,0.3878502359912982,0.37770911594983014,0.33154605935666304,0.6270595325672685,0.3058816822504121;
Leukotriene receptors,0.3407996132956933,0.4081569957992947,1.6476115585663034,0.3468013020091587,0.3439134979171695,0.5473531876464837,0.3878132155856324,0.5950682563053658,0.31197598096833934,0.30603264219956966,0.3058816822504121;
MECP2 regulates transcription of neuronal ligands,1.2568379862272068,0.301642737608084,1.7236398388371843,0.47044202413219355,0.35830085846035925,0.36317818600092355,0.3878132155856324,0.3713514704845122,0.3522221105554151,0.8681453836190971,0.3058816822504121;
Acyl chain remodelling of PC,0.5060144357640547,0.47551307151338007,3.4435609771743816,0.5576760922391598,1.1073522751388227,2.3492777554451685,0.3878132155856324,0.5019016194006931,0.3109538043884348,2.343504595172667,0.3058816822504121;
Prevention of phagosomal-lysosomal fusion,0.8100096260219354,0.3165159964142589,2.1338268224038983,0.48394439185316723,0.3764809604369917,0.30146276932778043,0.3878132155856324,0.6370660872345657,0.34010467491250734,0.3109481832046546,0.3058816822504121;
Transcription of the HIV genome,0.9613735400365993,0.41268909257052344,2.8424524108824842,1.4686888013281056,0.330372459861341,0.6434189199741671,0.3878132155856324,0.41481438088803907,0.34010467491250734,0.3458960799904469,0.3058816822504121;
SUMOylation of DNA methylation proteins,0.5897283133419277,0.4995829547349528,0.6680567965606966,0.4110205271218753,0.4054565637555915,0.4408110119089345,0.3876018339983382,0.3445913271108731,0.3329607429278685,0.3375933719277811,0.3058816822504121;
Chaperone Mediated Autophagy,0.5793064620356686,0.30844391279468925,0.626586313669297,0.39485276920195894,0.4651369059171854,0.35765380914162076,0.3872603314609396,0.3570304759287518,0.3728343545959842,0.7791804756619367,0.3058816822504121;
ROBO receptors bind AKAP5,2.990816677838629,1.1564022956796656,0.3289250898344628,0.460398612828236,0.5934207056339337,0.46598004575844243,0.387197954270815,0.4628527562793292,1.042470285322291,1.8839914734526437,0.3058816822504121;
Scavenging by Class B Receptors,1.2539408448910911,0.41068059354481484,0.4244230974768862,0.5140632896116977,0.3147704613843775,0.5587546077562368,0.3868942949860074,0.35971925328583354,0.3061329461218883,0.3548989056280423,0.3058816822504121;
Ca2+ pathway,0.7878708491951224,0.4867554201170968,2.1338268224038983,2.3559639263751104,0.3082126526753394,0.5261412771368904,0.3856957042472097,0.309018298085769,0.4399657892714404,0.33194577730543684,0.3058816822504121;
Signaling by FGFR1 in disease,0.30554816552217945,0.33281680434913724,0.47620779881555453,0.34114908780953945,0.3439134979171695,0.3619469067314098,0.38526617217035014,0.41975460648763435,0.31833320673388454,0.697425008539117,0.3058816822504121;
Role of ABL in ROBO-SLIT signaling,0.6959881424282498,0.3579101535729101,0.7338387423275315,0.3503872330012344,0.39794629746034765,0.37643217605883994,0.38526617217035014,0.4027649518660638,0.32819706770507,1.488628141354066,0.3058816822504121;
Na+/Cl- dependent neurotransmitter transporters,0.35867762533466935,0.421441415526736,0.5328735312756449,0.36590356653292744,0.3381607900325233,2.097361237964385,0.38526617217035014,0.48606186013240477,0.49675964274784545,0.32245690343173333,0.3058816822504121;
IRE1alpha activates chaperones,0.5259896618479669,0.3667015217797265,0.9788590761429402,0.3163170636750133,0.34278026633975034,0.3132801141574673,0.3844470891622668,0.3527982381055309,0.3217238872603119,0.3460910784833522,0.3058816822504121;
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,1.3922770579862402,1.0465409745822256,0.9079229255243332,2.390232580735559,0.4027637435721038,0.3665758794553794,0.3844470891622668,0.39361440195896213,0.33154605935666304,0.41104584371777314,0.3058816822504121;
Signaling by FGFR3,1.05959797977676,1.2032771054264193,2.733183778187461,0.7587344527398641,0.3824048831138682,0.50226676089624,0.3844470891622668,0.4815653043880472,0.6067524848790573,0.4130380185288276,0.3058816822504121;
Costimulation by the CD28 family,0.9972316535966268,0.31258968032485124,1.1975164472302646,0.3881184602725714,0.7825047167930168,0.47055855225156185,0.3844470891622668,0.31482486972733703,0.3265506469380085,1.0847504988898473,0.3058816822504121;
Defective CUBN causes hereditary megaloblastic anemia 1,1.1645252368847758,0.4697451878114334,2.3570706198998224,0.3861917421038416,0.3590225224597753,0.46829287577570267,0.3844470891622668,0.3112871161820099,0.36494779765230456,0.5985223052781407,0.3058816822504121;
TRAF6-mediated induction of TAK1 complex within TLR4 complex,1.9539621802767944,0.6748639225787441,0.7967758165849417,0.36926780817120297,0.977051416376294,0.33833577544409627,0.3844470891622668,0.48606186013240477,0.4644723627826459,2.0216331939235093,0.3058816822504121;
Regulation of signaling by CBL,1.3854551577291125,0.4052791032235589,0.7881088346638291,0.38459539265859194,1.3616013140800551,0.5245047266062759,0.3844470891622668,0.30308894197867353,0.3121738255632173,3.4449015650011026,0.3030467691849685;
Heme degradation,0.4416826026365212,0.3661244522353381,0.4755949692453443,0.3468013020091587,0.3532818365581648,0.3111782497541377,0.3844470891622668,0.6652097340320369,0.37714526130064224,0.39091888813155207,0.3058816822504121;
Negative regulation of TCF-dependent signaling by DVL-interacting proteins,0.4489840067171152,0.37650794154914907,0.902579832272734,0.3816686884212616,0.4146172972667351,0.4794000133923282,0.38319635177923206,0.6652097340320369,0.304022170806971,0.9125629518729945,0.3058816822504121;
Beta-oxidation of pristanoyl-CoA,0.5580015467292053,0.35463206527573876,0.9047166310520279,2.4802801431618846,1.0379883869928894,3.4797584798038175,0.38319635177923206,0.4160132539854251,0.3693665271664583,0.31100904921848943,0.3058816822504121;
Loss of function of MECP2 in Rett syndrome,0.5038902867280486,0.3294175279576714,1.5643463147942942,0.34710957224884215,0.35652570087271857,0.3695405452782485,0.38319635177923206,0.4628527562793292,2.3977188328456367,0.41912518944327204,0.3058816822504121;
ABO blood group biosynthesis,0.43154423820229537,0.5923514974245868,0.5257917995352324,0.3881184602725714,0.33140832466933967,0.5646191142917181,0.3825896189960456,0.7214872606359403,0.7441222546207356,0.46793777455222346,0.3032374359194824;
Amine ligand-binding receptors,0.38523662041238443,0.3231990336673937,2.9594726641660674,0.9177112728004277,0.3119959467823231,0.41817728800555737,0.3825896189960456,0.37363972655453026,0.3667930924250126,0.43049227661877426,0.3030467691849685;
Formation of annular gap junctions,0.3496032508674339,0.3210463195171016,1.9142549787365015,0.5312146974149726,0.5329320792508753,0.45440791578523587,0.3825896189960456,0.31539388260432966,0.31165489437756005,0.728520522915135,0.3058816822504121;
Synthesis of diphthamide-EEF2,0.5087320036543982,0.4379815512054201,0.4978925854600094,0.4497910348272781,0.4549475819776362,0.3548365526403741,0.3825514357548108,0.5795150420091576,0.33154605935666304,0.5278203201689747,0.3058816822504121;
ROS and RNS production in phagocytes,0.4441949457041505,0.7083061017751114,3.7915321306231187,0.842373315867933,0.3439134979171695,0.8807950592959372,0.3825514357548108,3.333731201280125,1.0867742081767566,0.9189824627807782,0.3058816822504121;
Chylomicron clearance,0.4632713188448469,0.576173559427021,0.3695648431874231,0.3163292158034775,0.3633380217657343,0.41548903650203944,0.3822345558457958,0.9408642598773541,0.3728343545959842,0.4238184686536508,0.3058816822504121;
Stimulation of the cell death response by PAK-2p34,0.4416826026365212,0.3170649431462248,0.8309627655875346,0.4697453280545078,0.35646676400014793,0.5599068983002935,0.3817837024771362,0.30396128062304534,0.9644846059805651,0.373504026161664,0.3058816822504121;
TRAF6 mediated IRF7 activation,0.7300732115368711,0.806942733657417,2.411391835264811,0.3628766921649118,0.3868892941028258,0.474224940380697,0.3796119923946582,0.36593959197886095,0.47514208089199056,0.47469881290334454,0.3058816822504121;
Defective LARGE causes MDDGA6 and MDDGB6,0.31473577248455875,0.3579101535729101,0.7635003516328472,0.4147520762862274,0.30846703927668234,0.39430841547958956,0.3795543049093919,0.6436789195508222,0.9045344860174249,0.4724375413774212,0.3058816822504121;
Alpha-oxidation of phytanate,0.36718360421201857,0.7841331427805789,0.3377952626136653,0.39485276920195894,0.45873877254042,0.43075902825616436,0.3788749646149368,0.6652097340320369,2.8924382379895186,0.9631457662941736,0.3058816822504121;
Pervasive developmental disorders,0.5060144357640547,0.3294175279576714,1.5673087390535125,0.34838389144222703,0.3560720414244286,0.3676748767985349,0.37763608863730913,0.4628527562793292,2.3977188328456367,0.41912518944327204,0.3058816822504121;
ATF6 (ATF6-alpha) activates chaperone genes,1.7874104207120947,0.3142762591661267,0.3222246234534123,0.6197330358455396,1.339724239377366,0.38104536656071447,0.37634310449402864,0.41975460648763435,0.7493321043329743,0.9842005411194646,0.3058816822504121;
PP2A-mediated dephosphorylation of key metabolic factors,0.3248950242998784,0.42498593976503624,0.36003177662526326,0.3503872330012344,0.3249489042896067,0.548310680618597,0.37634310449402864,0.4500870576843292,0.4398069151576111,0.49474662873127906,0.3030467691849685;
VEGFA-VEGFR2 Pathway,1.0987567001196927,0.46583473935581593,1.4745825779304063,0.48394439185316723,0.5905879164149995,0.34084875043490775,0.37634310449402864,0.3317123913477366,0.33154605935666304,0.38255419212893865,0.3022185153076614;
SMAD4 MH2 Domain Mutants in Cancer,0.3344139120290288,0.47698398560067923,0.4423519317641718,0.5375314615485541,0.35573771241937,0.3778854454032035,0.37634310449402864,0.39014468230695576,0.7283839345834368,0.5511134356695188,0.3024439670208732;
G alpha (s) signalling events,0.5045767511890444,0.9737758825165815,0.30823446357633005,0.3232519888569888,0.33627276072485157,0.46829287577570267,0.37634310449402864,0.6307067120683201,0.3061107917419532,0.5278203201689747,0.3032374359194824;
Intra-Golgi and retrograde Golgi-to-ER traffic,0.5449293344335326,0.8294461261044188,1.5918206722322519,1.6002895437380973,0.3590225224597753,0.3067879155501381,0.37625244107840755,0.6016263616729596,0.4188260016559483,0.7147958524686185,0.3058816822504121;
SHC-mediated cascade:FGFR1,0.4975336219701357,0.3650614398467666,0.4936950005019528,0.9968641398880723,0.39794629746034765,0.4902850695312733,0.376249194410195,0.4540751851007829,0.3944031754439474,0.3050628676150047,0.30516537453489034;
Gamma carboxylation, hypusine formation and arylsulfatase activation,0.8297301035060951,0.3202448349147819,1.180677839324132,0.3232519888569888,1.1160230815244887,0.3131733022391502,0.37610942860812696,0.3425206096678787,0.3470442987260421,0.8670481697574285,0.3058816822504121;
Asparagine N-linked glycosylation,0.6575892762752841,0.3342512441931818,0.44896251260719916,0.40304736475579483,0.6278261191361808,0.3293746091909782,0.3754707014420442,0.30676358637777745,0.31122200488443763,0.4540611718827999,0.3058816822504121;
SUMOylation of immune response proteins,0.31182352562261423,0.3363770646607851,1.3910627630217562,0.330334113068339,0.3535867649444133,0.42264146081960646,0.37546031910463185,0.5627095985093976,0.36494779765230456,0.4232200116160087,0.3024439670208732;
Synthesis of PS,0.3969035777499636,13.218565446537893,0.35583470878974294,3.934956808749101,0.6881908609437631,0.6614424948240106,0.3750857129744377,0.638700226611994,0.7106264920474042,0.6576413786888116,0.3030467691849685;
Plasma lipoprotein assembly, remodeling, and clearance,0.9442235379130722,0.42036494793775453,0.6371763478650965,0.3657188180620897,0.32162569628297455,0.5532264178274122,0.3750857129744377,0.4804005082663597,0.3388777404003391,0.37218965236252843,0.3058816822504121;
Interactions of Vpr with host cellular proteins,2.644215411394122,0.3289588011794796,1.8138294843570146,1.6928841781312194,0.31473900574551567,4.181834275178987,0.37507581162175624,0.7214872606359403,0.32085911455917404,0.6025484240342739,0.3058816822504121;
Nef and signal transduction,1.5803260038924056,0.5713455379432493,0.4760528568967101,0.32289368140643626,1.239479955932051,0.4253316158697854,0.37507581162175624,0.6799766290735694,0.3061107917419532,2.802341362090072,0.3058816822504121;
Regulation of TP53 Expression,0.3119979840557615,0.3650614398467666,0.9210789423815541,0.39485276920195894,0.38946451862069575,0.42768236538017645,0.3749062133939829,0.41975460648763435,0.3384177868520018,0.32837788404645557,0.3058816822504121;
Mitochondrial tRNA aminoacylation,0.5919316624496747,0.36250846227187006,1.8218732637195238,0.3271459557820616,0.3726312003584851,0.6339686800252128,0.3749062133939829,0.30318050255984674,0.3728343545959842,0.30738279210111424,0.3058816822504121;
Defective AMN causes hereditary megaloblastic anemia 1,1.1653793543517226,0.465436373448815,2.3570706198998224,0.3861917421038416,0.3655402882930478,0.46829287577570267,0.3749062133939829,0.3108923324961582,0.36494779765230456,0.5985223052781407,0.3058816822504121;
Chylomicron remodeling,3.5239547057790594,0.7816596912323202,0.4729950177607321,0.45814106070834476,0.3137861761703436,0.43075902825616436,0.3749062133939829,1.0469745782627364,0.3156659602261388,0.4121812366547547,0.3058816822504121;
TICAM1,TRAF6-dependent induction of TAK1 complex,0.3293713534384813,0.3051715086707191,1.8634477644547396,1.0032271343617318,0.3439134979171695,0.3028133569923738,0.3749062133939829,0.503648775901503,0.3340537124683427,0.30241267449194814,0.3058816822504121;
Presynaptic function of Kainate receptors,1.051208237648332,0.676678057295489,0.8657888542379367,1.8981215683289698,0.306397614617226,0.45182304898127246,0.37472889380691005,0.5675417635545577,0.33154605935666304,0.3972908458118306,0.3058816822504121;
Extrinsic Pathway of Fibrin Clot Formation,5.43040520996255,0.9874628953643209,0.509360240043381,0.30857160970704633,1.0867477696690342,0.33395231861614705,0.3746273471878832,0.4681429621674421,0.5140766613827893,1.474971793029636,0.3058816822504121;
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),0.3165446042742289,0.369781887516653,0.47470369218909914,0.3861917421038416,1.7213725713166497,0.31776991236841967,0.3739567433304407,0.43082664047868263,3.207767449927793,1.0835322007145531,0.3058816822504121;
Synthesis of PIPs at the plasma membrane,1.7712200780323972,0.44747775810796714,2.2504026887296833,0.6739977932252961,0.39794629746034765,0.4300466631842503,0.3736792569828743,0.31950585589685954,0.40728486195669966,2.7980008285229334,0.3058816822504121;
Tandem pore domain potassium channels,0.3413040478985904,0.39701699993581774,1.0394768555096892,0.3503872330012344,0.41200215293113845,0.31776991236841967,0.3736792569828743,0.30982906409707045,0.5527307274968848,0.34295065847682293,0.3058816822504121;
Toxicity of botulinum toxin type A (BoNT/A),1.218173616598005,0.46583473935581593,2.0519027066629905,0.543500529637991,0.7248348886290465,0.6056560839274541,0.3736792569828743,0.3725206349295344,0.304022170806971,0.38820904859778893,0.3058816822504121;
DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,0.3672789551152327,0.5698796886264856,0.3216124961513999,0.380333723709027,0.3764809604369917,0.4300466631842503,0.37353367787970637,0.5918767786718077,0.858026547560071,0.5124302984800859,0.3058816822504121;
Dopamine Neurotransmitter Release Cycle,0.5574066828561888,0.4081569957992947,0.7663667792126356,0.3156748741478961,0.35830085846035925,0.3028133569923738,0.37349608534279716,0.7013442998693656,0.3329607429278685,0.4724375413774212,0.3058816822504121;
Uptake and function of diphtheria toxin,0.4033398740708577,0.7834004270680736,0.3180102748962083,0.3265325825462171,0.3900512129307848,0.46101395366649894,0.37296165164417566,0.4160132539854251,0.31837078236812505,0.38534891690233036,0.3058816822504121;
Membrane Trafficking,0.4489840067171152,0.32979575975804937,0.7967758165849417,0.322985779213323,0.30246496029501807,0.5124763366932822,0.3727540812781761,0.32753430183444365,0.3728343545959842,0.8490622050611334,0.3024439670208732;
Phospholipid metabolism,1.05959797977676,0.3362344193434009,2.125111487806203,0.5852696699646033,1.120476767620852,2.575244576959524,0.3725306952207998,0.35971925328583354,0.3156659602261388,2.025736521273316,0.3058816822504121;
Signalling to ERKs,0.38523662041238443,0.7380453821386058,1.8437272037867236,0.4461636818038182,0.3274981301462102,0.3552318410118915,0.3722402750861015,0.3027579187486238,0.3863260201897388,0.5549688056015182,0.3058816822504121;
IRF3-mediated induction of type I IFN,0.39430453782135827,0.522282795009411,0.8047831011363191,0.35457616746105136,0.4054565637555915,0.4399866167593563,0.3722402750861015,0.3363632797967757,0.4026596990050985,0.31774785258472305,0.3058816822504121;
Wax biosynthesis,0.6188386975716889,0.46763856361506245,0.8881774991924806,0.7521841837642104,0.3791920767944086,0.5191204755954681,0.37212424156275375,0.6652097340320369,2.2276388926784056,0.9562192771334456,0.3058816822504121;
TRKA activation by NGF,0.3119979840557615,0.6255863960340599,1.3387838568320316,0.5874431926211804,0.3791920767944086,0.4900714565162325,0.37212424156275375,0.7214872606359403,0.3444643675395693,0.6278686644799669,0.3058816822504121;
Citric acid cycle (TCA cycle),1.05959797977676,0.32069448362191266,0.9783271346153586,0.3733837620133376,0.5170030772889699,0.39885350230807887,0.37212424156275375,0.6175042069029268,0.3293878277257215,0.3359029760347333,0.3058816822504121;
Regulation of pyruvate dehydrogenase (PDH) complex,0.31395498614929856,0.30188327596459563,0.8193549868659105,0.3232519888569888,0.3726312003584851,0.6261490231295497,0.37212424156275375,0.5174152264767676,0.3444643675395693,0.8384756124598138,0.3058816822504121;
Cytochrome c-mediated apoptotic response,0.4791592223021947,0.34355423434661836,0.3196134621449584,0.3662904234002687,0.35573771241937,0.32582525152199426,0.3716004414760695,0.7178761696994983,0.31837078236812505,0.43873817992078307,0.3058816822504121;
SMAD2/3 MH2 Domain Mutants in Cancer,0.33440806025273945,0.47698398560067923,0.4018400955900535,0.541039048298216,0.35573771241937,0.3778854454032035,0.3710251433676405,0.3908261042443016,0.729723837269398,0.5511134356695188,0.3024439670208732;
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,1.4691209524014543,0.7052414227406532,0.31188141411333176,0.3070450077802019,0.9205665655196127,0.42264146081960646,0.37095997068945535,0.515231060699031,0.37771151139769193,0.8067966244509088,0.3058816822504121;
Regulation of cortical dendrite branching,0.31186750211813125,0.4081569957992947,0.39270315707408476,0.39485276920195894,0.3764809604369917,0.6436104690705318,0.37095997068945535,0.3356960773573929,0.3179919430452987,0.33258796371861915,0.3058816822504121;
Activation of kainate receptors upon glutamate binding,0.35009297739730705,0.33148978438746796,0.3208535148713935,1.299827372328228,0.33140832466933967,0.42581828392550103,0.37095997068945535,0.37363972655453026,0.4748157664261176,0.5124302984800859,0.3058816822504121;
Diseases of Base Excision Repair,0.5557714001529779,0.5131391727266793,1.1950274300413128,0.7727786937880755,0.7681284723796576,0.5163579268941797,0.3702961064271438,0.30396128062304534,0.3293878277257215,0.32837788404645557,0.3058816822504121;
GPCR ligand binding,1.388253275386784,0.36231980452174045,1.2459312605891493,0.6337075582815598,1.3717591194169863,0.609620681310484,0.3702961064271438,0.34398443282195684,0.44204832249518705,2.2352529871625304,0.3058816822504121;
The IPAF inflammasome,0.9745947444501498,0.6617160530759545,0.8766094637153571,0.3881184602725714,0.33664443463132226,0.4306777496994055,0.36953504970640555,0.41975460648763435,0.3061107917419532,0.8653742857089531,0.3058816822504121;
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases,0.31395498614929856,0.7340550448862857,0.3112446042751675,0.3657188180620897,0.3439134979171695,0.3037454888756527,0.36953504970640555,0.36710932947589353,0.3404697512215013,0.3460910784833522,0.3024439670208732;
Josephin domain DUBs,0.6965200767654826,1.2567397901919064,0.3605928617833285,0.3881184602725714,0.4549475819776362,0.42581828392550103,0.36953504970640555,0.3101095001068416,0.3266862348880042,0.7072586773524772,0.3024439670208732;
Modulation by Mtb of host immune system,0.6667144050394884,0.4081569957992947,0.7655756230481994,0.37782083903056873,0.3363756870848458,0.31776991236841967,0.36953504970640555,0.3109857057051492,0.33154605935666304,0.4256081140909801,0.3058816822504121;
Response to elevated platelet cytosolic Ca2+,3.896167791690051,0.75022798269222,0.9754608804829907,0.32638786946977993,1.24961484388584,0.38644297502167896,0.36953504970640555,0.37363972655453026,0.3089310108463698,2.4072876984101277,0.3058816822504121;
Wax and plasmalogen biosynthesis,0.41368428722655964,0.3998527053714512,0.35261242756441274,0.3163292158034775,0.33313699616693,0.3620735944925361,0.36953504970640555,0.4628527562793292,0.33154605935666304,0.4523752385250782,0.3058816822504121;
RHO GTPases Activate NADPH Oxidases,0.9419200076086187,0.369781887516653,2.726760580678139,0.3541571802879987,1.283355176961649,0.9662702471036565,0.36953504970640555,0.45209511687783316,0.8059290852393105,2.997892669141395,0.3058816822504121;
tRNA modification in the mitochondrion,0.4892930819819199,0.6236604584259052,0.4708994487309099,0.39823957844843355,0.4478076746337553,0.416812166468743,0.36953504970640555,0.352267490683119,0.37721347556427365,0.7302267570893407,0.3058816822504121;
Sensing of DNA Double Strand Breaks,0.4817292801788386,0.8705631581546994,0.8171921409114342,0.3142325622507859,0.37908593583689865,0.4467220717805114,0.36953504970640555,0.3323267677217555,0.33154605935666304,0.4451611421708856,0.3058816822504121;
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,0.3217387546841015,0.3667015217797265,1.1879585187559678,0.33980610064939215,0.35830085846035925,0.5312410536886313,0.36953504970640555,0.45371620148804614,0.5213419672414269,0.9735912738582444,0.3030467691849685;
CLEC7A (Dectin-1) signaling,0.670812212167234,0.3166534718818594,0.651268592863442,0.33006496521827466,0.7448001569816128,0.9134979803271983,0.36953182480450225,0.7214872606359403,0.33154605935666304,0.41932959571843376,0.3058816822504121;
Biosynthesis of maresins,0.495644558835117,0.3667015217797265,1.6146972478235126,0.3693453361803258,0.4566501995022956,0.41162338965284934,0.36898426146076563,0.7214872606359403,0.5509514948484421,0.3084605076514881,0.3058816822504121;
Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD,0.5371694080478244,0.5063312115705851,1.5611113089133954,0.5158667963023624,0.48365622352261173,0.3976005671239824,0.36898426146076563,0.35200545937489847,0.33154605935666304,0.3322539577204294,0.3058816822504121;
Beta-oxidation of very long chain fatty acids,0.6873033978038362,0.43869536716528973,2.598409420625997,1.720791552618555,1.4497014587581227,2.904946665553424,0.36898426146076563,0.5389628321778192,0.3156659602261388,1.2561339572121097,0.3058816822504121;
Signaling by TGF-beta Receptor Complex,0.3617052308428381,0.413066088586355,1.6476115585663034,0.5259000391854405,0.3824048831138682,0.8470571551747722,0.36830426583688086,0.3094759427026921,0.5413514051593894,0.4209700519911368,0.3058816822504121;
Potassium transport channels,0.3501378526710248,0.4301018885789054,0.5201716289639017,0.4147520762862274,0.330372459861341,0.5266749632029869,0.36830426583688086,0.33990809468773525,0.3418975449068169,0.30585742098687774,0.3058816822504121;
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.40416822402795777,1.21945432362429,1.034735540642754,1.4471110075339846,0.3363756870848458,0.7809703216493559,0.36830426583688086,0.31482486972733703,0.3693665271664583,0.4232200116160087,0.3058816822504121;
RUNX3 regulates RUNX1-mediated transcription,0.48313498722766435,0.7127377023014966,0.3538601237188543,0.4318719248497713,0.6881908609437631,0.5192809610235131,0.3681928258021888,0.3301441399438418,0.36494779765230456,0.8600824733085335,0.3030467691849685;
Acrosome Reaction and Sperm:Oocyte Membrane Binding,0.36765290593325656,0.6066449927805835,1.5459410778839082,0.3739887061075729,0.4586136844958813,0.35399026492638497,0.3674843194624135,0.352267490683119,0.3498137063505275,0.33740247317007105,0.3058816822504121;
TBC/RABGAPs,0.3152956069819137,0.32162220022857385,2.3035001452578046,0.3527496754644661,0.5540428209571602,0.5892932499870671,0.3674843194624135,0.41975460648763435,0.6346345296616243,0.4517256911014107,0.3058816822504121;
Degradation of cysteine and homocysteine,1.542607112490525,0.7759719336519098,0.3557042064788556,1.468980363973735,0.330372459861341,0.5599581462367053,0.36665714167135427,0.3348159503392942,1.548245642681925,0.7746647484257355,0.3058816822504121;
MyD88 deficiency (TLR5),0.43617467770933954,0.5131391727266793,1.6460622164766627,0.4296023820159213,1.0702835859303041,0.4467220717805114,0.3663702481307469,0.8392145373470217,0.3406966434873319,0.4209700519911368,0.3058816822504121;
Activation of Matrix Metalloproteinases,0.4319217421672363,0.7142094393317582,0.3028277843853224,0.3271459557820616,0.397151474618249,0.3111782497541377,0.36554680558557456,0.4101348308681035,0.37771151139769193,0.47575535715786293,0.3058816822504121;
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,0.41368428722655964,0.5073445985405695,1.196277770842612,0.3503872330012344,0.33406583255714095,0.4925232526207759,0.36549351094675,0.32735598382599135,0.33154605935666304,0.3065044116856184,0.30540190655612415;
FOXO-mediated transcription of cell cycle genes,1.5117290814450903,0.7834067095934737,0.9314040112860305,0.33980610064939215,0.37908593583689865,0.3111782497541377,0.36532535855503473,0.4849021760868862,0.7162237456780991,0.35558280538559695,0.3058816822504121;
FCERI mediated Ca+2 mobilization,0.9739411088375305,0.31407750847502913,0.30734867613921363,0.34114908780953945,1.4497014587581227,0.41662170072861154,0.364395151862954,0.48606186013240477,0.41366042532312036,1.6021217513655717,0.3058816822504121;
Defective Mismatch Repair Associated With MSH3,0.6284918354782628,0.5698796886264856,0.41725135670861263,0.3816686884212616,0.3791920767944086,0.6983792545637864,0.364395151862954,0.4628527562793292,0.3693665271664583,0.3281579980837237,0.3058816822504121;
MAPK3 (ERK1) activation,0.3860301124096411,0.3199846646868602,1.1294572079446183,0.3617635162408894,0.5145051084896682,0.3111782497541377,0.3641885333610282,0.34396528640542523,0.3086647282719282,0.31895786627672174,0.3058816822504121;
mRNA Splicing - Major Pathway,0.5510883000732734,0.3846306930187274,0.37956752123552145,0.6865430266974362,0.3629943032542542,0.3158212132785428,0.3641465199107823,0.3867369015212186,0.37721347556427365,0.5404034066670892,0.3058816822504121;
CREB1 phosphorylation through the activation of Adenylate Cyclase,0.3957341132721857,0.311151884547695,0.6066943934222234,0.5860078639154138,0.3726312003584851,0.47111129867808327,0.3641465199107823,0.8392145373470217,0.4916245811979476,0.38820904859778893,0.3058816822504121;
Transport of small molecules,0.31186750211813125,0.3440697798842529,3.452337414547906,0.3527496754644661,1.1582851637021123,2.2486623509580124,0.3638446658484563,0.6849130563545062,0.31702718034113764,0.771084976623941,0.3058816822504121;
Loss of Function of SMAD4 in Cancer,0.33444767886969035,0.47713981016834073,0.4018400955900535,0.5425344887045433,0.35573771241937,0.37649015236135064,0.3638446658484563,0.3909454933235953,0.7308697433755641,0.5414036179247865,0.3020370130861136;
RAF/MAP kinase cascade,0.5340226374522729,0.31070106152335225,0.7223736399818569,0.3503872330012344,0.7398335368874693,0.5627584650399473,0.3638446658484563,0.5174152264767676,0.418328270869041,0.3533321295551025,0.3058816822504121;
Androgen biosynthesis,0.3672789551152327,0.47548325780365425,1.557330997271898,0.3503872330012344,0.3791920767944086,1.231516915340289,0.3638446658484563,0.44203855648039064,1.626325889348155,1.6091904161599597,0.3058816822504121;
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,0.5453650890659915,0.3051715086707191,3.675974566700656,0.3156748741478961,0.4549475819776362,0.4541009858801141,0.3629058503602362,0.4733768846338477,0.5527307274968848,0.372450817826102,0.3058816822504121;
Interleukin-1 signaling,1.056721271881593,0.30844391279468925,0.5303554176778794,0.4907418419064767,0.7925184275467501,1.1932180972393827,0.35987487710249,0.5036309725177871,0.3101164411511488,0.4779744186010394,0.3030467691849685;
Cam-PDE 1 activation,5.729335600523741,0.4973390331284095,0.6097275555725923,0.3208009770365678,0.32297793958928395,0.47533127791853086,0.35971104379517493,0.3663665799271314,0.40728486195669966,0.8670481697574285,0.3058816822504121;
Mitochondrial ABC transporters,0.4579156135741265,0.33128043805428026,0.8193549868659105,0.5043782219039552,0.4677023943293453,0.32040422109571975,0.35971104379517493,0.6834181834101111,0.3506743079000685,0.41656026628740567,0.3058816822504121;
Signaling by TGF-beta family members,1.0751753536267907,0.6032937423084861,1.4366923997510859,0.33564575743536246,0.3115859300677829,0.385859405075057,0.35887844443429434,0.4628527562793292,0.3575658238673175,0.33740247317007105,0.3058816822504121;
Activation of NMDA receptors and postsynaptic events,0.40511607004227757,0.3897456937069698,5.021904651581653,0.9307538981534129,1.4497014587581227,3.5894551210514725,0.35882552045599847,0.36710932947589353,2.57914587850426,0.9957966159779494,0.3058816822504121;
Transport of nucleotide sugars,0.715890744390093,0.3351332739777284,1.0394768555096892,0.40965022774647586,0.37205774949981,0.6421447264281962,0.35882552045599847,0.445309559217323,0.3300924222434923,1.0265290988563311,0.3058816822504121;
Intestinal saccharidase deficiencies,0.4325797764109255,0.9260469014459352,0.31213138471781515,0.3271459557820616,0.35830085846035925,0.3027894244324539,0.35882552045599847,0.5795150420091576,0.33154605935666304,0.7349362739842445,0.3058816822504121;
MAPK1/MAPK3 signaling,0.3672789551152327,0.36231980452174045,0.651814802653033,0.3739887061075729,0.697971698746192,0.5214535874144981,0.35882552045599847,0.638700226611994,0.5477038219353909,0.3013223548358037,0.3058816822504121;
TP53 Regulates Transcription of DNA Repair Genes,1.9470140752866025,0.8522925565223789,1.2689601743304062,2.7590056664965714,0.41200215293113845,1.5167052514088322,0.35882552045599847,0.34311923132904953,0.3234983503075021,0.30738279210111424,0.3058816822504121;
Terminal pathway of complement,2.9337535039581466,0.9398134822000689,2.3438149283962546,1.6396908958083662,0.33746473202377175,0.3829935829538375,0.35882552045599847,0.3677622666458591,0.43577411796286286,0.46991070134222973,0.3058816822504121;
NOTCH2 intracellular domain regulates transcription,0.5954492320468132,0.40577227024084006,0.3631909114164981,0.32978641818617105,0.7448001569816128,0.609620681310484,0.35882552045599847,0.35971925328583354,0.37714526130064224,1.5592364727125805,0.3058816822504121;
Clathrin-mediated endocytosis,0.3755897556963888,0.4736225824844101,0.5428814771604668,1.1521643255430283,0.32297793958928395,0.36949029037781234,0.35882552045599847,0.30676358637777745,0.7863744803902321,0.5209613107182163,0.3058816822504121;
Signaling by Non-Receptor Tyrosine Kinases,1.2972114744366496,0.5825284386456702,1.8776298415086516,0.3110195481167609,0.6818387521124429,0.6132682369934525,0.35882552045599847,0.5298509324100641,0.4834775083772459,0.8404697968174951,0.3058816822504121;
Transport of Mature Transcript to Cytoplasm,1.3179569748974824,0.3351332739777284,0.32477089426155636,0.3388488933313274,0.35577493496846524,0.4902850695312733,0.35798166029643,0.4849021760868862,0.3293878277257215,0.5103027601099676,0.3058816822504121;
Release of Hh-Np from the secreting cell,0.3914332839728542,0.6299182164641014,1.863192479141025,1.1268705255348308,0.4146172972667351,2.640018273127109,0.3567231251195197,0.3354845578006066,1.5033303966844398,0.46947200515560084,0.3058816822504121;
Effects of PIP2 hydrolysis,0.47061787251554776,0.7195811487203773,0.3021303718359221,0.45814106070834476,0.62889892014364,0.7301672142247028,0.35579412173589864,0.7316766047041314,0.30320189929542807,0.39091888813155207,0.3058816822504121;
PI-3K cascade:FGFR2,0.6188386975716889,0.311151884547695,0.6364659962092672,0.49786442742870163,0.6181909816472938,0.34931748325276374,0.355710096768767,0.5174152264767676,0.3294107031527259,0.41450631238909375,0.3058816822504121;
Synthesis of PIPs at the Golgi membrane,0.4300642653083229,0.6844171048356629,0.5001837274545424,0.33741769099486835,0.32789786054835535,0.30836634995479767,0.3555981136869151,0.5657544865458857,0.3693665271664583,0.3286979716130023,0.3058816822504121;
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),0.3845176721320277,0.3393935927201346,1.3839043179883173,0.8204438826608905,0.3722027189435112,0.3698556846412857,0.3555981136869151,0.4890921202267072,0.3522221105554151,0.36398845335653984,0.3058816822504121;
Signaling by NODAL,0.5494083030290889,0.7816704313010397,0.5839126285149882,0.3684705508289915,0.4617544101072961,0.332157455827418,0.3555981136869151,0.35971925328583354,0.3014096792738342,0.3333681131202209,0.3058816822504121;
N-glycan trimming and elongation in the cis-Golgi,0.4876897840147011,0.3351332739777284,1.032525609571466,0.35565566133138243,0.39841886726404796,0.3636895842323911,0.3555981136869151,0.30982906409707045,0.3293878277257215,0.30585742098687774,0.3058816822504121;
TFAP2 (AP-2) family regulates transcription of other transcription factors,0.6228686233239953,0.6255863960340599,0.7871802165794168,0.3503872330012344,0.3363756870848458,0.38134930669739914,0.3555981136869151,0.5753977044168755,0.3917839996697921,0.4121812366547547,0.3058816822504121;
Cargo concentration in the ER,0.5654079179337074,0.3010748960204856,0.7459007226163382,0.4693556350888502,0.30985369422832876,0.4496815285811097,0.3555981136869151,0.33696163270265517,0.31751321075844985,0.3779178337852975,0.3058816822504121;
Carnitine metabolism,0.6524190482509199,0.45420597324553597,1.3398696021617067,0.3468013020091587,0.304881911873929,1.861684214550161,0.3555981136869151,0.6807981296455126,0.36494779765230456,0.3126696769873146,0.30574005727865033;
Signaling by PTK6,1.3046211867829753,0.5825284386456702,1.8763118837089128,0.3106268127274079,0.6806700564364513,0.6132682369934525,0.3555981136869151,0.524218023045207,0.4834775083772459,0.8384756124598138,0.3058816822504121;
Glycoprotein hormones,0.3914332839728542,0.4582438890954255,0.5896694989391675,0.3163292158034775,0.39026309562416256,0.3111782497541377,0.3555981136869151,0.48606186013240477,0.31837078236812505,0.3113009883371781,0.3058816822504121;
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),0.39952318228467737,0.3667015217797265,1.4090442824121523,0.8387099204278657,0.3764809604369917,0.36661029332342004,0.3555981136869151,0.5111346635224848,0.3728343545959842,0.337617102183362,0.3058816822504121;
RUNX3 Regulates Immune Response and Cell Migration,0.9996697658828035,0.438351604480435,0.6482928743514884,0.3503872330012344,1.4497014587581227,0.6374443225425805,0.35453737235358596,0.35757863218968267,0.3693665271664583,2.650654247946607,0.3058816822504121;
NOTCH4 Intracellular Domain Regulates Transcription,1.4784262084293724,0.34832675318449347,1.4018896099198315,0.3070450077802019,0.3446597697341202,0.4095359585082957,0.35453737235358596,0.31539388260432966,0.41922428215661073,0.5968178087157961,0.3058816822504121;
Golgi Associated Vesicle Biogenesis,0.563031714284851,0.4358630027633813,0.7967758165849417,0.5875124415270933,0.3712409546165301,0.4008567504272784,0.35453737235358596,0.3862633797048435,0.3070173328785859,0.37636770226551464,0.3058816822504121;
Neurotransmitter release cycle,0.3851513712885939,0.3080444544591791,0.3222246234534123,0.4823062979997039,0.3285435148042968,0.4900916220639341,0.35453737235358596,0.30883045339476317,1.1102798778843102,0.4209700519911368,0.3058816822504121;
Nucleobase biosynthesis,3.3336284718584266,0.9394394484219818,2.143544166152827,2.0485501514521025,0.44083809749392705,4.453542839197305,0.35453737235358596,0.7214872606359403,0.3506743079000685,0.3890263489050837,0.3058816822504121;
PLC-gamma1 signalling,0.8095567597018617,0.40321170909752624,1.6476115585663034,0.32978641818617105,0.33140832466933967,0.30260243212920435,0.3536453516896549,0.6658934010577968,0.5380488165948838,0.3866317659379911,0.3030467691849685;
DAG and IP3 signaling,0.4133668113806695,0.35817300272844155,5.015737199730612,1.2577716347904175,1.4497014587581227,4.170257495204747,0.3536453516896549,0.6370660872345657,1.9947879666835042,2.089521959943691,0.3058816822504121;
Aquaporin-mediated transport,3.0534563828489176,1.0465409745822256,0.7085898925746626,0.6093374474314339,0.35573771241937,0.47055855225156185,0.3535747383775002,0.4836965380079519,0.32855021388126704,0.8961190619175127,0.3030467691849685;
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,0.49414180652094974,0.44475333864386085,1.5269775717194511,1.2153169436219713,1.1728272224370841,4.324517915897413,0.35275651302844235,0.7178761696994983,0.6674414987023212,2.1427736621192977,0.3030467691849685;
Tyrosine catabolism,0.6399199503876076,0.3667015217797265,1.1081772974668507,0.4543409796485814,0.37572915566633974,1.4806066665647906,0.35275651302844235,0.5918767786718077,0.33154605935666304,0.33239293645350926,0.3030467691849685;
Diseases of glycosylation,1.1546430605584026,0.7380453821386058,2.1478654153202856,0.7504145876370409,1.2687117260125473,1.1440271903015207,0.3526273764593656,0.3317123913477366,0.31952804471255203,1.963445422940632,0.3058816822504121;
Signalling to RAS,0.49291980934876795,0.3887280714075416,0.9180504274650662,0.7521841837642104,0.5277268907652843,0.4902850695312733,0.35125607875339077,0.6370660872345657,0.32397177416554596,0.4170778848741611,0.3058816822504121;
Alpha-protein kinase 1 signaling pathway,0.40092328276644357,0.5194893334998575,2.2805929725509984,0.34523110574342525,0.375988320392497,0.3027894244324539,0.35031095553688174,0.378954871891739,0.3187254357066004,0.3109481832046546,0.3058816822504121;
Transport of Mature mRNA Derived from an Intronless Transcript,2.892691015005507,0.5698796886264856,1.9444447660932058,2.0080005814819835,0.33664443463132226,4.460539542243616,0.34987066604975214,0.32587291250103156,0.441266538994127,0.6555964298037356,0.3058816822504121;
Urea cycle,2.9647803656121123,0.4631345202388002,2.726760580678139,0.4823062979997039,1.140011728673705,0.49516020035421604,0.34987066604975214,0.6370660872345657,0.4881499224650157,0.3302665829120577,0.3058816822504121;
Activation of RAC1,0.42627996245339855,0.4652165428488862,0.36876285793093794,0.3881184602725714,0.4929397770449673,1.3534178001491448,0.34987066604975214,0.9521400088762076,0.3156659602261388,0.5573257200598157,0.3058816822504121;
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,0.5654079179337074,0.301642737608084,1.6023323837370131,0.5069225882849688,0.36233576861030226,0.30146276932778043,0.34967255563532906,0.5389628321778192,0.3266862348880042,0.47469881290334454,0.3058816822504121;
Lewis blood group biosynthesis,0.6378824777339068,0.4631345202388002,1.9572998302173978,0.3070450077802019,0.35653904115763807,0.35399026492638497,0.34967255563532906,0.34469535582247823,0.46309482125230866,0.6749467764774163,0.3058816822504121;
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,0.6039790571344548,0.39450107866299366,0.3067161466326659,1.5323584022827281,0.6621291103011091,4.119452070482705,0.34913913454840045,0.6552415765802345,0.42382662266091486,0.36883842348143964,0.3058816822504121;
ChREBP activates metabolic gene expression,0.8546910920022099,0.3667015217797265,0.6214317248794013,1.1229056895464988,0.4146172972667351,0.3620735944925361,0.3478693232657636,0.33030236244002353,0.32397177416554596,0.9300772322158529,0.3058816822504121;
Pre-NOTCH Processing in the Endoplasmic Reticulum,1.3709725129855697,0.4081569957992947,1.393834649636601,0.3304831969753468,0.3396325673262649,0.5214535874144981,0.3476102449566626,0.337586279261894,0.3506743079000685,0.6740409396839165,0.3058816822504121;
ALKBH3 mediated reversal of alkylation damage,0.41368428722655964,0.32979575975804937,0.31065539004617965,0.3503872330012344,0.33910487705697223,0.48028547546007494,0.3476102449566626,0.9408642598773541,0.7782429355668223,0.4560939350823617,0.3058816822504121;
Thromboxane signalling through TP receptor,0.8854073286359903,0.5969687130222714,0.3044513732107998,1.4839082806637571,0.3874726764872815,0.4820137717943989,0.3476102449566626,0.352267490683119,0.3693665271664583,0.6899463049956933,0.3058816822504121;
Synthesis, secretion, and deacylation of Ghrelin,0.5495925396965357,0.30402224815377643,0.3773714963616337,0.4147520762862274,0.44260359177306835,0.3377290519605549,0.3476102449566626,0.31950585589685954,0.32819706770507,0.5201607101204013,0.3058816822504121;
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),0.382661322523146,0.4677308630861021,1.4710460677294306,0.3232519888569888,0.3446537762589258,0.47725795891754763,0.3476102449566626,0.3251934547032587,0.37714526130064224,0.4171509897051396,0.3024439670208732;
Cytochrome P450 - arranged by substrate type,0.6132772056690494,0.5134678000949939,0.5991827326592926,1.567906924623237,1.4497014587581227,1.5204481459170645,0.3476102449566626,0.6016263616729596,0.4491556453856495,1.3726163068894155,0.3058816822504121;
Chaperonin-mediated protein folding,0.8097927424557442,0.3105836898586958,0.47531146190153706,0.574529737874995,0.33627276072485157,0.35039829473538353,0.3476102449566626,0.3251934547032587,0.36419136224313775,0.8737848682167983,0.3058816822504121;
Signaling by MST1,1.4651975760211442,0.37261707238678665,0.7391101653549697,0.35099476720795914,0.7014212751515098,0.45670913707475397,0.3476102449566626,0.7214872606359403,0.3170116103066843,1.073154050051265,0.3058816822504121;
Constitutive Signaling by EGFRvIII,0.4416826026365212,0.36439859724819,0.3611076532427492,0.5345271340634699,0.397151474618249,0.7000382265221317,0.34730995609733323,0.352267490683119,0.8450953611952733,0.6518466751524737,0.3058816822504121;
p75NTR negatively regulates cell cycle via SC1,0.45668967406434435,1.1599948410697627,0.3186523149786101,0.6135521188653468,0.3363756870848458,0.5312000037032328,0.34654138263960454,0.3174126423874192,0.7682035069384494,0.30112320951753413,0.3058816822504121;
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,0.6036351212336205,0.39701699993581774,0.3070150931297956,1.5323584022827281,0.6625353621448575,4.119452070482705,0.346104741274391,0.6652097340320369,0.42382662266091486,0.36956882019668214,0.3058816822504121;
The role of Nef in HIV-1 replication and disease pathogenesis,1.825210279034467,0.41581422321241424,0.31326408886125773,0.3503872330012344,1.3778827873106971,0.3061210216620263,0.346104741274391,0.7214872606359403,0.5477038219353909,2.147656821886492,0.3058816822504121;
Eukaryotic Translation Elongation,0.3845176721320277,0.30402224815377643,1.5049532779644161,0.3105093363278997,0.330372459861341,0.46829287577570267,0.34541076234742724,0.35440324608796253,0.3728343545959842,0.4121812366547547,0.3032374359194824;
PTK6 promotes HIF1A stabilization,1.4931247926899316,0.5324309296314834,1.982134437236759,0.36497223208081386,0.8890740651874032,0.6565974083083047,0.34426148326157874,0.638700226611994,0.4211719884904539,1.5124537767487216,0.3024439670208732;
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),2.648795704955263,0.696503281480864,1.830851637594295,1.6332026463389901,0.37855439714361505,4.316479479523637,0.34426148326157874,0.35082679893314456,0.33154605935666304,0.40866758225795996,0.3058816822504121;
GABA synthesis,0.382661322523146,0.7847099280101452,0.7317982382126464,0.48726154948720196,0.37205774949981,0.3028133569923738,0.3437685361462886,0.3425206096678787,0.37721347556427365,0.44297218450032194,0.3058816822504121;
RNA Polymerase II Transcription Initiation And Promoter Clearance,0.3219535167637239,0.576173559427021,1.7392747843810215,0.5649603294597292,0.6260612349337609,0.3111782497541377,0.3437685361462886,0.7796931658740366,0.31837078236812505,0.4404591951700404,0.3058816822504121;
Signaling by Activin,0.6744349113521177,1.0346589951790564,0.4144710716473203,0.41179614815947363,0.41628652504749997,0.32009076565221883,0.3437685361462886,0.4849021760868862,0.31165489437756005,0.46947200515560084,0.3058816822504121;
Interleukin-12 signaling,0.532889148813832,0.3351332739777284,0.9816071760060163,0.3156748741478961,1.4614805506128528,1.7481318626952564,0.3437685361462886,0.3582339302818586,0.36494779765230456,1.2617125157892775,0.3058816822504121;
Budding and maturation of HIV virion,0.48339082434978015,0.3757662919161499,1.8718226839668777,0.529994372254881,0.3119959467823231,0.7284869631520305,0.3437685361462886,0.46950761507088173,0.3443921572946001,0.47469881290334454,0.3058816822504121;
Regulation of TP53 Degradation,0.378064225064369,0.30844391279468925,0.7613149469443117,0.3156748741478961,0.4146172972667351,0.3762215469973146,0.34360904716590324,0.5972444500514024,0.33154605935666304,0.462385235379379,0.3058816822504121;
Macroautophagy,0.4221864504607768,0.3202448349147819,0.3557042064788556,0.380333723709027,0.3363756870848458,0.359645047493023,0.34360904716590324,0.3620414290459302,0.34050073667628167,0.31100904921848943,0.3058816822504121;
Cytosolic iron-sulfur cluster assembly,2.112510394327114,0.3029713996082115,6.141570040292085,0.3503872330012344,1.4457081609297031,0.36661029332342004,0.34354178330022034,0.309018298085769,0.36494779765230456,0.5395292439805308,0.3058816822504121;
RNA polymerase II transcribes snRNA genes,0.3413040478985904,0.30188327596459563,1.092627766233976,0.3503872330012344,0.37205774949981,0.3111782497541377,0.34354178330022034,0.9674975239409703,0.6052596979838009,0.32845218465601295,0.3058816822504121;
Free fatty acid receptors,0.8072884376667768,0.3393935927201346,1.6908226443240146,0.3283439964211864,0.32162569628297455,0.5775505263212286,0.3434500546555622,0.6658934010577968,0.32562191479076025,0.35947978844318385,0.3030467691849685;
rRNA modification in the mitochondrion,1.1098280637652032,0.8627901050786347,1.037247511104453,0.33946015577309996,0.32812683021449074,0.3247733431537802,0.34285601282251044,0.6834181834101111,0.3828268894890131,0.3374205762234462,0.3030467691849685;
EPH-Ephrin signaling,0.7848146562853118,0.34088690059804977,0.35275308129702004,0.5934319195341671,0.5470726880024228,0.3665758794553794,0.34285601282251044,0.4313030976096779,0.327558860071622,0.30603264219956966,0.3058816822504121;
Defective GALNT12 causes colorectal cancer 1 (CRCS1),0.5029556465563574,0.32979575975804937,1.130794311151319,0.5093368965319863,0.44260359177306835,0.43795195395984354,0.34285601282251044,0.5795150420091576,0.4563643246022066,0.33443076555210144,0.3058816822504121;
Other semaphorin interactions,0.6575741754085398,0.7816596912323202,0.3081915935170801,0.39485276920195894,0.8200654672397518,0.5333671736672642,0.34285601282251044,0.39688813005863777,0.3667930924250126,1.598107084200298,0.3058816822504121;
Signaling by EGFRvIII in Cancer,0.4413392197585203,0.36305624463054287,0.36180188645199246,0.5353199316947554,0.397151474618249,0.6992148731079443,0.34285601282251044,0.352267490683119,0.8450953611952733,0.6525880495329303,0.3058816822504121;
Thyroxine biosynthesis,0.7973182508545181,1.1054457399439357,0.6975061126349537,0.669674837158151,0.4478085833375179,0.3976005671239824,0.34285601282251044,0.4671836385857672,0.8450953611952733,0.35882421529420916,0.3058816822504121;
STAT6-mediated induction of chemokines,0.6635617905334938,0.3214902380011182,1.0458807195359592,0.32289368140643626,0.44260359177306835,0.30849637038472894,0.34285601282251044,0.6121973354446032,0.3728343545959842,0.37636770226551464,0.3058816822504121;
Vitamin D (calciferol) metabolism,0.4603703614873541,0.4386912358120347,0.6760373314996082,0.30570651231582135,0.7649116976674908,0.5646191142917181,0.34285601282251044,0.682677286879512,0.30320189929542807,0.41376887048902816,0.3020370130861136;
Diseases associated with surfactant metabolism,0.34171450624887706,0.5194893334998575,1.35429807903111,0.9307538981534129,1.0379883869928894,0.47055855225156185,0.34259565949468435,0.42864408325691356,0.46398019506563953,2.147656821886492,0.3058816822504121;
Synthesis of IP2, IP, and Ins in the cytosol,0.5877105209035316,0.36231980452174045,0.6214317248794013,1.2623502550644612,0.6690453106869725,2.150693194430908,0.34259565949468435,0.6652097340320369,0.33154605935666304,0.37636770226551464,0.3058816822504121;
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,0.3224299584049261,0.5871328549623743,1.7392747843810215,0.5677066730846652,0.6121291063627028,0.3111782497541377,0.34259565949468435,0.7214872606359403,0.31837078236812505,0.4404591951700404,0.3058816822504121;
Regulation of Glucokinase by Glucokinase Regulatory Protein,2.648795704955263,0.6937041650548988,1.8296153084234053,1.6332026463389901,0.37648139823210575,4.316479479523637,0.34259565949468435,0.35082679893314456,0.33154605935666304,0.40866758225795996,0.3058816822504121;
Signaling by Hedgehog,0.9267563030733139,0.41933177387997705,1.7086072558279122,0.3590832973007553,1.1401422317835672,1.620924065450603,0.34259565949468435,0.3582339302818586,0.38714051412996464,0.3109481832046546,0.3058816822504121;
Apoptosis,0.40416822402795777,0.47548325780365425,1.5977118412502447,0.8227161874101095,0.8567437118151385,1.437240749725188,0.34259565949468435,0.3323267677217555,0.418328270869041,0.4678954462589095,0.3058816822504121;
CD28 co-stimulation,1.3743354640963164,1.2586274193626181,1.8138294843570146,0.7504145876370409,1.1431615389490235,0.6339686800252128,0.34259565949468435,0.5238886509233606,0.3170116103066843,2.0013458358771636,0.3058816822504121;
Ras activation upon Ca2+ influx through NMDA receptor,0.8667064535396588,0.3185764431331317,1.1645996582777804,0.4122898044496199,0.35830085846035925,0.4092044205303616,0.34259565949468435,0.3617517012302228,0.3331357954895238,0.30241267449194814,0.3058816822504121;
Phospholipase C-mediated cascade: FGFR1,0.5029556465563574,0.7690386449904469,0.3408790815282517,0.30359198798226317,0.4307330205893743,0.3338497085090671,0.34259565949468435,0.8811614588125113,0.3692084556559849,0.3811579239158923,0.3058816822504121;
G2 Phase,3.0537237371317154,0.5825284386456702,1.0955036913034901,4.085644736690576,0.4929397770449673,4.8446180123130445,0.34259565949468435,0.5972444500514024,0.45644750223509717,0.3429419463599997,0.3058816822504121;
IRAK4 deficiency (TLR2/4),1.4327786111183702,0.5357174180674569,0.6231240255902294,0.5016914801173993,0.8640785894418963,0.3128051476035714,0.3422341079843291,0.46950761507088173,0.418328270869041,2.039659599838557,0.3030467691849685;
Endosomal/Vacuolar pathway,0.4965796555872036,0.5160538865147885,0.8207710293913177,0.40965022774647586,1.283355176961649,0.7155883661323684,0.3422204473097813,0.3365679382419524,0.33154605935666304,0.923825570314111,0.3058816822504121;
The activation of arylsulfatases,0.44766682252123474,0.36231980452174045,1.6541049894515727,0.5099505515132051,1.4497014587581227,1.933698477684048,0.3422204473097813,0.5389628321778192,0.7740546118678892,0.9286390457962913,0.3058816822504121;
SLC transporter disorders,0.6959881424282498,0.4358630027633813,3.3125499363512008,1.7490889513800238,0.813000243923089,4.672309930071232,0.3422204473097813,0.7808545639669524,0.3327832096024327,0.5280321394999583,0.3032374359194824;
Interleukin-37 signaling,0.5564095875223556,0.3057534806262932,2.7906464934763218,0.3503872330012344,1.239479955932051,2.7553086261051587,0.3422204473097813,0.6799766290735694,0.5509514948484421,1.534402703378459,0.3058816822504121;
Nucleotide salvage,1.0520513798599003,1.2704541370857034,1.800774298705817,5.615690242831487,0.8612867915146504,3.37487704095253,0.3422204473097813,0.6652097340320369,2.3977188328456367,0.4540611718827999,0.3058816822504121;
HIV Transcription Initiation,0.3219535167637239,0.5878606479246475,1.7392747843810215,0.5687550309102548,0.48876405411175267,0.3111782497541377,0.3422204473097813,0.7214872606359403,0.31837078236812505,0.4404591951700404,0.3058816822504121;
Orexin and neuropeptides FF and QRFP bind to their respective receptors,0.7194352767078829,0.4301895395995331,2.0643625106227965,0.688837557276013,0.32162569628297455,0.339594936349701,0.3422204473097813,0.4198789594014035,0.36494779765230456,0.7131212844176323,0.3058816822504121;
Activation of the phototransduction cascade,0.644220260832819,0.571348221474136,0.37875043074378,0.6575968147138724,0.6340233186015363,0.30146276932778043,0.3422204473097813,0.6436789195508222,0.441266538994127,0.7364624317206159,0.3058816822504121;
Downstream signaling of activated FGFR3,0.583134493938734,0.32069448362191266,1.5335065153263014,0.7364570387607363,0.3791920767944086,0.31776991236841967,0.341301998152505,0.3317123913477366,0.5925824442312864,0.3109481832046546,0.3058816822504121;
Ion influx/efflux at host-pathogen interface,0.3697786288314644,0.32069448362191266,0.3126356010021651,0.5934319195341671,0.33140832466933967,0.8243783587208424,0.3409988406063306,0.32735598382599135,0.769406256133835,0.30245448354214916,0.3024439670208732;
Sperm Motility And Taxes,0.4975336219701357,0.32069448362191266,0.6572321378897701,0.33980610064939215,0.6340855228863872,0.6479996614849947,0.3408607551011007,0.35971925328583354,11.342112646606926,0.6749467764774163,0.3058816822504121;
Processing of Capped Intronless Pre-mRNA,0.41333274690186717,0.4697962182768528,0.3384666561332321,0.32305188352025016,0.3401010458333853,0.3632803726492419,0.34076819212750514,0.3356960773573929,0.3340537124683427,0.31100904921848943,0.3058816822504121;
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,1.1210736904742147,0.34355423434661836,0.3554138575034153,0.3213115419718923,0.5358107092946165,0.3620735944925361,0.34076819212750514,0.35971925328583354,0.30380343648068064,1.4609709916302518,0.3058816822504121;
Acyl chain remodelling of PS,0.382661322523146,0.3667015217797265,3.4288675997688203,0.380333723709027,0.8200654672397518,2.35088216331479,0.34076819212750514,0.3582339302818586,0.41515660090136897,1.7387034335731002,0.3058816822504121;
TGF-beta receptor signaling activates SMADs,0.4481980516666729,0.3918158246299093,0.7967758165849417,0.3816686884212616,0.3448121823661246,0.5138249529961795,0.34076819212750514,0.35082679893314456,0.3156659602261388,0.4523752385250782,0.3058816822504121;
TNF signaling,0.34465032118805244,0.9846254897589394,0.6664540834227072,0.5993005284414504,0.4620026084881862,0.6625151035877471,0.34076819212750514,0.36682087221042325,0.3693665271664583,0.4232200116160087,0.3058816822504121;
Signal Transduction,0.3295920706872582,0.4973390331284095,2.3392743670789615,0.38157528490434667,1.1381354044741434,1.0389610916940497,0.34032291999923175,0.3069745766481689,0.6052596979838009,0.9603438998378393,0.3058816822504121;
Downregulation of ERBB4 signaling,0.5347301483421762,0.3691439136623758,1.9114156473217863,0.40508555541811875,0.3439544493814969,0.32505069181290563,0.3396202652078413,0.5606601988216386,0.39496087833893867,0.30979469541785326,0.3058816822504121;
RNA Polymerase II Transcription Initiation,0.32466910742018407,0.5892408336468945,1.7392747843810215,0.5770272568140488,0.48243530040083926,0.3111782497541377,0.33927295942656893,0.7447812509860711,0.31837078236812505,0.4404591951700404,0.3058816822504121;
Translocation of ZAP-70 to Immunological synapse,0.8599107665737104,0.3090278240817252,0.5892396893085472,0.3271459557820616,0.6707343576859068,0.3298643498072546,0.33927295942656893,0.5627095985093976,0.3115924460534767,0.800110475091163,0.3058816822504121;
Beta-catenin phosphorylation cascade,0.3479743390395984,0.47698398560067923,1.8296153084234053,0.9885240910673796,0.32162569628297455,0.41758755108040946,0.33927295942656893,0.3251934547032587,0.6984965161303884,0.3337585302705513,0.3058816822504121;
Apoptotic cleavage of cellular proteins,0.47785491858863993,0.4081569957992947,0.996131501942276,0.45025906807447985,0.6503559917182676,1.8583810958050109,0.33927295942656893,0.3404366042983231,0.3331357954895238,0.30738279210111424,0.3058816822504121;
NOD1/2 Signaling Pathway,0.5494083030290889,0.8522925565223789,1.6410071299996396,0.380333723709027,1.007071052446887,2.0626384317360538,0.33905483284591975,0.34600861213325285,0.33154605935666304,1.223295380718546,0.3058816822504121;
Host Interactions of HIV factors,0.3854940984155354,0.7340550448862857,0.8216637342111406,0.5770272568140488,0.9200438033952797,1.1981792125246076,0.33905483284591975,0.36046186142273234,0.3094133922120638,0.30245448354214916,0.3058816822504121;
Cytosolic sensors of pathogen-associated DNA ,0.38232763216433213,0.41868856838297025,0.6273178275096073,0.3503872330012344,0.3296341258681911,0.34603236249915686,0.3387682491239659,0.40342728894670354,0.3973359698996325,0.4121812366547547,0.3030467691849685;
Toxicity of botulinum toxin type F (BoNT/F),0.4416826026365212,0.33281680434913724,1.7832362398483868,0.3861917421038416,0.33627276072485157,0.47055855225156185,0.33812806935491363,0.378954871891739,1.6877488247108394,0.3566887822435721,0.3058816822504121;
Advanced glycosylation endproduct receptor signaling,0.5261040254127887,0.32069448362191266,2.0022405769161096,0.5770272568140488,0.38403520953254044,0.3552318410118915,0.3376254080836331,0.5226955554832011,0.3013333079553526,0.4640617091673951,0.3058816822504121;
ER Quality Control Compartment (ERQC),0.32087837131504404,0.7209330154892243,0.788218684023441,0.562526663336046,0.4861060492278075,0.42768236538017645,0.3367796869790427,0.3251934547032587,0.3293878277257215,0.47469881290334454,0.3058816822504121;
HIV elongation arrest and recovery,1.5060229219178953,1.707790182337754,2.0667520485475013,3.800914998706141,0.4054565637555915,0.7469171680434654,0.3367796869790427,0.5381813133806432,0.44517628657026326,0.3527755914843758,0.3058816822504121;
Glyoxylate metabolism and glycine degradation,0.3836859470806495,0.3864631808225056,1.1775535350178448,0.4296023820159213,0.3439134979171695,0.3539791473043848,0.3367796869790427,0.46387415068046234,0.3061329461218883,0.39863298409526765,0.3024439670208732;
ADP signalling through P2Y purinoceptor 1,1.05959797977676,0.5878606479246475,0.9302168452857753,1.491994463684977,0.4677023943293453,0.47055855225156185,0.3367796869790427,0.3425206096678787,0.3156659602261388,0.7257968543160326,0.3058816822504121;
Triglyceride metabolism,3.318770594097615,0.6161081789146999,0.392980112613742,1.1320327613955314,0.3082126526753394,0.41662170072861154,0.336615030533237,0.3094759427026921,0.37273903590634216,0.30241267449194814,0.3058816822504121;
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,0.3695431711661575,0.5160538865147885,0.6835398032753831,2.7590857997482385,1.1750367961275083,1.6485815449078078,0.33628073124139507,0.48606186013240477,2.191963999524005,0.429118783483402,0.3058816822504121;
Nuclear import of Rev protein,2.3467505391278847,0.576173559427021,1.3434191521830625,1.268655527101135,0.35830085846035925,3.5894551210514725,0.33628073124139507,0.37363972655453026,0.39838117936895323,0.3133010171588978,0.3058816822504121;
RNA Polymerase II Promoter Escape,0.3250327858327181,0.59842826146496,1.7392747843810215,0.5770272568140488,0.48046633727165955,0.3111782497541377,0.33628073124139507,0.7517032281410067,0.31837078236812505,0.44065582267788694,0.3058816822504121;
Resistance of ERBB2 KD mutants to afatinib,1.603124623320052,0.4155240941545764,1.085977849808509,0.48276586608354205,0.4118967113859953,0.465783480452257,0.33614206675053726,0.35971925328583354,0.3388777404003391,0.39863298409526765,0.3058816822504121;
Defective LFNG causes SCDO3,1.5345670566679266,0.5131391727266793,1.6513953139199133,0.3163292158034775,0.35573771241937,0.46522895429078015,0.3360649160973243,0.3317123913477366,0.605967398728144,0.7511665021590007,0.3058816822504121;
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,0.44193241261666083,0.7599173481334801,0.9166214728095865,0.3881184602725714,0.5177268834707259,0.46829287577570267,0.33497582713699525,0.7178761696994983,0.3900183977157809,1.6978019077937714,0.3058816822504121;
Fertilization,0.4770618959027905,0.6161081789146999,1.1088565736270573,0.35607005789003415,0.41200215293113845,0.3336247107846666,0.33403820558461994,0.30762701980706253,12.622973040283064,1.2561339572121097,0.3032374359194824;
RUNX2 regulates genes involved in differentiation of myeloid cells,0.5564095875223556,0.6277754778003083,0.4107303226404909,0.30567379630646874,0.4478085833375179,0.6673841875619194,0.3339205640860592,0.37731415007330193,0.33154605935666304,0.40866758225795996,0.3058816822504121;
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,0.5954492320468132,0.32191146796407205,1.0825344059063156,1.0757855889695138,0.9505253515861846,6.102263114023866,0.3338188247989159,0.41975460648763435,0.36494779765230456,0.4637408625584409,0.3058816822504121;
Toxicity of botulinum toxin type D (BoNT/D),0.4416826026365212,0.33402483609309025,1.5277568268259665,0.3861917421038416,0.33627276072485157,0.474224940380697,0.3338188247989159,0.3811801504530512,1.6877488247108394,0.3567078624810329,0.3058816822504121;
TGFBR1 LBD Mutants in Cancer,2.2740267119532396,0.7123613805345899,0.7635003516328472,0.3071145468164127,0.5724292987597449,0.41758755108040946,0.3338188247989159,0.5578106790042832,0.8180319778289137,0.35377668335663576,0.3058816822504121;
Multifunctional anion exchangers,0.5065318103776832,0.4081569957992947,0.4686749892684955,0.3163292158034775,0.3226140943665297,0.37001148941847484,0.3338188247989159,0.45374902011684204,0.4170008088774537,0.4637408625584409,0.3058816822504121;
RNA Polymerase II HIV Promoter Escape,0.3250327858327181,0.6002170399104575,1.7392747843810215,0.5770272568140488,0.47179838603106633,0.3111782497541377,0.3338188247989159,0.7335689821727228,0.31837078236812505,0.44065582267788694,0.3058816822504121;
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,0.601196565535924,0.3225308422051359,1.0825344059063156,1.0757855889695138,0.9505253515861846,6.102263114023866,0.3338188247989159,0.42426681188822685,0.36494779765230456,0.4640617091673951,0.3058816822504121;
GAB1 signalosome,0.3836859470806495,0.4647212692143908,0.8422924064450359,2.6577022405852375,1.6211298642155623,2.5982391614029416,0.3338188247989159,0.33696163270265517,0.9045344860174249,3.314105425567513,0.3058816822504121;
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,0.9366618589263352,0.5246038407872321,0.4950648360779262,0.3861917421038416,0.33664443463132226,1.7726101787659474,0.3338188247989159,0.4815653043880472,0.33154605935666304,0.35602166590463147,0.3058816822504121;
Transcriptional Regulation by E2F6,0.3697786288314644,0.46476382621388357,0.4686749892684955,0.4787629375979512,0.35830085846035925,0.3027894244324539,0.3338188247989159,0.7086724457561365,0.3418975449068169,0.33619831583867554,0.3030467691849685;
RAB geranylgeranylation,0.4134991322625479,0.46767375142192513,4.858868540733221,0.32289368140643626,1.1380648165882117,2.5060064381106555,0.3338188247989159,0.6016263616729596,0.3083030765023187,2.0635130261661336,0.3058816822504121;
Displacement of DNA glycosylase by APEX1,0.7239736512740405,0.3173693456155217,0.36743428113510346,0.3503872330012344,0.3076326161437668,0.3483859100720798,0.3338188247989159,0.4147150908432823,0.33154605935666304,0.37636770226551464,0.3058816822504121;
Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI),0.5587013765220952,0.754486168889022,0.47160753149999735,0.3881184602725714,0.330372459861341,0.48487375011027734,0.3338188247989159,0.33990809468773525,0.4326147371542654,0.406803115424453,0.3058816822504121;
Transport of inorganic cations/anions and amino acids/oligopeptides,0.4029927195800096,0.30402224815377643,3.3125499363512008,1.3700034034562487,1.4497014587581227,3.3490681519284426,0.3338188247989159,0.3480320923463457,0.7763401413039768,3.0611752441228717,0.30276807564634967;
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,0.6037489866374824,0.3246766638088438,1.085977849808509,1.0550935631414733,0.9505253515861846,6.102263114023866,0.3338188247989159,0.42426681188822685,0.36494779765230456,0.4640617091673951,0.3058816822504121;
NrCAM interactions,0.3496032508674339,0.49037620732391435,0.6760373314996082,0.4760070704633726,0.45873877254042,0.6051375835311831,0.3338188247989159,0.31539388260432966,1.4145342693767153,0.3333681131202209,0.3058816822504121;
Utilization of Ketone Bodies,0.40611068900593167,0.6161081789146999,0.3617239240045207,0.49786442742870163,0.4304099574224199,0.30836634995479767,0.3338188247989159,0.41975460648763435,0.3506743079000685,0.4395763307211742,0.3058816822504121;
Defective DHDDS causes retinitis pigmentosa 59,0.3119979840557615,0.44565128603387577,0.40487844146094454,0.6613489803709619,0.36922641966847447,0.47111129867808327,0.3338188247989159,0.3094759427026921,0.3692084556559849,0.5278203201689747,0.3058816822504121;
Pausing and recovery of HIV elongation,1.5060229219178953,1.707790182337754,2.066464377214288,3.800914998706141,0.4087838908102159,0.7469171680434654,0.3338188247989159,0.5388818365263349,0.4455527516053413,0.3533672437172829,0.3058816822504121;
Biosynthesis of protectins,0.5087320036543982,0.34355423434661836,0.30747772415026436,0.7314997931615257,0.3824048831138682,0.4443707607673481,0.3338188247989159,0.36710932947589353,0.37714526130064224,0.30621433275255217,0.3058816822504121;
Toxicity of botulinum toxin type B (BoNT/B),0.7194352767078829,0.3351332739777284,1.8437272037867236,0.34114908780953945,0.33564982044763786,0.30146276932778043,0.3338188247989159,0.5389628321778192,0.3728343545959842,0.3359625402487366,0.3058816822504121;
Metabolism of vitamins and cofactors,0.9895905770638133,0.3142762591661267,4.165829338515609,0.3304831969753468,1.5828289611196062,1.5050866311704414,0.3338188247989159,0.34396528640542523,1.426065400577132,2.9958487648663104,0.3058816822504121;
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2,2.821230162436816,1.539015664676146,0.3240344544485519,0.33741769099486835,0.3764809604369917,0.9945345766707561,0.3338188247989159,0.48606186013240477,0.3234983503075021,0.3533672437172829,0.3058816822504121;
Fructose catabolism,0.95720318150801,0.301642737608084,1.6871466656300826,0.3881184602725714,0.5342874618581906,0.35080794711616836,0.3338188247989159,0.8762097574693818,0.418328270869041,0.4167336646038495,0.3058816822504121;
Purine ribonucleoside monophosphate biosynthesis,3.043475857206379,0.8522925565223789,2.1162320898537943,1.66344024485213,0.3833312594850901,4.316479479523637,0.33332763525274656,0.35971925328583354,0.33154605935666304,0.5281095055314579,0.3058816822504121;
InlB-mediated entry of Listeria monocytogenes into host cell,0.5205111652447068,0.5160538865147885,2.4570670351367867,0.3417816275918543,0.3535867649444133,0.3542943274052089,0.33332763525274656,0.6652097340320369,0.6065838599288306,0.7325121903592762,0.3058816822504121;
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation,0.48410836571178467,0.5698796886264856,0.530089235023403,0.5370351875778894,0.4240050290751324,0.41662170072861154,0.33332763525274656,0.33797550533038695,0.3670929745469339,0.39091888813155207,0.3058816822504121;
PTEN Regulation,0.33991984304289263,0.6633398676947236,0.632881360818366,0.32638786946977993,0.30246496029501807,0.3420003235500663,0.33314510283092924,0.35331581607193274,0.3327832096024327,0.3117369630687721,0.3058816822504121;
Retrograde transport at the Trans-Golgi-Network,0.3479743390395984,0.576173559427021,1.2858180776004795,0.3881184602725714,0.43796111504663937,0.44569311077594786,0.33314510283092924,0.30705368811069295,0.3406966434873319,0.3177166276162009,0.3058816822504121;
Loss of MECP2 binding ability to the NCoR/SMRT complex,0.3117629957183809,0.36250846227187006,0.3557042064788556,0.3881184602725714,0.35573771241937,0.43795195395984354,0.3331166429976132,0.32008659068880624,1.8334762683355712,0.30795647085368,0.3058816822504121;
p75NTR regulates axonogenesis,0.3501378526710248,0.3846306930187274,0.40487844146094454,1.1778410748784354,0.4105840647966351,0.3111782497541377,0.3331166429976132,0.48606186013240477,0.4892836787727304,0.3275771061088942,0.3058816822504121;
Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),0.44193241261666083,0.4081569957992947,1.405432806416354,0.6332344681637802,0.33910487705697223,0.49198416466376327,0.3331166429976132,0.4478369225572017,0.3522221105554151,0.3451238691514368,0.3058816822504121;
Intrinsic Pathway for Apoptosis,0.35172494850614644,0.6899363569587909,3.090767619940255,0.6290221373827818,0.3680813616467841,2.9260800317358027,0.3331166429976132,0.4815653043880472,0.31197598096833934,0.30621433275255217,0.3058816822504121;
COPI-mediated anterograde transport,0.3117629957183809,0.3667015217797265,0.480879486544494,0.34301251104610964,0.30418705243734856,0.32139120730383397,0.33288208544311204,0.32753430183444365,0.3156659602261388,0.47812431533965105,0.3058816822504121;
Nuclear Receptor transcription pathway,0.3697786288314644,0.34355423434661836,4.187500116061682,0.34114908780953945,0.4146172972667351,0.41704702540150257,0.33280379604915844,0.46950761507088173,0.42563818276787846,0.48863788812715925,0.3058816822504121;
CD28 dependent Vav1 pathway,0.618211570078509,0.49882509403717307,0.32450035288234036,0.7979862355282332,0.8854669310157873,0.3809356452270987,0.33280379604915844,0.3143698538499399,0.3384177868520018,2.0635130261661336,0.3058816822504121;
O-linked glycosylation,1.7662085352089978,0.6937041650548988,1.8316177664618771,0.3657188180620897,1.0149124975263089,0.4902850695312733,0.33280379604915844,0.515231060699031,0.327558860071622,1.9951696985404739,0.3058816822504121;
P2Y receptors,3.480020895714513,0.9285413398621923,0.35275308129702004,0.34114908780953945,0.3439134979171695,0.46829287577570267,0.33280379604915844,0.35971925328583354,0.3506743079000685,0.9717408988765865,0.3058816822504121;
IRAK4 deficiency (TLR5),0.30296962315825304,0.6667335201465007,0.7635003516328472,0.5900152111207688,0.3439134979171695,0.36504209043534924,0.33280379604915844,0.35082679893314456,0.37714526130064224,1.8247595302681476,0.3030467691849685;
Nicotinate metabolism,1.2684669889732714,0.9002960207629139,1.0757449387842182,0.7228781401305834,0.7460829399514947,0.43542751860299406,0.33280379604915844,0.34398443282195684,0.4610497497080712,1.4609709916302518,0.3058816822504121;
Transport of glycerol from adipocytes to the liver by Aquaporins,0.48313498722766435,0.6572357678985995,0.4278795218205806,2.7590857997482385,0.33627276072485157,0.8300173452917683,0.33280379604915844,0.36073163167381794,0.8450953611952733,0.47781560131935036,0.3058816822504121;
PTK6 Regulates Cell Cycle,0.7971887752597633,0.421441415526736,1.0313275062642102,2.2108397880598227,0.5820488601346345,4.316479479523637,0.33280379604915844,0.5065936427260506,0.37009557325665043,0.4173660100591315,0.3058816822504121;
rRNA processing,0.4246650451014949,0.41517216998759954,0.6807551355108914,0.3881184602725714,0.39113834579371415,0.30961296818736866,0.33280379604915844,0.3243800713154584,0.3266862348880042,0.30738279210111424,0.3058816822504121;
Regulation of RUNX2 expression and activity,0.5435134029461398,0.36250846227187006,0.48980167113873535,0.5904771114370055,0.7668371077295931,1.102098315814885,0.33280379604915844,0.9594651340712236,0.3329607429278685,0.4601156100258348,0.3058816822504121;
Inhibition of Host mRNA Processing and RNA Silencing,0.40661853415369204,0.3921661809702318,0.3315394577628418,0.4296023820159213,0.5552889058056465,0.5646191142917181,0.33280379604915844,0.48606186013240477,0.5782895603044629,0.4540611718827999,0.3058816822504121;
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,0.4416826026365212,0.3667015217797265,1.898532883215347,0.3881184602725714,0.3042255279326703,0.3111782497541377,0.33280379604915844,0.4172926860385218,0.37721347556427365,0.33443076555210144,0.3030467691849685;
Loss of phosphorylation of MECP2 at T308,0.41505802385788937,0.3486664547515465,1.052594944937501,0.3156748741478961,0.3791920767944086,0.4046395430642309,0.33280379604915844,0.315823518935115,0.36419136224313775,0.31055339429561507,0.3058816822504121;
Calnexin/calreticulin cycle,0.3288559388871276,0.7099330515316424,0.7771148898531554,0.9181669844743803,0.3726312003584851,0.4719885775701651,0.33280379604915844,0.31950585589685954,0.32397177416554596,0.5026703144243176,0.3058816822504121;
The retinoid cycle in cones (daylight vision),0.41368428722655964,0.4245237537802895,2.054519876435922,0.5770272568140488,0.36972642643050374,0.49408554235057933,0.33280379604915844,0.7424163509140581,0.33154605935666304,0.3126363644087619,0.3058816822504121;
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,0.6065438077322955,0.3229474247766884,1.092627766233976,1.0419632650279154,0.9505253515861846,6.102263114023866,0.33280379604915844,0.42426681188822685,0.36494779765230456,0.4640617091673951,0.3058816822504121;
Resistance of ERBB2 KD mutants to neratinib,1.603124623320052,0.4155240941545764,1.118372851142116,0.48547093371219235,0.41200215293113845,0.46829287577570267,0.33280379604915844,0.35971925328583354,0.3388777404003391,0.40065294812408603,0.3058816822504121;
Resistance of ERBB2 KD mutants to osimertinib,1.603124623320052,0.42036494793775453,1.5335065153263014,0.48394439185316723,0.41200215293113845,0.45670913707475397,0.332586947601805,0.35971925328583354,0.3389374015397122,0.39863298409526765,0.3058816822504121;
Alpha-defensins,0.40492512827144206,0.36250846227187006,0.570996877482731,0.6028394895080141,0.3726312003584851,0.3539791473043848,0.332586947601805,0.45482312314956885,0.34010467491250734,0.6577463599492671,0.3058816822504121;
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,0.5106793381285393,0.6441853723194954,0.7833772737092355,0.47221756857423275,0.33261410504422656,0.3829935829538375,0.33237853900718256,0.30883045339476317,0.605967398728144,0.5395292439805308,0.3058816822504121;
Fatty acids,0.3755897556963888,0.438351604480435,0.7459007226163382,0.481054275110977,0.41200215293113845,0.3111782497541377,0.33099403856113474,0.39214610867837385,1.2303442264601607,0.39091888813155207,0.3058816822504121;
Acyl chain remodelling of PE,0.48313498722766435,0.7607408691198698,4.5788775452422295,0.41422443678415527,0.6776561166140836,3.4293581478348734,0.33099403856113474,0.682677286879512,0.3156659602261388,1.397736080653779,0.3030467691849685;
Glycerophospholipid catabolism,0.44193241261666083,0.46421164678731563,2.117444700008685,0.3232519888569888,0.3226140943665297,0.40857645150366523,0.33099403856113474,0.3713514704845122,0.3728343545959842,0.7245974063522052,0.3058816822504121;
Retrograde neurotrophin signalling,0.6246582003732599,0.5650846677571137,0.5299509754140619,0.3163292158034775,0.311114601116272,0.37649015236135064,0.33099349252017224,0.35082679893314456,0.3693665271664583,0.41912518944327204,0.3030467691849685;
VLDL clearance,0.36507011621124635,0.5533034614471986,1.4018896099198315,0.3232519888569888,0.3764809604369917,0.4265726957936143,0.3308463726686434,0.32735598382599135,0.3121738255632173,0.4523752385250782,0.3058816822504121;
Toll-like Receptor Cascades,0.4890337317917532,0.32069448362191266,1.4422302729943435,0.39710621317627126,1.0012104566703892,0.8561005753286984,0.3308463726686434,0.35971925328583354,0.4156689500982106,1.7064426283862413,0.3058816822504121;
Defective CHST14 causes EDS, musculocontractural type,0.7239736512740405,0.32191146796407205,1.4132915985086576,2.054231473072177,0.32162569628297455,0.3510885741014246,0.3308463726686434,0.37363972655453026,0.3118594580677358,0.3533672437172829,0.3058816822504121;
Intestinal hexose absorption,0.3481518561848366,0.7398296891516988,2.3314130134838797,0.4975432167099843,0.3540024647605433,0.3298643498072546,0.3308463726686434,0.4815653043880472,0.3973359698996325,0.4237641280246898,0.3058816822504121;
Transcriptional Regulation by VENTX,1.5345670566679266,0.3998527053714512,3.356824672198266,0.4246158572684502,0.32297793958928395,0.34084875043490775,0.3308463726686434,0.3998593960551724,0.46398019506563953,0.32532264275231887,0.3058816822504121;
p130Cas linkage to MAPK signaling for integrins,0.3851513712885939,0.5698796886264856,0.6066943934222234,0.529994372254881,0.4027637435721038,0.47533127791853086,0.3308463726686434,0.5972444500514024,6.528093346078883,0.47469881290334454,0.3058816822504121;
Vesicle-mediated transport,0.44498379621009987,0.31070106152335225,0.5659493994463285,0.30570651231582135,0.3778170345464189,0.3829935829538375,0.3308463726686434,0.3365679382419524,0.3156659602261388,0.4569839190337219,0.3058816822504121;
Metabolism of carbohydrates,0.3033630444136484,0.7467837539344376,1.8956694496720314,0.3163292158034775,0.4393593943366305,0.9713193645723083,0.3308463726686434,0.45374902011684204,0.48960016442446236,0.37218965236252843,0.3058816822504121;
SUMOylation of chromatin organization proteins,1.2407590249616494,0.4583996963357266,0.3180102748962083,1.4546697777633681,0.3213805315612138,2.2894016663815893,0.3308463726686434,0.31950585589685954,0.3670929745469339,0.32837788404645557,0.3058816822504121;
Loss of MECP2 binding ability to 5mC-DNA,0.5259896618479669,0.32069448362191266,0.5080281462892785,0.38459539265859194,0.3722027189435112,0.3829935829538375,0.3308463726686434,0.35971925328583354,1.6598855005009734,0.43874853403209596,0.3058816822504121;
Downstream TCR signaling,0.4285257794946782,0.45420597324553597,0.5017359945597698,0.6748465678177983,0.8200654672397518,0.4265726957936143,0.3308463726686434,0.33696163270265517,0.3548089774272463,0.5509813135086672,0.3058816822504121;
Activation of the AP-1 family of transcription factors,0.3165446042742289,0.41268909257052344,0.5130503622174319,0.32978641818617105,0.31440942457661125,0.5163579268941797,0.33082807682648757,0.5613944991412845,0.33154605935666304,0.33619831583867554,0.3058816822504121;
RNA Polymerase II Transcription,0.3119979840557615,0.4081569957992947,0.7352959158860801,0.39144877960498997,0.3726312003584851,0.3336247107846666,0.33082807682648757,0.37363972655453026,0.32855021388126704,0.8136453284423216,0.3058816822504121;
Diseases of Cellular Senescence,0.6028468264166759,0.3257332039685752,1.0825344059063156,1.0415359764757817,0.9505253515861846,6.102263114023866,0.33071312188414137,0.4237457183321578,0.36494779765230456,0.4637408625584409,0.3058816822504121;
GABA synthesis, release, reuptake and degradation,0.335368352224608,0.7834004270680736,0.5494530568571484,0.3142325622507859,0.3732820537339127,0.3064229758099168,0.33071312188414137,0.39650492258849274,0.41359881610222476,0.3811579239158923,0.3030467691849685;
Signaling by Erythropoietin,1.3482789970068219,0.5737672906705947,1.0764082393445782,0.5474237161410291,1.309952482221205,0.9791760437254866,0.33071312188414137,0.37731415007330193,0.3063901120454567,2.9958487648663104,0.3058816822504121;
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1.7976209056623353,0.9363641915722525,1.0978943125065814,0.48853611966738064,0.3119959467823231,0.4820137717943989,0.32962118903959065,0.6370660872345657,0.9865225878995839,0.4540611718827999,0.3058816822504121;
Pentose phosphate pathway disease,0.6221424744211911,0.7142094393317582,0.8517982647455866,1.7850403391640262,0.7031803745821407,3.1448545162118844,0.32962118903959065,0.3646829165254219,0.3973359698996325,0.3928910506494723,0.3024439670208732;
Peptide hormone biosynthesis,0.6478889052228327,0.4310910365131154,0.6877021705263229,0.3198395805486888,0.39026309562416256,0.31657055824948344,0.32962118903959065,0.5942768010382316,0.3522221105554151,0.30129359272093664,0.3058816822504121;
Cardiac conduction,0.40416822402795777,0.5073445985405695,3.576704185968215,0.3163292158034775,0.9989839361691158,3.3346408342268075,0.32948718582293607,0.8986880030650579,1.4856470946987632,1.4826509973588882,0.3058816822504121;
Proline catabolism,0.4177545544865989,0.3313552666334787,2.733183778187461,0.380333723709027,0.3590225224597753,0.4449779716204163,0.32924935463025606,0.5174152264767676,6.605198863821674,0.7164596722064461,0.3058816822504121;
Acyl chain remodeling of CL,0.41878227920580746,0.4258452579224127,0.6951696532050551,0.5390862025986808,0.47884486203054755,0.552798145965709,0.3288947851868474,0.3015161787323837,0.3329607429278685,0.6789432446755621,0.3058816822504121;
Signaling by Overexpressed Wild-Type EGFR in Cancer,0.32098285604264903,0.4081569957992947,0.8904715042964058,1.869383782423567,1.3241905080609873,2.782404799622282,0.3286422946725419,0.4628527562793292,0.3266862348880042,1.6839835745055527,0.3058816822504121;
Acyl chain remodelling of PG,0.5110806458636459,0.30963854390385315,1.9403404753819906,0.3454633916917074,1.0102546585812715,1.5869323539619207,0.32661944996703796,0.6834181834101111,0.327558860071622,2.184054235873919,0.3058816822504121;
Acetylcholine binding and downstream events,0.39952318228467737,0.6748754522273666,0.4134699577910062,0.5213340061596343,0.32297793958928395,0.38644297502167896,0.32661944996703796,0.354491138179516,0.3357877544181321,0.3184671951240273,0.3058816822504121;
Loss of Function of TGFBR1 in Cancer,0.8782479825575166,0.7774348117233991,0.828654624804674,0.316589248679847,0.3394918967507969,0.5275438626003343,0.32661944996703796,0.36710932947589353,0.7763401413039768,0.3146249156431087,0.3058816822504121;
FGFR1c ligand binding and activation,0.5494083030290889,0.3659796444425064,0.39161510178558023,0.3861917421038416,0.311114601116272,0.329737027136899,0.3249321784884625,0.524218023045207,0.3990354706674196,0.41762998053200373,0.3030467691849685;
Fatty acyl-CoA biosynthesis,0.32213490899676,0.3351332739777284,0.42888022381690727,0.41581161145612344,0.30418705243734856,0.48717144573263077,0.3249321784884625,0.35357383253505825,0.33154605935666304,0.47469881290334454,0.3032374359194824;
RAB GEFs exchange GTP for GDP on RABs,0.33797301854850675,0.3029713996082115,1.2068521424678271,0.4697453280545078,0.30560761571670825,0.3479832638871655,0.3249321784884625,0.44786177552608863,0.3187254357066004,0.38300722113202923,0.3058816822504121;
Opsins,0.33553670619104653,0.4973390331284095,2.2570106663027447,0.39485276920195894,0.3285435148042968,0.34084875043490775,0.3249113834975611,0.4147150908432823,0.3693665271664583,0.49771037728506584,0.3030467691849685;
Phenylalanine and tyrosine metabolism,0.669260189457642,0.5131391727266793,1.6751374571721203,0.48853611966738064,0.5724292987597449,2.273153270135932,0.3245443113434812,0.35971925328583354,0.3170116103066843,0.30603264219956966,0.3058816822504121;
Resistance of ERBB2 KD mutants to lapatinib,1.603124623320052,0.4179128650456059,1.092627766233976,0.4895692785576774,0.41200215293113845,0.468029122621951,0.3241121485730582,0.36046186142273234,0.34010467491250734,0.40636451825236675,0.3058816822504121;
Energy dependent regulation of mTOR by LKB1-AMPK,0.3769156558790342,0.3324347048891436,0.35246737035240705,0.47150866089802457,0.44190872554450233,0.47725795891754763,0.3241121485730582,0.3303328609933325,0.4881499224650157,0.51104279764138,0.3032374359194824;
Negative regulation of NMDA receptor-mediated neuronal transmission,1.427543977892061,0.3691439136623758,0.4760528568967101,0.3881184602725714,0.33627276072485157,0.36661029332342004,0.3241121485730582,0.6061061238265077,1.7742376093178243,0.44065582267788694,0.3058816822504121;
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,0.9962224759148058,0.31070106152335225,0.6357182993488588,0.33925035064181597,0.40888718273980784,0.39668859506931625,0.3241121485730582,0.5562074498396701,0.48212320857995195,1.6873281038774426,0.3058816822504121;
Resistance of ERBB2 KD mutants to trastuzumab,1.603124623320052,0.41933177387997705,1.4105478965713865,0.48547093371219235,0.41200215293113845,0.46598004575844243,0.3241121485730582,0.36046186142273234,0.34010467491250734,0.4044798143565832,0.3058816822504121;
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,0.4565719948197997,0.3691439136623758,2.2258969211531747,0.3115144235208682,0.311114601116272,0.4182160797270904,0.3222619001240224,0.3207891067373377,0.3728343545959842,0.4121812366547547,0.3058816822504121;
NRIF signals cell death from the nucleus,0.3481518561848366,0.5001845172573633,0.7695585986948226,0.3232519888569888,0.9134772014451715,0.45137337253263515,0.3222619001240224,0.352267490683119,0.3406966434873319,0.5278203201689747,0.3058816822504121;
DSCAM interactions,0.32547764111405103,0.301642737608084,0.8781730033946207,0.3156748741478961,0.4143145939702929,0.44569311077594786,0.3220017422890478,0.5190190206746952,0.3156659602261388,0.34032309265129573,0.3058816822504121;
Regulation of Complement cascade,1.2375457594394272,0.5559716580164445,0.902579832272734,0.3142325622507859,1.5828289611196062,0.412076901991059,0.3216133115729174,0.3317123913477366,0.7209288851344792,2.2352529871625304,0.3058816822504121;
Glycogen breakdown (glycogenolysis),0.5065318103776832,0.7083061017751114,1.879272483096239,0.43126966076271606,0.377484511377512,0.48717144573263077,0.3212238141759389,0.35971925328583354,0.3973359698996325,0.34824375804500923,0.3058816822504121;
Lysosome Vesicle Biogenesis,0.5259896618479669,0.6684810088964953,0.3222246234534123,0.34493403884766827,0.4146172972667351,0.3028133569923738,0.3209904451350487,0.3578253404952037,0.8607865932569042,0.5840217680753644,0.3058816822504121;
Fructose metabolism,2.1701561230011186,0.9394394484219818,2.1351019041384744,0.3861917421038416,0.8350420563859239,0.4127644252979026,0.3209904451350487,0.30762701980706253,0.4644723627826459,1.459384829747789,0.3058816822504121;
Inhibition of Signaling by Overexpressed EGFR,0.3217387546841015,0.4081569957992947,0.8841879790629011,1.869383782423567,1.3241905080609873,2.782404799622282,0.3193084192310752,0.4628527562793292,0.3266862348880042,1.6839835745055527,0.3058816822504121;
MAPK targets/ Nuclear events mediated by MAP kinases,0.4791592223021947,0.7816704313010397,0.30734867613921363,0.39144877960498997,0.3542809798398846,0.5423918303447901,0.3193084192310752,0.5174152264767676,0.36912070063627533,0.5266784352668187,0.3058816822504121;
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,0.382661322523146,0.4660251239708507,0.8026246842195153,0.37058527397403485,0.30418705243734856,0.416812166468743,0.31890729468441015,0.35971925328583354,0.3484005984762255,0.9078004234832374,0.3030467691849685;
XBP1(S) activates chaperone genes,0.3773507963370561,0.4081569957992947,0.880273177041592,0.3198395805486888,0.3824048831138682,0.3111782497541377,0.31890729468441015,0.35971925328583354,0.33154605935666304,0.3396035592964414,0.3058816822504121;
Late Phase of HIV Life Cycle,0.3957341132721857,0.5129008496943859,1.1637210870873123,0.380333723709027,0.34597679685845784,0.5161708497611757,0.3182432196671143,0.34398443282195684,0.31837078236812505,0.3804737589978425,0.3058816822504121;
O2/CO2 exchange in erythrocytes,3.162575670441646,0.40321170909752624,1.45366218336228,0.46893785443744507,0.34635859902949345,0.36412558352903635,0.3181133531675912,0.3109857057051492,0.36091256993057036,0.4540611718827999,0.3058816822504121;
Hyaluronan biosynthesis and export,0.5018773643065748,0.3090278240817252,1.1458569171858222,0.7272749296705056,0.3791920767944086,0.7305728899620716,0.3181133531675912,0.35971925328583354,0.3329607429278685,0.39863298409526765,0.3058816822504121;
Zinc efflux and compartmentalization by the SLC30 family,0.32524261738351457,0.30814244538089003,1.9572998302173978,0.32552608200489686,0.33627276072485157,0.4265726957936143,0.31702961267101715,0.829854390072768,0.8549344099390915,1.0967240904727062,0.3058816822504121;
Rev-mediated nuclear export of HIV RNA,2.239895799933154,0.7083061017751114,1.5240522084792665,1.5654517786285682,0.34732075266316614,3.9580873428343493,0.31686115416266486,0.39014468230695576,0.38395097131164374,0.3811579239158923,0.3058816822504121;
Drug resistance in ERBB2 KD mutants,1.603124623320052,0.41581422321241424,1.1616578731869267,0.4921828466849897,0.4146172972667351,0.46829287577570267,0.31686115416266486,0.36073163167381794,0.34010467491250734,0.40866758225795996,0.3058816822504121;
Erythrocytes take up carbon dioxide and release oxygen,3.162575670441646,0.401504938997016,1.451147957905644,0.46898504590813767,0.34635859902949345,0.3633262214123277,0.316390332645419,0.3112535981389127,0.3596562854316725,0.4540611718827999,0.3058816822504121;
Drug-mediated inhibition of ERBB2 signaling,1.603124623320052,0.4167799254127193,1.3182378405298774,0.48737980949925297,0.41200215293113845,0.46829287577570267,0.316390332645419,0.36046186142273234,0.34010467491250734,0.4011547365457929,0.3058816822504121;
VLDLR internalisation and degradation,0.5087320036543982,0.6441853723194954,1.214509679032116,0.3388488933313274,0.39915625782545383,0.3528213145795389,0.315881977901702,0.33696163270265517,0.4385578450456547,0.8368997031223852,0.3058816822504121;
Dissolution of Fibrin Clot,0.3917250021201742,0.32979575975804937,0.5424432587873768,0.4760070704633726,0.631676288554392,1.0494027647055801,0.31584310428089984,0.30676358637777745,0.4502323698043533,1.136581308346117,0.3058816822504121;
Resistance of ERBB2 KD mutants to tesevatinib,1.603124623320052,0.41581422321241424,1.092627766233976,0.4952657549294414,0.4146172972667351,0.46829287577570267,0.3157250151176896,0.36073163167381794,0.34010467491250734,0.40937088734274674,0.3058816822504121;
Voltage gated Potassium channels,1.3213576237994762,0.4081569957992947,1.1249590638634006,0.4096323736562922,0.33096675554030125,0.48342847674028183,0.3155077926513175,0.30676358637777745,0.304022170806971,0.3577066336961194,0.3058816822504121;
Signaling by GPCR,1.1527960373936663,0.31445410540840596,1.7955688751623937,0.40965022774647586,1.4497014587581227,0.8300173452917683,0.31538064395939386,0.42864408325691356,0.36270058071958616,2.183014455168301,0.301074066609359;
Regulation of lipid metabolism by PPARalpha,0.3131846682126686,0.42498593976503624,0.7974382031525492,0.6436104697325299,0.3439134979171695,0.42924963491620954,0.31518323372504414,0.31482486972733703,0.32397177416554596,0.7131212844176323,0.3058816822504121;
Postsynaptic nicotinic acetylcholine receptors,0.4033398740708577,0.6632010765904364,0.38520303736265626,0.5282378846373398,0.330372459861341,0.38644297502167896,0.31518323372504414,0.35971925328583354,0.3359886954858688,0.3286979716130023,0.3058816822504121;
FMO oxidises nucleophiles,1.7874104207120947,0.3021233944379066,0.730308954681951,0.3861917421038416,0.5681648570673938,0.3420003235500663,0.31518323372504414,0.3046925177872838,0.33154605935666304,1.5950243908365798,0.3058816822504121;
Notch-HLH transcription pathway,0.4632713188448469,0.31070106152335225,1.0271210263264698,0.380333723709027,0.330372459861341,0.3440869436067876,0.31518323372504414,0.5795150420091576,0.43163069758557865,0.35321201477056985,0.3058816822504121;
Rhesus glycoproteins mediate ammonium transport.,0.48703880564889745,0.42498593976503624,1.2258250689951504,0.4259255290949236,0.4296256803634443,0.6289210074036768,0.31518323372504414,0.34398443282195684,0.32815084485870327,0.41104584371777314,0.3058816822504121;
Metabolism of RNA,0.30573757380670746,0.36231980452174045,0.3869404923795541,0.9782233095618497,0.37572915566633974,0.312405934491624,0.31518323372504414,0.3041958291035846,0.33154605935666304,0.6740409396839165,0.3058816822504121;
Cation-coupled Chloride cotransporters,0.33711529792883904,1.1017475137597903,2.165624764806423,0.38834181595987294,0.4027637435721038,0.4461518232477087,0.3150062893948549,0.6361388536970207,0.33154605935666304,0.5101211329757073,0.3058816822504121;
Synthesis of IPs in the nucleus,0.32648569807719524,0.3393935927201346,0.6869918082235649,0.4461636818038182,0.3791920767944086,0.4306777496994055,0.3150062893948549,0.4018372923384269,0.750007503821435,0.33619831583867554,0.3058816822504121;
Formation of Incision Complex in GG-NER,0.31667864267182433,0.35692546054244895,2.0283748895580045,0.3628766921649118,0.446334721160968,0.4379611725944341,0.3150062893948549,0.5753977044168755,0.3293878277257215,0.3173058300496171,0.3058816822504121;
IRS-mediated signalling,0.7669120937190577,0.4631345202388002,0.6989359608551208,0.34114908780953945,0.3645583937901488,0.46329118624362164,0.3150062893948549,0.7796931658740366,1.2632929927009808,0.3811579239158923,0.3058816822504121;
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,0.396617892903857,0.42498593976503624,1.8763118837089128,0.3503872330012344,0.33888923885821726,0.37158725940729187,0.3150062893948549,0.4628527562793292,0.30995709679984573,0.47469881290334454,0.3058816822504121;
Endosomal Sorting Complex Required For Transport (ESCRT),0.37784732019519435,0.3214902380011182,1.7007113797573465,0.33564575743536246,0.35055577872979593,0.4095359585082957,0.3150062893948549,0.5972444500514024,0.7209288851344792,0.5100898491572277,0.3058816822504121;
Integrin signaling,1.4202227422980767,0.4081569957992947,0.5956821402371679,0.4602774105125744,1.1849606392567074,0.33664035924109287,0.313979573698757,0.48606186013240477,0.58712505728644,2.9958487648663104,0.3058816822504121;
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,0.5580015467292053,0.3918158246299093,1.585507937318083,0.7678405916683597,0.3726312003584851,0.524085852020183,0.313979573698757,0.7372930190504967,0.5140766613827893,0.4724375413774212,0.3058816822504121;
Long-term potentiation,0.6092660510042243,0.31070106152335225,0.3554138575034153,0.31123391033016007,0.33910487705697223,0.5487753153582212,0.31397788167789686,0.34398443282195684,0.6206278086719139,0.47469881290334454,0.3058816822504121;
Vitamins B6 activation to pyridoxal phosphate,0.9750661435763117,0.6284234273435845,0.30823454012471696,0.4087888657980072,0.3791920767944086,0.37643217605883994,0.31397788167789686,0.3251934547032587,0.31966777048058687,0.6166970474254407,0.3058816822504121;
Glycogen storage diseases,0.3672789551152327,0.34082619400820896,0.6214317248794013,0.5016914801173993,0.7201364544849929,0.3620735944925361,0.31397788167789686,0.39214610867837385,0.3086647282719282,0.3172734172535683,0.3058816822504121;
Mitophagy,0.31609276627522503,0.3667015217797265,0.34733542328568157,0.39485276920195894,0.6232504230710858,0.7928599828495357,0.31397788167789686,0.5389628321778192,0.6038548806758468,0.38630092353663426,0.3058816822504121;
Sodium/Calcium exchangers,0.5866474679637819,0.340846924720855,2.318192736579381,0.3142325622507859,0.3726312003584851,0.6339686800252128,0.31397788167789686,0.48606186013240477,0.30150053284191936,0.3025747027936126,0.6091415281040035;
Resistance of ERBB2 KD mutants to AEE788,1.603124623320052,0.421441415526736,1.092627766233976,0.48962415448874347,0.4130708040105258,0.4641092916342805,0.31397788167789686,0.36046186142273234,0.34010467491250734,0.40725450707211985,0.3058816822504121;
Signaling by SCF-KIT,0.7982483117508167,0.4284698207307233,1.3211966950334608,0.3163292158034775,1.410302056499769,1.6961075555530742,0.31397788167789686,0.3274720765353536,0.3919555048208796,2.8608949272607695,0.3058816822504121;
InlA-mediated entry of Listeria monocytogenes into host cells,0.3603728060987278,0.3508263610994628,1.854973068315736,0.4268082758389676,0.3779978974972674,0.3321209692064086,0.31397788167789686,0.8762097574693818,0.3728343545959842,0.33194577730543684,0.3058816822504121;
Regulation of expression of SLITs and ROBOs,0.6233502926067588,0.3351332739777284,0.7765738182938368,0.3881184602725714,0.3396325673262649,0.42442973454356425,0.31397788167789686,0.5753977044168755,0.33154605935666304,0.33623172585815414,0.3024439670208732;
Localization of the PINCH-ILK-PARVIN complex to focal adhesions,0.32213490899676,0.8301826744756184,0.3186523149786101,0.35607005789003415,0.35573771241937,0.42559684233977757,0.31347173716917304,0.39214610867837385,0.3227320418931485,0.8378508818152849,0.3058816822504121;
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,0.939881054665771,0.3897456937069698,0.6572321378897701,0.39485276920195894,1.4497014587581227,0.6410017706458788,0.31347173716917304,0.42426681188822685,0.3724804279880947,2.281416999794312,0.3058816822504121;
Toxicity of botulinum toxin type C (BoNT/C),0.35985985502915246,0.388169017711386,1.838491459878411,0.39485276920195894,0.4146172972667351,0.42315261374826185,0.31347173716917304,0.309018298085769,0.32224753409943957,0.6749467764774163,0.3058816822504121;
Metal sequestration by antimicrobial proteins,0.5557714001529779,0.5194893334998575,1.665043193554629,0.3198395805486888,0.32162569628297455,0.383857697598681,0.31347173716917304,0.6834181834101111,8.427641480490022,1.2474803608385854,0.3058816822504121;
Olfactory Signaling Pathway,0.8072884376667768,0.44666980347972174,0.30134832367833375,0.3468013020091587,0.48046633727165955,0.312405934491624,0.31347173716917304,0.8392145373470217,0.32855021388126704,0.46793777455222346,0.3032374359194824;
TP53 Regulates Transcription of Caspase Activators and Caspases,0.9470885472493423,0.32644608695254396,0.6989359608551208,0.4339948646037047,0.47725936118460555,0.3061210216620263,0.31107968719808715,0.6849130563545062,0.3329607429278685,0.8151032653578858,0.3058816822504121;
Toll Like Receptor 4 (TLR4) Cascade,0.38525302097757547,0.5382762028604182,0.6638647364013122,0.30570651231582135,0.5342874618581906,0.5985249251637209,0.31107968719808715,0.3999878562041873,0.33154605935666304,0.4256081140909801,0.3058816822504121;
Protein-protein interactions at synapses,0.3699070080013097,0.32979575975804937,0.79012162826706,0.39485276920195894,0.3791920767944086,1.4443143830942757,0.3104979376751838,0.5972444500514024,0.36419136224313775,1.839546734252826,0.3058816822504121;
Initial triggering of complement,1.0925235400679418,0.4301895395995331,0.47531146190153706,0.3213115419718923,1.5061060989817545,0.3188192698585969,0.30949213360563826,0.35971925328583354,0.6052596979838009,1.8218862440784502,0.3058816822504121;
Phosphorylation of CD3 and TCR zeta chains,0.8921520239334149,0.3202448349147819,0.7924208271038619,0.45814106070834476,0.697971698746192,0.36410024619302145,0.3093772392186791,0.4147150908432823,0.30650882243172795,0.923825570314111,0.3058816822504121;
Vitamin B5 (pantothenate) metabolism,0.6041718194849711,0.3165159964142589,0.5146933511324959,0.6432246813744723,0.3073643548426107,0.5799501398656989,0.309350635148832,0.5238886509233606,0.4564353693270964,0.5026703144243176,0.3058816822504121;
DAP12 signaling,1.3428996436296396,0.6400399366779007,0.5439930076286128,0.4322123049503211,1.4497014587581227,0.39910699735035193,0.3092986023778024,0.35971925328583354,0.33154605935666304,2.098433648179519,0.3058816822504121;
rRNA processing in the mitochondrion,1.542607112490525,0.6441853723194954,0.37925042675300347,0.5120370352239828,0.4898488404558619,0.3181920679733564,0.3092986023778024,0.4628527562793292,0.46973565379933857,0.5612321401469508,0.3030467691849685;
Resistance of ERBB2 KD mutants to sapitinib,1.603124623320052,0.42036494793775453,1.7832362398483868,0.48547093371219235,0.4054565637555915,0.46101395366649894,0.30901069378096335,0.35971925328583354,0.3388777404003391,0.39863298409526765,0.3058816822504121;
Response of EIF2AK4 (GCN2) to amino acid deficiency,0.3755897556963888,0.47551307151338007,1.459986029735789,0.32552608200489686,0.3764809604369917,0.4753114756631176,0.30901069378096335,0.3293659749007217,0.41003154150330823,0.39091888813155207,0.3030467691849685;
Defective ABCG8 causes gallbladder disease 4 and sitosterolemia,0.5432415640828123,1.1599948410697627,2.1200110944346995,1.1578910544844385,0.7962633357453084,0.35399026492638497,0.308668678455119,0.30222076309715623,0.4420168778820556,0.4971343238169825,0.3058816822504121;
Neurotransmitter receptors and postsynaptic signal transmission,0.5232909476072556,0.35270932462766424,3.356824672198266,0.3501445212921916,1.1777384810077287,1.5445868811380588,0.308668678455119,0.5621778024384817,0.5843054969729731,0.4678954462589095,0.3058816822504121;
Disease,0.5482793760905095,0.4995829547349528,0.3222246234534123,0.7304175059341885,0.33140832466933967,0.4775455705323609,0.308668678455119,0.5875312333581726,0.3329607429278685,0.31100904921848943,0.3058816822504121;
Glycogen metabolism,0.4029927195800096,0.45420597324553597,0.902579832272734,0.5259000391854405,0.3906752657245087,0.3111782497541377,0.3085094453677238,0.30318050255984674,0.38536151369925536,0.3811579239158923,0.3058816822504121;
Infection with Mycobacterium tuberculosis,0.40092328276644357,0.5016280373708235,0.4151880804638908,1.1475094281804408,0.3701740018252065,0.34084875043490775,0.3085094453677238,0.3098058742439091,0.6966663041974297,0.5278203201689747,0.3058816822504121;
MyD88 deficiency (TLR2/4),1.4707569045924682,0.5131391727266793,0.5422569480362782,0.48547093371219235,0.8890740651874032,0.30259970477602033,0.3080483301462069,0.5238886509233606,0.3900183977157809,2.0095954563203344,0.3030467691849685;
Arachidonate production from DAG,0.3119979840557615,0.9846254897589394,0.33057703756507173,0.3070634265024376,0.4146172972667351,0.4449779716204163,0.30735017387723534,0.4628527562793292,0.3338465331875771,0.4678954462589095,0.3058816822504121;
G alpha (z) signalling events,2.89072583416433,0.9002960207629139,0.824931137133459,0.40891911027461275,1.0364678676169665,0.42195524817232105,0.30735017387723534,0.6031307118396994,0.4416449209335902,2.7157314183725685,0.3058816822504121;
Tachykinin receptors bind tachykinins,0.5367193506170276,1.1137098493153053,2.4111374592879504,0.4147520762862274,0.35830085846035925,0.5168045402496553,0.30735017387723534,0.6834181834101111,0.5925824442312864,0.47575535715786293,0.3058816822504121;
Metabolism of cofactors,0.4632713188448469,0.3239628347892972,4.045969726320059,0.5100938458195717,1.1073522751388227,1.646831701819799,0.30735017387723534,0.34835641075321955,3.0566691659980814,0.47855894419573153,0.3058816822504121;
Developmental Biology,0.3494888882207228,0.601299658616172,0.4129105594128844,0.4461636818038182,0.4053350549556549,0.346882106807832,0.30735017387723534,0.35971925328583354,0.3293878277257215,0.4700592520322819,0.3058816822504121;
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),0.37298018217520823,0.5698796886264856,2.612080435887825,0.39144877960498997,0.3176342054010501,0.4300466631842503,0.30698098942860236,0.5226955554832011,3.577673173252147,0.3109481832046546,0.3058816822504121;
Transcriptional regulation by RUNX2,0.6188386975716889,0.6255863960340599,1.070454754960547,0.48470506946712605,0.8791269779994055,1.5026301914622144,0.30698098942860236,0.37731415007330193,1.042470285322291,0.47781560131935036,0.3058816822504121;
Defective ABCG5 causes sitosterolemia,0.5415759740759772,1.2567397901919064,2.1197477679431342,1.1475094281804408,0.7962633357453084,0.35399026492638497,0.3063245256014681,0.30222076309715623,0.4416449209335902,0.5026703144243176,0.3058816822504121;
Signaling by WNT in cancer,0.670812212167234,0.42498593976503624,0.5182707098049141,1.0943006120142702,0.3119959467823231,0.36661029332342004,0.3063245256014681,0.3293659749007217,0.42563818276787846,0.37828060772016775,0.3058816822504121;
Downstream signaling of activated FGFR2,0.3217387546841015,0.4717509252281568,0.5595253132560759,0.34368068464006973,0.42318328395149263,0.30741925342711224,0.3063245256014681,0.32735598382599135,0.33154605935666304,0.4121812366547547,0.3058816822504121;
Glutamate Neurotransmitter Release Cycle,0.3914332839728542,0.4019664479252001,1.3345534265378263,0.7840965975542565,0.531793620499492,0.617122547965672,0.3063245256014681,0.6303443794140307,1.9577678968020311,0.6171820621879172,0.3058816822504121;
RNA Polymerase III Transcription Initiation From Type 2 Promoter,0.41199822110422263,0.3757662919161499,1.7306317027678155,0.3103014479071436,0.33096675554030125,1.2004624728743576,0.3063245256014681,0.4133310857960066,0.36494779765230456,0.5404034066670892,0.3058816822504121;
FCERI mediated MAPK activation,0.9811650749744681,0.33104113055729384,0.8881774991924806,0.5484133433813776,1.4497014587581227,0.37417155044874745,0.3063245256014681,0.5795150420091576,0.37721347556427365,1.3368607409961477,0.3058816822504121;
Loss of Function of TGFBR2 in Cancer,0.8667064535396588,0.4081569957992947,1.3196731963538364,0.3070450077802019,0.31259820086811796,0.3523625454456656,0.3063245256014681,0.34311923132904953,0.6193823331446574,0.3286979716130023,0.3058816822504121;
TGFBR2 Kinase Domain Mutants in Cancer,0.8667064535396588,0.4081569957992947,1.3212410046223684,0.3070450077802019,0.3119959467823231,0.3491683136349247,0.3063245256014681,0.34311923132904953,0.6378208783171073,0.3286979716130023,0.3058816822504121;
RAF-independent MAPK1/3 activation,0.4217790971947763,0.3659796444425064,1.6023323837370131,0.380333723709027,0.33140832466933967,0.3037454888756527,0.3054045076830352,0.6849130563545062,0.34010467491250734,0.32302208058832177,0.3058816822504121;
Regulation of actin dynamics for phagocytic cup formation,0.8638157782330808,0.4081569957992947,0.8833146903713517,0.3163170636750133,1.4497014587581227,0.31756868525892934,0.3054045076830352,0.5562074498396701,0.7235782422314483,1.8408357983929062,0.3058816822504121;
Platelet sensitization by LDL,0.8072884376667768,0.42498593976503624,0.4087214513303352,0.4296023820159213,0.44260359177306835,0.30930404734628464,0.3054045076830352,0.5388818365263349,0.3265506469380085,0.34303382656163733,0.3058816822504121;
Protein methylation,0.44766682252123474,0.3051715086707191,0.5699502777360049,0.34114908780953945,0.36125084206021507,0.359645047493023,0.3054045076830352,0.5578106790042832,0.4917345000954562,0.38489751646675285,0.3030467691849685;
Regulation of necroptotic cell death,0.3250327858327181,0.46633846452847055,0.4173066784472562,0.3232519888569888,0.3540024647605433,0.34084875043490775,0.3054045076830352,0.4313030976096779,0.371978773408492,0.5124302984800859,0.3024439670208732;
Highly sodium permeable acetylcholine nicotinic receptors,0.4525063879392483,1.294694436611799,1.0394768555096892,0.36821509953607356,0.3791920767944086,0.4306777496994055,0.3054045076830352,0.5174152264767676,0.3670929745469339,0.39863298409526765,0.3058816822504121;
AKT phosphorylates targets in the cytosol,0.7274971970433651,0.41268909257052344,0.379389836966941,0.43287052576841767,0.3540024647605433,0.4126833593188166,0.3054045076830352,0.5053548155512009,0.4644723627826459,0.31913461420888994,0.3058816822504121;
Infectious disease,0.6575892762752841,0.421441415526736,0.5376841516849769,0.3265325825462171,0.32162569628297455,0.38644297502167896,0.3054045076830352,0.48606186013240477,0.32083849079803073,0.4637408625584409,0.3058816822504121;
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),0.5261040254127887,0.7656302527157366,2.4610470687510575,0.5392477733014513,0.444957695365014,0.49663184207588706,0.3054045076830352,0.5856301026206966,0.30150053284191936,0.5358388118953283,0.3058816822504121;
Methylation,0.4762854385211099,0.32979575975804937,0.30747772415026436,0.4697453280545078,0.3167837445231829,0.5245047266062759,0.3054045076830352,0.30705368811069295,0.3065164849314509,0.3596609925416212,0.3058816822504121;
Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD),0.9113131731683377,0.6441853723194954,0.35275308129702004,0.5037883573514967,0.330372459861341,0.617122547965672,0.3054045076830352,0.48606186013240477,0.33154605935666304,0.8460229263211784,0.3058816822504121;
Fructose biosynthesis,2.0433505138837758,1.0346589951790564,1.2898911462912885,0.3503872330012344,0.7008282779048037,0.6910567342002203,0.3054045076830352,0.31950585589685954,0.3404697512215013,2.401748522196262,0.3058816822504121;
Organic cation transport,0.8121277182997256,0.42498593976503624,2.726760580678139,0.4087888657980072,1.4497014587581227,2.7527510053106834,0.3047944449878568,1.053092947380614,1.231500012211471,0.9584898257112828,0.3030467691849685;
Acetylcholine Neurotransmitter Release Cycle,0.37298018217520823,0.32069448362191266,0.6162678888004613,0.34049658036688124,0.31351737387980566,0.3828251833451506,0.3047944449878568,0.5795150420091576,0.5868559089955067,0.3586349562682923,0.3058816822504121;
ATF6 (ATF6-alpha) activates chaperones,2.0568280750905874,0.652403918986381,0.3152745597930626,0.42447319466534195,1.2574929567058153,0.5145174956340497,0.3047944449878568,0.445309559217323,0.36494779765230456,0.9594908929655769,0.3058816822504121;
Scavenging by Class F Receptors,0.4934344918726694,0.3579101535729101,0.7217394658501891,0.5484133433813776,0.311114601116272,0.6240899428585395,0.3047331045100306,0.8217497190823737,0.5848562993974026,0.4395763307211742,0.3058816822504121;
Formation of a pool of free 40S subunits,0.3016763054275278,0.5357174180674569,1.2533763494675076,0.3350938995998829,0.3119959467823231,0.5846450515458598,0.3047331045100306,0.32753430183444365,0.4502323698043533,0.5560681788194175,0.3030467691849685;
PI3K/AKT Signaling in Cancer,1.4880462630977418,0.39346922355107966,2.2862105325436706,0.44596925000073234,1.4497014587581227,0.9377313815819663,0.304253071829874,0.46237839526257996,0.3115924460534767,3.4449015650011026,0.3058816822504121;
Diseases associated with N-glycosylation of proteins,0.41932664382931056,0.47300501140253504,2.5449959312857753,0.41581161145612344,0.3226140943665297,0.35144361907627264,0.30415184463148515,0.7214872606359403,0.5477038219353909,0.4540611718827999,0.3058816822504121;
MAPK1 (ERK2) activation,0.33612450628963697,0.3051715086707191,1.994936069801295,0.3163292158034775,0.39794629746034765,0.4127644252979026,0.30415184463148515,0.33030236244002353,0.3329607429278685,0.46947200515560084,0.3030467691849685;
MTF1 activates gene expression,0.3291652184369379,0.8199100387559937,1.3087269907221424,0.9967028518277227,0.377484511377512,0.38644297502167896,0.30415184463148515,0.3425206096678787,0.40792594950136635,0.3172734172535683,0.3058816822504121;
Enzymatic degradation of dopamine by COMT,0.3914332839728542,0.6255863960340599,2.512971224502093,0.5900152111207688,0.5552889058056465,2.0626384317360538,0.30415184463148515,1.8257513115051232,1.0539282991803947,0.9660278811643943,0.3058816822504121;
GTP hydrolysis and joining of the 60S ribosomal subunit,0.3262414295770312,0.7052414227406532,1.2689601743304062,0.3462475327561106,0.30246496029501807,0.5567849800840404,0.30415184463148515,0.30676358637777745,0.6459758662785066,0.5297441870318507,0.3032374359194824;
Hydroxycarboxylic acid-binding receptors,0.33991984304289263,0.3351332739777284,0.3605928617833285,1.0907646901544714,0.4146172972667351,3.730850061680873,0.3040664332673842,0.30396128062304534,0.8502621880934423,0.6740409396839165,0.3058816822504121;
Post-translational modification: synthesis of GPI-anchored proteins,0.49066227406616864,0.36305624463054287,0.6214317248794013,0.32205046915340124,0.46163953884057446,0.7911930231341676,0.3039543540089008,0.340582058724253,0.31808512104917774,0.9632956580184687,0.3058816822504121;
Amino acid transport across the plasma membrane,0.43458744757661255,0.5160538865147885,3.675974566700656,2.097664066094128,1.2451236115215971,4.428446753861302,0.3039543540089008,0.4815653043880472,0.9668183243741935,2.089521959943691,0.3058816822504121;
Dopamine clearance from the synaptic cleft,0.3914332839728542,0.6161081789146999,2.5079272850792944,0.5950246338700154,0.5551253708919341,2.0626384317360538,0.3039323017339094,1.8257513115051232,1.0539282991803947,0.9660278811643943,0.3058816822504121;
Signaling by Receptor Tyrosine Kinases,1.3857873165171006,0.9660977933891726,1.6603178493216157,0.6038547805947612,0.6526875770884857,0.5352545584205672,0.3039323017339094,0.5190190206746952,0.3404697512215013,0.800110475091163,0.3058816822504121;
Regulation of TP53 Activity,2.500540184850819,0.7123613805345899,1.8763118837089128,2.019984956836407,0.4313244288305069,0.9645603131595664,0.3035992810797773,0.48606186013240477,0.6606921149715522,0.33239293645350926,0.3058816822504121;
Downregulation of TGF-beta receptor signaling,0.7103589167065222,0.3490468230306136,3.0769969401617354,0.380333723709027,0.397151474618249,1.3718446014931907,0.3035992810797773,0.37363972655453026,0.3329607429278685,0.33873573073084623,0.3058816822504121;
Inactivation, recovery and regulation of the phototransduction cascade,0.39955822389257056,0.3090278240817252,2.0978877734919505,0.30570651231582135,0.9714608555935811,1.7481318626952564,0.3034982518996828,0.352267490683119,0.37261869565630745,0.572602207453692,0.3032374359194824;
Interferon alpha/beta signaling,0.4029927195800096,0.5900981993023308,0.498071154827163,0.541039048298216,1.0285875537894056,0.41818316555703205,0.3034982518996828,0.36710932947589353,0.33154605935666304,0.39863298409526765,0.3032374359194824;
Programmed Cell Death,0.3497038684428297,0.4973390331284095,1.698699067760762,0.48853611966738064,0.8890740651874032,1.4787629582036443,0.3034982518996828,0.3677622666458591,0.8833437902205385,0.697425008539117,0.3058816822504121;
NADE modulates death signalling,0.32058587970876234,0.6396008930942215,0.9232876256047491,0.4296023820159213,0.3439134979171695,0.435132948930374,0.3034982518996828,0.4671836385857672,0.3406966434873319,0.47728954306028143,0.3058816822504121;
Conjugation of carboxylic acids,0.3729976114331958,0.49882509403717307,2.087085435394043,0.39710621317627126,0.33910487705697223,0.33395231861614705,0.3034982518996828,0.6292462693883455,0.3070173328785859,0.7257968543160326,0.3058816822504121;
MAP kinase activation,0.3250327858327181,0.438351604480435,0.7950820635273264,0.5139469552228029,0.35290876980663655,0.3829935829538375,0.3034982518996828,0.3242022969576613,0.33650663839080047,0.3291263913538232,0.3032374359194824;
ADP signalling through P2Y purinoceptor 12,1.9408956008642335,0.8294461261044188,0.3048452542582737,1.6668001642397512,0.3119959467823231,0.33395231861614705,0.3034982518996828,0.9408642598773541,0.3406966434873319,0.34824375804500923,0.3058816822504121;
Metabolism of Angiotensinogen to Angiotensins,2.9866905932379337,0.3090278240817252,1.8240138127563188,0.5045085811872515,0.31450144039499167,0.3540970261426587,0.3034982518996828,0.5389628321778192,0.32855021388126704,0.30603264219956966,0.3058816822504121;
tRNA modification in the nucleus and cytosol,0.44351687530887374,0.5910305353386011,1.7306317027678155,1.5852347381666423,0.33627276072485157,0.6359263323973807,0.3031019743929323,0.3463888680005867,0.33154605935666304,0.3533672437172829,0.3058816822504121;
Striated Muscle Contraction,0.31186750211813125,0.4064277384336719,0.7320923959849781,0.3861917421038416,0.3226140943665297,0.4541009858801141,0.30270065892004105,0.33696163270265517,0.37721347556427365,0.3146249156431087,0.3030467691849685;
Diseases of Mismatch Repair (MMR),0.6036351212336205,0.3393935927201346,0.34430735045688526,0.45814106070834476,0.3791920767944086,0.5588744344857842,0.30270065892004105,0.4628527562793292,0.33154605935666304,0.4678954462589095,0.3058816822504121;
CLEC7A (Dectin-1) induces NFAT activation,1.8074713715703983,0.42498593976503624,1.0158975894954936,3.2470119190423508,0.3439134979171695,2.255810356712936,0.30270065892004105,0.9521400088762076,2.531897285809031,0.7364624317206159,0.3030467691849685;
Establishment of Sister Chromatid Cohesion,0.5010655922836115,0.4916469925647314,1.8437272037867236,0.3156748741478961,0.32297793958928395,0.3028133569923738,0.30270065892004105,0.36046186142273234,0.6175389953182515,0.3811579239158923,0.3058816822504121;
Vasopressin-like receptors,0.4217790971947763,0.3918158246299093,0.7819373367192614,0.7727786937880755,0.330372459861341,0.4541009858801141,0.30270065892004105,0.5745029716188665,0.371978773408492,0.8460229263211784,0.3058816822504121;
WNT5A-dependent internalization of FZD2, FZD5 and ROR2,0.4890337317917532,0.35692546054244895,0.39161510178558023,0.34712825185525215,0.3119959467823231,0.3111782497541377,0.3025280506307136,0.6016263616729596,0.3728343545959842,0.4209700519911368,0.3058816822504121;
Signaling by plasma membrane FGFR1 fusions,0.3136107765403995,0.34397653289691277,1.0006984045453402,0.39144877960498997,0.3439134979171695,0.31832290639955163,0.3025280506307136,0.340582058724253,0.9669431885640539,0.589535193417865,65.39232061410526;
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,0.3816727111491427,0.32162220022857385,0.7307846017705633,0.3265325825462171,0.3013380984971104,0.46829287577570267,0.30249786734746753,0.30676358637777745,0.3265506469380085,0.6373351344924745,0.3058816822504121;
Rab regulation of trafficking,0.3914332839728542,0.4386912358120347,1.1573377809759182,0.44798489210058173,0.3439134979171695,0.47055855225156185,0.30249786734746753,0.4681429621674421,0.36494779765230456,0.3928910506494723,0.3058816822504121;
NTRK3 as a dependence receptor,0.7973182508545181,0.57958684356827,1.4034515722757035,0.4852641909894103,0.3712537213651401,0.3543706998655714,0.30249786734746753,0.34518615928891455,0.3616710313863541,0.40829289210720515,0.3058816822504121;
Regulation of PTEN localization,0.4416826026365212,0.3156043243918511,1.3078152524104625,0.5390862025986808,0.3226140943665297,0.5407089222379899,0.30249786734746753,0.3236959244504871,0.33154605935666304,0.34295065847682293,0.3058816822504121;
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,0.7298262053873593,0.8836678283697568,0.6547727419832847,1.580407776886763,1.136888493800863,2.17654915439661,0.30249786734746753,0.3254865987722037,0.4564353693270964,0.8222033546450297,0.3058816822504121;
Attachment of GPI anchor to uPAR,0.30735682749868515,0.4973390331284095,1.9365202542765205,0.4786089579511159,0.4146172972667351,0.38644297502167896,0.30249786734746753,0.35971925328583354,0.6052596979838009,0.8084765055104299,0.3058816822504121;
Glucagon signaling in metabolic regulation,2.3112254318403194,1.1599948410697627,0.350539890489017,1.5852347381666423,0.5063148250480233,0.4920901921689334,0.30249786734746753,0.42495982760195505,0.3227320418931485,0.47469881290334454,0.3058816822504121;
Tat-mediated HIV elongation arrest and recovery,1.542607112490525,1.7291076827125254,2.1687143387491252,3.913966070448805,0.37246026243621355,0.77398465505314,0.30249786734746753,0.6538798067228582,0.418328270869041,0.3160906252949544,0.3058816822504121;
Pausing and recovery of Tat-mediated HIV elongation,1.542607112490525,1.7291076827125254,2.1865103302376663,3.913966070448805,0.3726312003584851,0.77398465505314,0.30249786734746753,0.6436789195508222,0.418328270869041,0.3160906252949544,0.3058816822504121;
Calmodulin induced events,0.4892930819819199,0.4583996963357266,4.858868540733221,0.9532116501847283,1.4497014587581227,3.455836115267905,0.30249786734746753,0.5226955554832011,0.32345422674270613,3.0611752441228717,0.3058816822504121;
Interferon gamma signaling,0.6780733998458848,0.4691874280398756,0.5588904502460691,0.3861917421038416,1.1777384810077287,0.3145723753771386,0.30249786734746753,0.9652238352966773,0.34050073667628167,1.097733596205147,0.3058816822504121;
Class B/2 (Secretin family receptors),0.9470885472493423,0.7925878159421703,1.3087269907221424,0.41179614815947363,0.5858717531200833,0.31776991236841967,0.30249786734746753,0.33696163270265517,0.3065164849314509,1.0847504988898473,0.3058816822504121;
Oncogene Induced Senescence,1.2262298178883932,0.5210248569214392,0.33588723836329554,4.171909516233354,1.1431615389490235,5.246658956357051,0.30249786734746753,0.6795783218532508,0.47514208089199056,0.5278203201689747,0.3032374359194824;
Manipulation of host energy metabolism,0.8095567597018617,0.3791687430799317,0.6066943934222234,2.3917445439303706,0.8512166326960373,2.0291495635387604,0.30249786734746753,0.5012508880889713,5.3400741007360715,0.4121680782244751,0.3058816822504121;
Amino Acid conjugation,0.37338376901850856,0.49882509403717307,2.09212786564033,0.3952396679299647,0.33746473202377175,0.33395231861614705,0.30249786734746753,0.6292462693883455,0.3061329461218883,0.73064839721532,0.3058816822504121;
Organelle biogenesis and maintenance,0.38506906139280406,0.36250846227187006,0.734791934999741,0.3198395805486888,0.3824048831138682,0.4902850695312733,0.30249786734746753,0.30980925894012945,0.47281314511628797,0.39863298409526765,0.3058816822504121;
MECP2 regulates transcription of genes involved in GABA signaling,0.4590724754446923,0.49023002456961257,0.7060971157697995,0.5343931423671431,0.3439134979171695,0.32118190498455845,0.30249786734746753,0.35971925328583354,0.3296727090655753,0.5080260427043916,0.3058816822504121;
Signaling by high-kinase activity BRAF mutants,0.3501378526710248,0.32033896412378116,1.6023323837370131,0.39485276920195894,0.4146172972667351,0.37649015236135064,0.30249786734746753,0.39048239961549064,0.3529982847066724,0.4601156100258348,0.3030467691849685;
Intraflagellar transport,1.0121638929383572,0.4230718299545977,4.842470890520244,0.9949167947264004,1.9467043304439409,3.2763800293142706,0.30249786734746753,0.3404366042983231,1.2632929927009808,1.9753244592729775,0.3030467691849685;
Digestion of dietary carbohydrate,0.6188386975716889,0.46978811903228695,2.612080435887825,0.39710621317627126,0.31583541384964053,0.41186476367059427,0.30249786734746753,0.35249199406325815,0.31075100083854396,0.8222033546450297,0.3058816822504121;
Signaling by BMP,0.4146405080672999,0.9846254897589394,0.43068441469191265,1.407164329759116,0.377484511377512,0.5581083835580521,0.30249786734746753,0.39014468230695576,0.47227709359950737,0.4170778848741611,0.3058816822504121;
Inositol transporters,0.6956803145143993,0.32191146796407205,0.3327614819001198,0.5043782219039552,0.3363756870848458,0.48487375011027734,0.30249786734746753,0.7441213175540436,1.2709446346905675,0.514447818538236,0.3032374359194824;
Transport of vitamins, nucleosides, and related molecules,0.46946449844294713,0.31070106152335225,0.6291296359654621,0.3503872330012344,0.330372459861341,0.4541009858801141,0.30249786734746753,0.37363972655453026,0.3174470162698381,0.3095581397528177,0.3058816822504121;
Activation of caspases through apoptosome-mediated cleavage,0.3208413612620982,0.5878606479246475,0.8797002459054192,0.3861917421038416,0.6231688405270283,0.47055855225156185,0.30249786734746753,0.37770911594983014,3.818346982569422,0.8672178481874911,0.3058816822504121;
Viral mRNA Translation,0.3914332839728542,0.438351604480435,1.5977118412502447,0.3208009770365678,0.3764809604369917,0.46829287577570267,0.30249786734746753,0.32753430183444365,0.3883724698878107,0.3811579239158923,0.3030467691849685;
L13a-mediated translational silencing of Ceruloplasmin expression,0.3119979840557615,0.5194893334998575,1.2664242412085094,0.33980610064939215,0.3073643548426107,0.7309847014592421,0.30249786734746753,0.31539388260432966,0.5487340163011186,0.5295654644999037,0.3030467691849685;
SUMOylation of SUMOylation proteins,2.1766464010048794,0.3105836898586958,1.4713618768318604,1.1578910544844385,0.33664443463132226,3.711169818455469,0.30249786734746753,0.524218023045207,0.3900183977157809,0.3173722816858016,0.3058816822504121;
Signaling by TGF-beta Receptor Complex in Cancer,0.9759808104049144,1.1481194892693714,0.7613149469443117,0.36582554472611584,0.3726312003584851,0.3260350496628621,0.30249786734746753,0.5753977044168755,0.35498837673230227,0.35947978844318385,0.3058816822504121;
Organic anion transport,0.3081642843377598,0.3661244522353381,0.3180102748962083,0.5370306927262527,0.30418705243734856,0.3321209692064086,0.30249786734746753,0.48606186013240477,0.3693665271664583,0.715327269151891,0.3058816822504121;
Presynaptic nicotinic acetylcholine receptors,0.3969035777499636,0.3029713996082115,1.1841713365801751,0.55939732041043,0.30320248709849507,0.3028133569923738,0.30249786734746753,0.3251934547032587,0.30622273051319776,0.3890263489050837,0.3058816822504121;
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,0.44766682252123474,0.5387021974648836,0.9716560298487351,0.3163292158034775,0.3302201513440906,0.3111782497541377,0.30249786734746753,0.4045210707684523,0.3329607429278685,0.41912518944327204,0.3058816822504121;
FGFRL1 modulation of FGFR1 signaling,0.34221982112063715,0.9846254897589394,1.3087269907221424,1.0907646901544714,0.32297793958928395,0.4541009858801141,0.30249786734746753,0.6612375993830337,1.016202858953107,0.4678954462589095,0.3058816822504121;
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins,6.401872385738441,1.2397120796373553,1.208844962801516,0.5051382176619013,0.7052081630476319,0.5138249529961795,0.30249786734746753,0.4467806963553069,0.48210053953606175,1.0782287355523688,0.3058816822504121;
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.32648569807719524,0.46476382621388357,3.0717146287933357,0.6332344681637802,0.3764809604369917,0.5658129824557446,0.30249786734746753,0.4628527562793292,0.33154605935666304,0.5323145474341873,0.3030467691849685;
Neurotransmitter clearance,0.4025554105549951,0.30402224815377643,2.9594726641660674,0.520633663964261,0.8460285966547827,1.5782222605191605,0.30249786734746753,0.5941411603251999,1.6615370450893527,1.4816810756480672,0.3058816822504121;
GPVI-mediated activation cascade,0.42992726818516147,0.557222577400574,0.8724582219656833,0.42329081273942404,0.3726312003584851,0.3620735944925361,0.3024683895579509,0.7013442998693656,0.423716321008238,0.31100904921848943,0.3058816822504121;
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,6.781528579055216,0.9900473145611959,0.6874299491778388,0.34049658036688124,0.9348745206097536,0.32044843640589793,0.3024683895579509,0.34311923132904953,0.4204065326622499,1.384478164121816,0.3058816822504121;
Regulation of cholesterol biosynthesis by SREBP (SREBF),0.32400304823221204,0.3659796444425064,0.33331159890704415,0.3503872330012344,0.5342874618581906,0.3420003235500663,0.3024683895579509,0.5627095985093976,0.33154605935666304,0.47469881290334454,0.3058816822504121;
Interleukin-27 signaling,0.46794058811129796,0.3554356032670192,1.1785352110260354,0.3881184602725714,0.9200438033952797,0.7878528298200614,0.3024683895579509,0.3425206096678787,0.33154605935666304,1.5702940380886865,0.3058816822504121;
CaM pathway,0.48916147950698513,0.4589854816754815,4.858868540733221,0.9593667979564253,1.4497014587581227,3.455836115267905,0.3024683895579509,0.5226955554832011,0.3234983503075021,3.0611752441228717,0.3058816822504121;
Passive transport by Aquaporins,1.3793635776940794,0.4906211694986659,0.5439930076286128,1.5852347381666423,0.3587100823402415,0.43075902825616436,0.3024683895579509,0.7157035988615835,1.1984861090736147,0.51104279764138,0.3058816822504121;
Estrogen-stimulated signaling through PRKCZ,0.9137447321525463,0.3351332739777284,1.4363500776096747,0.5879866812394244,0.30418705243734856,0.39803963701985956,0.3024683895579509,0.3015161787323837,0.34010467491250734,0.4835502797846719,0.3058816822504121;
Pyruvate metabolism and Citric Acid (TCA) cycle,0.33895461643817115,0.36250846227187006,0.4760528568967101,0.3608556579170667,0.3916174297412545,0.7244646422251708,0.3024683895579509,0.7335689821727228,0.4156689500982106,0.572602207453692,0.3058816822504121;
Transmission across Electrical Synapses ,0.51684419531862,0.301642737608084,2.1089503100865317,0.3232519888569888,0.3082126526753394,0.30896963226502344,0.3024683895579509,0.319929158053878,0.3061107917419532,0.4540611718827999,0.3058816822504121;
Metabolism of amino acids and derivatives,0.33991984304289263,0.4132837240099325,0.30734867613921363,0.3213115419718923,0.3764809604369917,0.31756868525892934,0.30220831391131003,0.5167969904376682,0.3973359698996325,0.4121680782244751,0.3058816822504121;
ERK/MAPK targets,0.4261767330323052,0.5357174180674569,0.366877559563859,0.3347311511299859,0.3082126526753394,0.4769486051022631,0.30220831391131003,0.3703701780047286,0.3065164849314509,0.4130380185288276,0.3058816822504121;
Electric Transmission Across Gap Junctions,0.5116047986203965,0.301642737608084,2.109360493775048,0.3232519888569888,0.3082126526753394,0.30896963226502344,0.30220831391131003,0.3196577017246086,0.3061107917419532,0.4540611718827999,0.3058816822504121;
MET activates RAS signaling,0.5494083030290889,0.335630131897455,0.3196134621449584,0.48853611966738064,0.41200215293113845,0.31776991236841967,0.30220831391131003,0.4160132539854251,0.3167022141326965,0.38946540392582374,0.3030467691849685;
Regulation of gene expression in early pancreatic precursor cells,0.3117629957183809,0.39346922355107966,2.109360493775048,0.3070450077802019,0.42272067676020203,0.64726610301408,0.30220831391131003,0.3663665799271314,0.4917345000954562,0.5105655863752099,0.3058816822504121;
Synthesis of PIPs at the ER membrane,0.3165446042742289,0.3846306930187274,1.7735146388341438,0.5639637347319942,0.3076326161437668,0.5646191142917181,0.30220831391131003,0.32753430183444365,0.30320189929542807,0.6343528131464561,0.3030467691849685;
